<SEC-DOCUMENT>0000355019-21-000040.txt : 20211013
<SEC-HEADER>0000355019-21-000040.hdr.sgml : 20211013
<ACCEPTANCE-DATETIME>20211012185408
ACCESSION NUMBER:		0000355019-21-000040
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20211013
DATE AS OF CHANGE:		20211012

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		211319692

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>fonar_10-k.htm
<DESCRIPTION>FONAR CORPORATION 10-K FOR YEAR ENDING JUNE 30, 2021
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:FONR="http://fonar.com/20210630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_FONR_fonar.com_20210630 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20200701_20210630 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_062_N_5_Integer -->
<body style="font: 11pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2021-06-30" id="xdx2ixbrl0071" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxReceivable" contextRef="AsOf2021-06-30" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-06-30" id="xdx2ixbrl0138" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0186" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0188" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PaymentsOnNotesReceivableFromEmployeeStockholders" contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PaymentsOnNotesReceivableFromEmployeeStockholders" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PaymentsOnNotesReceivableFromEmployeeStockholders" contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671" id="xdx2ixbrl0378" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CompensatoryElementOfStockIssuances" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0539" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfImagingCenter" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0762" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0795" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesAddedAcquisition" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0877" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0880" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2020-07-01to2021-06-30" id="xdx2ixbrl0882" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1030" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1033" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1036" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" contextRef="From2020-07-01to2021-06-30" id="xdx2ixbrl1049" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1105" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1110" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1120" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1141" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30_custom_NotePayable3Member" id="xdx2ixbrl1270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2020-06-30_custom_NotePayable3Member" id="xdx2ixbrl1272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1371" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2020-06-30" id="xdx2ixbrl1448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1538" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="xdx2ixbrl1596" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1598" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember" id="xdx2ixbrl1721" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember" id="xdx2ixbrl1731" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="xdx2ixbrl1739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1745" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1747" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="xdx2ixbrl1778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2019-06-30_custom_MedicalReceivablesMember" id="xdx2ixbrl1782" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2019-07-012020-06-30_custom_MedicalReceivablesMember" id="xdx2ixbrl1786" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20210630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2020-07-01to2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-15_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-15_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-15_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-15_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember550836687">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember550836687">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_HDMMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_DiagnosticImagingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_ClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_ClassAMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-012013-02-13_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-01</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:OutsideInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-01</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-03-05_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-08_custom_ClassAMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012028-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2028-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_EmployeeStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ABillingCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:ABillingCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_BensonhurstMRILimitedPartnershipMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:CovenantNotToCompeteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_MedicalReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:MedicalReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_MedicalReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:MedicalReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_MedicalReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:MedicalReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012021-08-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="N">
      <xbrli:measure>FONR:Integer</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001046" toRefs="Footnote001051"></ix:relationship>
  <ix:relationship fromRefs="Fact001047" toRefs="Footnote001051"></ix:relationship>
  <ix:relationship fromRefs="Fact001536" toRefs="Footnote001613"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1538" toRefs="Footnote001613"></ix:relationship>
  <ix:relationship fromRefs="Fact001540" toRefs="Footnote001613"></ix:relationship>
  <ix:relationship fromRefs="Fact001578" toRefs="Footnote001613"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1580" toRefs="Footnote001613"></ix:relationship>
  <ix:relationship fromRefs="Fact001582" toRefs="Footnote001613"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1721" toRefs="Footnote001789"></ix:relationship>
  <ix:relationship fromRefs="Fact001729" toRefs="Footnote001789"></ix:relationship>
  <ix:relationship fromRefs="Fact001737" toRefs="Footnote001789"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1745" toRefs="Footnote001789"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 11pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: center; text-indent: 0"><span style="font: 14pt Arial, Helvetica, Sans-Serif">SECURITIES
AND EXCHANGE COMMISSION</span></td>
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: right; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: right; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: center"><span style="font: 12pt Arial, Helvetica, Sans-Serif">WASHINGTON,
D.C. 20549</span></td>
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: right; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: right; text-indent: 0">&#160;</td>
<td style="border-bottom: windowtext 1pt solid; font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: center">&#160;</td>
<td style="font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; text-align: right; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 25%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: windowtext 1pt solid; font: 11pt/115% Arial, Helvetica, Sans-Serif; padding: 0; width: 50%; text-align: center; text-indent: 0"><span style="font: 18pt Arial, Helvetica, Sans-Serif"><b>FORM
<span id="xdx_900_edei--DocumentType_c20200701__20210630_zGe2Iea1nQV8"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></td>
<td style="padding: 0; width: 25%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_90E_edei--DocumentAnnualReport_c20200701__20210630_zOcftSoKAqYf"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>For
the fiscal year ended</b> <b><span id="xdx_907_edei--DocumentPeriodEndDate_c20200701__20210630_z4QMvfUvNo45"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_901_edei--CurrentFiscalYearEndDate_c20200701__20210630_zY34NAe34IKc"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, 2021</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">OR</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_90B_edei--DocumentTransitionReport_c20200701__20210630_zS34E46zdLJ8"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>&#160;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND</span> EXCHANGE ACT OF 1934</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">For the transition period from _____________
to _____________</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Commission File No. <span id="xdx_90F_edei--EntityFileNumber_c20200701__20210630_zn3hMXkKWAa8"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><img src="fonar-logo.jpg" alt="" style="height: 38px; width: 250px" />&#160;</span><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="vertical-align: top; width: 6%; line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 88%; text-align: center; line-height: 115%"><span style="font: 24pt Arial, Helvetica, Sans-Serif"><b><span id="xdx_90C_edei--EntityRegistrantName_c20200701__20210630_z8bqRGQ2qMO4"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></b></span></td>
<td style="vertical-align: top; width: 6%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="line-height: 115%">&#160;</td>
<td style="text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;(Exact name of registrant as specified in its charter)</span></td>
<td style="line-height: 115%">&#160;</td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20200701__20210630_zisbBI2R13Oc" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td>
<td style="line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20200701__20210630_zGAo2dR6Z8ml"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td>
<td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="line-height: 115%">&#160;</td>
<td style="text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(State of incorporation)</span></td>
<td style="line-height: 115%">&#160;</td>
<td style="text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(IRS Employer Identification Number)</span></td>
<td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="line-height: 115%">&#160;</td>
<td style="line-height: 115%">&#160;</td>
<td style="line-height: 115%">&#160;</td>
<td style="line-height: 115%">&#160;</td>
<td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="width: 6%; line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 44%; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20200701__20210630_zF9th0gR2jLf"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20200701__20210630_z7WHknYjoRj1"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20200701__20210630_zwIsN9gjeH54"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
<td style="width: 3%; line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; width: 41%; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_edei--EntityAddressPostalZipCode_c20200701__20210630_zwex9QOuEf1c"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td>
<td style="width: 6%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="line-height: 115%">&#160;</td>
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(Address of principal executive offices)</span></td>
<td style="line-height: 115%">&#160;</td>
<td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(Zip Code)</span></td>
<td style="line-height: 115%">&#160;</td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="vertical-align: top; width: 20%; line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 60%; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_edei--CityAreaCode_c20200701__20210630_z9ETxSgKuC19"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_90E_edei--LocalPhoneNumber_c20200701__20210630_zszo1djTLqJf"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></td>
<td style="vertical-align: top; width: 20%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="line-height: 115%">&#160;</td>
<td style="text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;(Registrant&#8217;s telephone number, including area code) </span></td>
<td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="line-height: 115%">&#160;</td>
<td style="line-height: 115%">&#160;</td>
<td style="line-height: 115%">&#160;</td></tr>
<tr>
<td style="vertical-align: top; line-height: 115%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Securities registered pursuant to Section 12(b) of the Act:</span></td>
<td style="vertical-align: top; line-height: 115%">&#160;</td></tr>
<tr>
<td style="vertical-align: top; line-height: 115%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Common Stock, par value $.0001 per share</span></td>
<td style="vertical-align: top; line-height: 115%">&#160;</td></tr>
<tr>
<td style="vertical-align: top; line-height: 115%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
<td style="vertical-align: top; line-height: 115%">&#160;</td></tr>
<tr>
<td style="vertical-align: top; line-height: 115%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Securities registered pursuant to Section 12(g) of the Act:</span></td>
<td style="vertical-align: top; line-height: 115%">&#160;</td></tr>
<tr>
<td style="border-bottom: black 1pt solid; vertical-align: top; line-height: 115%">&#160;</td>
<td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">None</span></td>
<td style="border-bottom: black 1pt solid; vertical-align: top; line-height: 115%">&#160;</td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Indica<span style="font-family: Arial, Helvetica, Sans-Serif">te
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744;&#160;<span id="xdx_901_edei--EntityWellKnownSeasonedIssuer_c20200701__20210630_zTUZ9dNodbCh"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
&#9746; .</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744;&#160;<span id="xdx_904_edei--EntityVoluntaryFilers_c20200701__20210630_zclxdTwbAh2k"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
&#9746; .</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90F_edei--EntityCurrentReportingStatus_c20200701__20210630_zIJWIVk2b198"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span></span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span style="font-size: 11pt">&#9746;
No &#9744; .</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during
the preceding 12 months (or for su<span style="font-family: Arial, Helvetica, Sans-Serif">ch
shorter period that the registrant was required to submit and post such files). <span id="xdx_909_edei--EntityInteractiveDataCurrent_c20200701__20210630_zTPzRhL1Ice9"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;&#9746; No &#9744;</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;<span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark if disclosure of delinquent filers, pursuant to Item 405 of Regulation S-K, &#167;229.405 of this Chapter, is not
contained, and will not be contained, to the best of the registrant&#8217;s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this 10-K or any amendment to the Form 10-K. &#9746;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer and &#8220;smaller reporting
company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 33%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Large accelerated filer&#160;&#9744;</span></td>
  <td style="width: 34%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Accelerated filer&#160;&#160;&#9744;</span></td>
  <td style="width: 33%"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_edei--EntityFilerCategory_c20200701__20210630_zjNLFbgXh199"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span>&#160;&#160;&#9746;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font: 11pt Arial, Helvetica, Sans-Serif">Smaller reporting company&#160;&#160;<span id="xdx_90A_edei--EntitySmallBusiness_c20200701__20210630_zIJnV4vFwlE4"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td>
  <td><span style="font: 11pt Arial, Helvetica, Sans-Serif">Emerging Growth Company&#160;&#160;<span id="xdx_908_edei--EntityEmergingGrowthCompany_c20200701__20210630_ztHabCrgT994"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
  <td><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;&#9744; <span id="xdx_902_edei--EntityShellCompany_c20200701__20210630_zRbBVYecx9K5"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;&#160;.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
aggregate market value of the shares of Common Stock held by non-affiliates as of December 31, 2020 based on the closing price
of $17.36 per share on such date as reported on the NASDAQ System, was approximately $<span id="xdx_903_edei--EntityPublicFloat_iI_pp0n3_dm_c20201231_z1LA8SComGw3" title="Entity Public Float"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">110</ix:nonFraction></span> million. The other outstanding classes
do not have a readily determinable market value.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">As
of September 15, 2021, <span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_c20210915__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zJsfa8P5xEi9" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-09-15_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span> shares of Common Stock, <span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_c20210915__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7prQhginXbi" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-09-15_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction> </span>shares of Class B Common Stock, <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20210915__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zjbLRIK77Nge" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-09-15_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span> shares of Class C Common
Stock and <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20210915__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zSFD38xXmqQ2" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-09-15_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span> shares of Class A Non-voting Preferred Stock of the registrant were outstanding.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">DOCUMENTS INCORPORATED BY REFERENCE</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; width: 12%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; width: 2%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; width: 10%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; width: 1%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="border-bottom: windowtext 1pt solid; padding: 0; vertical-align: bottom; width: 66%; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">FORM
10-K ITEMS</span></td>
<td style="padding: 0; vertical-align: bottom; width: 1%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="border-bottom: windowtext 1pt solid; padding: 0; vertical-align: top; width: 8%; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">PAGE</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">PART
I</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
1.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_001">Business</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">4</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
1A.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_002">Risk Factors</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">30</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
1B.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_003">Unresolved Staff Comments</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">33</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
2.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_004">Properties</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">33</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
3.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_005">Legal Proceedings</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">33</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
4.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_006">Mine Safety Disclosures</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">34</span></td></tr>
<tr style="font-size: 11pt; text-align: left; vertical-align: top">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">PART
II</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
5.</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_010">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters</a></span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">34</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
6.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_011">Selected Financial Data</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">35</span></td></tr>
<tr style="font-size: 11pt; text-align: left; vertical-align: top">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
7.</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_012">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">36</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
8.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#c_001">Financial Statements</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0">47</td></tr>
<tr style="font-size: 11pt; text-align: left; vertical-align: top">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
9.</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_013">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">90</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
9A.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_014">Controls and Procedures</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">90</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
9B.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_015">Other Information</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">91</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">PART
III</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
10.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_016">Directors and Executive Officers</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">91</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
11.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_017">Executive Compensation</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">95</span></td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
12.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_018">Security Ownership of Certain Beneficial Owners and Management</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">98</span></td></tr>
<tr style="font-size: 11pt; text-align: left; vertical-align: top">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
13.</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_019">Certain Relationships and Related Transactions, and Director Independence</a></span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-align: center">100</td></tr>
<tr style="background-color: white; font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
14.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_020">Principal Accountant Fees and Services</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">101</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">PART
IV</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">Item
15.</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial"><a href="#b_021">Exhibits</a></span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt arial">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">102</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PART I</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_001"></span>ITEM 1. BUSINESS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">GENERAL</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar Corporation, sometimes referred
to as the &#8220;Company&#8221; or &#8220;Fonar&#8221;, is a Delaware corporation which was incorporated on July 17, 1978. Our address
is 110 Marcus Drive, Melville, New York 11747 and our telephone number is 631-694-2929. Fonar also maintains a website at www.fonar.com.
Fonar provides copies of its filings with the Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K and amendments to
these reports to stockholders on request.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We conduct our business in two segments.
Our medical equipment segment is conducted directly through Fonar. Our physician management and diagnostic services segment is
conducted through our subsidiary Health Diagnostic Management, LLC (&#8220;HMCA&#8221;), also called Health Management Company of
America. HMCA provides management services, administrative services, billing and collection services, credentialing services, contract
negotiations, compliance consulting, purchasing, IT services, hiring, conducting interviews and managing personnel, storage of
medical records, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical
providers engaged in diagnostic imaging. In addition to acting as a management company, HMCA owns and operates four diagnostic
imaging facilities in Florida, where the corporate practice of medicine is permitted.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We restructured the corporate organization
of our physician and diagnostic services management segment of our business effective July 1, 2015. Imperial Management Services,
LLC (&#8220;Imperial&#8221;), a subsidiary which owned the assets used in the business of its parent, Health Management Corporation
of America (which is wholly-owned by Fonar), transferred those assets to Health Diagnostics Management, LLC (&#8220;HDM&#8221;),
which is another subsidiary of Health Management Corporation of America. As a result, going forward our physician and diagnostic
management business will be conducted entirely through HDM, which is operating under the assumed name Health Management Company
of America.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar is engaged in the business of designing,
manufacturing, selling and servicing magnetic resonance imaging scanners, also referred to as &#8220;MRI&#8221; or &#8220;MR&#8221;
scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions
and injuries. Fonar&#8217;s founders built the first MRI scanner in 1977 and Fonar introduced the first commercial MRI scanner in 1980.
Fonar is also the originator of the iron-core non-superconductive and permanent magnet MRI technology.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s iron frame technology made Fonar
the originator of &#8220;open&#8221; MRI scanners. We introduced the first &#8220;open&#8221; MRI in 1980. Since that time we have
concentrated on further application of our &#8220;open&#8221; MRI, introducing most recently the Upright&#174; Multi-Position&#8482;&#8221;
MRI scanner (also referred to as the &#8220;Upright&#174;&#8221; or &#8220;Stand-Up&#174;&#8221; MRI scanner) and the Fonar 360&#8482;
MRI scanner. The Fonar 360&#8482; MRI is not presently being marketed.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 17 to the Consolidated Financial
Statements for separate financial information regarding our medical equipment and physician and diagnostic management services
segments.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FORWARD LOOKING STATEMENTS.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain statements made in this Annual
Report on Form 10-K are &#8220;forward-looking statements&#8221;, within the meaning of the Private Securities Litigation Reform
Act of 1995, regarding the plans and objectives of Management for future operations. Such statements involve known and unknown
risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking
statements are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based,
in part, on assumptions involving the expansion of business. These assumptions involve judgments with respect to, among other things,
future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking statements
are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this Annual Report will prove to be accurate. In light of the significant uncertainties inherent in our
forward-looking statements, the inclusion of such information should not be regarded as a representation by us or any other person
that our objectives and plans will be achieved.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Among the risks and assumptions which
must now be taken into account is the COVID-19 virus, which adds additional uncertainties to future expectations. Although the
impact will be negative, the severity, duration and recurrence of new strains of the COVID-19 virus such as the Delta variant adds
a new dimension to the difficulties facing our business and the world economy in general.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">THE UPRIGHT&#174; MRI SCANNER</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI scanner is the product
we are presently promoting. The Upright&#174; MRI (also known as the &#8220;Stand-Up&#174; MRI&#8221;) is a &#8220;whole-body&#8221;
MRI, meaning it can be used to scan any part of the body. Unlike conventional recumbent MRI scanners, where the patient must lie
on his or her back, the Upright&#174; MRI permits MRI scans to be taken in a weight-bearing state. Patients can be scanned while
standing, sitting, bending or lying down. This means that an abnormality or injury, such as a slipped disk, may be scanned in a
weight-bearing posture, which more often than not is the position in which patients experience pain. An adjustable bed allows patients
to stand, sit or lie on their backs, sides or stomachs. The Upright&#174; MRI is by design a non-claustrophobic MRI scanner. We
have introduced the name &#8220;Upright&#174;&#8221; as an alternative to &#8220;Stand-Up&#174;&#8221; because of the multiplicity of
positions in which the patient may be scanned where the patient is not standing.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of June 30, 2021, HMCA manages a total
of 39 MRI scanners. Twenty-five (25) MRI scanners are located in New York and fourteen (14) which are located in Florida. We believe
that the utilization of Fonar UPRIGHT&#174; MRI scanning systems has been a significant factor in maintaining the patient volume
of the scanning facilities and our ability to cope with the effects of the COVID-19 pandemic. In addition, a new facility managed
by the Company has been opened in Pembroke Pines, Florida and a total of four additional MRI scanners were added in New York.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">MEDICAL EQUIPMENT SEGMENT</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PRODUCTS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fonar Upright&#174; MRI is a weight-bearing
whole-body open MRI system which enables positional MRI (pMRI&#174;) applications. Operating at a magnetic field strength of 0.6
Tesla, the scanner is a powerful, diagnostically versatile and cost-effective open MRI that provides a broad range of clinical
capabilities and a complete set of imaging protocols. Patients can be scanned standing, bending, sitting, upright at an intermediate
angle and in the conventional recumbent position. This multi-positional MRI system accommodates an unrestricted range of motion
for flexion, extension, lateral bending, and rotation studies of the cervical (upper) and lumbar (lower) spine. Previously difficult
patient scanning positions can be achieved and compared using the system&#8217;s MRI-compatible, three-dimensional, motorized patient
handling system. The system&#8217;s lift and tilt functions deliver the targeted anatomical region to the center of the magnet. True
image orientation is assured, regardless of the rotation angle, via computer read-back of the table&#8217;s position.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There is considerable evidence that the
weight-bearing Upright&#174; MRI provides medical benefits not duplicated by any other MRI scanner because patient positioning plays
a critical role in accurately detecting clinically significant pathology.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For instance, the Fonar Upright&#174;
technology has demonstrated its key value on patients with the Arnold-Chiari Syndrome, which is believed to affect 200,000 to 500,000
Americans. In this syndrome, brain stem compression and subsequent severe neurological symptoms occur in these patients, when because
of weakness in the support tissues within the skull, the brain stem descends and is compressed and entrapped at the base of the
skull in the foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the skull.
The brain structures &#8220;entrapped&#8221; in Chiari Syndrome are the lowest lying structures of the brain, the tonsils of the
cerebellum. The Chiari Syndrome is therefore alternately named Cerebellar Tonsillar Ectopia (CTE) indicating the displacement (ectopia)
of these Cerebellar tonsils in this syndrome. Classic symptoms of the Chiari Syndrome include the &#8220;drop attack,&#8221; where
the patient unexpectedly experiences an explosive rush at the base of the brain which runs down the body to the extremities, causing
the patient to collapse in a temporary neuromuscular paralysis. These symptoms subside when the patient is lying down. Conventional
lie-down MRI scanners cannot make an adequate evaluation of the pathology since the patient&#8217;s pathology is most visible and the
symptoms are most acute when the patient is scanned in the upright weight-bearing position.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A publication in the Journal &#8220;Brain
Injury&#8221; (Brain Injury 2010, 24 (7-8) 988-994) of 1,200 neck pain patients reported that the fallen cerebellar tonsils of the
brain (CTE) were missed 75% of the time when the patient was scanned only in the recumbent position. It is critical to have an
image of the patient in an upright position so that the neurosurgeons can fully evaluate the brain stem and choose the most appropriate
surgical approach for an operative repair.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The study was published by 10 authors
from distinguished universities in the United States and around the world. The study reported that Cerebellar Tonsillar Ectopia
Herniation (CTE) was missed 75% of the time when the patient was scanned lying down instead of upright. At the current rate of
1,000,000 automobile whiplash injuries in the U.S. per year, 750,000 patients each year would have the pathology responsible for
their symptoms go undetected if they were examined solely in a conventional recumbent-only MRI.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI has also demonstrated
its value for patients suffering from scoliosis. Scoliosis patients typically have been subjected to routine x-ray exams for years
and must be imaged upright for an adequate evaluation of their scoliosis. Because the patient must be standing for the exam, an
x-ray machine has been the only modality that could provide that service. The Upright&#174; MRI is the only MRI scanner that allows
the patient to stand during the MRI exam. Fonar has developed a new RF receiver and scanning protocol that for the first time allows
scoliosis patients to obtain diagnostic pictures of their spines without the risks of x-rays. A study by the National Cancer Institute
(2000) of 5,466 women with scoliosis reported a 70% increase in breast cancer resulting from 24.7 chest x-rays these patients received
on average in the course of their scoliosis treatment.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other important new applications are
Upright&#174; imaging of the pelvic floor and abdomen to image prolapses and inguinal hernias. Fonar has also developed the first
non-invasive method to image the prostate: the patient simply sits on a flat, seat-like coil.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI is also the world&#8217;s
most non-claustrophobic whole-body MRI scanner. Frequently, patients can simply walk into the magnet, stand or sit for their scans
and then walk out. The magnet&#8217;s front-open and top-open design provides an unprecedented degree of comfort because there is nothing
in front of the patient&#8217;s face except a large (42&#8221;) flat-screen TV that is mounted on the wall. The default position for the
bed is a tilt back of six degrees that minimizes patient motion. Special RF receiver coil fixtures, a patient seat, Velcro straps,
and transpolar stabilizing bars are also used to keep the patient comfortable and motionless throughout the scanning process.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Full-range-of-motion studies of the joints
in multiple directions are possible, an especially useful feature for sports injuries. Full range of motion cines, or movies, of
the lumbar spine can also be achieved under full body weight.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fonar Upright&#174; MRI operates at
a significantly higher magnetic field strength than earlier open MRIs that preceded it, and, therefore, benefits from more of the
MRI image-producing signal needed to make high-quality MRI images.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar maximizes image quality through
an optimal combination of image signal to noise (S/N) and contrast-to noise (C/N) ratios. Technical improvements incorporated into
the scanner design include increased image processing speed, high-S/N Organ Specific(TM) RF receiver coils, high performance front-end
electronics featuring high-speed, wide-dynamic-range analog-to-digital conversion and a miniaturized ultra-low-noise pre-amplifier,
high-speed automatic tuning, bandwidth-optimized pulse sequences, multi-bandwidth sequences, and off-center FOV imaging capability.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to the signal-to-noise ratio,
however, a major determinant of image quality that must be considered is contrast, the quality that enables reading physicians
to clearly distinguish adjacent, and sometimes minute, anatomical structures from their surroundings. This quality is measured
by contrast-to-noise ratios (C/N). Unlike S/N, which increases with increasing field strength, relaxometry studies have shown that
C/N peaks in the mid-field range and actually falls off precipitously at higher field strengths. The Upright&#174; MRI scanners
operate squarely in the optimum C/N range.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR&#8217;s scanners are equipped with a
variety of software features which enhance versatility and diagnostic capability. For example, SMART&#8482; scanning allows for
same-scan customization of multi-slice scans, each slice with its own thickness, resolution, angle and position. This is an important
feature for scanning parts of the body that include small-structure sub-regions requiring finer slice parameters. There is also
Multi-Angle Oblique&#8482; (MAO) imaging, and oblique imaging.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During fiscal 2021, sales of our Upright&#174;
MRI scanners accounted for approximately 0.8% of our total revenues and 10.0% of our medical equipment revenues, as compared to
0.1% of total revenues and 1.0% of medical equipment revenues in fiscal 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR&#8217;s principal marketing efforts with
respect to its products have been focused on the Upright&#174; MRI, which we believe is a particularly unique product. It is the
only MRI scanner which is both open and allows for weight-bearing imaging. We expect to continue our focus on the Upright&#174;
MRI in the immediate future.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The materials and components used in
the manufacture of our products (circuit boards, computer hardware components, electrical components, steel and plastic) are generally
available at competitive prices. We have not had difficulty acquiring such materials.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PRODUCT MARKETING</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The principal markets for the Company&#8217;s
scanners are private diagnostic imaging centers and hospitals.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We use internal personnel and independent
manufacturer&#8217;s representatives for domestic and foreign markets. None of Fonar&#8217;s competitors are entitled or been licensed to make
the Fonar Upright&#174; MRI scanner.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s Website includes interactive
product information for interested customers.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During fiscal 2021 and previously sales
were made to foreign customers. CEO Matthias Schulz of Medserena, Fonar&#8217;s principal foreign sales representative and distributor,
has said, &#8220;The large number of requests coming from our physicians in Germany are arising because of the special medical need
for FONAR&#8217;s unique technology. This is in spite of an intensely active MRI market in Germany, where there are already many conventional
lie-down MRIs installed.&#8221;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s marketing strategy has been designed
to reach key purchasing decision makers with information concerning the Upright&#174; MRI. This has led to many inquiries and to
some sales of the Upright&#174; MRI scanner and is intended to increase Fonar&#8217;s presence in the medical market. Fonar focuses on
four target audiences: neurosurgeons, orthopaedic surgeons, radiologists and physicians in general.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt">
<tr style="vertical-align: top; text-align: justify">
<td style="padding: 0; width: 50pt; text-align: right; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">1)</span></td>
<td style="padding: 0; width: 4pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Neurosurgeons
and Orthopaedic Surgeons: These are the surgeons who can most benefit from the superior diagnostic benefits of the Fonar Upright&#174;
MRI with its Multi-Position&#174; MRI diagnostic ability.</span></td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="padding: 0; text-align: right; text-indent: 0">&#160;</td>
<td style="padding: 0; text-indent: 0">&#160;</td>
<td style="padding: 0; text-align: justify; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">2)</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Radiologists:
These physicians can now offer a new Multi-Position&#174;, weight-bearing MRI modality to their referring physicians.</span></td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="padding: 0; text-align: right; text-indent: 0">&#160;</td>
<td style="padding: 0; text-indent: 0">&#160;</td>
<td style="padding: 0; text-align: justify; text-indent: 0">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="padding: 0; text-align: right; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">3)</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">All Physicians:
The vast number of doctors who send patients for MRI&#8217;s need to be aware of the diagnostic advantages of the Fonar Upright&#174;
Multi-Position&#8482;.</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our advertising for Fonar and HMCA re-enforces
the unique value provided by Fonar MRI scanners. We have increased internet awareness of our product by driving patient traffic
to the Upright&#174; scanning centers we manage via the Fonar website (www.fonar.com) as well as by creating Websites for each HMCA
location. These websites give prospective customers of Upright&#174; MRI scanners a view of operating Upright&#174; MRI centers and
highlight the benefits of using an Upright&#174; MRI scanner. A complete list of the sites managed by HMCA can be found at HMCA&#8217;s
website, hmca.com.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our marketing efforts, however, have
been compromised by the COVID-19 panademic and economic challenges felt worldwide as a result.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">SERVICE AND UPGRADES FOR MRI SCANNERS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our customer base of installed scanners
has been and will continue to be an additional source of income, independent of direct sales.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Income is generated from the installed
base in two principal areas, namely, service and upgrades. Service and maintenance revenues from our external installed base were
approximately $7.7 million in fiscal 2021 and $8.2 million in fiscal 2020. Our objective is to maintain service revenues at present
levels or better, based on the longevity of the technology, and the refurbishments and upgrades which keep the scanners competitive
with the latest techniques.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We also anticipate that our scanners
will result in upgrades income in future fiscal years. The potential for upgrades income, originates in the versatility and productivity
of the Upright&#174; Imaging technology. New medical uses for MRI technology are constantly being discovered and are anticipated
for the Upright&#174; Imaging technology as well. New features can often be added to the scanner by the implementation of little
more than versatile new software packages, which when coupled with hardware upgrades can add years of useful life to the scanner.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">RESEARCH AND DEVELOPMENT</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the fiscal year ended June 30,
2021, we incurred expenditures of $1,635,979, none of which were capitalized, on research and development, as compared to $2,025,376,
none of which were capitalized, during the fiscal year ended June 30, 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development activities have
focused principally on software improvements to the user interface of the MRI scanner. The Windows-based Sympulse&#8482; platform
controls all of the functions of the Upright&#174; scanner except those of the versatile, multi-position patient table. Separate,
dedicated, motion-control software is used to maneuver the Upright&#174; bed, and development of this software is ongoing as well.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">While software improvements to the user
interface are important in their own right, significant value is added to the MRI scanner by the modification of existing protocols
for examining various parts of the body, and the development of new protocols that utilize new underlying capabilities of the pulse
sequence software. Over time, FONAR users have become accustomed to the steady improvement in the recommended clinical protocols
that accompany new software releases. More significantly, in recent years we have seen increasing adoption of FONAR-recommended
clinical protocols over those developed on site. This is a testament to the superior image quality they produce in attractively
short scan times.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The development of clinically practical
scan protocols and software depends on close contact between research and development scientists and engineers, and end users.
That close contact is facilitated in part by the relationship with HMCA and the scanning centers. In addition to that collaboration,
R&amp;D staff have pursued a variety of novel and Upright&#174; MRI-specific research projects. It is anticipated that these will
ultimately lead to new applications that are made available to existing customers as upgrade add-ons to their machines. For example,
phase-contrast imaging techniques originally developed for angiography have recently been applied to cerebro-spinal fluid (CSF)
flow. Analysis of CSF flow in upright and recumbent postures may prove to be of significant value in the evaluation of a variety
of disorders.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">BACKLOG</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our backlog of unfilled orders at September
15, 2021 was approximately $62,000, as compared to $457,000 at September 15, 2020. It is expected that the existing backlog of
orders will be filled within the 2022 fiscal year.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PATENTS AND LICENSE</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We currently have numerous patents in
effect which relate to the technology and components of our MRI scanners. We believe that these patents, and the know-how we have
developed, are material to our business.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">One of our patents, issued in the name
of Dr. Damadian and licensed to Fonar, was United States patent No. 3,789,832, Apparatus and Method for Detecting Cancer in Tissue,
also referred to in this report as the &#8220;1974 Patent&#8221;. The 1974 Patent was the first MRI patent issued by the United States
Patent Office. The development of our MRI scanners has been based upon the 1974 Patent, and we believe that the 1974 Patent was
the first of its kind to utilize MR to scan the human body and to detect cancer. The 1974 Patent was extended beyond its original
17-year term and expired in February, 1992.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have significantly enhanced our patent
position within the industry and now possess a substantial patent portfolio which provides us, under the aegis of United States
patent law, &#8220;the exclusive right to make, use and sell&#8221; many of the scanner features which Fonar pioneered and which
are now incorporated in most MRI scanners sold by the industry. As of June 30, 2021, 220 patents had been issued to Fonar, and
approximately 11 patents were pending. A number of Fonar&#8217;s existing patents specifically relate to protecting Fonar&#8217;s position
in the Upright MRI market. The patents further enhance Dr. Damadian&#8217;s pioneer patent, the 1974 Patent, that initiated the MRI industry
and provided the original invention of MRI scanning. The terms of the patents in Fonar&#8217;s portfolio extend to various times.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We also have patent cross-licensing agreements
with other MRI manufacturers. We have not licensed, however, any technology relating to Upright&#174; MRI scanning.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PRODUCT COMPETITION</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">MRI SCANNERS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">MRI takes advantage of the nuclear magnetic
resonance signal elicited from the body&#8217;s tissues and the exceptional sensitivity of this signal for detecting disease discovered
by Fonar. Much of the serious disease of the body occurs in the soft tissue of vital organs. The maximum contrast available by
x-ray with which to discriminate disease is 4%. Brain cancers differ from surrounding healthy brain by only 1.6% while the contrast
in the brain by MRI is 25 times greater at 40%. X-ray contrasts among the body&#8217;s soft tissues are maximally 4%. Their contrast
by MRI is 32.5 times greater (130%).</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The soft tissue contrasts with which
to distinguish cancers on images by MRI are up to 180%. In the case of cancer these contrasts can be even more marked making cancers
readily visible and detectable anywhere in the body. This is because the nuclear resonance signals from the body&#8217;s normal soft
tissue vital organs, differ so dramatically from each other (e.g. small intestine 257 milliseconds, brain 595 milliseconds). Liver
cancer and healthy liver signals differ by 180% for example.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A majority of the MRI scanners in use
in hospitals and outpatient facilities and at mobile sites in the United States are based on high field (1.5 - 3.0 Tesla) air core
superconducting magnet technology.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Open MRIs manufactured by Fonar&#8217;s competitors,
are recumbent-only machines based on Fonar&#8217;s original iron-frame vertical magnetic field magnet design. These systems have been
manufactured and sold by many of our largest competitors over the years. They generally operate at low field strengths (0.2 - 0.35
Tesla). Their prevalence in the marketplace has led to the perception in the medical community that Open MRIs are useful only for
anxious and claustrophobic patients, that the Open MRI&#8217;s image quality is poor, and that the scan times are long. Recently our
competitors have introduced higher field strength Open MRI products (0.5 &#8211; 1.2 Tesla). Significantly better imaging performance
(especially at 1.2 T) compared to the low field strength systems, is beginning to change that perception. However, Fonar continues
to maintain its competitive advantage at 0.6 Tesla due to our front-open non-claustrophobic configuration in which there is nothing
in front of the patient&#8217;s face, and our unique ability to scan patients in weight-bearing positions. It is also noteworthy that
our horizontal transaxial magnetic field allows the Upright MRI, in contrast to the recumbent-only Open MRIs, to use the same flat
planar-style radiofrequency receiver coil as the high-field MRI systems to image the lumbar and thoracic spine.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright MRI uses the same configuration
RF receiver coil as a high-field MRI system to image the spine other Open MRIs cannot do this. (This is because of the rule in
MRI that the axis of symmetry of the RF receiver coil should be perpendicular to the direction of the main magnetic field). The
upright patient sits comfortably with his back against a flat (&#8220;planar&#8221;) RF receiver coil in our horizontal transaxial
magnetic field. In contrast, the vertical magnetic field in the recumbent-only Open MRI precludes the use of this type of receiver
coil.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Relative to the high-field systems, the
Upright MRI has two major competitive advantages:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Sometimes patient positioning is more
consequential than a small increase in the image resolution and decrease in the scan time. As it is critical for physicians to
not &#8220;miss&#8221; anything in the images, they recognize that the position-dependent pathology visualized with the Upright MRI
will be invisible (&#8220;missed&#8221;) if their patients are scanned at a higher field strength.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Image artifacts arising from metal implants
such as surgical screws are diminished with the 0.6 Tesla Upright MRI compared to those from the high-field MRIs. It is well known
that such artifacts get smaller as the MRI magnet&#8217;s field strength is reduced, so the anatomy adjacent to implanted hardware will
be less obscured with the Upright MRI. This is particularly valuable for surgeons referring their postoperative patients for diagnostic
imaging studies.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar faces competition within the MRI
industry from such firms as General Electric Company, Philips N.V., Toshiba Corporation, Hitachi Corporation and Siemens A.G. Most
competitors have marketing and financial resources more substantial than those available to us. They have in the past, and may
in the future, heavily discount the sales price of their scanners. Such competitors sell both high field air core superconducting
MRI scanners and iron frame products. Fonar&#8217;s original iron frame design, ultimately imitated by Fonar&#8217;s competitors to duplicate
Fonar&#8217;s origination of &#8220;Open&#8221; MRI magnets, gave rise to current patent protected Upright&#174; MRI technology with the
result that Fonar today is the unique and only supplier of the highest field MRI magnets (0.6 Tesla) that are not superconducting,
do not use liquid helium and are not therefore susceptible to severe consequences and downtime cause by a system quench.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The iron frame, because it controls the
magnetic lines of force and places them where wanted and removes them from where not wanted, provides a more versatile magnet design
than is possible with air core magnets. Air core magnets contain no iron but consist entirely of turns of current carrying wire.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar expects to be the leader in weight-bearing
and positional MRI for providing dynamic visualization of body parts including the spine and extremities.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">OTHER IMAGING MODALITIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s MRI scanners also compete with
other diagnostic imaging systems, all of which are based upon the ability of energy waves to penetrate human tissue and to be detected
by either photographic film or electronic devices for presentation of an image on a display monitor. Three different kinds of energy
waves - X-ray, gamma and sound - are used in medical imaging techniques which compete with MRI medical scanning, the first two
of which involve exposing the patient to potentially harmful radiation. These other imaging modalities compete with MRI products
on the basis of specific applications.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">X-rays are the most common energy source
used in imaging the body and are employed in three imaging modalities:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 24px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">1.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Conventional X-ray systems, the oldest method of imaging, are typically used to image bones and teeth. The image resolution of adjacent structures that have high contrast, such as bone adjacent to soft tissue, is excellent, while the discrimination between soft tissue organs is poor because of the nearly equivalent penetration of x-rays.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 24px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">2.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Computerized Tomography, also referred to as &#8220;CT&#8221;, systems couple computers to x-ray instruments to produce cross-sectional images of particular large organs or areas of the body. The CT scanner addresses the need for images, not available by conventional radiography, that display anatomic relationships spatially. However, CT images are generally limited to the transverse plane and cannot readily be obtained in the two other planes, sagittal and coronal. Improved picture resolution is available at the expense of increased exposure to x-rays from multiple projections. Furthermore, the pictures obtained by this method are computer reconstructions of a series of projections and, once diseased tissue has been detected, CT scanning cannot be focused for more detailed pictorial analysis or obtain a chemical analysis.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 24px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">3.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Digital radiography systems add computer image processing capability to conventional x-ray systems. Digital radiography can be used in a number of diagnostic procedures which provide continuous imaging of a particular area with enhanced image quality and reduced patient exposure to radiation.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 24px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">4.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Nuclear medicine systems, which are based upon the detection of gamma radiation generated by radioactive pharmaceuticals introduced into the body, are used to provide information concerning soft tissue and internal body organs and particularly to examine organ function over time.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 24px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">5.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Ultrasound systems emit, detect and process high frequency sound waves reflected from organ boundaries and tissue interfaces to generate images of soft tissue and internal body organs. Although the images are substantially less detailed than those obtainable with x-ray methods, ultrasound is generally considered harmless and therefore has found particular use in imaging the pregnant uterus.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">X-ray machines, ultrasound machines,
digital radiography systems and nuclear medicine compete with the MRI scanners by offering significantly lower price and space
requirements. However, Fonar believes that the utility of the images produced by its MRI scanners is generally superior to the
utility of the images produced by those other methodologies.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">GOVERNMENT REGULATION</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA Regulation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Food and Drug Administration in accordance
with Title 21 of the Code of Federal Regulations regulates the manufacturing and marketing of Fonar&#8217;s MRI scanners. The regulations
can be classified as either pre-market or post-market. The pre-market requirements include obtaining marketing clearance, proper
device labeling, establishment registration and device listing. Once the products are on the market, Fonar must comply with post-market
surveillance controls. These requirements include the Quality Systems Regulation, or &#8220;QSR&#8221;, also known as Current Good
Manufacturing Practices or CGMPs, and Medical Device Reporting, also referred to as MDR regulations. The QSR is a quality assurance
requirement that covers the design, packaging, labeling and manufacturing of a medical device. The MDR regulation is an adverse
event-reporting program.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Classes of Products</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Under the Medical Device Amendments of
1976 to the Federal Food, Drug and Cosmetic Act, all medical devices are classified by the FDA into one of three classes. A Class
I device is subject only to general controls, such as labeling requirements and manufacturing practices; a Class II device must
comply with certain performance standards established by the FDA; and a Class III device must obtain pre-market approval from the
FDA prior to commercial marketing. Fonar&#8217;s products are Class II devices. Class II devices are subject to &#8220;General Controls&#8221;;
General Controls include:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1. Establishment registration of companies
which are required to register under 21 CFR Part 807.20, such as manufacturers, distributors, re-packagers and re-labelers.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2. Medical device listing with FDA of
devices to be marketed.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3. Manufacturing devices in accordance
with the Current Good Manufacturing Practices Quality System Regulation in 21 CFR Part 820.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">4. Labeling devices in accordance with
labeling regulations in 21 CFR Part 801 or 809.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">5. Submission of a Premarket Notification,
pursuant to 510(k), before marketing a device.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to complying with general
controls, Class II devices are also subject to special controls. Special controls may include special labeling requirements, guidance
documents, mandatory performance standards and post-market surveillance.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On October 3, 2000 Fonar received FDA
clearance for the Upright&#174; MRI under the name &#8220;Indomitable&#8221;.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Premarketing Submission</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Each person who wants to market Class
I, II and some III devices intended for human use in the U.S. must submit a 510(k) to FDA at least 90 days before marketing unless
the device is exempt from 510(k) requirements. A 510(k) is a pre-marketing submission made to FDA to demonstrate that the device
to be marketed is as safe and effective, that is, substantially equivalent, SE, to a legally marketed device that is not subject
to pre-market approval, PMA. Applicants must compare their 510(k) device to one or more similar devices currently on the U.S. market
and make and support their substantial equivalency claims.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FDA is committed to a 90-day clearance
after submission of a 510(k), provided the 510(k) is complete and there is no need to submit additional information or data.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The 510(k) is essentially a brief statement
and description of the product. As Fonar&#8217;s scanner products are Class II products, there are no pre-market data requirements.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An investigational device exemption,
also referred to as IDE, allows the investigational device to be used in a clinical study pending FDA clearance in order to collect
safety and effectiveness data required to support the Premarket Approval, also referred to as PMA, application or a Premarket Notification
pursuant to 510(k), submission to the FDA. Clinical studies are most often conducted to support a PMA.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the most part, however, we have not
found it necessary to utilize IDE&#8217;s. The standard 90 day clearance for our new MRI scanner products classified as Class II products
makes the IDE unnecessary, particularly in view of the time and effort involved in compiling the information necessary to support
an IDE.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Quality System Regulation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Quality Management System is applicable
to the design, manufacture, administration of installation and servicing of magnetic resonance imaging scanner systems. The FDA
has authority to conduct detailed inspections of manufacturing plants, to establish Good Manufacturing Practices which must be
followed in the manufacture of medical devices, to require periodic reporting of product defects and to prohibit the exportation
of medical devices that do not comply with the law.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical Device Reporting Regulation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Manufacturers must report all MDR reportable
events to the FDA. Each manufacturer must review and evaluate all complaints to determine whether the complaint represents an event
which is required to be reported to FDA. Section 820.3(b) of the Quality Systems regulation defines a complaint as, &#8220;any written,
electronic or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness,
or performance of a device after it is released for distribution.&#8221;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A report is required when a manufacturer
becomes aware of information that reasonably suggests that one of their marketed devices has or may have caused or contributed
to a death, serious injury, or has malfunctioned and that the device or a similar device marketed by the manufacturer would be
likely to cause or contribute to a death or serious injury if the malfunction were to recur.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Malfunctions are not reportable if they
are not likely to result in a death, serious injury or other significant adverse event experience.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A malfunction which is or can be corrected
during routine service or device maintenance still must be reported if the recurrence of the malfunction is likely to cause or
contribute to a death or serious injury if it were to recur.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have established and maintained written
procedures for implementation of the MDR regulation. These procedures include internal systems that:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">provide
for timely and effective identification, communication and evaluation of adverse</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">events;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">provide
a standardized review process and procedures for determining whether or not an</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">event
is reportable; and</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">provide
procedures to insure the timely transmission of complete reports.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">These procedures also include documentation
and record keeping requirements for:information that was evaluated to determine if an event was reportable;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">all medical
device reports and information submitted to the FDA;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">any information
that was evaluated during preparation of annual certification reports; and</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">systems
that ensure access to information that facilitates timely follow up and inspection by</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">FDA.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA Enforcement</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA may take the following actions to
enforce the MDR regulation:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA-Initiated or Voluntary Recalls</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Recalls are regulatory actions that remove
a hazardous, potentially hazardous, or a misbranded product from the marketplace. Recalls are also used to convey additional information
to the user concerning the safe use of the product. Either FDA or the manufacturer can initiate recalls.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There are three classifications, i.e.,
I, II, or III, assigned by the Food and Drug Administration to a particular product recall to indicate the relative degree of health
hazard presented by the product being recalled.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class I</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Is a situation in which there is a reasonable
probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class II</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure
to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious
adverse health consequences is remote.&#8195;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class III</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure
to, a violative product is not likely to cause adverse health consequences.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar has initiated six voluntary recalls.
Five of the recalls were Class II and one was Class III. The recalls involved making minor corrections to the product in the field.
Frequently, corrections which are made at the site of the device are called field corrections as opposed to recalls.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Civil Money Penalties</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FDA, after an appropriate hearing,
may impose civil money penalties for violations of the FD&amp;C Act that relate to medical devices. In determining the amount of
a civil penalty, FDA will take into account the nature, circumstances, extent, and gravity of the violations, the violator&#8217;s ability
to pay, the effect on the violator&#8217;s ability to continue to do business, and any history of prior violations.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Warning Letters</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA issues written communications to
a firm, indicating that the firm may incur more severe sanctions if the violations described in the letter are not corrected. Warning
letters are issued to cause prompt correction of violations that pose a hazard to health or that involve economic deception. The
FDA generally issues the letters before pursuing more severe sanctions.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Seizure</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A seizure is a civil court action against
a specific quantity of goods which enables the FDA to remove these goods from commercial channels. After seizure, no one may tamper
with the goods except by permission of the court. The court usually gives the owner or claimant of the seized merchandise approximately
30 days to decide a course of action. If they take no action, the court will recommend disposal of the goods. If the owner decides
to contest the government&#8217;s charges, the court will schedule the case for trial. A third option allows the owner of the goods to
request permission of the court to bring the goods into compliance with the law. The owner of the goods is required to provide
a bond or, security deposit, to assure that they will perform the orders of the court, and the owner must pay for FDA supervision
of any activities by the company to bring the goods into compliance.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Citation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A citation is a formal warning to a firm
of intent to prosecute the firm if violations of the FD&amp;C Act are not corrected. It provides the firm an opportunity to convince
FDA not to prosecute.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Injunction</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An injunction is a civil action filed
by FDA against an individual or company. Usually, FDA files an injunction to stop a company from continuing to manufacture, package
or distribute products that are in violation of the law.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Prosecution</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Prosecution is a criminal action filed
by FDA against a company or individual charging violation of the law for past practices.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign and Export Regulation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We obtain approvals as necessary in connection
with the sales of our products in foreign countries. In some cases, FDA approval has been sufficient for foreign sales as well.
Our standard practice has been to require either the distributor or the customer to obtain any such foreign approvals or licenses
which may be required.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Legally marketed devices that comply
with the requirements of the Food Drug &amp; Cosmetic Act require a Certificate to Foreign Government issued by the FDA for export.
Other devices that do not meet the requirements of the FD&amp;C Act but comply with the laws of a foreign government require a
Certificate of Exportability issued by the FDA. All products which we sell have FDA clearance and would fall into the first category.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign governments have differing requirements
concerning the import of medical devices into their respective jurisdictions. The European Union, also referred to as EU, has some
essential requirements described in the EU&#8217;s Medical Device Directive, also referred to as MDD. In order to export to one of these
countries, we must meet the essential requirements of the MDD and any additional requirements of the importing country. The essential
requirements are similar to some of the requirements mandated by the FDA. In addition the MDD requires that we enlist a Notified
Body to examine and assess our documentation, a Technical Construction File, and verify that the product has been manufactured
in conformity with the documentation. The notified body must carry out or arrange for the inspections and tests necessary to verify
that the product complies with the essential requirements of the MDD, including safety performance and Electromagnetic Compatibility,
also referred to as EMC. Also required is a Quality System, ISO-13485, assessment by the Notified Body. We were approved for ISO
13485 certification for its Quality Management System in April, 2003.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We received clearance to sell the Upright&#174;
MRI scanners in the EU in May, 2002.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other countries require that their own
testing laboratories perform an evaluation of our devices. This requires that we must bring the foreign agency&#8217;s personnel to the
USA to perform the evaluation at our expense before exporting.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Some countries, including many in Latin
America and Africa, have very few regulatory requirements, beyond FDA clearance.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">To date, Fonar has been able to comply
with all foreign regulatory requirements applicable to its export sales.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PHYSICIAN AND DIAGNOSTIC SERVICES MANAGEMENT
BUSINESS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Health Diagnostics Management, LLC (HDM)
is owned by Health Management Corporation of America (70%) and investors (30%). Health Management Corporation of America is owned
100% by Fonar Corporation.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HDM operates under the assumed name &#8220;Health
Management Company of America&#8221; (&#8220;HMCA&#8221;).</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The combined business (HDM and Health
Management Corporation of America) will be referred to as &#8220;HMCA&#8221; for all periods before and after July 1, 2015, unless
otherwise indicated.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA provides comprehensive non-medical
management services to diagnostic imaging facilities. These services include administrative services, billing and collection services,
credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training,
supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services,
accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of June 30, 2021, HMCA managed a total
of 39 MRI scanners of which twenty-five (25) scanners are located in New York and 14 scanners are located in Florida. For the 2021
fiscal year, the revenues HMCA recognized from the MRI facilities has increased to $80.9 million from $77.2 million in fiscal 2020.
Five<b> </b>of the facilities in Florida are owned by HMCA subsidiaries, where the corporate practice of medicine is permitted.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe the utilization of FONAR Upright&#174;
MRI scanning systems, which are produced under the protection of our patents, accounts for the historically robust patient volume
at the scanning facilities and, most recently, our steady recovery from the effects of the COVID-19 pandemic. During fiscal 2021,
second MRI scanners were installed at our facilities in Islandia, New York and White Plains, New York and a new facility was installed
in Pembroke Pines, Florida. The Company also acquired an existing facility in West Yonkers, NY in March 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA GROWTH STRATEGY</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s growth strategy focuses on upgrading
and expanding the existing facilities it manages and expanding the number of facilities it either owns or manages for its clients,
including new sites. In connection with improving the performance of the facilities, we have added high field MRI scanners, extremity
scanners and x-ray machines to the Upright&#174; MRI scanners at certain of the sites where such additional diagnostic imaging modalities
are expected to produce the greatest return. In addition we plan to install three new facilities in fiscal 2022: one in New York
and two in Florida.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PHYSICIAN AND DIAGNOSTIC MANAGEMENT SERVICES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s services to the facilities it
manages encompass substantially all of their business operations. Each facility is controlled, however, not by HMCA, but by the
physician owner, or in the case of the four Florida sites owned by HMCA subsidiaries, by the medical director. All medical services
are performed by physicians and other medical personnel under the physician-owner&#8217;s supervision. HMCA is the management company
and performs services of a non-medical nature. These services include:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1. Offices and Equipment. HMCA identifies,
negotiates leases for and/or provides office space and equipment to its clients. This includes technologically sophisticated medical
equipment. HMCA also provides improvements to leaseholds, assistance in site selection and advice on improving, updating, expanding
and adapting to new technology.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2. Personnel. HMCA staffs all the non-medical
positions of its clients with its own employees, eliminating the client&#8217;s need to interview, train and manage non-medical employees.
HMCA processes the necessary tax, insurance and other documentation relating to employees.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3. Administrative. HMCA assists in the
scheduling of patient appointments, purchasing of office and medical supplies and equipment and handling of reporting, accounting,
processing and filing systems. It prepares and files the physician portions of complex applications to enable its clients to participate
in managed care programs and to qualify for insurance reimbursement. HMCA assists the clients to implement programs and procedures
to ensure full and timely regulatory compliance and appropriate cost reimbursement under no-fault insurance and Workers&#8217; Compensation
guidelines, as well as compliance with other applicable governmental requirements and regulations, including HIPAA and other privacy
requirements.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">4. Billing and Collections. HMCA is responsible
for the billing and collection of revenues from third-party payors including those governed by No-Fault and Workers&#8217; Compensation
statutes. HMCA is presently using a third party to perform its billing and collection services for its clients&#8217; No-Fault and Workers&#8217;
Compensation scanning business.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">5. Cost Saving Programs. Based on available
volume discounts, HMCA seeks to assist in obtaining favorable pricing for office and medical supplies, medical imaging film, equipment,
contrast agents, such as gadolinuim, and magnavist and other inventory for its clients.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">6. Diagnostic Imaging and Ancillary Services.
HMCA can offer access to diagnostic imaging equipment through diagnostic imaging facilities it manages. The Company is expanding
the ancillary services offered in its network to include x-rays, and other MRI equipment such as high-field (1.5 or 3.0 Tesla magnet
strength) MRI scanners and extremity MRI scanners.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">7. Marketing Strategies. HMCA is responsible
for developing and proposing marketing plans for its clients.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">8. Expansion Plans. HMCA assists the
clients in developing expansion plans including the opening of new or replacement facilities where appropriate.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s objective is to free physicians
from as many non-medical duties as is practicable, allowing physicians to spend less time on business and administrative matters
and more time practicing medicine.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The exceptions to this general model
of operation are five of the facilities located in Florida. These Florida facilities are owned by limited liability companies which,
as our subsidiaries, conduct their operations directly and bill and collect their fees from the patients and third party payors.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The facilities enter into contracts with
third party payors, including managed care companies. None of HMCA&#8217;s clients, however, participate in any capitated plans or other
risk sharing arrangements. Capitated plans are those HMO programs where the provider is paid a flat monthly fee per patient.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The management fees payable by the facilities
to HMCA are flat monthly fees. In fiscal 2020, the aggregate amount of management fees was $4,530,422 per month. In fiscal 2021,
the aggregate amount of management fees was $4,897,720 per month.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fees under the management agreements
are subject to adjustment by mutual agreement on an annual basis.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Damadian owns three HMCA-managed
MRI facilities in Florida. The fees for these three sites in Florida owned by Dr. Damadian are flat monthly fees which are subject
to adjustment by mutual agreement on an annual basis. In fiscal 2021, the aggregate monthly amount of management fees payable to
HMCA by these sites was $931,561 as compared to $897,745 in fiscal 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Florida facilities owned by HMCA
subsidiaries directly bill their patients or the patients&#8217; insurance carriers. Patient fees net of provision for bad debts were
$23,307,389 in fiscal 2021 as compared to $22,495,260 in fiscal 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA contracts with an outside billing
company (located in Melville, New York) to perform billing and collection for their clients&#8217; No-Fault and Workers&#8217; Compensation
business. The fixed monthly fees were $85,000 for HMCA in fiscal 2020 and part of fiscal 2021. This contract was terminated as
of January 1, 2021. The Company also entered into a one year renewable agreement to provide IT services to the billing company
for a monthly fee of $23,884.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA MARKETING</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s marketing strategy is to expand
the business and improve the facilities which it manages. HMCA is seeking to increase the number of locations of those facilities
where market conditions are promising and to promote growth of our clients&#8217; and Florida subsidiaries&#8217; patient volume and revenue.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">DIAGNOSTIC IMAGING FACILITIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Diagnostic imaging facilities managed
by HMCA provide diagnostic imaging services to patients referred by physicians. The facilities are operated in a manner which eliminates
the admission and other administrative inconveniences of in-hospital diagnostic imaging services. Imaging services are performed
in an outpatient setting by trained medical technologists under the direction of physicians. Following diagnostic procedures, the
images are reviewed by the interpreting physicians who prepare reports of these tests and their findings. The vast majority of
reports for the New York facilities are transcribed by HMCA personnel and the remainder are outsourced to professional transcription
services. Reports for the Florida facilities are outsourced to professional transcription services.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA develops marketing programs and
educational programs in an effort to establish and maintain referring physician relationships for our clients and Florida subsidiaries.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Managed care providers are an important
factor in the diagnostic imaging industry. To further its position, HMCA is seeking to expand the imaging modalities offered at
its managed and owned diagnostic imaging facilities. Three facilities in New York and six facilities in Florida have two or more
MRI scanners. One facility in New York and two in Florida also perform X-rays. During fiscal 2020, a second MRI was installed at
our Ormond Beach, Florida facility and a new HMCA facility became operational in Pembroke Pines, Florida.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">REIMBURSEMENT</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s clients receive reimbursements
for their services through Medicare, Medicaid, managed care, private commercial insurance, third party administrators, Workers&#8217;
Compensation, No-Fault and other insurance.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medicare</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Medicare program provides reimbursement
for hospitalization, physician, diagnostic and certain other services to eligible persons 65 years of age and over and certain
other individuals. Providers are paid by the federal government in accordance with regulations promulgated by the Department of
Health and Human Services, HSS, and generally accept the payment with nominal deductible and co-insurance amounts required to be
paid by the service recipient, as payment in full. Hospital inpatient services are reimbursed under a prospective payment system.
Hospitals receive a specific prospective payment for inpatient treatment services based upon the diagnosis of the patient.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Under Medicare&#8217;s prospective payment
system for hospital outpatient services, or OPPS, a hospital is paid for outpatient services on a rate per service basis that varies
according to the ambulatory payment classification group, or APC, to which the service is assigned rather than on a hospital&#8217;s
costs. Each year the Centers for Medicare and Medicaid Services, or CMS, publishes new APC rates that are determined in accordance
with the promulgated methodology.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Services provided in non-hospital based
freestanding facilities are paid under the Medicare Physician Fee Schedule, or MPFS. All of HMCA&#8217;s clients are presently in this
category. The MPFS is updated on an annual basis and sometimes modified more frequently.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have experienced reimbursement reductions
for radiology services provided to Medicare beneficiaries, including reductions pursuant to the Deficit Reduction Act, or DRA.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">CMS&#8217; 2010 regulatory changes to the MPFS
included a downward adjustment to services primarily involving the technical component rather than the physician work component,
by adjusting downward malpractice payments for these services. These adjustments have been phased in over a four year period. For
our fiscal year ended June 30, 2021, Medicare revenues represented approximately 3.4% of the revenues for HMCA&#8217;s clients and subsidiaries
as compared to 3.8% for the fiscal year ended June 30, 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medicaid</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Medicaid program is a jointly-funded
federal and state program providing coverage for low-income persons. In addition to federally-mandated basic services, the services
offered and reimbursement methods vary from state to state. In many states, Medicaid reimbursement is patterned after the Medicare
program; however, an increasing number of states have established or are establishing payment methodologies intended to provide
healthcare services to Medicaid patients through managed care arrangements. In fiscal 2021, approximately 0.09% of the revenues
of HMCA&#8217;s clients were attributable to Medicaid, as compared to 0.07% in fiscal 2020. Four of the Florida facilities (those owned
by HMCA subsidiaries) do not participate in Medicaid.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Managed Care and Private Insurance.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Health Maintenance Organizations, or
HMO&#8217;s, Preferred Provider Organizations, or PPOs, and other managed care organizations attempt to control the cost of healthcare
services by a variety of measures, including imposing lower payment rates, preauthorization requirements, limiting services and
mandating less costly treatment alternatives. Managed care contracting is competitive and reimbursement schedules in many cases
can be at or below Medicare reimbursement levels. Some managed care organizations have reduced or otherwise limited, and other
managed care organizations may reduce or otherwise limit, reimbursement in response to reductions in government reimbursement.
These reductions could have an adverse impact on our financial condition and results of operations. These reductions have been,
and any future reductions may be, similar to the reimbursement reductions previously proposed.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA COMPETITION</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The physician and diagnostic management
services field is highly competitive. A number of large hospitals have acquired medical practices and this trend may continue.
HMCA expects that more competition will develop. Many competitors have greater financial and other resources than HMCA.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">With respect to the diagnostic imaging
facilities managed by HMCA, the outpatient diagnostic imaging industry is highly competitive. Competition focuses primarily on
attracting physician referrals at the local market level and increasing referrals through relationships with managed care organizations,
as well as emphasizing to potential referral sources the advantages of Upright&#174; MRI scanning. HMCA believes that principal
competitors for the diagnostic imaging centers are hospitals and independent or management company-owned imaging centers. Competitive
factors include quality and timeliness of test results, ability to develop and maintain relationships with managed care organizations
and referring physicians, type and quality of equipment, facility location, convenience of scheduling and availability of patient
appointment times. HMCA believes that it will be able to effectively meet the competition in the outpatient diagnostic imaging
industry with the Fonar Upright&#174; MRI scanners and strategically placed high field MRI scanners at its facilities.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">GOVERNMENT REGULATION APPLICABLE TO HMCA</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FEDERAL REGULATION</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The healthcare industry is highly regulated
and changes in laws and regulations can be significant. Changes in the law or new interpretation of existing laws can have a material
effect on our permissible activities, the relative costs associated with doing business and the amount of reimbursement by government
and other third-party payors.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Federal False Claims Act</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The federal False Claims Act and, in
particular, the False Claims Act&#8217;s &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; provisions allow a private individual to bring
actions in the name of the government alleging that a defendant has made false claims for payment from federal funds. After the
individual has initiated the lawsuit the government must decide whether to intervene in the lawsuit and to become the primary prosecutor.
If the government declines to join the lawsuit, the individual may choose to pursue the case alone, although the government must
be kept apprised of the progress of the lawsuit, and may intervene later. Whether or not the federal government intervenes in the
case, it will receive the majority of any recovery.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">When an entity is determined to have
violated the federal False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil
penalties for each separate false claim and the government&#8217;s attorneys&#8217; fees. Liability arises when an entity knowingly submits,
or causes someone else to submit, a false claim for reimbursement to the federal government. The False Claims Act defines the term
&#8220;knowingly&#8221; broadly, though simple negligence will not give rise to liability under the False Claims Act. Examples of
the other actions which may lead to liability under the False Claims Act are set forth below:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Failure to comply with the many technical
billing requirements applicable to our Medicare and Medicaid business.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">Failure to comply with the
prohibition against billing for services ordered or supervised by a physician who is excluded from any federal healthcare program,
or the prohibition against employing or contracting with any person or entity excluded from any federal healthcare program.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">Failure to comply with the
Medicare physician supervision requirements for the services we provide, or the Medicare documentation requirements concerning
physician supervision.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fraud Enforcement and Recovery Act
of 2009 expanded the scope of the False Claims Act by, among other things, broadening protections for whistleblowers and creating
liability for knowingly retaining a government overpayment, acting in deliberate ignorance of a government overpayment or acting
in reckless disregard of a government overpayment. The healthcare reform bills in the form of the Patient Protection and Affordable
Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, &#8220;PPACA&#8221;) expanded on
changes made by the 2009 Fraud Enforcement and Recovery Act with regard to such &#8220;reverse false claims.&#8221; Under PPACA,
the knowing failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding
cost report is due, whichever is later, constitutes a violation of the False Claims Act. HMCA and its clients have never been sued
under the False Claims Act and believe they are in compliance with the law.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stark Law</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Under the federal Self-Referral Law,
also referred to as the &#8220;Stark Law&#8221;, which is applicable to Medicare and Medicaid patients, and the self-referral laws
of various States, certain health practitioners, including physicians, chiropractors and podiatrists, are prohibited from referring
their patients for the provision of designated health services, including diagnostic imaging and physical therapy services, to
any entity with which they or their immediate family members have a financial relationship, unless the referral fits within one
of the specific exceptions in the statutes or regulations. The federal government has taken the position that a violation of the
federal Stark Law is also a violation of the Federal False Claims Act. Statutory exceptions under the Stark Law include, among
others, direct physician services, in-office ancillary services rendered within a group practice, space and equipment rental and
services rendered to enrollees of certain prepaid health plans. Some of these exceptions are also available under the State self-referral
laws. HMCA believes that it and its clients are in compliance with these laws.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Anti-kickback Regulation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We are subject to federal and state laws
which govern financial and other arrangements between healthcare providers. These include the federal anti-kickback statute which,
among other things, prohibits the knowing and willful solicitation, offer, payment or receipt of any remuneration, direct or indirect,
in cash or in kind, in return for or to induce the referral of patients for items or services covered by Medicare, Medicaid and
certain other governmental health programs. Under PPACA, knowledge of the anti-kickback statute or the specific intent to violate
the law is not required. Violation of the anti-kickback statute may result in civil or criminal penalties and exclusion from the
Medicare, Medicaid and other federal healthcare programs, and according to PPACA, now provides a basis for liability under the
False Claims Act. In addition, it is possible that private parties may file &#8220;qui tam&#8221; actions based on claims resulting
from relationships that violate the anti-kickback statute, seeking significant financial rewards. Many states have enacted similar
statutes, which are not limited to items and services paid for under Medicare or a federally funded healthcare program. Neither
HMCA nor its clients engage in this practice.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In fiscal 2021, approximately 3.4% of
the revenues of HMCA&#8217;s clients were attributable to Medicare and 0.09% were attributable to Medicaid. In fiscal 2020, approximately
3.8% of the revenues of HMCA&#8217;s clients were attributable to Medicare and 0.07% were attributable to Medicaid.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Deficit Reduction Act (DRA)</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On February 8, 2006, the President signed
into law the DRA. Effective January 1, 2007, the DRA provides that Medicare reimbursement for the technical component for imaging
services (excluding diagnostic and screening mammography) performed in freestanding facilities will be capped. Payment is the lesser
of the Medicare Physician Fee Schedule or the Hospital Outpatient Prospective Payment System (OPPS) rates. Implementation of these
reimbursement reductions contained in the DRA has had an adverse effect on our business. We have been able to counter this effect
by increasing our clients&#8217; scan volumes through our vigorous marketing efforts and reducing our operating expenses.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The DRA also codified the reduction in
reimbursement for multiple images on contiguous body parts previously announced by CMS, the agency responsible for administering
the Medicare program. In November 2005, CMS announced that it would pay 100% of the technical component of the higher priced imaging
procedure and 50% of the technical component of each additional imaging procedure for imaging procedures involving contiguous body
parts within a family of codes when performed in the same session. CMS had indicated that it would phase in this 50% rate reduction
over two years, so that the reduction was 25% for each additional imaging procedure in 2006 and another 25% reduction in 2007.
However, for services furnished on or after July 1, 2010, the PPACA requires the full 50% reduction to be implemented.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Health Insurance Portability and Accountability
Act</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Congress enacted the Health Insurance
Portability and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security
of patients&#8217; individually identifiable healthcare information. HIPAA, among other things, amends existing crimes and criminal penalties
for Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-governmental healthcare benefit
programs by means of false or fraudulent representations in connection with the delivery of healthcare services is subject to a
fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities
that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services to
federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business,
financial condition and results of operations.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Further, HIPAA requires healthcare providers
and their business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;).
HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting
the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed
into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business
associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity,
(2) substantive security and privacy obligations, including new federal security breach notification requirements to affected individuals,
DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition
on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties
that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per occurrence. In
2013 additional legal requirements were adopted to provide further protection for PHI.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, many states have enacted
comparable privacy and security statues or regulations that, in some cases, are most stringent than HIPAA requirements. In those
cases it may be necessary to modify our operations and procedures to comply with the more stringent state laws, which may entail
significant and costly changes for us. We believe that we are in compliance with such state laws and regulations. However, if we
fail to comply with applicable state laws and regulations, we could be subject to sanctions.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe that we are in compliance
with the current HIPAA requirements, as amended by HITECH, together with other legislation and regulations, and comparable state
laws, but we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that
enforcement agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations
of our contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards may result
in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs,
including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results
of operations.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Civil Money Penalty Law and Other Federal
Statutes</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Civil Money Penalty, or CMP, law
covers a variety of practices. It provides a means of administrative enforcement of the anti-kickback statute, and prohibits false
claims, claims for medically unnecessary services, violations of Medicare participating provider or assignment agreements and other
practices. The statute gives the Office of Inspector General of the HHS the power to seek substantial civil fines, exclusion and
other sanctions against providers or others who violate the CMP prohibitions.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, in 1996, Congress created
a new federal crime: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits
knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of
this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs such as the Medicare
and Medicaid programs.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certificates of Need</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Some states require hospitals and certain
other healthcare facilities and providers to obtain a certificate of need, or CON, or similar regulatory approval prior to establishing
certain healthcare operations or services, incurring certain capital projects and/or the acquisition of major medical equipment
including MRI and PET/CT systems. We are not operating in any such states.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Patient Protection and Affordable Care
Act</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 23, 2010, President Obama signed
into law healthcare reform legislation in the form of PPACA. The implementation of this law has had a significant impact on the
healthcare industry. Most of the provisions of PPACA are being phased in over time and can be conceptualized as a broad framework
not only to provide health insurance coverage to millions of Americans, but to fundamentally change the delivery of care by bringing
together elements of health information technology, evidence-based medicine, chronic disease management, medical &#8220;homes,&#8221;
care collaboration and shared financial risk in a way that will accelerate industry adoption and change. We are unable to predict
the full impact of PPACA at this time primarily due to the previous administration&#8217;s efforts to repeal and replace the PPACA, or
to utilize executive action to modify the Act&#8217;s provisions where possible.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">State Regulation</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to the federal self-referral
law and federal Anti-kickback statute, many States, including those in which HMCA and its clients operate, have their own versions
of self-referral and anti-kickback laws. These laws are not limited in their applicability, as are the federal laws, to specific
programs. HMCA believes that it and its clients are in compliance with these laws.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Various States prohibit business corporations
from practicing medicine. Various States, including New York, also prohibit the sharing of professional fees or fee splitting.
Consequently, in New York HMCA leases space and equipment to clients and provides clients with a range of non-medical administrative
and managerial services for agreed upon fees. Under Florida law a business entity can bill patients and third party payors directly
if that entity is properly licensed through AHCA. All of the eight facilities in Florida are licensed healthcare clinics through
AHCA.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s clients and subsidiaries generate
revenue from patients covered by no-fault insurance and workers&#8217; compensation programs. For the fiscal year ended June 30, 2021
approximately 55.5% of our clients&#8217; receipts were from patients covered by no-fault insurance and approximately 9.4% of our client&#8217;s
receipts were from patients covered by workers&#8217; compensation programs. For the fiscal year ended June 30, 2020, approximately 56.7.%
of HMCA&#8217;s clients&#8217; receipts were from patients covered by no-fault insurance and approximately 9.11% of HMCA&#8217;s clients&#8217; receipts
were from patients covered by workers&#8217; compensation programs. The foregoing numbers do not include payments from third party administrators.
In the event that changes in these laws alter the fee structures or methods of providing service, or impose additional or different
requirements, HMCA could be required to modify its business practices and services in ways that could be more costly to HMCA or
in ways that decrease the revenues which HMCA receives from its clients.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Compliance Program</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We maintain a program to monitor compliance
with federal and state laws and regulations applicable to the healthcare entities. The compliance program includes the adoption
of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others
may report regulatory or ethical concerns. We believe that our compliance program meets the relevant standards provided by the
Office of Inspector General of the Department of Health and Human Services.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An important part of our compliance program
consists of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We
also assist our clients with educational programs designed to familiarize them with the regulatory requirements and specific elements
of our compliance program.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA believes that it and its clients
are in compliance with applicable Federal, State and local laws. HMCA does not believe that such laws will have any adverse material
effect on its business.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">EMPLOYEES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar and HMCA had approximately 495
employees as of September 24, 2021. This total number included employees engaged in production, customer support, research and
development, information technology, employees engaged in marketing and sales, billing and collection, legal and compliance matters,
as well as transcriptionists, Florida technologists, field service technicians and individuals in various administrative positions.
A significant number of employees were employed at the MRI facilities managed or owned by HMCA, primarily in administrative positions.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_002"></span>ITEM 1A. RISK FACTORS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An investment in our securities is subject
to various risks, the most significant of which are summarized below.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">1.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. We are experiencing lower reimbursement rates from Medicare, other government programs and private insurance companies. To date, we have been able to counter the impact of these reductions by increasing our volume of scans notwithstanding the Covid-19 pandemic, and reducing our operating expenses, thereby maintaining profitability in this business segment. There is, however, no assurance that we will be able to continue to do so.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">2.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Demand
for MRI Scanners. The reduced reimbursement rates also affects our sales of MRI scanners negatively. With lower revenue projections,
prospective customers would demand lower prices for scanners. Although the reduced reimbursements may not affect foreign demand,
a lower number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">3.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources, production capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although Fonar is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be convinced that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective will be reached, particularly with customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing positions.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">4.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties to the facilities we manage or own for the services we perform. If these physicians and other third parties were to reduce the number of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net revenue and operating margins.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">5.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed care organizations within New York or Florida could have a negative impact on the utilization and pricing of services performed at the facilities HMCA manages or owns to the extent these organizations exert control over patients&#8217; access to diagnostic imaging services, selections of the provider of such services and reimbursement rates for those services.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">6.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;FONAR
CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">7.</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Eligibility
Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the number of
patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will increase the
participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A
shift in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients
may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with
a corresponding decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand
for MRI scans as they become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid
program and state decisions on whether to participate in the expansion of such programs also could increase the number of patients
who participate in such programs and the number of uninsured patients. Even for those patients who remain in private insurance
plans, changes to those plans could increase patient financial responsibility, resulting in a greater risk of uncollectible receivables.
These factors and events could have a material adverse effect on our business, financial condition, and results of operations.</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;8.</span></td>
<td style="padding: 0; text-align: justify; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Possible
changes in Florida Insurance Law. In early 2019, two senate bills and one house bill in Florida were introduced, all of them calling
for the repeal of PIP and replacing PIP with $25,000 Bodily Injury Coverage and Property Damage Liability Coverage. Another Florida
senate bill was introduced that would preserve PIP but dramatically cut reimbursement rates. None of the proposed bills made it
onto the 2019 legislative agenda. During Fonar&#8217;s fiscal 2021, the Florida house and senate reached an agreement and passed similar
legislation. It was, however, vetoed by the Governor. We cannot predict whether such efforts by the Florida legislature will continue
or be successful. Currently, drivers and passengers get car damages and PIP, paid for up to $10,000, no matter who is at fault
in an accident. Drivers have to pay an additional cost to insurance companies to pay for bodily injuries which covers them if
they are at fault. While PIP is required, coverage for bodily injury is not.</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Over
the past several years there have been various bills introduced by a number of Florida legislators to eliminate PIP and instead
mandate coverage including some combination of a minimum of bodily injury and a reduced or no amount of medical payments (Medpay
coverage). Eliminating PIP would mean that the $10,000 drivers now get paid toward medical costs through their insurers might
not be there for them to pay for injured drivers. Importantly, payments would be reduced by approximately 60% due to claims being
paid at commercial rates or through legal settlements instead of at the presently prevailing PIP fee schedule. This would negatively
impact our seven diagnostic imaging facilities (both those we own and those we manage) with more unpaid bills, lower reimbursement
rates and elongated waiting times. To date proponents of these changes have been unsuccessful.</span><span style="font-family: Arial, Helvetica, Sans-Serif">
</span></td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">9.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Federal and state privacy and information security laws. We must comply with numerous federal and state laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by the federal HITECH Act. If we fail to comply with applicable privacy and security laws, regulations and standards, properly maintain the integrity of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">Information security risks
have significantly increased because of the proliferation of new technologies, the use of the internet and telecommunications technologies
to conduct our operations, and the increased sophistication and activities of organized crime, hackers, terrorists and other external
parties, including foreign state agents. Our operations rely on the secure processing, transmission and storage of confidential,
proprietary and other information in our computer systems and networks.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">10.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">COVID-19. Although we believe we have taken the proper steps and made a good recovery from the impact of the first wave of the COVID-19 virus, new strains of the disease have developed and future variants may continue to develop. The course and severity of the virus in the following months, and the ultimate economic and medical impact it will have worldwide and at home, have so far eluded more than minimal predictability.</span></td></tr>
</table>
<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
    <td style="padding: 0; width: 48px; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">11.</span></td>
    <td style="padding: 0; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of credit markets. Turbulence and uncertainty in the United States and international markets and economies may adversely affect our liquidity, financial condition, revenues, profitability and business operations generally.</span></td></tr>
</table>
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_003"></span>ITEM 1B. UNRESOLVED STAFF COMMENTS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">None.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_004"></span>ITEM 2. PROPERTIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar and HMCA currently lease approximately
78,000 square feet of office and plant space at its principal offices in Melville, New York. The term of the lease runs through
November, 2026. Management believes that the premises will be adequate for its current needs. HMCA also maintains office space
for the Facilities owned by its subsidiaries in Florida and for its clients at the clients&#8217; sites in New York and Florida under
leases having various terms. HMCA owns the building for the client&#8217;s premises in Tallahassee, Florida. The Company received approval
from the Suffolk County IDA on February 29, 2016 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing
January, 2017.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_005"></span>ITEM 3. LEGAL PROCEEDINGS.<br />
<br />
There are
no material legal proceedings threatened or pending against the Company.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_006"></span>ITEM 4. MINE SAFETY DISCLOSURES.<br />
<br />
Not
Applicable</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PART II</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_010"></span>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON
EQUITY AND RELATED STOCKHOLDER MATTERS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our Common Stock is traded in the Nasdaq
SmallCap market under the National Association of Securities Dealers Automated Quotation System, also referred to as &#8220;NASDAQ&#8221;,
under the symbol FONR. The following table sets forth the high and low trades reported in NASDAQ System for the periods shown.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Fiscal Quarter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">High</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Low</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: center">January - March</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">2017</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">17.30</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">April - June</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17.20</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">July - September</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">31.90</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.31</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">October - December</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">33.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">21.10</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">January - March</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">29.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22.15</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">April - June</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.31</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">July - September</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">28.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23.70</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">October - December</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19.63</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">January - March</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23.85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.01</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">March - June</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.85</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">July - September</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.44</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">October - December</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19.07</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">January - March</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">April - June</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.85</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">July - September</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">26.49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.31</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">October- December</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22.49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16.74</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">January- March</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17.31</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">April- June</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16.58</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">July- September 24</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16.51</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Performance Graph</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following graph compares the annual
change in the Company&#8217;s cumulative total shareholder return on its Common Stock during a period commencing on June 30, 2017 and
ending on June 30, 2021 (as measured by dividing (i) the sum of (A) the cumulative amount of dividends for the measurement period,
assuming dividend reinvestment and (B) the difference between the Company&#8217;s share price at the end and the beginning of the measurement
period; by (ii) the share price at the beginning of the measurement period) with the cumulative total return of each of: (a) the
CRSP Composite Total Return Index for Nasdaq (&#8220;Nasdaq&#8221;); and (b) the CRSP Total Return Index for Nasdaq Healthcare companies
(&#8220;Nas-Hea.&#8221;) during such period, assuming a $100 investment on June 30, 2017. The stock price performance on the graph
below is not necessarily indicative of future price performance.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">Relative Dollar Values</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2017</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 29, 2018</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 28, 2019</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">Fonar Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95.68</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">77.52</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">77.02</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">61.63</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>NASDAQ</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">122.31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130.39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">168.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">243.43</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>NAS-Hea</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">110.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">113.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">140.03</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">175.00</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="fonar_stock-graph.jpg" alt="" style="height: 318px; width: 675px" />&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On September 30, 2021, we had approximately
993 stockholders of record of our Common Stock, 12 stockholders of record of our Class B Common Stock, 3 stockholders of record
of our Class C Common Stock and 1,155 stockholders of record of our Class A Non-voting Preferred Stock.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At the present time, the only class of
our securities for which there is a market is the Common Stock.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We currently have a policy of retaining
earnings to finance the development and expansion of our business. We expect to continue this policy for the foreseeable future.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_011"></span>ITEM 6. SELECTED FINANCIAL DATA.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following selected consolidated financial
data has been extracted from our consolidated financial statements for the five years ended June 30, 2021. This consolidated selected
financial data should be read in conjunction with our consolidated financial statements and the related notes included in Item
8 of this form.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0; text-align: left; text-indent: 0">STATEMENT OF OPERATIONS</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2019</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2018</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2017</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">89,929,765</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">85,690,462</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">87,192,887</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">81,515,994</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">78,036,586</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Cost of revenues</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46,456,127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,296,825</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,984,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">41,950,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38,052,425</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and Development Expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,635,979</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,025,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,812,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,755,747</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,480,670</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income(Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,673,811</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11,704,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513,674</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,452,185</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,678,798</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic Net Income (Loss)per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.26</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.98</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Diluted Net Income (Loss) per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Basic Weighted average number of shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,505,283</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,443,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,354,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,287,510</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,161,599</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Diluted Weighted average number of shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,632,787</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,571,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,481,607</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,415,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,289,103</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;BALANCE SHEET DATA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Working capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,534,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">77,226,104</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,998,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">52,497,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">39,177,703</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">189,506,195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">180,259,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">133,560,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">118,310,945</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">98,762,566</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long-term debt and obligations under capital leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,808,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,116,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">273,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">306,035</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">336,761</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholder&#8217;s equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">135,370,125</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">126,242,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">118,112,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,234,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">82,909,953</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_012"></span>ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATION.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">INTRODUCTION.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar was formed in 1978 to engage in
the business of designing, manufacturing and selling MRI scanners. HMCA, a subsidiary of Fonar, provides management services to
diagnostic imaging facilities.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s principal MRI product is its
Upright&#174; MRI (also called Stand-Up&#174; MRI) scanner. The Upright&#174; MRI allows patients to be scanned for the first time
under weight-bearing conditions. The Stand-Up&#174; MRI is the only MRI capable of producing images in the weight-bearing state.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At 0.6 Tesla field strength, the Upright&#174;
MRI is among the highest field open MRI scanners in the industry, offering non-claustrophobic MRI together with high-field image
quality. Fonar&#8217;s open MRI scanners were the first high field strength open MRI scanners in the industry.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA generates revenues from providing
comprehensive management services, including development, administration, accounting, billing and collection services, together
with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form of fees which
are earned under contracts with HMCA&#8217;s clients except for its three Florida subsidiaries which engage in the practice of medicine,
and bill and collect fees from patients, insurers and other third party payors directly.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The most significant adverse impact on
on our Company in fiscal 2020 has been the COVID-19 pandemic. Although it had seemed the worst had passed, events have shown a
spike in new cases due primarily to the new Delta strain in the viruses. This is by no means a problem confined to our Company,
but regardless of our best efforts, our results of operation and financial condition are potentially volatible and severe.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Since March, 2020 the global pandemic
of COVID-19 has caused turbulence and uncertainty in the United States and international economies which have adversely affected
our profitability and business operations. Generally COVID-19 had caused us to require that much of our workforce work from home
and has restricted the ability of our personnel to travel for marketing purposes or to service our customers. The Company experienced
a sudden drop in scan volume for a short term period and while we are not back to pre-COVID-19 levels, the scan volume has risen.
During the fourth quarter of Fiscal 2020, the Company was able to enact certain measures to allow the Company to survive during
the global pandemic and to prevent further losses or additional decreases in scan volume. The Company immediately enacted wide
scale furloughs, deferment of up to 50% of management salaries, halted variable compensation plans. Rent deferrals were negotiated
with nearly all landlords. Reductions of the salaries of non-controlling interest group members, who were actively involved in
the management of the Company, accounted for most of the payroll savings. The Company also received some government stimulus funds
from the Paycheck Protection Program (&#8220;PPP) and Medicare advances/stimulus payments. Although we are unable to predict if
there will be additional consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with
the positive cash flows, low debt and cash on hand, it will be able to continue operations going forward. One of the concerns we
have are the increased strictness in enforcement of COVID-19 mandates, such as the requirement that employees in healthcare facilities
be vaccinated or frequently test. We are in fact facing some of these challenges now. So far we have been able to navigate through
these requirements and avoid any significant disruption to our business.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Critical Accounting Policies</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our discussion and analysis of financial
condition and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S.
generally accepted accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements.
These estimates and assumptions affect various matters, including:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">our reported amounts of assets
and liabilities in our consolidated balance sheets at the dates of the financial statements</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">our disclosure of contingent
assets and liabilities at the dates of the financial statements; and</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">our reported amounts of net
revenue and expenses in our consolidated statements of operations during the reporting periods</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">These estimates involve judgments with
respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could
differ materially from these estimates.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Securities and Exchange Commission
defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition
and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need
to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. In the notes
to our consolidated financial statements, we discuss our significant accounting policies.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe the following critical accounting
policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.
We recognize revenue and related costs of revenue from sales contracts for our MRI scanners and major upgrades, under the percentage-of-completion
method. Under this method, we recognize revenue and related costs of revenue, as each sub-assembly is completed. Amounts received
in advance of our commencement of production are recorded as customer advances.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We continuously, qualitatively and quantitatively
evaluate the realizability (including both positive and negative evidence) of the net deferred tax assets and assess the valuation
allowance periodically. Our evaluation considers the financial condition of the Company and both the business conditions and regulatory
environment of the industry. If future taxable income or other factors are not consistent with our expectations, an adjustment
to our allowance for net deferred tax assets may be required. For net deferred tax assets we consider estimates of future taxable
income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.
Our ability to project future taxable income may be significantly affected by our ability to determine the impact of regulatory
changes which could adversely affect our future profits. As a result, the benefits of our net operating loss carry forwards could
expire before they are utilized.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At June 30, 2020, the net deferred tax
asset was valued at $18,809,757. At June 30, 2021, the net deferred tax asset was valued at $15,958,961.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We depreciate our long-lived assets over
their estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful
lives or the lease term of the facility for which these assets are associated.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company provides for medical receivables
that could become uncollectible by establishing an allowance for doubtful accounts in order to adjust medical receivables to estimated
net realizable value. In evaluating the collectability of medical receivables, the Company considers a number of factors, including
the age of the account, historical collection experiences, payor type, current economic conditions and other relevant factors.
There are various factors that impact collection trends, such as payor mix, changes in the economy, increase burden on copayments
to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and
can have an impact on collection trends and the estimation process.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We amortize our intangible assets, including
patents, and capitalized software development costs, over the shorter of the contractual/legal life or the estimated economic life.
Our amortization life for patents and capitalized software development costs is 15 to 17 years and 5 years, respectively. Our amortization
of the non-competition agreements entered into with certain individuals in connection with the HDM transaction are depreciated
over seven years, and customer relationships are amortized over 20 years.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Goodwill is recorded as a result of business
combinations. Management evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances
suggest that the carrying amount may not be recoverable. Impairment of goodwill is tested by comparing the reporting unit&#8217;s carrying
amount, including goodwill, to the fair value of the reporting unit. The fair value of a reporting unit is estimated using a combination
of the income or discounted cash flows approach and the market approach, which uses comparable market data. If the carrying amount
of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the amount
of impairment loss, if any. Based on our test for goodwill impairment, we noted no impairment related to goodwill. However, if
estimates or the related assumptions change in the future, we may be required to record impairment charges to reduce the carrying
amount of goodwill.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We periodically assess the recoverability
of long-lived assets, including property and equipment, intangibles and management agreements, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">RESULTS OF OPERATIONS. FISCAL 2021 COMPARED
TO FISCAL 2020</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In fiscal 2021, we recognized net income
of $13.7 million on revenues of $89.9 million, as compared to net income of $11.7 million on revenues of $85.7 million for fiscal
2020. This represents an increase in revenues of 4.9%. Patient fee revenue net of contractual allowances increased by 3.6%. Total
costs and expenses increased by 1.1%. Our consolidated operating results increased by $3.4 million to an operating income of $17.1
million for fiscal 2021 as compared to operating income of $13.7 million for fiscal 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Discussion of Operating Results of Medical
Equipment Segment</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fiscal 2021 Compared to Fiscal 2020</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenues attributable to our medical
equipment segment increased by 6.8% to $9.0 million in fiscal 2021 from $8.5 million in fiscal 2020, with product sales revenues
increasing by 332.9% from $298,000 in fiscal 2020 to $1.3 million in fiscal 2021. Service revenue decreased from $8.2 million in
fiscal 2020 to $7.7 million in fiscal 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI is unique in that
it permits MRI scans to be performed on patients upright in the weight-bearing state and in multiple positions that correlate with
symptoms.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Product sales to unrelated parties increased
by 332.9% in fiscal 2021 from $298,000 in fiscal 2020 to $1.3 million in fiscal 2021. There were no product sales to related parties
in fiscal 2021 or 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe that one of our principal
challenges in achieving greater market penetration is attributable to the better name recognition and larger sales forces of our
larger competitors such as General Electric, Siemens, Hitachi, Philips and Toshiba and the ability of some of our competitors to
offer attractive financing terms through affiliates, such as G.E. Capital.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, lower reimbursement rates
have reduced the demand for our MRI products, resulting in lower sales volumes. As a result of fewer sales, service revenues have
decreased since as older scanners are taken out of service, there are fewer new scanners available to sign service contracts.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The operating loss for the medical equipment
segment decreased from an operating loss of $6.4 million in fiscal 2020 to an operating loss of $3.4 million in fiscal 2021. The
losses are attributable most significantly to the fact that costs increased by a greater amount than revenues. The increase in
costs was primarily due to the increase in business activity which resulted in our increased revenues.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We recognized revenues of $733,000 from
the sale of our Upright&#174; MRI scanners in fiscal 2021, while in fiscal 2020, we recognized revenues of $96,000 from the sale
of Upright&#174; MRI scanners.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development expenses decreased
to $1.6 million in fiscal 2021 from $2.0 million in fiscal 2020. Our expenses for fiscal 2021 represented continued research and
development of various upgrades for the Upright&#174; MRI scanner. The reason for the decrease in research and development was due
mainly to supply chain related delays due to the COVID-19 pandemic.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Discussion of Operating Results of Physician
and Diagnostic Services Management Segment.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fiscal 2021 Compared to Fiscal 2020</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenues attributable to the Company&#8217;s
physician and diagnostic services management segment, HMCA, increased to $80.9 million in fiscal 2021 as compared to $77.2 million
in fiscal 2020. The increase in revenues was due to $812,000 of patient fees (net of contractual allowances and discounts less
provision for bad debts) from patient and third party payors recognized by five of the facilities in Florida. Also management and
other fees increased by $2.9 million due to two additional scanners being installed in existing facilities.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cost of revenues as a percentage of the
related revenues for our physician and diagnostic services management segment increased from $39.8 million or 51.5% of related
revenues for the year ended June 30, 2020 to $42.6 million, or 52.7% of related revenues for the year ended June 30, 2021. The
revenues increased more than the costs relating to these revenues.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Operating results of this segment increased
from operating income of $20.1 million in fiscal 2020 to operating income of $20.5 million in fiscal 2021. We believe that our
efforts to expand and improve the operation of our physician and diagnostic services management segment are directly responsible
for the profitability of this segment and our company as a whole.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the fiscal years ended June 30, 2021
and June 30, 2020 12.2% and 11.9%, respectively, of total revenues were derived from contracts with facilities owned by Dr. Raymond
V. Damadian, the Chairman of the Board and principal stockholder of Fonar. The agreements with these MRI facilities are for one-year
terms which renew automatically on an annual basis, unless terminated. The fees for these sites, which are located in Florida, are
flat monthly fees.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Discussion of Certain Consolidated Results
of Operations</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fiscal 2021 Compared to Fiscal 2020</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Interest and investment income decreased
in 2021 compared to 2020. We recognized interest income of $311,931 in 2021 as compared to $502,145 in fiscal 2020, representing
a decrease of 37.8%.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Interest expense of $248,665 was recognized
in fiscal 2021, as compared to interest expense of $74,321 in fiscal 2020. The increase in interest expense is attributable to
an assessment of additional taxes and interest in connection with a state income tax audit.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The 30% noncontrolling interest allocations
of $3,466,000 and $3,465,000 for fiscal 2021 and fiscal 2020 respectively, have been calculated by Income from operations, and
adding depreciation and amortization net of miscellaneous losses and other income from the Physician and Diagnostic Service Management
segment (See Note 17).</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">While revenue increased by 4.9% selling,
general and administrative expenses decreased by 7.4% to $24.7 million in fiscal 2021 from $26.7 million in fiscal 2020. This increase
was almost exclusively due to reserves placed on service contracts and management fees and other receivables resulting from the
COVID-19 pandemic. It is too early to know how much of these reserves will be recovered. Also Fonar resolved certain sales tax
liabilities during the year and was able to reverse accrued interest and penalties of $602,000 which was recorded under selling,
general and administrative expenses.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The compensatory element of stock issuances
increased from $0 in fiscal 2020 to $83,277 in fiscal 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from service and repair fees
decreased from $8.2 million in fiscal 2020 to $7.7 million in fiscal 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Continuing our tradition as the originator
of MRI, we remain committed to maintaining our position as the leading innovator of the industry through investing in research
and development. In fiscal 2021 we continued our investment in the development of various upgrades for the UPRIGHT&#174; MRI, with
an investment of $1,635,979 in research and development, none of which was capitalized, as compared to $2,025,376, none of which
was capitalized, in fiscal 2020. The research and development expenditures were approximately 18.1% of revenues attributable to
our medical equipment segment and 1.8% of total revenues in 2021, and 23.9% of medical equipment segment revenues and 2.4% of total
revenues in fiscal 2020. This represented a 19.2% decrease in research and development expenditures in fiscal 2021 as compared
to fiscal 2020.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the physician and diagnostic services
management segment, HMCA, revenues increased to $80.9 million in fiscal 2021 as compared to $77.2 million in fiscal 2020. This
is primarily attributable to an increase in patient scans resulting from our marketing efforts.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the fiscal year 2021 the Company
recorded an income tax expense of $4.0 million compared with an income tax expense of $2.4 million for 2020. The income tax benefits
are attributable to the expected tax benefits associated with the projected realization and utilization of our net operating losses
in future periods. The Company has recorded a deferred tax asset of $16.0 million as of June 30, 2021, primarily relating to the
tax benefits from the net operating loss carry forwards available to offset future taxable income. The utilization of these tax
benefits is dependent on the Company generating future taxable income. Although the Company is expecting to generate taxable income
in future periods, they cannot accurately measure the full impact of the adoption of healthcare regulations, including the impact
of continuing changes in MRI scanning reimbursement rates, and the severity and the duration of the COVID-19 virus, which could
materially impact operations. A partial valuation allowance will be maintained until evidence exists to support that it is no longer
needed.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have been taking steps to improve HMCA
revenues by our marketing efforts, which focus on the unique capability of our Upright&#174; MRI scanners to scan patients in different
positions. We have also been increasing the number of health insurance plans in which our clients participate. The utilization
of these tax benefits is dependent on the Company generating future taxable income and other factors. A partial valuation allowance
will be maintained until evidence exists to support that it is no longer needed, (principally related to research and development
credits).</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p><p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our management fees are dependent on
collection by our clients of fees from reimbursements from Medicare, Medicaid, private insurance, no fault and workers&#8217; compensation
carriers, self&#8211;pay and other third-party payors. The health care industry is experiencing the effects of the federal and
state governments&#8217; trend toward cost containment, as governments and other third-party payors seek to impose lower reimbursement
and utilization rates and negotiate reduced payment schedules with providers. The cost-containment measures, consolidated with
the increasing influence of managed-care payors and competition for patients, have resulted in reduced rates of reimbursement for
services provided by our clients from time to time. Our future revenues and results of operations may be adversely impacted by
future reductions in reimbursement rates.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain third-party payors have proposed
and implemented changes in the methods and rates of reimbursement that have had the effect of substantially decreasing reimbursement
for diagnostic imaging services that HMCA&#8217;s clients provide. To the extent reimbursement from third-party payors is reduced, it
will likely have an adverse impact on the rates they pay us, as they would need to reduce the management fees they pay HMCA to
offset such decreased reimbursement rates. Furthermore, many commercial health care insurance arrangements are changing, so that
individuals bear greater financial responsibility through high deductible plans, co-insurance and higher co-payments, which may
result in patients delaying or foregoing medical procedures. More frequently, however, patients are scanned and we experience difficulty
in collecting deductibles and co-payments. We expect that any further changes to the rates or methods of reimbursement for services,
which reduce the reimbursement per scan of our clients may partially offset the increases in scan volume we are working to achieve
for our clients, and indirectly will result in a decline in our revenues.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 23, 2010, President Obama signed
into law healthcare reform legislation in the form of the Patient Protection and Affordable Care Act, or PPACA. The ultimate impact
of the PPACA is uncertain but to date has reduced our revenues from what they otherwise would have been.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, the use of radiology benefit
managers, or RBM&#8217;s has increased in recent years. It is common practice for health insurance carriers to contract with RBMs to
manage utilization of diagnostic imaging procedures for their insureds. In many cases, this leads to lower utilization of imaging
procedures based on a determination of medical necessity. The efficacy of RBMs is still a highly controversial topic. We cannot
predict whether the healthcare legislation or the use of RBMs will negatively impact our business, but it is possible that our
financial position and results of operations could be negatively affected.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">LIQUIDITY AND CAPITAL RESOURCES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash, and cash equivalents increased
by 20.8% from $36.8 million at June 30, 2020 to $44.5 million at June 30, 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash provided by operating activities
for fiscal 2021 approximated $19.1 million. Cash provided by operating activities was attributable to the net income of $13.7 million,
depreciation and amortization of $4.1 million, deferred income tax expense benefit of $2.9 million which was offset by the increase
in accounts, and medical and management fee receivables of $12.1 million.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash used in investing activities for
fiscal 2021 approximated $4.8 million. The cash used in investing activities was attributable to purchases of property and equipment
of $3.5 million, the purchase of an imaging center for $1.1 million and costs of patents of $164,000.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash used in financing activities for
fiscal 2021 approximated $6.6 million. The principal uses of cash used in financing activities included the proceeds from loans
and capital lease obligations of $63,000, and repayment of borrowings and capital lease obligations of $103,000, and distributions
to non-controlling interests of $6.6 million.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Total liabilities increased slightly
by 0.2% during fiscal 2021, from approximately $54.0 million at June 30, 2020 to approximately $54.1 million at June 30, 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As at June 30, 2021, our obligations
included approximately $877,000 in various state sales taxes, inclusive of penalties and interest. The Company is in the process
of negotiating settlements of these obligations.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At June 30, 2021, we had working capital
of approximately $88.5 million as compared to working capital of $77.2 million at June 30, 2020, and stockholders&#8217; equity of $135.4
million at June 30, 2021 as compared to stockholders&#8217; equity of $126.2 million at June 30, 2020. For the year ended June 30, 2021,
we realized a net income of $13.7 million.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our principal sources of liquidity are
derived from revenues.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our business plan includes a program
for manufacturing and selling our Upright&#174; MRI scanners. In addition, we are enhancing our revenue by participating in the
physician and diagnostic services management business through our subsidiary, HMCA and have upgraded the facilities which it manages,
most significantly by the replacement of the original MRI scanners with new Upright&#174; MRI scanners. As of June 30, 2021, HMCA
manages a total of 39 MRI scanners of which 25 MRI scanners are located in New York and 14 are located in Florida. We have also
intensified our marketing activities through the hiring of additional marketers for HMCA&#8217;s clients.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our business plan also calls for a continuing
emphasis on providing our customers with enhanced equipment service and maintenance capabilities and delivering state-of-the-art,
innovative and high quality equipment upgrades at competitive prices. Fees for on-going service and maintenance from our installed
base of scanners were $8.2 million for the year ended June 30, 2020 and $7.7 million for the year ended June 30, 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In order to promote profitability and
to reduce demands on our cash and other liquid reserves, we maintain an aggressive program of cost cutting. Previously, these measures
included consolidating HMCA&#8217;s office space with Fonar&#8217;s office space and reducing the size of our workforce, compensation and benefits.
We continue to reduce and contain expenses across the board. The cost reductions are intended to enable us to withstand periods
of low volumes of MRI scanner sales, by keeping expenditures at levels which can be supported by service revenues and HMCA revenues.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Current economic credit conditions have
contributed to a slower than optimal business environment. As a result our business may suffer, should the credit markets not improve
in the near future. The direct impact of these conditions is not fully known.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenues from HMCA have been the principal
reason for our profitability, and we have so far been able to maintain and increase such revenues by increasing the number of scans
being performed by the sites we manage and those we own, notwithstanding reductions in reimbursement rates from third party payors.
The likelihood and effect of any subsequent reductions is not fully known.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Capital expenditures for fiscal 2021
approximated $3.7 million. Capitalized patent costs were approximately $164,000. Purchases of property and equipment were approximately
$3.5 million.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In July, 2020, we completed the installation
of a new MRI facility in Pembroke Pine, Florida.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In March 2021, we acquired a facility
by purchase of all of its assets in Yonkers, NY. HMCA will provide the use of the facility and provide non-medical services to
Comprehensive MRI of New York, P.C., a medical practice for which we provide equipment, supplies and non-medical services at other
facilities as well.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar is committed to making capital
expenditures in the 2021 fiscal year, for placing three additional scanners at facilities located in Florida and New York. One
of the facilities in Florida will be a new stand-alone facility and another will be the addition of an additional machine in Florida.
The location in New York will also be a new stand-alone facility. The current estimated costs of these capital expenditures is
approximately $3.0 million.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company believes that its business
plan has been responsible for the past five consecutive fiscal years of profitability (fiscal 2021, fiscal 2020, fiscal 2019, fiscal
2018 and fiscal 2017) and that its capital resources will be adequate to support operations at current levels through September
30, 2022.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 20, 2020, we entered into a
$4,917,325 loan agreement with the Paycheck Protection Program (&#8220;PPP&#8221;) under the CARES Act. Due to an abundance of caution,
however, on May 1, 2020, we returned the full amount of the loan, since it became increasingly unclear whether or not a public
company would be required to seek other sources of financing.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On June 30, 2020, the Company received
loan proceeds in the amount of $700,764 under the Paycheck Protection Program (&#8220;PPP&#8221;). The PPP, established as part of
the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provides for loans to qualifying businesses for
amount up to 2.5 times of the average monthly payroll expenses of the qualifying business. The Company applied for this additional
loan exclusively for the Florida locations during June 2020 due to the fact that the COVID-19 virus was increasing in Florida.
The loans and accrued interest are forgivable after 24 weeks as long as the borrower uses the loan proceeds for eligible purposes,
including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced
if the borrower terminates employees or reduces salaries during the 24 week period. This loan was forgiven during August 2021.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During August 2021 the Company renewed
their revolving credit agreement. The terms include borrowing limits of up to $10,000,000 and the agreement was extended to August
2022. The interest rate on unpaid principal remains at 4% along with certain financial covenants still applicable.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">ITEM 7A. QUALITATIVE AND QUANTITATIVE
DISCLOSURES ABOUT MARKET RISK</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company does not have any investments
in marketable securities, foreign currencies, mutual funds, certificates of deposit or other fixed rate instruments. All of our
funds are in cash accounts or money market accounts which are liquid.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">All of our revenue, expense and capital
purchasing activities are transacted in United States dollars.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 11 to the consolidated Financial
Statements for information on long-term debt.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;ITEM 8.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span id="c_001"></span>FINANCIAL STATEMENTS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">PAGE.</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 89%; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><a href="#a_002">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
<td style="padding: 0; width: 11%; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">48</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><a href="#a_003">CONSOLIDATED BALANCE SHEETS</a></span></td>
<td style="padding: 0; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">51</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">At
June 30, 2021 and 2020</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><a href="#a_004">CONSOLIDATED STATEMENTS OF INCOME</a></span></td>
<td style="padding: 0; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">54</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">For
the Years Ended June 30, 2021 and 2020</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><a href="#a_005">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</a></span></td>
<td style="padding: 0; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">56</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">For
the Years Ended June 30, 2021 and 2020</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><a href="#a_006">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></span></td>
<td style="padding: 0; text-align: center; line-height: 115%; text-indent: 0">58</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">For
the Years Ended June 30, 2021 and 2020</span></td>
<td style="padding: 0; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; text-align: justify; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><a href="#a_007">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></span></td>
<td style="padding: 0; text-align: center; line-height: 115%; text-indent: 0"><span style="font: 11pt Arial, Helvetica, Sans-Serif"></span>59</td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif"><span id="a_002"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">To
the Board of Directors and Stockholders of</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">FONAR
Corporation and Subsidiaries</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: justify; margin-right: 0; margin-left: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Opinion
on the Financial Statements</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: justify; margin-right: 0; margin-left: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">We
have audited the accompanying consolidated balance sheets of FONAR Corporation and Subsidiaries (the &#8220;Company&#8221;) as of June
30, 2021 and 2020, the related consolidated statements of income, stockholders&#8217; equity and cash flows for each of the two years
in the period ended June 30, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our
opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2021
and 2020, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2021, in conformity
with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: justify; margin-right: 0; margin-left: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Basis
for Opinion</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#34;PCAOB&#34;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provides a reasonable basis for our opinion.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Critical
Audit Matters</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">The
critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Patient
Accounts Receivable Reserve &#8211; Refer to Note 3 to the financial statements </span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Critical
Audit Matter Description </span></span></p>

<p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; color: #1F497D"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; color: #1F497D"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: center; margin-bottom: 0pt"><span style="font: normal 11pt Times New Roman, Times, Serif">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Continued)</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Patient
accounts receivable is recorded at net realizable value based on the estimated amounts the Company expects to receive from patients and
third-party payers. Estimates of&#160;contractual allowances under managed care, commercial, and governmental insurance plans are based
upon the payment terms specified in the related contractual agreements or as mandated under government payer programs. Management continually
reviews the contractual allowance estimation process to consider and incorporate updates to laws and regulations and the frequent changes
in managed care&#160;contractual terms resulting from contract renegotiations and renewals. Receivables related to uninsured patients
and uninsured copayment and deductible amounts for patients who have health insurance coverage may have discounts applied. The Company
also records estimated implicit price concessions&#160;(based on historical experience) related to accounts to record the accounts receivable
at the amount the Company expects to collect from patients and third-party payers. &#160;This implied concession requires extensive judgment
and subjective assumptions. Implicit price concessions relate primarily to amounts due directly from patients and are based upon management&#8217;s
assessment of historical write-offs and expected net collections, business and economic conditions, trends in federal, state, and private
employer health care coverage, and other collection indicators. Auditing management&#8217;s estimate of the price concessions was complex
and judgmental due to the significant data inputs and subjective assumptions utilized in determining the net realizable value of accounts
receivable.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">How
the Critical Audit Matter Was Addressed in the Audit</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Our
audit procedures related to the net realizable value of patient accounts receivable included the following:</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We obtained an understanding, evaluated the design, and tested the operating effectiveness of certain controls that address the risks
of material misstatement relating to the measurement of service fee revenue and receivables. </span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We tested informational technology general controls around the Company&#8217;s billing system and associated database. </span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We evaluated management&#8217;s methodology and related assumptions, including cash collections, by comparing actual results to management&#8217;s
historical estimates. </span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We tested the underlying data related to the recognition of patient level charges and the subsequent activities, including cash collections
and non-cash adjustments. </span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We tested the contractual rates set forth by the third-party payers which are input into the Company&#8217;s billing system and then
billed to patients and/or third-party payers. </span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We tested the mathematical accuracy of the estimates applied to period-end accounts receivable. </span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Times New Roman, Times, Serif">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We evaluated the appropriateness of the industry, economic, and Company factors that were used in determining the net realizable value
of patient accounts receivable. </span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Management
Fee Accounts Receivable Reserve &#160;&#8211; Refer to Note 3 to the financial statements. </span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Management
fee accounts receivable is related to fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;)
under management agreements. Payment of the outstanding fees is dependent on the PCs ability to collect fees from third-party payers
and patients because the management fees are collateralized by the PCs accounts receivable. &#160;The Company records the management
fee accounts receivables net of the estimated implicit price concessions based on the PCs likelihood to collect on the accounts. &#160;Implicit
price concessions on the PCs are estimated by management in the same manner the patient accounts receivable are analyzed. This implied
concession requires extensive judgment and subjective assumptions. Implicit price concessions relate primarily to amounts due directly
from patients and are based upon management&#8217;s assessment of historical write-offs and expected net collections, business and economic
conditions, trends in federal, state, and private employer health care coverage, and other collection indicators. Auditing management&#8217;s
estimate of the price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized in
determining the net realizable value of accounts receivable.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;<br /></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;<span style="text-decoration: underline">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span> (Continued)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif"><span style="text-decoration: underline">How
the Critical Audit Matter Was Addressed in the Audit</span></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Our
audit procedures related to the management fee accounts receivable reserve are consistent with the audit procedures associated with the
patient fee accounts receivable reserve. In addition, we traced the management fees to the underlying agreements and the general ledger.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">/s/
Marcum llp</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">Marcum
llp&#160;</span></p>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">We
have served as the Company&#8217;s auditor since 1990, such date takes into account the merger of Tabb, Conigliaro, McGann, P.C. (&#8220;Tabb&#8221;)
into another firm in approximately 2001 and the former partners of Tabb joining Marcum LLP in 2002.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">New
York, New York</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">October
12, 2021</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">/s/
Marcum llp&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">Marcum
llp</span></p>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="a_003"></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASSETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_zNy5mFCRihja" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20210630_zuLJH554Aby3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20200630_z0Xp0wQ0aIKa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_iB_zyegDwnS63Jc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    Assets:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_maCzyEX_zWXYBZeht9e6" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    and cash equivalents</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,460,411</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,802,342</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--ShortTermInvestments_i01I_maCzyEX_z1HsKS98PXuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
    term investments</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,177</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,884</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--AccountsReceivableServiceAndRepairFees_i01I_pp0p0_maCzyEX_z3l31oYK24A9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; net of allowances for doubtful accounts of $442,270 and $514,561 at June 30, 2021 and 2020, respectively</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,525,435</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,312,999</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--AccountReceivableRelatedParties_i01I_pp0p0_maCzyEX_zC8el8KvpPo" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; related party</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,977</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,988</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--MedicalReceivable_i01I_maCzyEX_zZxh1UlZTR81" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivables - net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,900,489</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,171,782</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--ManagementAndOtherFees_i01I_pp0p0_maCzyEX_zM3WieikRgN8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable &#8211; net of allowances for doubtful accounts of $15,786,878 and $11,063,233 at June 30, 2021 and 2020,
    respectively</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,947,863</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,437,768</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_pp0p0_maCzyEX_z4trxeHXC2ni" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $4,184,399 and
    $3,322,055 at June 30, 2021 and 2020, respectively</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,814,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,896,482</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ContractWithCustomerAssetGrossCurrent_i01I_maCzyEX_z67ZBVJ8s05d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Contract
    assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0071">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_maCzyEX_zI69aa93WG06" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,663,419</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,648,770</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--IncomeTaxReceivable_i01I_pp0p0_maCzyEX_zrZOXMQxpvJf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    tax receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0077">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeTaxReceivable" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">671,185</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzyEX_ztWqcHJuYhs3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,227,463</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,757,499</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--AssetsCurrent_i01TI_mtCzyEX_maCzSKF_zLPYVNs0OUX1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Current Assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,583,484</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,889,532</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--AccountsReceivableNetLongTerm_i01I_maCzSKF_zFsb0UwkXJl9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; long term</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,879,946</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,730,071</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maCzSKF_zeKectU7zOVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax asset</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,958,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,809,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzSKF_zxoxmiyEceEk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,850,139</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,364,034</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pp0p0_maCzSKF_zmQAvGWtd4Te" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use-asset
    &#8211; operating leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,133,285</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,392,458</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maCzSKF_zvbka4BzDnta" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use-asset
    &#8211; financing lease</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,126,990</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,325,870</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--Goodwill_i01I_maCzSKF_zPVCRlcJdwcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,985,397</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzSKF_zsXF37qVcTb1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    intangible assets &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,037,599</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,109,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAssets_i01I_maCzSKF_zUZBUrht3AN4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,514</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">653,132</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--Assets_i01TI_mtCzSKF_zTqQ5WZN2MRl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">189,506,195</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,259,380</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_407_eus-gaap--LiabilitiesCurrentAbstract_iB_zwjUJf9GfwPb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    Liabilities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_i01I_maCzofv_zF8E78kCnpz4" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    portion of long-term debt and capital leases</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173,206</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,379</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_i01I_maCzofv_zqsLzhOWq4h8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,866,035</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,965,259</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_i01I_maCzofv_zZfCXFZMKEb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,162,118</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,185,098</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maCzofv_zAZE2icqCA9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liability &#8211; current portion</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,533,656</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,370,149</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_maCzofv_z7GNt53K4S82" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liability &#8211; current portion</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,741</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,699</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--DeferredRevenueCurrent_i01I_maCzofv_zSuW2eYVZM5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned
    revenue on service contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,365,825</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,105,265</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--CustomerDeposits_i01I_maCzofv_zcOT0wytY0O1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,101</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">854,579</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ContractWithCustomerLiabilityCurrent_i01I_maCzofv_zlQwz5aoYkub" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Contract
    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,739</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0138">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesCurrent_i01TI_mtCzofv_maCzvtZ_z7JHCGxUCXt7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Current Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,049,421</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,663,428</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zcxEgt77AsL7" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Term Liabilities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredRevenueNoncurrent_i01I_maCzWB9_zRASRffk7AKd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned
    revenue on service contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,800,522</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,655,605</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maCzWB9_zzfazYk2vA15" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax liability</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,316</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,106</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--AccountsPayableRelatedPartiesNoncurrent_i01I_maCzWB9_zB0qudEvmrij" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Due
    to related party medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCzWB9_zU0OCw5xf6N7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liability &#8211; net of current portion</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,975,132</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,104,464</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maCzWB9_zi4O9w4u6esb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liability &#8211; net of current portion</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,431</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,251,171</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--LongTermDebtAndCapitalLeaseObligations_i01I_maCzWB9_zvRSkh7JyGj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    debt and capital leases, less current portion</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,254</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">865,416</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--OtherLiabilities_i01I_maCzWB9_zBomOwDqN6Ae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,331</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,311</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesNoncurrent_i01TI_mtCzWB9_maCzvtZ_z1lGin2i1J07" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Long-Term Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,086,649</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,353,736</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--Liabilities_i01TI_mtCzvtZ_maCzo4f_maLASEzct5_zscrgVl1UiS2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,136,070</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,017,164</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commitments,
Contingencies and Other Matters</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">STOCKHOLDERS&#8217;
EQUITY</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40F_eus-gaap--StockholdersEquityAbstract_iB_zN4NGZrbWDrb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stockholders&#8217;
    Equity:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Class
    A non-voting preferred stock $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_c20200630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_c20200630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2021 and 2020, <span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    and outstanding at June 30, 2021 and 2020</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PreferredStockValue_i01I_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zMFNMwkPLkm" title="Preferred Stock Value" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--PreferredStockValue_i01I_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zHAQWSzeZ4Lg" title="Preferred Stock Value" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Preferred
    stock $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2021 and 2020, issued and outstanding &#8211; <span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zkTOzriXazz5"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></span></span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PreferredStockValue_i01I_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zSKcpsHt9eg" title="Preferred Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0186">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PreferredStockValue_i01I_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z1jglA7Pg2t" title="Preferred Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0188">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    stock $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2021 and 2020, <span id="xdx_903_eus-gaap--CommonStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,565,853</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    <span id="xdx_902_eus-gaap--CommonStockSharesIssued_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,459,106</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    at June 30, 2021 and 2020, respectively; <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,447,463</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">outstanding
    at June 30, 2021 and 2020, respectively</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--CommonStockValue_i01I_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zJFOsbyYM1Yj" title="Common Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">657</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--CommonStockValue_i01I_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1xdrAIaUOh4" title="Common Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B convertible common stock (10 votes per share) $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2021 and 2020, <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    and outstanding at June 30, 2021 and 2020</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--CommonStockValue_i01I_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zWLCRw3tbJT4" title="Common Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0203">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--CommonStockValue_i01I_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2iupRQnmc63" title="Common Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0205">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C common stock (25 votes per share) $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2021 and 2020, <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    and outstanding at June 30, 2021 and 2020</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--CommonStockValue_i01I_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICYK4FoujHi" title="Common Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--CommonStockValue_i01I_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYELgraXMbm3" title="Common Stock Value" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_i01I_maCz7GQ_maSEzed2_z56DZ5luQdhk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid-in capital
    in excess of par value</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,100,976</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,076,888</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maCz7GQ_maSEzed2_zzYGIFY11Yid" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    deficit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,007,663</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56,215,251</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_405_eus-gaap--TreasuryStockValue_i01NI_pp0p0_di_msSEzed2_zGd3dQNBCxT7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    stock, at cost &#8211; 11,643 shares of common stock at June 30, 2021 and 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">675,390</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">675,390</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--StockholdersEquity_i01TI_pp0p0_mtSEzed2_maSEIPAz2Zl_zdm1vU7HxU3g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Fonar Corporation&#8217;s Stockholders&#8217; Equity</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">138,418,649</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,186,963</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--MinorityInterest_i01I_maCzEKl_maSEIPAz2Zl_z7FmXCG1M0ti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling
    interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,048,524</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,253</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01I_pp0p0_mtSEIPAz2Zl_maLASEzct5_zCelMOPDmwU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Stockholders&#8217; Equity</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">135,370,125</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,242,216</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzct5_zdruDSthrhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Liabilities and Stockholders&#8217; Equity</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,506,195</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">180,259,380</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="a_004"></span>FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF INCOME</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_zUgKgzbwkmK5" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF INCOME" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20210630_zm6jwQ4Kbpae" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20190701__20200630_zSj4kAyZqK3j" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_409_eus-gaap--RevenuesAbstract_iB_zMTyYPv7kp9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCzFHr_z6RH64PkneMk" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    fee revenue, net of contractual allowances and discounts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,307,389</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,495,260</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--ProductSalesNet_i01_maCzFHr_z4yDUWioqd71" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Product
    sales &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,288,483</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">297,613</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--ServiceAndRepairFeesNet_i01_maCzFHr_zggJl4YxApm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,638,608</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,055,490</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCzFHr_zR5XIAABJeM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; related parties &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--ManagementAndOtherFeesNet_i01_maCzFHr_zjrIqOhTIaE" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,609,449</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,565,405</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCzFHr_zf7gYeR0Q5r5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; related party medical practices &#8211; net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,975,836</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,166,694</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--Revenues_i01T_mtCzFHr_maCza1M_z8bF5p2fSoma" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,929,765</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">85,690,462</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--CostsAndExpensesAbstract_iB_zDzjy7QYb7i8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--CostsRelatedToProductSales_i01_maCzNfg_zDdCeVs59hva" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to product sales</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,032,676</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">745,375</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzNfg_zEfqo5GMuiU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,740,625</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,731,397</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzNfg_zCtiqv8gPZ8k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees &#8211; related parties</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,466</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,298</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzNfg_z7h5kqbxEgRc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to patient fee revenue</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,917,635</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,880,265</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzNfg_zMGSMBJzuolg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,384,557</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,951,301</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_pp0p0_maCzNfg_zN4i3eXtG3z3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees &#8211; related party medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,341,168</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,951,189</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzNfg_z9a479iNg9ll" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
    and development</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,635,979</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,025,376</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzNfg_zyHu4ocBaaR9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Selling,
    general and administrative, inclusive of compensatory element of stock issuances of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
    the years ended June 30, 2021 and 2020 respectively</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,740,044</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,717,345</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--CostsAndExpenses_i01T_mtCzNfg_msCza1M_zyMVlgnb5LRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,832,150</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,039,546</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCza1M_maCzFDh_zPJiALUc55yh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    from Operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,097,615</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,650,916</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--OtherExpensesAbstract_iB_zaMDmCjzoce9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Income and (Expenses):</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--InterestExpense_iN_di_msCzFDh_zaEdJRQGZpVh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    expense</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,665</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,321</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_eus-gaap--InvestmentIncomeNet_maCzFDh_zNQUnpyAwG6i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Investment
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">311,931</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">502,145</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherNonoperatingIncomeExpense_maCzFDh_zWwb0K0vQ7Q" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">504,450</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,771</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzFDh_maCzoRe_zbu8rYvBjOR3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    before provision for income taxes and noncontrolling interests</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,665,331</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,149,511</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzoRe_z3WGW1Z46Fs5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    for Income Taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,991,520</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,444,778</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--ProfitLoss_iT_mtCzoRe_zWnEejj7HVF3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673,811</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,704,733</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_zu6CTdoUfrOf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Noncontrolling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,466,223</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,464,528</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40F_eus-gaap--NetIncomeLoss_z49ULFS3n9ql" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,207,588</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,240,205</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF INCOME (Continued)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Common&#160;Stockholders</span></td><td style="width: 8%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,592,134</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,735,650</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_pp0p0" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">458,710</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_pp0p0" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">376,055</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class C Common&#160;Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,744</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Basic Net Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Basic Net Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.20</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Diluted Net Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.45</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Diluted Net Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.18</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    and Diluted Income Per Share &#8211;&#160;Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic Net Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic Net Income Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.34</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average
    Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_pdd" title="Weighted Average Basic Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_pdd" title="Weighted Average Basic Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,443,713</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average
    Diluted Shares Outstanding &#8211; Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQCS2bZtOD3g" title="Weighted Average Basic Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,632,787</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zclHX2rexxx7" title="Weighted Average Basic Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,571,217</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic and Diluted Shares Outstanding &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Weighted Average Basic and Diluted Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Weighted Average Basic and Diluted Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="a_005"></span>FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FOR
THE YEARS ENDED JUNE 30, 2021 AND 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_114_zeAht4ZDMdp1" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--ClassANonVotingPreferredMember_zeOZtb9iRWo3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zqsc0OKwVXU7" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_custom--ClassCCommonStockMember_znBrkGWw7t7" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Non-Voting Preferred</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Shares</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    Amount</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr id="xdx_434_c20190701__20200630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zZ7MPUxuYKz4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    July 1, 2019</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharesIssued_iS_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziq05wj0sxmg" title="Beginning Balance, Shares" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,357,482</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">638</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_zx8h4QVv2Vjk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0364">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0365">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zkZSCfHoUWlc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0367">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMK0mPUrSow3" title="Stock issued to employees under stock bonus plans, Shares" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">89,981</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0369">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--PaymentsOnNotesReceivableFromEmployeeStockholders_z9dbiYPLDUT3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payments
    on notes receivable from employee stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0373">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0374">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0375">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_znvbkIMd8fek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0378">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0379">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_433_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z5RXCxVYoPQ5" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance, June
    30, 2020</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesIssued_iS_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRNNu2Qpee4i" title="Beginning Balance, Shares" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember550836687" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,447,463</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember550836687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--ProfitLoss_zGWqiKgQJXH" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0387">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0388">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0389">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zNGnxLeRiaF7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0391">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSMBZQm4U65c" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">106,747</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0393">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zHeCJZh5icL7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0396">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0397">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0398">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_43A_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zPd1YQ6P1i7i" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance, June
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharesIssued_iE_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwhD6YDtwAHl" title="Ending Balance, Shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember550836687" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember550836687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 75%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zbyYRYCFR3b8" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zGpLfu81avNb" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid-in
    Capital in Excess of Par Value</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td></tr>
<tr id="xdx_43C_c20190701__20200630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zGMXjphLRAic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    July 1, 2019</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">181,086,517</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64,455,456</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_405_eus-gaap--ProfitLoss_zIawO833Q4F6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0409">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,240,205</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zZoGdcldwAbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,990,371</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0413">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zS9if0a3bZtl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_43B_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zFRjYYRPGH05" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance, June
    30, 2020</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,076,888</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56,215,251</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_409_eus-gaap--ProfitLoss_zvDC5jKmKiUk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0421">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,207,588</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_z5TfLehxaaXg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,024,088</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0425">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_z5YYKG8ocH1l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0427">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_433_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zO1hqKfdXMRj" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance, June
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,100,976</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,007,663</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FOR
THE YEARS ENDED JUNE 30, 2021 AND 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_z5Zz4bvwnKW7" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zgFtHg3ZSO" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4BA_z4KUOgEqSPPi" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling
    Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_43B_c20190701__20200630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zRGhJFjONjgb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    July 1, 2019</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,155,725</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,112,103</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--ProfitLoss_zYVQ8IIcf6K5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0437">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,464,528</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,704,733</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zW7KHo1Cb4tf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0441">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,990,380</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zmI7CHBWFSbb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0445">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,565,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,565,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_43B_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z7kvjF85nUx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance, June
    30, 2020</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,253</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,242,216</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ProfitLoss_zTwDFkVD5A2h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,466,223</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673,811</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_z4XvS0jlPMe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,024,098</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zmRS4LOvku7i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,570,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,570,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_43F_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zhJQpy4S2g37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance, June
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,048,524</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,370,125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="a_006"></span>FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_112_z1q8AUTNvcrk" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49E_20200701__20210630_zmHY3r0GTmnk" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20190701__20200630_zhpa9kOpENBj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zyFVAaCFeNM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    FLOWS FROM OPERATING ACTIVITIES</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ProfitLoss_maCzXEl_zYWlGP37pXF9" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673,811</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,704,733</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zIBswo2zNlpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Adjustments
    to reconcile net income to net cash provided by operating activities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherDepreciationAndAmortization_i01_maCzXEl_zPxfTd4k8Qfd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,081,687</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,908,648</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--ProvisionForBadDebts_i01_maCzXEl_zL0JOjSEOt67" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    for bad debts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,585,989</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,695,420</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCzXEl_zewBTfJcSjh6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax - net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,855,006</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,118,829</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxCreditsAndAdjustments_i01_maCzXEl_z4Sm0Yy3Jgu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    tax receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeTaxCreditsAndAdjustments" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">671,185</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeTaxCreditsAndAdjustments" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528,815</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_maCzXEl_z54t7DNtiu2b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
    on right-of-use assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,458,053</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,005,560</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--CompensatoryElementOfStockIssuances_i01_maCzXEl_zwf9DRmKI157" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CompensatoryElementOfStockIssuances" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,277</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i01_maCzXEl_z0HTvc00nCk4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued for costs and expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,940,821</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,990,380</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_i01N_di_msCzXEl_zBzVZJ3d8MJb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Abandoned
    patents</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">534</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0500">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_ziG0vjZG7Yca" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Increase)
    decrease in operating assets, net:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzXEl_zXvLM9H6YXo3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts,
    medical and management fee receivables</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,110,859</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,797,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInReceivables_i01N_di_msCzXEl_zF884C8FMoQ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,944</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,889</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInCommodityContractAssetsAndLiabilities_i01N_di_msCzXEl_zkbd9X0UENAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Contract
    assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">372,277</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzXEl_zgxxA6x8hoKf" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,649</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">149,396</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzXEl_zKOpkM6Z68pi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">526,425</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,287</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCzXEl_zvPgp52vE6sc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,087</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,350</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB_ztAHDVIsw9T3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Increase
    (decrease) in operating liabilities, net:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzXEl_zRl01EmRA6vb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">99,224</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,032</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maCzXEl_zODHvKm38Hq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,382,497</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,556,437</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maCzXEl_zBEo7XHGEjt8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    advances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">123,478</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingLiabilities_i01_maCzXEl_ziotu8PHTMr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">965,825</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,657</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_di_msCzXEl_zS6vu4pQCaAe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,698</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0539">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--IncreaseDecreaseInContractLiabilities_i01_maCzXEl_z6s76ISyHa6e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Contract
    liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,739</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0542">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_maCzXEl_z8I96f3WGHs3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,020</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,855</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzXEl_maCzHIy_zRaNOJIQocq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    CASH PROVIDED BY OPERATING ACTIVITIES</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,088,001</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,402,763</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zyUy4KJLkAA9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    FLOWS FROM INVESTING ACTIVITIES</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzw7N_znBpbvntbCE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchases
    of property and equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,533,091</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,522,997</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_eus-gaap--PaymentsForProceedsFromShortTermInvestments_i01N_di_msCzw7N_ziCbR1h3rO0c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Proceeds
    of Short term investment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,062,932</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--PurchaseOfImagingCenter_i01N_di_msCzw7N_zQxmFCdZiiij" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of imaging center</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PurchaseOfImagingCenter" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,122,508</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0560">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCzw7N_za5v9ZvltWn4" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cost of patents</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,705</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,522</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzw7N_maCzHIy_zPGjETUAun6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,819,597</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,422,413</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zncSMVMS4Omh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    FLOWS FROM FINANCING ACTIVITIES:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzVpW_z2lPwfwmpZf7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Repayment
    of borrowings and capital lease obligations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,335</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,957,936</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromIssuanceOfDebt_i01_maCzVpW_zQxEfDBdcw94" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Proceeds
    from debt</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,618,089</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msCzVpW_zEWfQOMygTQ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,570,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,565,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzVpW_maCzHIy_z2WOkVUohZfa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    CASH USED IN FINANCING ACTIVITIES</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,610,335</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,904,847</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCzHIy_zWY9VlObpgj1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,658,069</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,920,329</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01S_zYdY3Vur8G68" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    AND CASH EQUIVALENTS &#8211; BEGINNING OF YEAR</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,802,342</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,882,013</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01E_zrwbIuekoxOh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    AND CASH EQUIVALENTS &#8211; END OF YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,460,411</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,802,342</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="a_007"></span><br />
FONAR CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_801_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zSrIMiBonpE6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82C_z6jXO2zr5IN2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#8220;MRI&#8221;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_900_ecustom--ImperialContributionPercentage_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z0Km41pjoJHf"><ix:nonFraction name="FONR:ImperialContributionPercentage" contextRef="AsOf2015-07-01_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z976zDP9yjm6"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2015-07-01_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
in HDM, and the original investors in HDM retained a <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z9llCzq97kXe"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2015-07-01_custom_HDMMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted
by HDM.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel to travel
for marketing purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and
the Company has been steadily recovering to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able
to enact certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases
in scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#8216;PPP&#8217;) program
and Medicare advances/stimulus payments. Although we are unable to predict if there will be additional consequences on our operations
from the continuing global pandemic of COVID-19 and the new variants, the Company believes with the positive cash flows, low debt and
cash on hand, it will be able to continue operations going forward.</span></p>

<ix:exclude><p id="xdx_234_zxNQtRsNbtM5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zhuMoQtL84I1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zVhaMeFt9VZ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_23B_zr8RStqnDx7f" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zPK7yHIwKKUi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zcfxwNJybWwd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zqER2a0kfRsf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z1N2ApVf55o3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zYulH27BVNMd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_821_zVDO5JLtNpz2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zLtLsqmwhe23" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zxPf8p16bxF8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84C_eus-gaap--UseOfEstimates_zBqSjqTontc6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_860_zcH5SNBobXa4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Use
of Estimates</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:InventoryWorkInProcessPolicy"><p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zvuNP967cxF2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zYqIXvW9FN3d" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zIbbGTvGSA3h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zAHENb4dKiq1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and Equipment</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment procured in the normal course of business is stated at cost. Property and equipment purchased in connection with an acquisition
is stated at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting
purposes using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter
of the useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses
totaled approximately $<span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,051,000</ix:nonFraction></span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,870,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for the
years ended June 30, 2021 and 2020 respectively. The estimated useful lives in years are generally as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment"><table cellspacing="0" cellpadding="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
Useful Life in Years for Property and Equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">13</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
development and demonstration equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
and equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">2</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
and fixtures</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">9</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
improvements</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
<td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">28</ix:nonNumeric></span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23D_zKeQX0Rsl5yb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 60 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zaP7FJLXB9d2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zzxQI6RwvYL3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z6sXfxUPXDKe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z0r8f7rdQGL7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zC8v6mYRcnU7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zpl76ivvRiMc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zcCurBkSrjZ3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zgIqKKXYtDG2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zZz8Q5RcxKQf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_ztuPuSG6wJ2g" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Lived
Assets</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaSg3dJzIcK1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zfJcFT8xxeee" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Intangible Assets</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1)
Patents and Copyrights</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight-line basis over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyj86MpWUw6f"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_IntellectualPropertyMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2)
Non-Competition Agreements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
non-competition agreements are being amortized on the straight line basis over the length of the agreement (<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zXlMLHrL1Fg3"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3)
Customer Relationships</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight line basis over <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zW7GgkeyX1q9"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_848_eus-gaap--GoodwillDisclosureTextBlock_zpRTJLmWQx53" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zPbmbZCubsO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing the
reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount of the reporting
unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure the amount of impairment
loss, if any.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock"><p id="xdx_848_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zkKMC3wi5Hra" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86A_zzDdrzGNAwc5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquired
assets and assumed liabilities</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to ASC No. 805-10-25, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, but during the allowed measurement period not to exceed one year from the acquisition date, the Company adjusts
the provisional amounts recognized at the acquisition date by means of adjusting the amount recognized for goodwill.</span></p>

<ix:exclude><p id="xdx_238_zmWoXzuf1ndb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zmonEIlZtkge" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 61 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zt943qDABBS3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_23E_zmUZPKwUidTk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zMMDCt24BLub" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zrPiDG5INJta" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zcV5gHI2j9qf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zfI68gKpZlqc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z0KEVWqaaXli" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_z7pbiOEpTgY2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zuVgzj3IKn35" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on sales contracts for scanners, included in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from product sales (upgrades and supplies) is recognized upon shipment.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2021, the Company has twenty
two <span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20210630_zcSncm0bFo95"><ix:nonFraction name="FONR:ManagementAgreementsWithCompanyTotalMedicalPractices" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">22</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">management
agreements of which three <span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20210630_zwDV9ROkB2Uj"><ix:nonFraction name="FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are with
PC&#8217;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (&#8220;the Related medical practices&#8221;) and nineteen
<span id="xdx_905_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20210630_zASamHcSk18a"><ix:nonFraction name="FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">19</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$<span id="xdx_904_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_za2HOkZvPstc"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMinimum" contextRef="AsOf2021-06-30_custom_DiagnosticImagingFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to $<span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_z3UgKWymxQM4"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMaximum" contextRef="AsOf2021-06-30_custom_DiagnosticImagingFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">522,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts
for estimated uncollectible fees, which is reflected in other operating expenses on the Statement of Operations. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2018, the Company adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board
(&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company applied the modified retrospective approach to all contracts when adopting ASC 606. As a result, at the adoption of ASC 606 the
majority of what was previously classified as the provision for bad debts in the statement of operations is now reflected as implicit
price concessions (as defined in ASC 606) and therefore included as a reduction to net operating revenues in 2019. For changes in credit
issues not assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the
statement of operations.</span></p>

<ix:exclude><p id="xdx_23A_zL45BuS3qV7a" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zOkyZPMxqJid" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 62 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_ztUiBbvSuQ1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_231_zrYIddNfyGR1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z23DVwpg0mt3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zlhXFEJS22ja" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zWYXTo5zmHXj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zWTLenVlWt57" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zKyrJC7zTnt" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z6tZepzFDVzc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z65MZ4Llgap4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zk1u7LQdikMa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition
standards that required it to be presented separately as a component of net operating revenues.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2021 and 2020 are summarized in the following table.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" title="Net Patient Fee Revenue" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,100,440</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" title="Net Patient Fee Revenue" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2019-07-012020-06-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,545,987</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" title="Net Patient Fee Revenue" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">968,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" title="Net Patient Fee Revenue" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2019-07-012020-06-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,038,288</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" title="Net Patient Fee Revenue" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,011,111</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" title="Net Patient Fee Revenue" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2019-07-012020-06-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,028,737</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,227,783</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2019-07-012020-06-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">882,248</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,307,389</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,495,260</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_z8WrJQIPxgf1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_867_zAFh41uMKkSg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and Development Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.</span></p>

<ix:exclude><p id="xdx_234_zE0ZWlrCC5Ui" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zTj8mKh0JVUg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 63 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zPAzd2aAOt2g" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_239_z0eeCbx6RYNj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z5UW5f6RFQj3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zz1akqHtjgIg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_237_zmfmInMZh138" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zoNF4MbVgA72" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zMb738XQXHuj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVXAGHqj5Gw3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zprP5qeyBaw6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
costs are expensed as incurred. Advertising expense approximated $<span id="xdx_904_eus-gaap--AdvertisingExpense_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">633,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">566,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and for
the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:ShippingsAndHandlingCostPolicyTextBlock"><p id="xdx_844_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zxSiwQ5y1MAi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_z0SYCump33c7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shipping
Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s shipping and handling costs are included in revenue from product sales and the related expense included in costs related
to product sales is $<span id="xdx_90C_ecustom--ShippingAndHandlingExpense_c20200701__20210630_pp0p0"><ix:nonFraction name="FONR:ShippingAndHandlingExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,215</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_906_ecustom--ShippingAndHandlingExpense_c20190701__20200630_pp0p0"><ix:nonFraction name="FONR:ShippingAndHandlingExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,056</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
the years ended June 30, 2021 and 2020 respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zA5xsR1rShAh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86D_zQ9eRVz29CBl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
Taxes</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:CustomerAdvancesPolicyTextBlock"><p id="xdx_845_ecustom--CustomerAdvancesPolicyTextBlock_zaq3qTpC6NKd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_869_zdANIG3i80mf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
Advances</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zmWFhyEeRnsl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86B_za9HiphMAcj8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the
Two-Class Method&#8221;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2021 and 2020, diluted EPS for common shareholders
includes <span id="xdx_90C_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20190701__20200630_pdd"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.</span></p>

<ix:exclude><p id="xdx_237_z1E6FeuvYIkd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zKYp58ZEpP84" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 64 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zVqLwFuZg4kb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zCBy8h3akYm8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zigmdvuKZEm4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zbFiFKC21Ewl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z3Sc07CHls56" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zlyyyDLodXz4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zURIChPw3hR5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zWyrbpKShvkh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zdUz0CSjgmRh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zVBPA61S1FKk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BF_zClNNIkWZL8a"><span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
    Per Share</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,207,588</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,592,134</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,744</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.57</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,632,787</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.45</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,240,205</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,735,650</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,500</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,443,713</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,443,713</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.28</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.20</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.34</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" title="Weighted average shares outstanding" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,443,713</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0795">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,571,217</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.18</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.34</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A8_zzHEmSqwJ6E6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFXANRH7PhBg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zGeYtXpuQ5a4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>

<ix:exclude><p id="xdx_231_zDXz4cAYw1ub" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_ztlOXH767eWd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 65 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zAGXPrB1sqw5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_237_zrejnI6TqIQ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zicePwHvdMrh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zOYeutBvUz6d" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zSzGe4RWJ3Mi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zqo3LpW4ckn3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zYjSFkRKkTxg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zCYsOhXUbqbf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zXSCVqo92S6c" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
Term Investments</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zMEReFdwkn94" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zCZ12RgmjCLa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2021, the Company had cash on deposit of approximately $<span id="xdx_90C_eus-gaap--Cash_c20210630_pp0p0"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,609,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20210630_pp0p0"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zPMBJMQeMLx7"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zrOkxu7pQv2g"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012020-06-30_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively. Net management fee receivables from the related
party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zHvSLpgsqtMl"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zPb9MQN8nj7i"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012020-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOyVwEzJJY21" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_ztzpkTwsHCm9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2021 and 2020, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>

<ix:exclude><p id="xdx_233_z3WKZtROBTZa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zrPEsfq5cOPd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 66 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zEr4T9sEv2Pc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zs7D4V2XRvY4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zrWC5qNpBYuh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zoYdznNrZsNh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zgXCpPJGXnvb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zIXWbaTXwPrf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zfRVHRT72IUb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zwOmrtsxa5X6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zhx4jgMFiT22" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_868_zYdBpS4sSaS6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Pronouncements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
December 2019, the FASB issued ASU 2019-12 (&#8220;ASU 2019-12&#8221;), Income Taxes (Topic 740). ASU 2019-12 removes certain exceptions
related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition
of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12
was effective beginning in the first quarter of 2021. Certain amendments in this update must be applied on a prospective basis, certain
amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through
a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. The adoption of this update did not have a material
impact on our financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2017-04, Intangibles &#8211; Goodwill and Other (Topic
350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required
the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the
procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The
amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning
after December 15, 2019. The Company adopted the Standard on July 1, 2020 and the impact of adopting this guidance had no material impact
on our Consolidated Financial Statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2021
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those pronouncements will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<ix:exclude><p id="xdx_23D_zFdfIBnrzIZe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 67 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zekgPlWN2hn3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_235_z0iP2YUqSlGd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zjWmnmcoidHi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z1QfWgyVM7si" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zsoM4alnHLOj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_804_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zCLMPZEgKfec" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_82A_zea6mcqT0vBk">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following four years at June 30, 2021 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoBFjbafe4G9" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_z38JyVFkWP0a" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivables
    - Non Current - net</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210630_zuHAmvvH42O6" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pp0p0_maARBFLzg6L_zQnwfqZLr0fb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueOneToTwoYears" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,020,140</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_maARBFLzg6L_zIFq4Asfjxqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,020,140</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_maARBFLzg6L_z1E8DF4fWvr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">599,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_maARBFLzg6L_zioLAlunrAD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueFourToFiveYears" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,697</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pp0p0_mtARBFLzg6L_zpQKMbMNJrNj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,800,522</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<ix:exclude><p id="xdx_232_zQGGnY6H2kjk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 68 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zr2aTqWOKJje" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zcTQXM9GtH5e" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zSEYngnZwXvc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zzdmdCyBeoy6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zaAKD4aQcLJi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zzGOU8JSQPrc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s receivables from the related and non-related professional corporations (&#8220;PCs&#8221;) substantially consist of fees
outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third party
medical reimbursement organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90B_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20210630_zwU20bZAzQyk"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_903_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20190701__20200630_zS8V3puKjQHe"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
respectively, of the PCs&#8217; 2021 and 2020 net revenues were derived from no-fault and personal injury protection claims. The Company
considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#8217;s expectations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related party medical practices accounted for approximately <span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20210630_zYtXfSBRIwUi"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90C_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20190701__20200630_zYeh3N6eWUH4"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company,
which have arisen under each individual management agreement.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table sets forth the number of our facilities for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zqieCF8R7qc8" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B0_zzzGG3b2SDtk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20200701__20210630_zZQlJWUvrOl3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20190701__20200630_ztsqqEiy72Jj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Year Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40F_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_uN_znGr62zMQxE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at Beginning of Year)</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="N">25</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="N">26</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Facilities
    Added by:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ManagedFacilitiesAddedAcquisition_uN_zRoaEaKANBvh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquisition</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagedFacilitiesAddedAcquisition" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0877">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--ManagedFacilitiesAddedByInternalDevelopment_uN_zXRGLSNcSI11" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Internal
    development</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0880">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ManagedFacilitiesClosedDuringYear_uN_zHHJ2Z6ihqVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
    Facilities Closed</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0882">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="N">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_uN_zGJjal9NGXx2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at End of Year)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="N">27</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="N">25</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>





<ix:exclude><p id="xdx_237_zp488bPylltl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 69 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zKeIyLPMWDUg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zAWwS1aaNIWh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zlhlQdiReUYa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zMERzGrITWV8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock"><p id="xdx_803_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_zhJ1WWO5fEQh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_z93nS4bFuySh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; CONTRACT ASSETS AND LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
relating to uncompleted contracts as of June 30, 2021 and 2020 about contract assets and contract (liabilities) is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zlhn1AN11dV" summary="xdx: Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0; padding-right: 0"><span id="xdx_8BB_zwtFauVdJpP5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">`Costs
    and Estimated Earnings on Uncompleted Contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210630_zxPyr040yaSh" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20200630_z6tLCJpz5K42" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_407_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzX6u_z9fo0QQbVcUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    incurred on uncompleted contracts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsIncurredOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">294,783</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsIncurredOnUncompletedContracts" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">448,437</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzX6u_zWePQjsPMiO7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
    earnings</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EstimatedEarnings" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">567,978</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EstimatedEarnings" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">309,248</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzX6u_maCAEEIz60s_zXtcV4aEcssc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and estimated earnings on uncompleted contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsAndEstimatedEarningsOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">862,761</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsAndEstimatedEarningsOnUncompletedContracts" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">757,685</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz60s_zo5aWfzTjK22" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Billings to date</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:BillingsToDate" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">877,500</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:BillingsToDate" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">604,852</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz60s_z3DkGDjrfMti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and estimated earnings in excess of billings on uncompleted contracts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,739</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">152,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_805_eus-gaap--InventoryDisclosureTextBlock_z2bhGtPO2vgl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zzuPqy0yPFJf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
5 &#8211; INVENTORIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying consolidated balance sheets consist of:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEZlWDlLOQva" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zyPaFYGMnLZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210630_z9YOyYUuJnVb" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200630_zfDZsGiiNszj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_408_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWz0L2_zoKmIuMutIOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,393,329</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,544,036</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWz0L2_zuuS48pQnW8i" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">270,090</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,734</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWz0L2_zVe2OZvxW0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,663,419</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,648,770</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNC6esK4vxh9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span id="xdx_821_zga6IPHNiRqh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
6 - PROPERTY AND EQUIPMENT</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2021 and 2020, is comprised of:&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwUO3RV0kjm8" summary="xdx: Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zkCxt8jO2F4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and Equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,826,829</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,434,063</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,029,551</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,901,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,450,664</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,291,666</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,961,887</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,736,825</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">939,614</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">939,614</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,277,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20200630_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,373,184</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated depreciation and amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20210630_zvVIPqA3ouae" title="Less: Accumulated depreciation and amortization of property and equipment" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,427,461</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20200630_zuNN7xmynn1h" title="Less: Accumulated depreciation and amortization of property and equipment" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,009,150</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" title="Property and Equipment AfterAccumulated depreciation and amortization" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,850,139</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20200630_pp0p0" title="Property and Equipment AfterAccumulated depreciation and amortization" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,364,034</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
and amortization of property and equipment for the years ended June 30, 2021 and 2020 was $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSoldDepreciationAndAmortization_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" contextRef="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,696,986</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--CostOfGoodsAndServicesSoldDepreciationAndAmortization_c20190701__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" contextRef="From2019-07-012020-06-30_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,144,580</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<ix:exclude><p id="xdx_235_zvug84Ve16Z5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 70 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zHirrwgv1sGi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zNaxz8M5GMm8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z7h3IWjfc3uk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z36qRYYiMsj2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zcIkDvtxxIP4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_805_eus-gaap--LesseeOperatingLeasesTextBlock_zXV6cHCPDnx8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zfNxIgBcMGec" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; OPERATING &amp; FINANCING LEASES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases
as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase by the
lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line
basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with
a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less will be accounted for similar
to existing guidance for operating leases. The standard was effective for us beginning July 1, 2019. We have elected the optional transition
method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented
in the consolidated financial statements. We have also elected the transition package of thee practical expedients permitted within the
standard which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and indirect
costs. The adoption of this guidance had a material impact on the Company&#8217;s balance sheet by virtue of including the present value
of its future operating lease payments as a liability of $<span id="xdx_900_eus-gaap--OperatingLeasePayments_pp0n3_dm_c20200701__20210630_zxPuq0Ogikvc"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">33.3</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
and related right-to-use lease assets as of July 1, 2019. At the time of adoption of this guidance we had no significant financing leases.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as
of June 30, 2021 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zMDOU8DTqM0l" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_8BF_zEcB5YqbzAxl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    of operating and financing lease payments</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Year
    Ending<br />
    June 30,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    Lease<br />
    Payments</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" title="2022" style="width: 26%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,077,656</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" title="2022" style="width: 26%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" title="2023" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,172,157</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" title="2023" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" title="2024" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,837,900</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" title="2024" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" title="2025" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,725,550</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" title="2025" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" title="2026" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,285,124</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" title="2026" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" title="Thereafter" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,950,126</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" title="Thereafter" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">162,898</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PresentValueDiscount_c20210630_pp0p0" title="Present Value discount" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,539,725</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PresentValueDiscountFinancingLease_c20210630_pp0p0" title="Present Value discount, Financing Lease" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">133,441</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_c20210630_pp0p0" title="Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,508,788</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210630_pp0p0" title="Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,251,172</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>





<ix:exclude><p id="xdx_230_zal9J8WuZeo4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 71 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zLVpnAbde4ea" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zwCk5QWHGj4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_ziNwZ8Wk6kS1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zyA9h9R4NMF3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zuQp7almICTa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zRbGWIJRLSpl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; OPERATING &amp; FINANCING LEASES (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
Average Remaining Lease Term</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases - years</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zyiKeR8aFeId" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2021-06-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">9.4</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease - years</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_901_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zHyDciq5j3Od" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2021-06-30" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">5.6</ix:nonNumeric></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average
    Discount Rate</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zX3jn1iTNo2j" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zLJKkgRcvkFi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A7_zvb9V3irp98k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
components of lease expense were as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zNBBitWNGn5a" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zsnyY55tolR" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    of lease expense</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20200701__20210630_zz0TZKPAK4Sh" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20190701__20200630_zjPNhS75wov1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease cost</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,145,701</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,135,604</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease cost:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    of leased equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1030">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    on lease liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,472</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1033">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    finance lease cost</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">246,353</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1036">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
cash flow information related to leases was as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zxciqAwBS698" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_zlpYDIrDrba8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
    cash flow information related to leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20200701__20210630_zI5AZPQZsM68" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20190701__20200630_zG5ySzJR2yw2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    year ended</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,970,934</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,170,977</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    cash flows from financing leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,038</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    &amp; equipment assets obtained in exchange for lease obligations:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td id="xdx_F42_zfwrmZn7BRha"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases(1)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2020-07-01to2021-06-30" id="Fact001046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,531,889</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2019-07-012020-06-30" id="Fact001047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,786,611</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_zqRFsh9v7ux" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1049">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,325,871</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F0E_z1lTZArbGDC8" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
  <td id="xdx_F14_zlPnT2lvPHtl" style="padding-left: 11pt; text-indent: -11pt"><ix:footnote id="Footnote001051" xml:lang="en-US"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  for the year ended June 30, 2020 include the transition adjustment for the adoption of topic 842 of $31,651,110.</span></ix:footnote></td></tr>
</table>


<ix:exclude><p id="xdx_23F_zS6JHFwzq0Oh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 72 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zdN2H75EOzNd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_23D_znW8PCX79fRf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zbPws3zj2vMb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zCUlRa9MkRf9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zV1bNIMmSJdd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_zsaTfRi9NyKl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_zQMXwypJdeZ3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - OTHER INTANGIBLE ASSETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, at June 30, 2021 and 2020 are comprised of:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbXy2181BX2g" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zILyUXvgO2Gb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intagible Assets - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" title="Other intangible assets - gross" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004,847</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" title="Other intangible assets - gross" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004,847</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - gross" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,244,892</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - gross" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,081,721</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-competition
    agreements</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Other intangible assets - gross" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,150,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Other intangible assets - gross" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,100,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - gross" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,900,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - gross" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,800,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" title="Other intangible assets - gross" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,299,739</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630_pp0p0" title="Other intangible assets - gross" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,986,568</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20210630_zTn2YN4m0lY2" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,262,140</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200630_pp0p0" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,877,439</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iI_pp0p0_c20210630_zCuIGUHQA6gi" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--OtherIntangibleAssetsNet_c20200630_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,109,129</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
estimated amortization of other intangible assets for the five years ending June 30, 2026 and thereafter is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zBuqZYKbMIwk" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zB5P59yB77f9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    Of Other Intangible Assets</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49B_20210630_zeJIn3QGdWfj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zSxXkzAjN876" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zGDhhxG9qfoa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjs3UftClBE5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years<br />
    Ending June 30,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and Copyrights</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-
    <br /> competition</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Relationships</span></td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">423,209</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">185,709</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">389,168</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,168</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1100">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">388,867</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">188,867</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">383,912</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">183,912</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1110">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">373,220</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,220</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1115">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,079,223</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">765,056</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1120">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,314,167</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_z5Jw5o8TSqsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,685,932</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,314,167</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
weighted average amortization period for other intangible assets is <span id="xdx_906_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20200701__20210630_zBl64AhToYm3"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">11.4</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years
and they have no expected residual value.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
related to the above intangible assets for the years ended June 30, 2021 and 2020 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZJ5f4yVc1ta" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zmE4HPVTja7e" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; Beginning of Year</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_zJtB6wn9h7g9" title="Balance - Beginning of Year" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,109,129</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20190701__20200630_zz3zceFQ0pDa" title="Balance - End of Year" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,755,675</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
    capitalized</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" title="Amounts capitalized" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">313,705</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--AmountsCapitalized_c20190701__20200630_pp0p0" title="Amounts capitalized" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">117,522</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Software
    or patents written off</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pp0p0" title="Software or patents written off" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">534</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_c20190701__20200630_pp0p0" title="Software or patents written off" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1141">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" title="Amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">384,701</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AdjustmentForAmortization_c20190701__20200630_pp0p0" title="Amortization" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">764,068</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; End of Year</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_zFrPxUK9UwN4" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20190701__20200630_zpoSwOBJRgX6" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,109,129</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>





<ix:exclude><p id="xdx_23A_zMjeotorOvVf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 73 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zUYKnHTIMiAa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zTRBq1ih7X0c" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zZGsw7OEIaNh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zMHUdJESZci7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_z1ibyfNfdsHi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zNMvFIdfS7Qd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - OTHER INTANGIBLE ASSETS (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the years ended June 30, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,701</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-07-012020-06-30_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">183,592</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
software development costs were fully amortized as of June 30, 2018.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of non-competition agreements for the years ended June 30, 2021 and 2020 amounted to $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,500</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-07-012020-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">390,476</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the years ended June 30, 2021 and 2020 amounted to $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">192,500</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-07-012020-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">190,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:CapitalStockAndOptionsDisclosureTextblock"><p id="xdx_80A_ecustom--CapitalStockAndOptionsDisclosureTextblock_zuqPAGn0nYXe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_825_zlRKkpR0Jfbk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 - CAPITAL STOCK</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90E_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" name="us-gaap:DividendsPayableNature">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B Common Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90D_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonClassBMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class
B common stock is convertible into shares of common stock on a one-for-one basis.</ix:nonNumeric></span> <span id="xdx_900_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonClassBMember" name="us-gaap:CommonStockVotingRights">Class
B common stock has 10 votes per share</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
There
were </span><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7zfDcLZUZ73" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction>
</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">of
such shares outstanding at June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
C Common Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three
shares of Class C common stock for each share of the Company&#8217;s outstanding Class B common stock. </span><span id="xdx_907_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" name="us-gaap:CommonStockVotingRights">The
Class C common stock has 25 votes per share</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
as compared to 10 votes per share for the Class B common stock and </span><span id="xdx_908_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockVotingRights">one
vote per share for the common stock.</ix:nonNumeric></span> <span id="xdx_90B_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zj0iLxmvlPQ8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</ix:nonNumeric></span> <span id="xdx_90C_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" name="us-gaap:DividendsPayableNature">Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions.</ix:nonNumeric></span> <span id="xdx_90A_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zIZP2n6HBl6i" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class
C common stock is convertible into shares of common stock on a three-for-one basis.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 74 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zeakYn5rMjG6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zjtEVsKagXD1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zAK8JNs04r7h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zSatowY9tAnh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zTbmCYrnUQYe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_za9TEjKHo5Ll" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 - CAPITAL STOCK (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zwOLoFTgSnVg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
A Non-Voting Preferred Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with
special dividend rights and the declaration of a stock dividend on the Company&#8217;s common stock consisting of </span><span id="xdx_904_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_PreferredClassAMember" name="us-gaap:CommonStockVotingRights">one
share of Class A non-voting preferred stock for every five shares of common stock.</ix:nonNumeric></span> <span id="xdx_900_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zEmgKU33Vj45" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_PreferredClassAMember" name="us-gaap:DividendsPayableNature">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million
and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection
with the enforcement of five of the Company&#8217;s patents in its patent lawsuits, less the revised special dividend payable on the
common stock with respect to one of the Company&#8217;s patents.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks
equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
Bonus Plans</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock. On August 10, 2010, the Company filed Form S-8 to register the <span id="xdx_90E_ecustom--SharesRegistered_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="FONR:SharesRegistered" contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares.
As of June 30, 2021, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,177</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2021 and 2020, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">106,747</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2019-07-012020-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">89,981</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
were issued respectively, of which $<span id="xdx_907_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20200701__20210630_zXhva5SmCQTa"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,277</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20190701__20200630_zlUj96hniVBb"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">were
expensed and included in selling, general and administrative expenses for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Options</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company had stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and
consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of
time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board
of Directors, generally the fair value of the Company&#8217;s common stock at the date of grant. The options must be exercised within
ten years from the date of grant.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 75 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zuzjOwt4JlZa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_239_zGYHKkGiMbTl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zJkRlIchKRvj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zS14G68OyBU6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zTbiqt4md7H2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zZkWyEMq2DQ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_z7jLKZJpDuC6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
February 13, 2013 the Company entered into an agreement with outside investors to acquire a <span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember__srt--OwnershipAxis__custom--HDMEquityMember_z3jCRuZcsDS5"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_ClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
controlling interest in a newly formed limited liability company, Health Diagnostics Management LLC (HDM). According to the February
13, 2013 LLC operating agreement of HDM there are two classes of members; Class A members and one Class B member. The Class A members
have an ownership interest of <span id="xdx_90C_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_zACopkDN6aOi"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_ClassAMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. The Class B member (HMCA) has an ownership of <span id="xdx_90D_ecustom--OwnershipPercentageAcquired_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember__srt--OwnershipAxis__custom--HDMEquityMember_zz6lUk9EkLci"><ix:nonFraction name="FONR:OwnershipPercentageAcquired" contextRef="AsOf2013-02-13_custom_ClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of
ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be allocated
among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be
allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions
of the operating agreement. The Company contributed $<span id="xdx_905_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember_pp0p0"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-012013-02-13_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,200,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to HDM
and the group of outside investors contributed $<span id="xdx_907_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OutsideInvestorsMember_pp0p0"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,800,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for its
non-controlling membership interest.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 5, 2013 HDM purchased from Health Diagnostics, LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve
(<span id="xdx_902_ecustom--PurchaseOfStandupMriCenters_iI_uN_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zbtIDdlBxJS2"><ix:nonFraction name="FONR:PurchaseOfStandupMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
Stand-Up MRI Centers and two (<span id="xdx_909_ecustom--PurchaseOfOtherMriCenters_iI_uN_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zyIQuekcC5Ee"><ix:nonFraction name="FONR:PurchaseOfOtherMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_90F_ecustom--ConsiderationToOutsideInvestors_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zqdB35NzycNh"><ix:nonFraction name="FONR:ConsiderationToOutsideInvestors" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">1.5</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
to outside investors) aggregating $<span id="xdx_903_ecustom--TotalPurchasePrice_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkIIF4PChiCc"><ix:nonFraction name="FONR:TotalPurchasePrice" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">35.9</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $<span id="xdx_906_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zMzR7z1hBn09"><ix:nonFraction name="FONR:ConsiderationForNoncompetitionAndConsultingAgreements" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">4.1</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business Combinations&#8221;. The Company
recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair
value of the identified net assets acquired.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
January 8, 2015, the Company purchased 20% of the Class A members ownership interest at a cost of $<span id="xdx_908_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_pp0p0"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" contextRef="AsOf2015-01-08_custom_ClassAMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,971,094</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The Company has a <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_z0J4trW8Vire"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2015-01-08_custom_ClassAMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60.4</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in HDM after this transaction.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amount
of each class of HDM members&#8217; equity as of June 30, 2021 and 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zO8VxsqLDxlb" summary="xdx: Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B6_zIR8pg3tdXKi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A And B Members' Equity (HDM Acquisition)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Members</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Member</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Members</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Member</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Opening
    Members&#8217; Equity</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,253</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,850,419</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,155,725</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,543,786</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Share of Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,466,223</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,402,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,464,528</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,291,633</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,570,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">15,330,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,565,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">12,985,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ending Members&#8217;
    Equity</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,048,524</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,923,380</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zokGHiJavRd3" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,253</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zr22B74hWXZh" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,850,419</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 76 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zV3MXldFo2Ji" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_235_zn8jt5XNcJug" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z5DyOl5QpQD4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zmOddb9nYGhi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z9sptplUhLva" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock"><p id="xdx_80F_eus-gaap--DebtAndCapitalLeasesDisclosuresTextBlock_zOwgACrmdvz8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82A_z2f2Jf39Ekrf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt, notes payable and capital leases consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfDebtTableTextBlock_z8EditiZWPTf" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zKynI8lRFbah" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    debt, notes payable and capital leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Note
    payable requiring monthly payments of interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zC0c6XA3xS68"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-07-012021-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    until May 2009 followed by <span id="xdx_90A_ecustom--NumberOfInstallment_uN_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zllq7TdCexnk"><ix:nonFraction name="FONR:NumberOfInstallment" contextRef="From2020-07-012021-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="N">240</ix:nonFraction>
    </span></span><span id="xdx_90A_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_NotePayable1Member" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment">monthly</ix:nonNumeric>
    </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">payments
    of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2020-07-012021-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,472</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">through
    <span id="xdx_902_ecustom--MaturityDate_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRfWKu8kbBP6"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_NotePayable1Member" name="FONR:MaturityDate">October
    2026</ix:nonNumeric></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
    The loan is collateralized by a building with a net book value of $<span id="xdx_90C_ecustom--BookValueOfBuilding_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"><ix:nonFraction name="FONR:BookValueOfBuilding" contextRef="AsOf2021-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">413,330</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    of June 30, 2021.</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">232,696</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2020-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">273,031</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;Note
    payable received under the Paycheck Protection Program (&#8216;PPP&#8217;) which was established as part of the Coronavirus Aid,
    Relief and Economic Security Act (&#8220;Cares Act&#8217;) that provides for loans to qualifying businesses for amounts up to 2.5
    times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds
    are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven
    portion of the PPP loan is payable over <span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zn4ddeuwAEB9"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_NotePayable2Member" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">5</ix:nonNumeric>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">five
    years at an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdaRErAXaOH6"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-07-012021-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
    with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note
    was forgiven in August 2021.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,764</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2020-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,764</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;The
    revolving credit note was extended to August 2021. The Company can borrow up to $<span id="xdx_902_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zszCbI2JN9Sg"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2020-07-012021-06-30_custom_NotePayable3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zvYUPPkmTRD6"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-07-012021-06-30_custom_NotePayable3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.0</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line. See
    Note 21.</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1270">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1272">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_c20210630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">933,460</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_c20200630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">973,795</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Current portion</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20210630_pp0p0" title="Current portion of Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,206</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20200630_pp0p0" title="Current portion of Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,379</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20210630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">760,254</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20200630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">865,416</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>





<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 77 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_z3EecvLN0U25" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zqs8ah7h7Re3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zWxSDR1D7f5f" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_znRWlGzxP10a" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zk6kcfBmSIAk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z6SuOIEucXR6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zALZh6SEO9Of" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
maturities of debt over the next five years and thereafter are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z13f5Inpfas5" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zUvG19y8jUs4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Maturities
    Of Long-Term Debt</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20200630_zrMZukqNhGb1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ending June 30,</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDACztt9_zTOCSVW27rL9" style="vertical-align: bottom; background-color: White">
    <td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,206</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDACztt9_zN7k2APePLlf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">180,972</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_maLTDACztt9_zkPHvGBUAHWi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">183,919</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDACztt9_z6F16gNgf416" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">187,155</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_maLTDACztt9_zn5DgNIOzstg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">190,601</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_maLTDACztt9_z17A7qz8cCM6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,607</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_iTI_pp0p0_mtLTDACztt9_znBQguf7Gx0a" style="vertical-align: bottom; background-color: White">
    <td style="color: White; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Term
    Debt Over Five Years and Thereafter</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">933,460</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zye8e684ovI4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_z8upLoiDpZBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - INCOME TAXES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net. Penalties if incurred would be recognized as a component of &#8220;Selling, general
and administrative&#8221; expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2016 for federal
and 2015 for state.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has recorded a deferred tax asset of $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20210630_zFrLyfiLZhWd"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,958,961</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and a
deferred tax liability of $<span id="xdx_901_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20210630_pp0p0"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,316</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as of
June 30, 2021, primarily relating to its net Federal operating loss carryforwards of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,574,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">available
to offset future taxable income through 2031. In addition the Company has state operating loss carryforwards of approximately $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_iN_di_c20200701__20210630_zIeZ68hBeGta"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,094,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and city
operating loss carryforwards of approximately $<span id="xdx_90C_eus-gaap--OtherOperatingIncome_c20200701__20210630_zJti3qAzLEU2"><ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,470,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 78 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_znZeocY5Tvng" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_233_zP6tJZwGXWpg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zdXr2v5TF9tl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zWBhtgBVKqma" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zDYcEMgfQ8W9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zqE6zYJvuo46" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zP8H4EZlpUIa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of June 30, 2021, no such changes in ownership have occurred.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which temporary
differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable income,
the regulatory environment of the industry, and tax planning strategies in making this assessment. At present, the Company believes that
it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
valuation allowance for deferred tax assets decreased during the year ended June 30, 2021, by approximately $<span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20210630_pp0p0"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,547,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The valuation allowance decreased by approximately $<span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20200630_pp0p0"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">during
the year ended June 30, 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operation losses, temporary changes to prior and
future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security
taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and enhanced recoverability
of AMT tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At
the present time, the only impact of the CARES Act to the <span id="xdx_901_ecustom--ReimbursementOfAlternativeMinimumTaxCreditsDescription_c20200701__20210630"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="FONR:ReimbursementOfAlternativeMinimumTaxCreditsDescription">Company
is allowing a full reimbursement of $1,342,370 of tax credits relating to the alternative minimum tax credits. The Company received the
first half payment in June 2020. The balance of alternative minimum tax credits of $671,185 was received in July 2020. Previously, these
credits were to be refunded over a 3 year period.</ix:nonNumeric></span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
we continue to monitor tax implications of the CARES Act and other state and federal stimulus tax legislation, we may make adjustments
to our estimates and record additional amounts for tax assets and liabilities.</span></p>

<ix:exclude><p id="xdx_239_zfQNOiLPmON" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 79 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zJOGWbbpV3Cf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_234_zz9gyxm7nTJa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zW1PWG9tRIAi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zaD5m13hlSP9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zmmeUYESDAja" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zKP3L3jWs5b4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
of the provision (benefit) for income taxes are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYT7CWqwymq" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span id="xdx_8B9_z4K8VtLimNF5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of The Benefit Provision For Income Taxes</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20210630_z4x9AAuSlfCd" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20190701__20200630_zk4oDg9F7dhl" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_406_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zVytMF3cwEcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">187,255</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zzU5WvcCzqF3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,136,514</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">513,204</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzKST_maITEBzgpd_zMFOkPzHrjT3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,136,514</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">325,949</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzjFJ_zXuyD9yVQX7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
    deferred taxes</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,718,046</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,349</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzjFJ_zGswvQaRXdfh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    deferred taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,960</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,480</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzjFJ_maITEBzgpd_zwUycu6NvH6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,855,006</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,118,829</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzgpd_zHbVbpnj7b8b" style="vertical-align: bottom; background-color: White">
    <td style="color: White"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    (Benefit) for Income Taxes - Net</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,991,520</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,444,778</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
reconciliation of the federal statutory income tax rate to the Company&#8217;s effective tax rate as reported is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zVTM9VhrIY65" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z4to7WYmYz01" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20200701__20210630_zmI4FwNIjjWg" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_490_20190701__20200630_zi05QEafvJz" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zESbB2xsLx14" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Taxes
    at federal statutory rate</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zzBlmvW5YL4b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    and local income taxes (benefit), net of federal benefit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zzg1GSyoBPN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non
    Controlling interest</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.9</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zCry4Cxz3CK1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Expiration
    of tax credits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zbn8hWeq0LFb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Return
    to provision adjustments</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1371">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zq3gQPwgrSM2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Change
    in the valuation allowance</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">20.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zh14IEcjuPL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
<tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zsWYExNh9PD3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
    income tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22.6</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17.3</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2021, the Company has net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $35,574,000 that will be available
to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant
to Section 1502 of the Internal Revenue Code.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has, for federal income tax purposes, research and development tax credits and investments tax credits carryforwards aggregating
$<span id="xdx_902_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_c20210630_pp0p0"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,733,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
However, the realization of these credits may be limited as a result of expiring prior to their utilization. These credits can only be
applied after all net operating losses have been used, which expire through 2031. As such, the Company has established a valuation reserve
for anticipated unused credits of $<span id="xdx_909_eus-gaap--ValuationAllowancesAndReservesBalance_c20210630_pp0p0"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">890,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition, for New York State income tax purposes, the Company has tax credit carryforwards aggregating approximately $<span id="xdx_908_eus-gaap--TaxCreditCarryforwardAmount_c20210630_pp0p0"><ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which,
are accounted for under the flow-through method.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 80 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z4pspJY5jFH9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_233_ztveHVYDJy28" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zrTD21CyEBE9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zPsLmA2EwkZa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z8NlFktzXtt7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zerwAmxiU0zg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zcTG23ZFyo39" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company was also under audit with New York State for income tax and was assessed additional taxes of $<span id="xdx_908_ecustom--AdditionalTaxes_c20200701__20210630_zeCqbPXooala"><ix:nonFraction name="FONR:AdditionalTaxes" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,272</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">plus
interest and penalties. These amounts are accrued for at June 30, 2021 and included in other current liabilities and were paid in August
2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Significant
components of the Company&#8217;s deferred tax assets and liabilities at June 30, 2021 and 2020 are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTJrnFRjjav6" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zBhejEtOfbKg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of Company's Deferred Tax Assets And Liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210630_zbRsvgODI2a9" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20200630_zaq807P4ffl2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    tax assets:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzcuf_zmvEX3bmoaA9" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,827,382</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,946,801</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzcuf_zUaMTmMMobZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-deductible
    accruals</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">749,902</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzcuf_zE14Y8VOTrvc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    operating carryforwards</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,285,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,720,637</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzcuf_zd0RTYzMxeMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
    credits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,732,650</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,647,217</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzcuf_zGtEscVuBHm8" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventory</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,316</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">69,940</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzcuf_zZJHJsOQKUB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment and depreciation</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">187,632</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">168,371</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzcuf_maDTANzjWq_z5Cg3nyuUTac" style="vertical-align: bottom; background-color: White">
    <td style="color: White"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    Tax Assets - gross</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,849,045</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,246,799</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzjWq_zyfxNSxTwb52" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Valuation
    allowance</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">890,084</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,437,042</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzjWq_maDTALNzli5_ztJ0VLwWUDjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,958,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,809,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzVX4_ztv7fFKyUCz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangibles</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,316</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,106</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzVX4_msDTALNzli5_zD1fg6nC7Gy4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,316</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,106</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzli5_zTjFUCV8AYI7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    deferred tax asset</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,720,645</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,575,651</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z0nMoH7p0At4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82A_zdrj6p5ruTX6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
13 - OTHER CURRENT LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
in other current liabilities are the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqXD9yhClk44" summary="xdx: Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_za7z03jDFjzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20210630_zg7zzsxnhNak" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20200630_zvqVfRqMuOMd" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOLCzdL8_zC97enrNuCle" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,406,982</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,491,941</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zqVlW8vYuwUc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation
    accruals</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">900,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">442,802</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOLCzdL8_zAyEEkYFc8zl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">644,623</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,353,200</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pp0p0_maOLCzdL8_zqd7NaqxgEy2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">774,234</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1448">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOLCzdL8_zT1rAwnUEQO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,827</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,867</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maOLCzdL8_zrKouvLUvxAh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,262</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">120,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--SelfInsuranceReserve_iI_pp0p0_maOLCzdL8_zV9TWuVLHdYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,548</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">86,504</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0_maOLCzdL8_zxdCsbyQsbu2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">493,042</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">877,787</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zmuj7cg9j3a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">715,600</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">699,997</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_mtOLCzdL8_zICACAUAwJe3" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other current
    liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,162,118</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,185,098</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>





<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 81 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zoqhZXUnuVfj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zfase0yaeSe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zA71o7CFQEUj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z1TxagiaPA27" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zVNeOi9xPahj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znFaJPRNRMRk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82F_z1cmcXPMVnBh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
14 - COMMITMENTS AND CONTINGENCIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leases</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through
March 2030. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain
maintenance costs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Rent
expense for operating leases approximated $<span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:LeaseAndRentalExpense" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,146,000</ix:nonFraction></span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_900_eus-gaap--LeaseAndRentalExpense_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:LeaseAndRentalExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,136,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company received approval from the Suffolk County IDA on February 29, 2016 of a <span id="xdx_902_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20190101__20281231_z4Q5Ha62jtR9"><ix:nonFraction name="FONR:PropertyTaxAbatementFromSuffolkCountyIda" contextRef="From2019-01-012028-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
property tax abatement, valued at $<span id="xdx_900_ecustom--PropertyTaxAbatement_c20190101__20281231_pp0p0"><ix:nonFraction name="FONR:PropertyTaxAbatement" contextRef="From2019-01-012028-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">440,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
over a 10 year period commencing January 2017.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Employee
Benefit Plans</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has a non-contributory 401(k) Plan (the &#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at
least 21 years of age with no minimum service requirements. There were $<span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,799</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">employer
contributions to the Plan for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_903_ecustom--EmployeeStockPurchasePlanEspp_c20200701__20210630__us-gaap--EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis__us-gaap--EmployeeStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_EmployeeStockMember" name="FONR:EmployeeStockPurchasePlanEspp">The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2021.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90E_ecustom--LitigationSettelementDescription_c20190701__20200630" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2019-07-012020-06-30" name="FONR:LitigationSettelementDescription">In
September 2019, The Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course
of the arbitration proceedings. The Company is estimating the leasehold holdover charges to be approximately $900,000.</ix:nonNumeric></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2021 this amount has been accrued for under other current liabilities.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_906_ecustom--LitigationSettelementDescription_c20200701__20210630" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" name="FONR:LitigationSettelementDescription">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900,000 was paid by the Company&#8217;s insurance on September
15, 2020 with the remaining $315,000 paid by the Company on September 28, 2020.</ix:nonNumeric></span></p>

<ix:exclude><p id="xdx_237_zOPVJAIJ8Ft7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 82 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zFoVrj5g27o2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_239_zuyNaORdhSy4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zppX9rWd2OWl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z6P8UeTaUrX3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zWmX57ER1dDb" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z6yLL93exsH2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
14 - COMMITMENTS AND CONTINGENCIES (Continued)</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
Company is subject to other legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims besides the claim above. In the opinion of management, and with consultation with legal council,
the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial
position or results of operations of the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has satisfied most of its delinquencies in filing sales tax returns for certain states, for which the Company has transacted
business. The Company has recorded tax obligations of approximately $<span id="xdx_909_eus-gaap--SalesAndExciseTaxPayableCurrentAndNoncurrent_c20210630_pp0p0"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">645,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">plus
interest and penalties of approximately $<span id="xdx_904_ecustom--RecordedSalesTaxObligationsInterestAndPenalties_c20210630_pp0p0"><ix:nonFraction name="FONR:RecordedSalesTaxObligationsInterestAndPenalties" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">232,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">until
the remaining states have been resolved.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_904_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_c20200701__20210630_pp0p0"><ix:nonFraction name="FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">per person
and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2021
and 2020, the Company had approximately $<span id="xdx_904_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20210630_pp0p0"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_905_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20200630_pp0p0"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the consolidated balance sheets.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the years covered by this report.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_808_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zW2tpuhqvagf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_821_z2WP7FkPc2mb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
15 - SUPPLEMENTAL CASH FLOW INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2021 and 2020 the Company paid $<span id="xdx_906_eus-gaap--InterestPaid_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,178</ix:nonFraction></span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90C_eus-gaap--InterestPaid_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,200</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for interest,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2021 and 2020 the Company paid $<span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,032</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_908_eus-gaap--IncomeTaxesPaid_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">228,204</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for income
taxes, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2021 and 2020, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20200701__20210630_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,364</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20190701__20200630_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">89,981</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock for costs and expenses totaling $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_pp0p0_c20200701__20210630_z7eRX6BZBc79"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,940,821</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20190701__20200630_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,990,380</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the year ended June 30, 2020 the Company entered into a capital lease for the purchase of equipment in the amount of $<span id="xdx_904_eus-gaap--AmortizationOfLeasedAsset_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfLeasedAsset" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,350,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 83 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zDpnZ84FCsJ1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_236_zY9O5k1rxOph" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z8iUQj1VjVl3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zzorAqqtYaS8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zdX6PqxpbRX7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zMP6TwyWwjjg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
15 - SUPPLEMENTAL CASH FLOW INFORMATION (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zwedKxlHEclk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the year, the Company resolved certain sales tax liabilities and was able to reverse accrued interest and penalties in the amount of
$<span id="xdx_90C_ecustom--SellingGeneralAndAdministrativeExpenses_c20200701__20210630_zo2n4RLqGU9a"><ix:nonFraction name="FONR:SellingGeneralAndAdministrativeExpenses" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">602,000</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which
has been recorded under selling, general and administrative expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z6udcfPaMmY7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82E_zWZVmygsJMu7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
16 &#8211; RELATED PARTY TRANSACTIONS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20200701__20210630__dei--LegalEntityAxis__custom--ABillingCompanyMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_ABillingCompanyMember" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#8217; Compensation claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2021 for another year.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20200701__20210630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2020-07-012021-06-30_custom_BensonhurstMRILimitedPartnershipMember" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.</ix:nonNumeric></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zP1Wk4JaEhD" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zZU24sYETvXj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
17 - SEGMENT AND RELATED INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company provides segment data in accordance with the provisions of ASC topic 280, &#8220;Disclosures about Segments of an Enterprise
and Related Information&#8221;.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment
sales are market-based. The Company evaluates performance based on income or loss from operations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 84 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zw4X84XcXUpl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_23D_z6jl1Zx1itd8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zJfiUuGYIlnd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zTYvF6dCtZB2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zSvPVgv8Dcse" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zpggIjxHq64c" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
17 - SEGMENT AND RELATED INFORMATION (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_ziLc0fiPcRsc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zp3TRcW9zs84" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span id="xdx_8B1_zBC1GDej9gwl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
    Segment Financial Information</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
    and Servicing of Medical</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    of Diagnostic Imaging</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2021:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Center</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total Revenues - Net" style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,037,091</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total Revenues - Net" style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,892,674</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" title="Total Revenues - Net" style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,929,765</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjWEe6ibgvM6" title="Intersegment net revenues" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="Fact001536" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">901,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zd6UUM6bPeE3" title="Intersegment net revenues" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1538">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____z1HeNFaEFOV3" title="Intersegment net revenues" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-01to2021-06-30" id="Fact001540" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">901,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,410,189</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,507,804</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,097,615</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,830</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,816,857</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,081,687</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Compensatory element of stock issuances" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Compensatory element of stock issuances" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1556">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" title="Compensatory element of stock issuances" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total identifiable assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,592,582</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total identifiable assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">164,913,613</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsNet_c20210630_pp0p0" title="Total identifiable assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,506,195</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">291,294</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,405,502</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,696,796</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;&#160;Fiscal
    2020:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,463,103</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,227,359</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--Revenues_c20190701__20200630_pp0p0" title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">85,690,462</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span id="xdx_F4A_z2f1lgHdBOa5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____z1UtNFLi7ex4" title="Intersegment net revenues" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="Fact001578" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">875,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____z5k3P2XQRg2j" title="Intersegment net revenues" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1580">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630_fKg_____zvAtxyGLfSS1" title="Intersegment net revenues" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2019-07-012020-06-30" id="Fact001582" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">875,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,425,411</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,076,327</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630_pp0p0" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,650,916</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">368,498</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,540,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630_pp0p0" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,908,648</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Compensatory element of stock issuances" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Compensatory element of stock issuances" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1598">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20190701__20200630_zYrjZsbmjWf4" title="Compensatory element of stock issuances" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2019-07-012020-06-30" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total identifiable assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,492,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total identifiable assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149,790,753</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_c20200630_pp0p0" title="Total identifiable assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">180,283,510</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,440,640</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,981,773</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630_pp0p0" title="Capital expenditures" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,422,413</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F05_zEREwuyQ0VD7" style="text-align: justify; padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
  <td id="xdx_F12_z53lLUQTqWb6" style="text-align: justify; padding-left: 11pt; text-indent: -11pt"><ix:footnote id="Footnote001613" xml:lang="en-US"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation</span></ix:footnote></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A2_z1sj9fDSkh29" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
Product Sales</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting
to <span id="xdx_90E_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20200701__20210630_zcPiCn948zbd"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.3</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_904_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20190701__20200630_zy6Yr2rzfF6c"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of product sales revenues to third parties for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:ExportProductSales"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ExportProductSales_z4Z2dMGvGDZ1" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B6_z92wpdhnlKK3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
    Product Sales</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_zCNqWwICHib1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_DO" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--DO_zbuHrPBs4Bic" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2019-07-012020-06-30_country_DO" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zXTLPwTWl7Eb" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zDfEYGapqgx9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2019-07-012020-06-30_country_CA" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zaUTjm7YMkhi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_zkdxuozLYLOe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2019-07-012020-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.2</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zJ4twkroHeV2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zaToq3FDmsff" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2019-07-012020-06-30_country_PR" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp_c20200701__20210630_zXC9OYVV9YVd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.3</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--ForeignProductSales_dp_c20190701__20200630_zroALeKRx2ek" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.2</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 85 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zNjvQ4cMGZs8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_230_zEASVIrMAAOd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z1G3uqHCEwti" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zxrfsnouky8g" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zKTwqX9Lfan" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zNjT7MmTVYG8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
17 - SEGMENT AND RELATED INFORMATION (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zO8Q9F2s9Cm9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
Service and Repair Fees</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair
of medical equipment amounting to <span id="xdx_906_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20200701__20210630_zGsZoBcrc6kk"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_900_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20190701__20200630_zv0zD1guyZ24"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.6</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of consolidated net service and repair fees for the years ended June 30, 2021 and 2020 respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="FONR:ExportServiceRevenues"><table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ExportServiceRevenues_z7IxUfVXDBAa" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BD_zHJlKwDqPLCa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
    Service and Repair Fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zAOjZpSvEHFf" title="Foreign Service and Repair fees" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zXZVn5akPBPk" title="Foreign Service and Repair fees" style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Switzerland</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zwxPmRN7ETI2" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_CH" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CH_zG2ngUskvLg" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_CH" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zyYiiTRHkSB1" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_z70xhn2aRoXh" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">England</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_zdtuo3HGYI52" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_GB" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GB_zyjcZPie06rd" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_GB" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_z8F1YCdf3bs2" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zesJtEZtoB0h" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Greece</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zXuegxBIhZo" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_GR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GR_zTn5sOnOxVk3" title="Foreign Service and Repair fees" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_GR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Australia</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp0_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zLI9bng1yptl" title="Foreign Service and Repair fees" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_AU" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_z6BT6oIJTjTc" title="Foreign Service and Repair fees" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30_country_AU" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zMNMHCtJnQXl" title="Foreign Service and Repair fees" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-01to2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.5</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630_zOdmbw7kYBZ2" title="Foreign Service and Repair fees" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.6</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
Company does not have any material assets outside of the United States.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80C_eus-gaap--BusinessCombinationDisclosureTextBlock_zj6eFgN8plob" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_827_zOehxc7sPdz4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
18 &#8211; ACQUISTION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 29, 2021, the Company completed the acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company
used an incremental borrowing rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We
made a preliminary fair value determination of the acquired assets and assumed liabilities as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zXdJuyVSagVa" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z6jPGMAKvh29" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
    value assets and assumed liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210329_zxfeHguUkri1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_zeqWo4kPhdwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">650,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_zpPw0naz6u21" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right
    to use assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">434,219</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zyLV05W04Kce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangible
    assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--SecurityDeposit_iI_zrF1ibx6TGm1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Security
    Deposit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,628</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_zSdLGpf7aCa9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right
    to use liability</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">434,219</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--Goodwill_iI_zVEbHrQrgOi4" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,880</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_zSvJXDE1DCPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    purchase consideration</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,122,508</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 86 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zgto6XIe2fv" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_238_zWZoSRhNGlpk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zpmvMjbTOmdg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zwU1NQCPwXq" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zNP3LtWdJeZk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zFBz3Uz7p8ie" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
18 &#8211; ACQUISTION (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zmUOzBYCE66h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 805-10-25-1, Business Combinations &#8211; Overall Recognition, the Company recorded the transaction as a business
combination. ASC 805-10-25-1 provides the requirements of recording the transaction by applying the acquisition method. The acquisition
method requires the Company to determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must
be determined if there is a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and you
must be able to recognized and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded
as a business combination.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
net assets acquired and consideration is as follow:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zPivPWwGYqbd" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zpnI1WtS9nI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    assets acquired</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210329_zCUgbAtbWGye" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    Improvements</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_zzyOOWKnUiX2" title="Intangible assets" style="width: 18%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    Equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_zrxAuUiyOWNg" title="Intangible assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Lists</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zQ5RWzklSZge" title="Intangible assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Covenant
    Not to Compete</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_zIotqYfuDrnf" title="Intangible assets" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--SecurityDeposit_iI_zKk4Ycko5JMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Security
    Deposit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,628</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--ClosingCostsExpensed_iI_zFJHgEbtC2ze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Closing
    costs - expensed</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ClosingCostsExpensed" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,478</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--GoodwillGross_iI_zOzfAQbOY2Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:GoodwillGross" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,880</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--BusinessCombinationContingentConsiderationAsset1_iI_zbSEWojYvxyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    Consideration Paid</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:BusinessCombinationContingentConsiderationAsset1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,125,986</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
results of operations of Rockland Management Group were diminutive and did not affect the pro forma results of operations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"><p id="xdx_80E_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zykeErPpT7Fl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82F_zCEHf9CxCB8j" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following represents a summary of allowance for doubtful accounts for the years ended June 30, 2021 and 2020 respectively:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zerqICWYroB5" summary="xdx: Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_zKV0Z4emBGC3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summary
    of Allowance For Doubtful Accounts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br /> June 30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span id="xdx_F21_zT3MX0oVtua7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions
    (1)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br /> June 30, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zuGPhkmgJbrk" title="Beginning Balance" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,561</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zAPq7TNWLFLk" title="Additions (Included in provision for bad debts)" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1721">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Deductions" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,291</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z1D6nWiS4d5h" title="Ending Balance" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">442,270</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEd0CAFZHqri" title="Beginning Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,063,233</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zomO96pjBJGc" title="Additions (Included in provision for bad debts)" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001729" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,723,645</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" title="Deductions" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBmFysJHP051" title="Ending Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,786,878</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zl351PL54CRf" title="Beginning Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,322,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zW8wR0i7BDs8" title="Additions (Included in provision for bad debts)" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001737" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">862,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" title="Deductions" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1739">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkaBXZwiYgH4" title="Ending Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,184,399</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zbbCCTfQrp3h" title="Beginning Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zDuFC1AZDBq1" title="Additions (Included in provision for bad debts)" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1745">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_pp0p0" title="Deductions" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1747">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zVVu0iBWB774" title="Ending Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 87 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zZB5XWSiWbVa" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>




<ix:exclude><p id="xdx_239_zEdITmjbpTT7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_za09j6vqmIQ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zs31yvGM3qu3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zMKqHr1itMod" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zzhNNapsbiv1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zcmLhXyRjQle" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zemU3sZSx1fj" title="Beginning Balance" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2019-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">190,244</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Additions (Included in provision for bad debts)" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2019-07-012020-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">380,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Deductions" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2019-07-012020-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,683</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7sZGNZZ8Qne" title="Ending Balance" style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,561</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zqOGS2IkEvQ8" title="Beginning Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,404,944</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" title="Additions (Included in provision for bad debts)" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,526,742</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" title="Deductions" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,868,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zrnCJZhe17A6" title="Ending Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,063,233</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhEJUeMEVxKe" title="Beginning Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,310,731</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" title="Additions (Included in provision for bad debts)" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,011,324</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" title="Deductions" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1778">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkNJFjRIeU16" title="Ending Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,322,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zTY47H0LBznf" title="Beginning Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1782">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" title="Additions (Included in provision for bad debts)" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2019-07-012020-06-30_custom_MedicalReceivablesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" title="Deductions" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1786">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zcUXU7sz30Vc" title="Ending Balance" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_MedicalReceivablesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F08_zfCQTmMiYeVd" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
  <td id="xdx_F15_zbz2USYUnRJ1" style="padding-left: 11pt; text-indent: -11pt"><ix:footnote id="Footnote001789" xml:lang="en-US"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
  in provision for bad debts.</span></ix:footnote></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A6_zP04amakyl7g" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:QuarterlyFinancialInformationTextBlock"><p id="xdx_805_eus-gaap--QuarterlyFinancialInformationTextBlock_zip9jYPUHDVj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_zXfWr7YNTiS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(000&#8217;s
omitted, except per share data)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_z33KCVI9QJEe" summary="xdx: Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B4_zEkfJ54PT243" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Quarterly
    Financial Data</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zzeuI3PaBu9e" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zwmkSlA3CFsc" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zx6GVjWqt04l" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zdLGta2Dn3e6" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zVYpdzISdTB3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">December
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">March
    31, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,979</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,164</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,090</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,697</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,930</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,829</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,182</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,853</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,832</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,251</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,299</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,196</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,674</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.37</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.45</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.36</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.54</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.11</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.45</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20190701__20190930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJgiPxxxFyxf" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20191001__20191231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvVGE27sjcIg" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20200101__20200331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvei2r7PuAq3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z1CXj7B8qNJ8" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20190701__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zbyL9jYtrAd9" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">December
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">March
    31, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_40D_eus-gaap--Revenues_zIDIPJoGbZL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,747</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,451</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,686</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,806</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">85,690</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--CostsAndExpenses_zypLUvICwEp7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,261</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,430</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,071</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,278</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,040</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_znl4OZJzXxoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,506</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,209</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,914</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,076</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,705</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--EarningsPerShareBasic_zkN8CsWhxjxf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.48</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.45</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.18</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.09</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.20</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_zue1lAGxHVY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.47</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.18</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.09</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.18</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A7_zUlIdy6oidwh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 88 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z84jD43Zjtxe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z0H1grJyPaBf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z4dbAcisV5T3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zPTkXNeJV5X2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2021 and 2020</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zzn125LO70d5" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-01to2021-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zE2iSUI0bktc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zy0vTOzkcnwe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
21 &#8211; SUBSEQUENT EVENTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
August 2021 the Company amended their revolving credit agreement. The agreement was extended to August 2022.&#160;The interest rate on
borrowings remains at <span id="xdx_908_eus-gaap--DebtorInPossessionFinancingFeeOnUnusedBorrowings_iI_dp_c20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQg4F74UgQw3"><ix:nonFraction name="us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings" contextRef="AsOf2021-08-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
along with certain financial covenants.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
loan of $<span id="xdx_904_eus-gaap--ProceedsFromLoans_c20210801__20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSza1KTzoT81"><ix:nonFraction name="us-gaap:ProceedsFromLoans" contextRef="From2021-08-012021-08-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700,764</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">received
under the Paycheck Protection Program was forgiven in August 2021.</span></p>

</ix:nonNumeric><p id="xdx_81F_zce8PLDpmK2l" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 89 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_013"></span>FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
have been no disagreements with our independent registered public accounting firm or other matters requiring disclosure under Regulation
S-K, Item 304(b).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_014"></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ITEM
9A. CONTROLS AND PROCEDURES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Evaluation
of Disclosure Controls and Procedures</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of the end of the period covered by this Annual Report on Form 10-K, we performed an evaluation under the supervision of and with the
participation of management, including our Principal Executive Officer and our Acting Principal Financial Officer, of the design and
effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act
of 1934 as amended (the &#8220;Exchange Act&#8221;). Based upon that evaluation, our Principal Executive Officer and Acting Principal
Financial Officer concluded, as of the end of the period covered by this Annual Report that our disclosure controls and procedures were
effective.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management&#8217;s
Report on Internal Control Over Financial Reporting</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting, as is defined in the Exchange
Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our
financial reporting and the preparation of financial statements for external reporting purposes in accordance with GAAP.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 90 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO-2013). Based on this
evaluation, our management concluded that our internal control over financial reporting was effective at June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Based
on the COSO criteria, management concluded that our internal controls were effective to prevent material misstatements of the Company&#8217;s
annual or interim financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Changes
in Internal Controls over Financial Reporting</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the
most recent fiscal quarter and year ended June 30, 2021 that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_015"></span>Item
9B. OTHER INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">None.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
III</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="b_016"></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ITEM
10. DIRECTORS AND EXECUTIVE OFFICERS.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Directors
serve from the date of their election until the next annual meeting of stockholders and until their successors are elected and qualify.
With the exception of Dr. Raymond V. Damadian, who does not receive any fees for serving as a director, each director receives $20,000
per annum for his or her service as a director. Officers serve at the discretion of the Board of Directors.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
majority of our board of directors is composed of independent directors: Charles N. O&#8217;Data, Ronald G. Lehman and Richard E. Turk.
The outside directors also serve as the members of the audit committee, which is a standing committee of the board of directors having
a charter describing its responsibilities. Mr. O&#8217;Data has been designated as the audit committee financial expert.. Mr. Lehman
would also qualify as an audit committee financial expert, and has acted in Mr. O&#8217;Data&#8217;s place when Mr. O&#8217;Data is unavailable
to do so. His relevant experience is described in his biographical information.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 91 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
have adopted a code of ethics applicable to, among other personnel, our principal executive officer, principal financial officer, controllers
and persons performing similar functions. The code is designed to deter wrongdoing and to promote: 1. honest and ethical conduct, including
the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; 2. full, fair, accurate,
timely and understandable disclosure in reports and documents that we file or submit to the Securities and Exchange Commission and in
other public communications we make; 3. compliance with applicable governmental laws, rules and regulations; 4. the prompt internal reporting
of violations of the code to an appropriate person or persons identified in the code and 5. accountability for adherence to the code.
We will provide a copy of the code to any person who requests a copy. A person may request a copy by writing to Fonar Corporation, 110
Marcus Drive, Melville, New York 11747, to the attention of the Legal Department or Investor Relations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
officers and directors of the Company are set forth below:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt; background-color: rgb(204,238,255)">
<td style="padding: 0; width: 26%; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
V. Damadian</span></td>
<td style="padding: 0; width: 16%; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85</span></td>
<td style="padding: 0; width: 58%; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
of the Board of Directors, Director, Principal Financial Officer, Treasurer</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt; background-color: White">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
R. Damadian</span></td>
<td style="padding: 0; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">57</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">President,
Chief Executive Officer</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt; background-color: rgb(204,238,255)">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
B. Bonanni</span></td>
<td style="padding: 0; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">66</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
Vice President and Chief Operating Officer</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt; background-color: White">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
J.V. Chan</span></td>
<td style="padding: 0; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">83</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt; background-color: rgb(204,238,255)">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Charles
N. O&#8217;Data</span></td>
<td style="padding: 0; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt; background-color: White">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
J. Lehman</span></td>
<td style="padding: 0; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">45</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt; background-color: rgb(204,238,255)">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
E. Turk</span></td>
<td style="padding: 0; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
</table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
V. Damadian, M.D. has been the Chairman of the Board since its inception in 1978 and Treasurer since February, 2001. Up until February
11, 2016, Dr. Damadian also served as the President and Chief Executive Officer of Fonar. Dr. Damadian was employed by the State University
of New York, Downstate Medical Center, New York, as an Associate Professor of Biophysics and Associate Professor of Internal Medicine
from 1967 until September 1979. He received an M.D. degree in 1960 from Albert Einstein College of Medicine, New York, and a B.S. degree
in mathematics from the University of Wisconsin in 1956. In addition, Dr. Damadian conducted post-graduate work at Harvard University,
where he studied extensively in the fields of physics, mathematics and electronics. Dr. Damadian is the author of numerous articles and
books on the nuclear magnetic resonance effect in human tissue, which is the theoretical basis for the Fonar MRI scanners. He is a 1988
recipient of the National Medal of Technology. In 1989 he was inducted into the National Inventors Hall of Fame, for his contributions
in conceiving and developing the application of magnetic resonance technology to medical applications including whole body scanning and
diagnostic imaging. Dr. Damadian is the President, Treasurer and director of Health Management Corporation of America (&#8220;HMCA&#8221;),
and a Manager of Health Diagnostics Management, LLC (&#8220;HDM&#8221;) which three entities are subsidiaries of Fonar. Raymmond Damadian
is the father of Timothy Damadian and the brother of Claudette J.V. Chan.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 92 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian has been the President and Chief Executive Officer of Fonar since February 11, 2016. From 2010 to 2016 he served as an independent
consultant, with a focus on the Company&#8217;s MRI facility management business. Timothy Damadian began his career at Fonar in 1985,
installing MRI scanners and components for Fonar customers. Over the course of the following 16 years, he held positions of increasing
authority, eventually becoming Vice President of Operations. In 1997, Timothy Damadian was appointed President of the newly formed Health
Management Corporation of America (HMCA), a wholly-owned subsidiary of Fonar that was formed to manage medical and diagnostic imaging
offices. In 2001, Timothy Damadian left Fonar to form Integrity Healthcare Management, Inc., a diagnostic imaging management company
that would eventually manage 11 MRI scanning centers in New York and Florida. The company was a success and was sold to Health Diagnostics,
LLC in 2007. Mr. Damadian returned to Fonar as a consultant in 2010. He also serves as a Manager of Health Diagnostics Management, LLC,
which are subsidiaries of HMCA. Timothy Damadian is the son Dr. Damadian and nephew of Claudette J.V. Chan.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
B. Bonanni has served as Chief Operating Officer (COO) and Executive Vice President (EVP) for Fonar Corporation since June 27, 2016.
Prior to his appointment as COO, Mr. Bonanni had served the Company as Vice President since 1989, during which time he oversaw general
operations, research and development, manufacturing, service, sales, finance, accounting and regulatory compliance. Prior to 1989, Mr.
Bonanni held the title of Vice President of Production and Engineering from the time of Fonar&#8217;s initial public offering in 1981.
Mr. Bonanni joined the Company as an electrical engineer in 1978. He holds a Bachelor of Electrical Engineering degree from Manhattan
College.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
J.V. Chan has been a Director of Fonar since October 1987 and Secretary of Fonar since January 2008. Mrs. Chan was employed from 1992
through 1997 by Raymond V. Damadian, M.D. MR Scanning Centers Management Company and since 1997 by HMCA, as &#8220;site inspector,&#8221;
in which capacity she is responsible for supervising and implementing standard procedures and policies for MRI scanning centers. From
1989 to 1994 Mrs. Chan was employed by St. Matthew&#8217;s and St. Timothy&#8217;s Neighborhood Center, Inc., as the director of volunteers
in the &#8220;Meals on Wheels&#8221; program, a program which cares for the elderly. From approximately 1983 to 1989, Mrs. Chan was President
of the Claudette Penot Collection, a retail mail-order business specializing in women&#8217;s apparel and gifts. Mrs. Chan practiced
and taught in the field of nursing until 1973, when her son was born. She received a bachelor of science degree in nursing from Cornell
University in 1960. Mrs. Chan is the sister of Raymond V. Damadian and aunt of Timothy Damadian.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Charles
N. O&#8217;Data has been a Director of Fonar since February 1998. From 1961 to 1997, Mr. O&#8217;Data was the Vice President for Development
for Geneva College, a liberal arts college located in western Pennsylvania. In that capacity, he acted as the College&#8217;s chief investment
officer. His responsibilities included management of the College&#8217;s endowment fund and fund raising. In July 1997, Mr. O&#8217;Data
retired from Geneva College after 36 years of service to assume a position of National Sales Executive for SC Johnson Company&#8217;s
Professional Markets Group, a unit of SC Johnson Wax, and specialized in healthcare and education sales, a position he held until the
spring of 1999. In his capacity with SC Johnson he was responsible for sales to the nation&#8217;s three largest Group Purchasing Organizations
which included some 4,000 hospitals. Mr. O&#8217;Data presently acts as an independent financial consultant to various entities. Mr.
O&#8217;Data served on the board of The Medical Center, Beaver, Pennsylvania, now a part of Heritage Valley Health System, a 500 bed
acute care facility, for 26 years, three as its Chair. Mr. O&#8217;Data also served on the board of Amerinet, a shared-services and group
purchasing organization covering seven states. He founded The Beaver County Foundation, a Community Foundation, in 1992, and serves as
its President. Mr. O&#8217;Data is listed as a finance associate in the Middle States Association, Commission on Higher Education. The
commission is the formal accrediting body for higher education in the eastern region of the country. In this capacity he evaluates the
financial aspects of educational organizations. Mr. O&#8217;Data is a graduate of Geneva College, where he received a B.S. degree in
Economics in 1958.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
G. Lehman has been a Director of Fonar since April, 2012, when he was unanimously appointed by the remaining four Directors to fill the
vacancy resulting from the death of former Director Robert Djerejian. From October, 2009 to the present, Mr. Lehman has served as Managing
Director of Investment Banking with Bruderman Brothers, LLC, a private New York-based broker-dealer registered with the Securities and
Exchange Commission and which is a member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection
Corporation (SIPC). Mr. Lehman directly manages all facets of the firm&#8217;s transaction processes, from deal origination, to sourcing
capital, to negotiating deal structures, through documentation and closing. The firm provides buy and sell-side advisory, capital raising,
and consulting services to lower middle-market companies. Mr. Lehman specializes in advising healthcare services companies and has recently
completed several recapitalizations in the industry. He also participates in the firm&#8217;s merchant banking investments and oversees
many of these assignments. From May, 2008 to October, 2009, Mr. Lehman served as Senior Vice President of Acquisitions at Health Diagnostics,
LLC, where he managed the company&#8217;s acquisition and corporate finance activities. From March, 2000 to May, 2008, Mr. Lehman worked
for various Bruderman entities as a buy and sell-side advisor and as a principal in several private equity transactions. From September,
1998 to March, 2000, Mr. Lehman worked at Deutsche Bank Securities, Inc. and last held the position of Associate in their Global Custody
Group. Mr. Lehman graduated from Columbia University with a B.A. in 1998.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 94 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
E. Turk has been a Director of Fonar since June, 2020, when he was appointed to fill the vacancies on the Board of Directors and Audit
Committee of the Board of Directors resulting from the death of his predecessor, Robert J. Janoff. Mr. Turk is the Chief Development
Officer of PRISM Vision Group, a private equity-backed, multi-location, outpatient comprehensive eye care practice headquartered in Union,
New Jersey. Since joining PRISM in November, 2018, Mr. Turk has helped source, analyze, and complete 12 acquisitions. He spearheaded
growth efforts that helped PRISM expand from a single-speciality (retina) provider with 17 locations and 21 physicians to a comprehensive,
vertically-integrated, multi-specialty, eye care organization with approximately 90 physicians and more than 50 locations across New
Jersey, Pennsylvania, Delaware and Maryland. Prior to his tenure at PRISM, Mr. Turk was employed by Professional Physical Therapy, a
private equity-backed outpatient physical and occupational therapy company headquartered in Uniondale, New Jersey with more than 180
locations across New York, New Jersey, Connecticut, Massachusetts and New Hampshire. During his four years at Professional Physical Therapy,
Mr. Turk sourced, analyzed, and completed 32 acquisitions comprised of 116 clinics, expanding the company&#8217;s services and adding
three states. From 2007 to 2014, Mr. Turk was employed by Bruderman Brothers, a broker dealer involved in investment banking, merchant
banking, investment advisory, and consulting for lower middle market companies ($10M-$250M of enterprise value) in a variety of industries,
including healthcare. Mr. Turk was Vice President of Bruderman Brothers from 2011 to 2014. Mr. Turk graduated from Columbia University
with a B.A. in American History in 2007.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_017"></span>ITEM
11. EXECUTIVE COMPENSATION.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">With
the exception of the Chief Executive Officer and the Chairman of the Board of Directors, the compensation of the Company&#8217;s executive
officers is based on a combination of salary and bonuses based on performance. The Chairman of the Board&#8217;s compensation consists
of a salary. The Chief Executive Officer and the Chairman of the Board have no understandings with the Company with respect to bonuses,
options or other incentives; they are not subject to our general policy later discussed.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Board of Directors does not have a compensation Committee. Dr. Raymond V. Damadian, Chairman of the Board, controls over 50% of the voting
power of our capital stock. Dr. Damadian is both an executive officer and a member of the Board of Directors. Dr. Damadian, the Chief
Executive Officer and the Chief Operating Officer, participate in the determination of compensation for the Company&#8217;s management
and other employees.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Board of Directors has established an audit committee. The members of the committee are Charles N. O&#8217;Data, Ronald G. Lehman and
Richard E. Turk.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
compensation policy includes a combination of salary, commissions, bonuses, stock bonuses and stock options, designed to incentivize
our employees. There is no universal plan applicable to all of our employees. The fixed and variable components of our employees&#8217;
compensation tend to be individualized, based on a combination of the employees&#8217; performance, responsibilities and position, our
assessment of how best to motivate a person in such a position and the needs and preferences of the particular employees, as negotiated
between employees and their supervisors or management.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
is set forth in the following Summary Compensation Table the compensation provided by us during fiscal 2021, 2020 and 2019 to our Principal
Executive Officer, and our acting Principal Financial Officer. There is set forth in the following Outstanding Equity Awards Table and
Director Compensation Table the required information.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">I.
SUMMARY COMPENSATION TABLE</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    and All Other Principal Position</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Salary<br />
    ($)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    Bonuses<br />
    ($)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    Awards<br />
    ($)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Compensation ($)</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(a)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(b)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(c)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(d)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(e)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(f)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian</span></td><td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,800</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,800</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">President,
    Principal</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2019</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,800</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,800</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
    V. Damadian</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">153,095</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">458,895</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
    of the Board,</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">153,095</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">153,095</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasurer
    and</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2019</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">153,095</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">458,895</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principal
    Financial Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    Bonanni</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,038</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,931</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">298,969</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
    Operating Officer and</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,496</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,902</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">299,398</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Vice President</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2019</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">145,672</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,740</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,565</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">II.
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Number
    Of Securities Underlying Unexercised Options (#) Exercisable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Option
    Exercise Price ($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Option
    Exercise Expiration Date</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(a)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(b)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(c)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian, President and Principal Executive Officer</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">N/A</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
    V. Damadian, Chairman of the Board, Treasurer and Principal Financial Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">N/A</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    Bonanni, Chief Operating Officer and Executive Vice President</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">N/A</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 96 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">III.
DIRECTOR COMPENSATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fees
    Earned or Paid in Cash ($)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    <br /> ($)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
    V. Damadian</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
    J.V. Chan</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Robert
    J. Janoff (deceased)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Charles
    N. O&#8217;Data</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
    G. Lehman</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
    E. Turk</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">EMPLOYEE
COMPENSATION PLANS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fonar&#8217;s
2005 Incentive Stock Option Plan, adopted on February 15, 2005, was intended to qualify as an incentive stock option plan under Section
422A of the Internal Revenue code of 1954, as amended. The Plan permits the issuance of stock options covering an aggregate of 80,000
shares of common stock of Fonar. The options issued have an exercise price equal to the fair market value of the underlying stock on
the date the option is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary
termination of employment. The Plan terminated on February 14, 2015.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fonar
adopted its 2010 Stock Bonus Plan, on June 28, 2010. This Plan permits Fonar to issue an aggregate of 2,000,000 shares of common stock
of Fonar as bonus or compensation. As of June 30, 2021, 450,177 shares were available for issuance.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_018"></span>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table sets forth the number and percentage of shares of Fonar&#8217;s securities held by each director, by each person known
by us to own in excess of five percent of Fonar&#8217;s voting securities and by all officers and directors as a group as of September
1, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    and Address of Beneficial Owner (1)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shares
    Beneficially Owned</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Percent
    of Class</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
    V. Damadian, M.D.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">c/o
    Fonar Corporation, Melville, New York</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director
    and Treasurer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5%
    + Stockholder</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">121,402</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.85</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,447</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">99.98</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">19,093</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.09</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Kayne
    Anderson Rudnick</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Investment
    Management LLC</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1800
    Avenue of the Stars, 2nd Floor</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Los
    Angeles, CA 90067</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">788,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12.03</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Renaissance
    Technologies LLC</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Renaissance
    Technologies Holding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Corporation</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">800
    Third Avenue</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">New
    York, New York 10022</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">489,816</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7.47</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dimensional
    Fund Advisors LP</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building
    One</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6300
    Bee Cave Road</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Austin,
    Texas 78746</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">404,018</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.16</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>





<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 98 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Continued:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    and Address of Beneficial Owner (1)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shares
    Beneficially Owned</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Percent
    of Class</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian,</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">President
    and Chief Executive Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">800</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    B. Bonanni,</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Vice President</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">And
    Chief Operating Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">49,726</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,285</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
    Chan</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director
    and Secretary</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">106</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Charles
    N. O&#8217;Data</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">658</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
    G. Lehman</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,330</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
    E. Turk</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
    Officers and Directors</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    a Group (7 persons)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">209,892</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.20</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,447</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">99.98</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,210</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.77</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*
Less than one percent</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<hr style="border-width: 0; background-color: Black; height: 1px; color: Black; width: 25%; margin-top: 1pt; margin-bottom: 1pt" />
<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.
Address provided for each beneficial owner owning more than five percent of the voting securities of Fonar.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_019"></span>ITEM
13.&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to HMCA&#8217;s management agreements with its clients, HMCA provides comprehensive non-medical management and administrative services,
including billing and collection of accounts, payroll and accounts payable processing, office facilities, supplies and utilities. Under
the management agreements, HMCA also provides service for the Fonar Upright&#174; MRI scanners through Fonar. In total, as of September
15, 2021, 22 of our clients had management agreements with HMCA. Five sites in Florida are owned and operated directly by HMCA subsidiaries.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
fees charged under the management agreements are flat fees charged on a monthly basis. These fees ranged from $77,000 to $530,000 per
month in fiscal 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dr.
Raymond Damadian, the Chairman of the Board and principal stockholder of the Company, owns three of the imaging facilities in Florida
managed by HMCA. The facilities owned by Dr. Damadian in Florida paid HMCA flat rate monthly fees ranging from $258,035 to $347,881 per
month during fiscal 2021. These fees are renegotiable on an annual basis.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the fiscal years ended June 30, 2021 and June 30, 2020, the net revenues received by HMCA from the imaging facilities owned by Dr. Damadian
were approximately $11.0 million, and $10.2 million respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dr.
Damadian owns a .75% interest in Health Management Company of America&#8217;s Class A membership interests. Dr. Damadian is also a Manager
of Health Management Company of America.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian, the President and Chief Executive Officer of Fonar, is one of the owners of a billing company, which performs billing and collection
services for HMCA with respect to No-Fault and Workers&#8217; Compensation claims of HMCA&#8217;s clients. The monthly fee charged to
HMCA is $85,000. These services were terminated on January 1, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the billing company for a monthly
fee of $23,884. Timothy Damadian is also a Manager of Health Management Company of America. The agreement was renewed on June 1, 2020
and June 1, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
Lehman, a Director of Fonar, holds a .0378% interest in Health Management Company of America&#8217;s Class A membership interests.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
J.V. Chan, a Director and the Secretary of Fonar, owns a .0378% interest in Health Management Company of America&#8217;s Class A Membership
interests.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_020"></span>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Audit
Fees</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
aggregate fees billed by Marcum LLP for the audit of our annual consolidated financial statements for the fiscal year ended June 30,
2021 and the reviews of the financial statements included in our Forms 10-Q for the fiscal year ended June 30, 2021 were $345,000.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
aggregate fees billed by Marcum LLP for the audit of our annual financial statements for the fiscal year ended June 30, 2020 and the
reviews of the financial statements included in our Forms 10-Q for the fiscal year ended June 30, 2020 were $409,000.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Audit
Related Fees</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for the fiscal years ended June 30, 2021 or June 30, 2020 for services related to the Audit or review
of our financial statements that are not included under the caption &#8220;Audit Fees&#8221;.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for the fiscal years ended June 30, 2020 or June 30, 2019 for designing, operating, supervising or implementing
any of our financial information systems or any hardware or software systems for our financial information</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
Fees</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for tax compliance, tax advice and tax planning in the fiscal year ended June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees billed by Marcum LLP for tax compliance, tax advice and tax planning in the fiscal year ended June 30, 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
Other Fees</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for any other services during the fiscal years ended June 30, 2021 and June 30, 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Since
January 1, 2003, the audit committee has adopted policies and procedures for pre-approving all non-audit work performed by the auditors.
Specifically, the committee must pre-approve the use of the auditors for all such services. The audit committee has pre-approved all
non-audit work since that time and in making its determination has considered whether the provision of such services was compatible with
the independence of the auditors.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
audit committee believes that the provision by Marcum LLP of services in addition to audit services in previous years were compatible
with maintaining their independence.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 101 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
IV</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="b_021"></span>ITEM
15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">a)
FINANCIAL STATEMENTS AND SCHEDULES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following consolidated financial statements are included in Part II, Item 8.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Report
of Independent Registered Public Accounting Firm</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Balance Sheets as at June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Statements of Income for the Years Ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Statements of Stockholders&#8217; Equity for the Years Ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Statements of Cash Flows for the Years Ended June 30, 2021 and 2020 .</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
to Consolidated Financial Statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
required by schedules called for under Regulation S-X is either not applicable or is included in the consolidated financial statements
or notes to the financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">b)
REPORTS ON FORM 8-K</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501921000032/fonar_8k.htm">1.
Registrant&#8217;s Report on Form 8-K containing the Company&#8217;s Earnings Report for Fiscal Year 2020, September 28, 2021. Commission
File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501921000022/fonar_8-k.htm">2.
Registrant&#8217;s Report on Form 8-K reporting the results of the election of directors and selection of auditors at the annual meeting
of stockholders. May 28, 2021. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501921000020/fonar_8-k.htm">3.
Registrant&#8217;s Report on Form 8-K filed on May 14, 2021, Item 2.02: Results of Operations and Financial Condition for the fiscal
quarter ended March 31, 2021.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">c)
EXHIBITS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.1
Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s registration
statement on Form S-1,Commission File No. 33-13365.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-95-000015.txt">3.2
Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s
registration statement on Form S-8, Commission File No. 33-62099.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501901500018/ex0403.txt">3.3
Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.3
to the Registrant&#8217;s registration statement on Form S-3, Commission File No. 333-63782.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501903000019/x033.txt">3.4
Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.3
of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.5
By-Laws, as amended, of the Registrant incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s registration statement on Form
S-1, Commission File No. 33-13365.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.1
Specimen Common Stock Certificate incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-1,
Commission File No. 33-13365.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.2
Specimen Class B Common Stock Certificate incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s registration statement on
Form S-1, Commission File No. 33-13365.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 102 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10.1
License Agreement between the Registrant and Raymond V. Damadian incorporated by reference to Exhibit 10 (e) to Form 10-K for the fiscal
year ended June 30, 1983, Commission File No. 0-10248.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000036.txt">10.2
Stock Purchase Agreement, dated July 31, 1997, by and between U.S. Health Management Corporation, Raymond V. Damadian, M.D. MR Scanning
Centers Management Company and Raymond V. Damadian, incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Form 8-K, July
31, 1997, commission File No: 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000029.txt">10.3
Merger Agreement and Supplemental Agreement dated June 17, 1997 and Letter of Amendment dated June 27, 1997 by and among U.S. Health
Management Corporation and Affordable Diagnostics Inc. et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K,
June 30, 1997, Commission File No: 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000004.txt">10.4
Stock Purchase Agreement dated March 20, 1998 by and among Health Management Corporation of America, Fonar Corporation, Giovanni Marciano,
Glenn Muraca et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, March 20, 1998, Commission File No: 0-10248.</a>&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000013.txt">10.5
Stock Purchase Agreement dated August 20, 1998 by and among Health Management Corporation of America, Fonar Corporation, Stuart Blumberg
and Steven Jonas, incorporated by reference to Exhibit 2 to the Registrant&#8217;s 8-K, September 3, 1998, Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501902000016/x99.txt">10.6
2002 Incentive Stock Option Plan incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8,
Commission File No.: 333-96557.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501905000018/x2-50801.txt">10.7
Asset Purchase Agreement dated July 28, 2005 among Health Plus Management Services, L.L.C., Health Management Corporation of America,
Dynamic Healthcare Management, Inc. and Fonar Corporation, incorporated by reference to Exhibit 2 to the Registrant&#8217;s Form 8-K,
August 2, 2005, Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501908000021/x10.txt">10.8
Partnership Interest Purchase Agreement dated September 29, 2008 by and between Diagnostic Management, LLC and Raymond V. Damadian, M.D.
MR Scanning Centers Management Company, incorporated by reference to Exhibit 10.35 to Form 10-K for the fiscal year ended June 30, 2008.
Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501910000014/x99.txt">10.9
2010 Stock Bonus Plan, incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8, Commission
File No. 333-168771.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501911000020/fonar10x.txt">10.10
Operating Agreement for Imperial Management Services, LLC, incorporated by reference to Exhibit 10.37 to Form 10-K for the fiscal year
ended June 30, 2011. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm">10.11
Operating Agreement for Health Diagnostics Management, LLC, incorporated by reference to Exhibit 10.38 to Form 10-K for the fiscal year
ended June 30, 2013. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm">10.12
Modification to Operating Agreement for Health Diagnostics Management, LLC., See Exhibits. incorporated by reference to Exhibit 10.38
to Form 10-K for the fiscal year ended June 30, 2013. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 103 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000007/fonar_exhibit-10.htm">10.13
Purchase Agreement dated March 5, 2013 among Health Diagnostics Management, LLC, Health Diagnostics, LLC and others. Incorporated by
reference to Exhibit 10.1 to the Registrant&#8217;s Form 8-K filed March 11, 2013. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501904000028/x141.txt">14.1
Code of Ethics, incorporated by reference to Exhibit 14.1 of Registrant&#8217;s Form 10-K for the fiscal year ended June 30, 2004, Commission
File No.: 0-10248.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-21.htm">21.1
Subsidiaries of the Registrant. See Exhibits.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-23.htm">23.1
Independent Registered Public Accounting Firms Report. See Exhibits.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-31.htm">31.1
Section 302 Certification. See Exhibits.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-32.htm">32.1
Section 906 Certification. See Exhibits.</a></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SIGNATURES.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td colspan="2" style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dated:
October 12, 2021</span></td>
<td colspan="2" style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0; width: 50%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">By:
</span></td>
<td style="border-bottom: Black 1pt solid; padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0; width: 45%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Timothy
R. Damadian</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
R. Damadian, President </span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
Principal Executive Officer</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td colspan="2" style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">By:</span></td>
<td style="border-bottom: Black 1pt solid; padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Raymond
V. Damadian </span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
V. Damadian, Principal </span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financial
Officer, Chairman of </span></td></tr>
<tr style="vertical-align: top; font-size: 11pt">
<td style="padding: 0; white-space: nowrap; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; white-space: nowrap; text-align: justify; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">the
Board and Treasurer</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="font-size: 11pt">
<td style="border-bottom: black 1pt solid; padding: 0; vertical-align: bottom; width: 28%; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Signature</span></td>
<td style="padding: 0; vertical-align: bottom; width: 4%; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; vertical-align: bottom; width: 45%; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Title</span></td>
<td style="padding: 0; vertical-align: bottom; width: 4%; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: black 1pt solid; padding: 0; vertical-align: top; width: 19%; text-align: center; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Date&#160;</span></td></tr>
<tr style="font-size: 11pt">
<td style="padding: 0; vertical-align: top; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/
Raymond V. Damadian Raymond V. Damadian</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
of the Board of Directors, Director, Principal Financial Officer, Treasurer</span></td>
<td style="padding: 0; vertical-align: bottom; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; vertical-align: top; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">October
12, 2021</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Claudette
J.V. Chan</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">October
12, 2021&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
J.V. Chan</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Charles
N. O&#8217;Data</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">October
12, 2021&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Charles
N. O&#8217;Data</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Ronald
G. Lehman</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">October
12, 2021&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
G. Lehman</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Richard
E. Turk</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">October
12, 2021&#160;</span></td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
E. Turk</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; font-size: 11pt; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 104 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: normal 11pt Times New Roman, Times, Serif">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>fonar-logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar-logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "8 ^<# 2(  A$! Q$!_\0
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M$:C^%I9B?S ']:SF^+7B GY;730/0Q2'_P!G%<)16+Q-5]3T8Y/@E_R[_/\
MS.Z_X6SXB_Y]M,_[\R?_ !RC_A;/B/\ Y]],_P"_,G_QRN%HI?6:O<K^R,%_
MS[7X_P"9W7_"V?$7_/MIG_?F3_XY1_PMGQ%_S[Z7_P!^9/\ XY7"T4?6:O</
M[(P7_/M?C_F=U_PMGQ%_S[Z9_P!^9/\ XY1_PMKQ%_S[Z7_WYD_^.5PM%'UF
MKW#^R,%_S[7X_P"9W7_"V?$7_/OIG_?F3_XY1_PMGQ%_S[:9_P!^9/\ XY7"
MT4?6:O</[(P7_/M?C_F=U_PMGQ%_S[Z9_P!^9/\ XY1_PMGQ%_S[Z7_WYD_^
M.5PM%'UFKW#^R,%_S[7X_P"9WB?%K7P?GM--8>@C<?\ LYK2M_C#*"!<Z,NW
MN8I^?R(_K7F-%-8FJNI,LFP37P?G_F>U6'Q4T"ZP+H7%DWK)&77\US_*NML=
M4L=3B$ME=PW"$9S&X-?-%2VUU<6<PFM9Y891T>-RI_,5M#&R7Q(\^OP[2DKT
M9-/SU1]/45Y'X:^*-S!(EMKB^=$3C[4HPR_50.?PKU6TNX+ZVCN;65989!N5
MU.017;3JQJ*\3YO%X&MA)6J+Y]"Q1116IQB5C>(?$MCX:M8KB^69DE?8OE(&
M.<9]16S7G7Q>_P"0+I__ %\G_P!!-9U9.,')'5@J,:^(A2GLV6_^%K^'O^>=
M]_WY'_Q5'_"V/#W_ #SOO^_(_P#BJ\6HKSOKE0^L_P!7L)W?W_\  /:?^%K^
M'O\ GG??]^1_\51_PM?P]_SSOO\ OR/_ (JO%J*/KE3R#_5["=W]_P#P#VG_
M (6QX>_YYWW_ 'Y'_P 51_PM?P__ ,\K[_OR/_BJ\6HH^N5/(/\ 5["=W]__
M  #VG_A:_A[_ )YWW_?D?_%4?\+7\/?\\[[_ +\C_P"*KQ:BCZY4\@_U>PG=
M_?\ \ ]I_P"%K^'O^>=]_P!^1_\ %5U.C:U9:]IZ7MC(6B8X(8893Z$>M?-M
M=/X(\4OX;U8"5B;&<A9ESPOHWX5I2QDG*T]CEQN04XT7*A?F7<]\HID4J31+
M)&P9& *LIR"/6GUZ)\GY,6BBB@ HHHH **** .-U#XDZ)IFH3V4\=X986VML
MB!&?;FJW_"U_#W_/.^_[\C_XJO+_ !8<^*]2/?SVK&KS)8NHI-*Q]C0R'"SI
M1D[W:77_ (![3_PMCP]_SSOO^_(_^*H_X6OX>_YYWW_?D?\ Q5>+45/URIY&
MO^KV$[O[_P#@'M/_  M?P]_SSOO^_(_^*H_X6QX>_P">=]_WY'_Q5>+44?7*
MGD'^KV$[O[_^ ?17AWQ+8^)K::XL5F"1/L;S4"\XSZFMFO.OA#_R!=0_Z^1_
MZ"*]%KT:4G."D^I\ICJ,:&)G2ALF+1116AR!1110 4444 %%%(Q"J22  ,DF
M@#)U[Q%I_ARUCN-0=PLC;45%W,Q^E<]_PM7PY_T^?]^/_KUYUXZ\0?V]X@D,
M;$VMOF.(=C@\G\:Y>O.JXN2DU'8^LP>0TIT8RK7YF>V_\+5\.?\ 3Y_WX_\
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MFR[_ ,+5\.?]/G_?G_Z]'_"U?#OI>?\ ?G_Z]>*45YWURH?6?ZO83N_O_P"
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M)\[6HU*,^2HK,6BBBJ,CP7XB_P#(]7_TC_\ 05KE>WX?TKJ?B+_R/5_](_\
MT%:Y7M^%>)6_B2/TC+_]UI^B_(7O1V_S[4=Z!T'^?2LSK#_"BD[4M !1110
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M #[P?]_EH_X5AXF_Y]X/^_RUVG_"VM$_Y]KW_OA?\:/^%M:)_P ^U[_WPO\
MC1[+#?S?B'U[-_\ GW^'_!.+_P"%8>)O^?>#_O\ +1_PK#Q-_P ^\'_?Y:[3
M_A;6A_\ /M>_]\+_ (T?\+:T/_GVO?\ OA?\:/98;^;\0^O9O_S[_#_@G%_\
M*P\3?\^\'_?Y:/\ A6/B;_GW@_[_ "UVG_"VM$_Y]KW_ +X7_&C_ (6UH?\
MS[7O_?"_XT>RPW\WXA]>S?\ Y]_A_P $XO\ X5CXF_Y]X/\ O\M'_"L?$W_/
MO!_W^6NT_P"%M:'_ ,^U[_WPO^-'_"VM#_Y]KW_OVO\ C1[+#?S?B'U[-_\
MGW^'_!.+_P"%8^)O^?>#_O\ +1_PK'Q-_P ^\'_?Y:[3_A;6A_\ /M>_]^U_
MQH_X6UHG_/M>_P#?L?XT>RPW\WXA]>S?_GW^'_!.+_X5CXF_Y]X/^_RT?\*Q
M\3?\^\'_ '^6NT_X6UH?_/M>_P#?"_XT?\+:T/\ Y]KW_OA?\:/98;^;\0^O
M9O\ \^_P_P""<7_PK'Q-_P ^\'_?Y:/^%8>)O^?>#_O\M=I_PMK0_P#GVO?^
M_:_XT?\ "VM#_P"?:]_[X7_&CV6&_F_$/KV;_P#/O\/^"<7_ ,*Q\3?\^\'_
M '^6C_A6/B;_ )]X/^_RUVG_  MK0_\ GVO?^^%_QH_X6UH?_/M>_P#?"_XT
M>RPW\WXA]>S?_GW^'_!.+_X5CXF_Y]X/^_RUU?@K0/%GAR^$4\<;:;*?WB>>
M#L/]X"K/_"V=#_Y]KW_OA?\ &C_A;6A_\^U[_P!\+_C50C0@^92_$QKULSQ$
M'3J4KI^7_!.^HKD-&^(NC:SJ*648GAED^X95 !/ID$UU]=D9QDKQ9X%:A4HR
MY:D;,*\Z^+W_ "!;#_KY/_H)KT6O.OB]_P @6P_Z^3_Z":SQ'\-G5E?^^4_4
M\AHHHKQC]$"CM110 4444 %'^%%% !1110!ZC\-/%V=NA7TG/_+L['_QW_"O
M4J^7HI7@E26)BLB,&5AV(Z5[UX*\4IXDTD>80+V$;9E]?]H>QKTL)7YER2W/
MCL\R[V4OK%-:/?R9U%%%%=I\Z%%%% !1110!\Y^*O^1JU+_KNU8];/BT;?%>
MIC_INU8U>'/XF?IF%_@0]%^04445!N%%%% 'KWP@_P"0+J'_ %\C_P!!%>C"
MO.?A!_R!=0_Z^!_Z"*]&%>SA_P"$C\\S7_?:GK_D%%%%;'GA1110 4444 )7
M&?$7Q#_8^@M:P/MN[OY%P>57N?Z5V$LJ0Q/+(P5$!9B>P%?//BO77\0:_/=D
M_N@=D(/9!_G-<V)J\D++=GKY-@OK.(4I?#'5_H8M%%%>2?>!1110 4444 %%
M'>B@ HXQ_P#7HHH$>X?#GQ"=9T$6T[YN[3$;9ZLO8UV=?.WA377\/:_!>Y/D
MG]W,/5#U_+K7T-%(DT22QD,C@$$=Q7K86KSPL]T?"9S@OJV(YH_#+5?J2444
M5TGD!1110 4444 %><_%W_D"V'_7<_RKT:O.?B[_ ,@:P_Z[G^58XC^$ST,J
M_P!\I^O^9Y#124M>,?H84444 %%%% !1110 4444 %%)2T %%%% !1110 44
M44 %%%% "H[Q2+)&[(ZG<K*<$'U!KVKP'XV77K<:??L%U*)>#VF4#J/?U'^1
MXI5BPO9]-OX+VU?9- X9#_,?0C(_&MJ-9TY>1YV8X"&+I6^TMF?3=%4-&U.+
M6='M=0A&%GC#;3_">X_ Y%%>PG=71^?2BXR<7NCQ3XB_\CU?_P#;/_T%:Y;M
M^%=5\1?^1ZO_ /MG_P"@BN4[?A7BUOXDC]&R_P#W6GZ(7O1V'^?2CO1V'^?2
MLSL#M12=OPI: +MIH^I:A"9K.PN)XPVTM%&6 /'''U%6/^$9UW_H$7O_ 'Y:
MO4OA-_R*D_\ U^/_ .@I7>5WT\)&45*Y\MBL^K4:\Z:BM'8^<?\ A&==_P"@
M1>_]^31_PC.N_P#0(O?^_)KZ/HJ_J4.YS_ZQU_Y%^)\X?\(QKO\ T"+W_OR:
M/^$9UW_H$7O_ 'Y/^%?1]%'U*/</]8Z_\B_$^</^$8UW_H$7O_?EJ/\ A&-=
M_P"@1>_]^37T=11]2CW#_6.O_(OQ/G'_ (1C7?\ H$7O_?EJ/^$8UW_H$7O_
M 'Y-?1U%'U*/</\ 6.O_ "+\3YQ_X1C7?^@1>_\ ?EJ/^$8UW_H$7O\ WY-?
M1U%'U*/</]8Z_P#(OQ/G+_A&-=_Z!%Y_WY-==\.-%U33_%0FN]/N8(O)<;Y(
MRHS]:]?H[U4,)&$E),QQ&>UJ]*5)Q5F<C\1M9?2?"TBPN5GNF$*$=0#U/Y U
MX57JGQ1L=4U.^L(;.RGGAB1F9HT) 8G_  %<!_PC&N_] F[_ ._1KFQ7-*IH
MM$>QDCHT<*G*23>NYE45K?\ ",:[_P! F[_[]&C_ (1C7?\ H$W?_?HUS\DN
MQ['UJA_.OO1DT5J_\(QKO_0)N_\ OT:/^$8UW_H$W?\ WZ-+V<NP?6J'\Z^]
M&53HXWE<)&C.YX"J,DUJ#PQKI./[*N_^_1KV3PAX1L] TZ&1X$?4'4-)*PR0
M3V'IBM:6'E-V>APX[-J.&A>/O-]$SRJP\ ^([]5=;!H4;H9CM_'!YK3_ .%5
M>(/[UK_W\KVNBNU8.FMSYV?$&+;]VR^1XK_PJKQ!_?M/^_G_ -:D_P"%5>(/
M[]I_W\_^M7M=%/ZG2)_M_&=U]QXI_P *J\0?W[3_ +^?_6H_X55X@_OVO_?R
MO:Z*/J=(/[?QG=?<>*?\*J\0?W[3_OY_]:C_ (53X@_OVO\ W\_^M7M=%'U.
MF']OXSNON/%#\*O$ 'WK7_OY61J/@?Q#I:-)-I[O&.KQ'>!]<=*^@J*3P=-[
M%PXAQ2?O)/Y'RZP*L58$,.H-)7M7CSP9;ZKI\M_8VX74(QN_=K_K1Z$>M>5?
M\(QKO_0)N_\ OT:XJM"<)6W/I,'FE#$T^=OE?9LRJ*UO^$8UW_H$W?\ WZ-'
M_",:[_T";O\ []&LO9R['7]:H?SK[T9-%:W_  C&N_\ 0)N_^_1H_P"$8UW_
M *!-W_WZ-')+L'UJA_.OO1EQR/#*DD;%70AE(Z@U]%>&=6&M^'[2^)!=TQ)C
M^\.#7A/_  C&N_\ 0)N_^_1KU#X7V^H6.EW=G?6LT 64/'YB%0<CG'Z5UX3F
MC)IK1G@Y][&M04XR3<7WZ'>]Z\Z^+W_(%L/^OD_^@FO1:\Z^+W_(%L/^OD_^
M@FNS$?PV>#E?^^4_4\AHHHKQC]#"BBB@ HHHH **** "BBB@ K3T#6[CP_JT
M5];D_+Q(F>'7N*S**<6XNZ(J4XU(.$UHSZ7TO4K?5M.AO;5P\4JY&#T/H?>K
ME>(_#WQ8VB:D+"ZD/V&X;'/2-_7Z5[:"& 8$$'H17L4:JJ1OU/S[,<%+"5G!
M[='Y#J***V. **** /G?QB"/%NI CGSC6'70>.%V^,=1'_33-<_VKPZOQL_2
ML&[X>#\E^04445!TA1110!Z]\(?^0)J'_7P/_017HPKSKX0_\@2__P"O@?\
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M/^?C^X^D_P"WM)_Z"-M_W\%']O:3_P!!&V_[^"OFS ]!1@>@H^O/L'^K4/\
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MAK K?\$_\CEI?_77^AJZ?QHYL9_N\_1_D?0M%%%>X?FH4444 %%%% !1110
M4444 >3_ !=T]([G3]010&D#0N?7&"O\S7F=>J?&"[7R-+LQC>7>4^P  '\S
M^5>5UY&*255V/O<D<G@H\WG]P4445SGK!1110!Z-\(#_ ,3?4QGCR$_]"-%2
M?!^%C?ZK/_"L4:?4DL?_ &6BO7PO\)'P6=M/&RMY?D<]\1?^1ZO_ *1_^@K7
M*]OPKJOB+_R/5_\ 2/\ ]!6N6[?A_2O,K?Q)'V67_P"ZT_1?D'>@=!_GTH[T
M=A69UA12=J6@#JO#?CJ]\-::]E;VT,JM*9,N3U( _I6Q_P +;U3_ )\;;\S7
MGM%:JO4BK)G!4RS"5).<X*[/0O\ A;>J?\^-M^9H_P"%MZI_SXVWYFO/:*KZ
MS5[D?V1@O^?:_'_,]"_X6YJG_/C;?F:/^%N:I_SXVWYFO/:*7UFKW#^R,%_S
M[7X_YGH7_"W-4_Y\;;\S1_PMS5/^?&V_,UY[11]9J]P_LC!?\^U^/^9Z%_PM
MO5/^?&V_,T?\+;U3_GQMOS->>T4_K-7N']D8+_GVOQ_S/0O^%N:I_P ^-M^9
MH_X6WJG_ #XVWYFO/:*7UFKW#^R,%_S[7X_YGH7_  MO5/\ GQMOS->KV%RU
MYI=M=, K30K(0.Q*@_UKYFKZ3T+_ )%_3O\ KUC_ /0179A*DIM\S/ SW!T,
M.H.E&U[GSUKC[M?U D\_:7_]"-4,CUKZ1?P]H\CL[Z;;,['))C&2:3_A&M%_
MZ!=K_P!^Q42P4F[W.FGQ%3A!1Y'IZ'S?D49'J*^D/^$:T3_H%VO_ '[%'_"-
MZ)_T"[7_ +]BE]1EW+_UDI_R/\#YOR/6C(]:^D/^$:T3_H%VO_?L4?\ "-Z)
M_P! NU_[]BCZC+N'^LE/^1_@>0?#'!\:P?\ 7*3_ -!->YU0M=%TRRF$UM8P
M0R@8#(F#5^NNA3=./*SP,RQBQ=;VL5;2PM%%%;' %%%% !1110 4444 %%%%
M "5\]^-\#QEJ6"/]9_05]"5G3:#I5S,\TVGV\DCG+,R DUA7I.K&R/2RS'1P
M=1SDKW5CYLR/449'J*^D/^$:T3_H%VO_ '[%'_"-:)_T"[7_ +]BN7ZC+N>Y
M_K)3_D?X'S?D>HHR/45](?\ "-Z)_P! NU_[]BC_ (1O1/\ H%VO_?L4?49=
MP_UDI_R/\#YOR/6NJ^'//C>RQC[K_P#H->S?\(UHO_0+M?\ OV*EMM$TRSG$
M]M8P12KT=$ (JH8-QDI7,,3G].M1E34'JK%^O.OB]_R!;#_KY/\ Z":]%KSK
MXO?\@6P_Z^3_ .@FNG$?PY'D97_OE/U/(:.U%%>,?H84>E%% !7H'PD?;XAO
M%_O6_P#6O/\ UKM_A6Y7Q=M_O0-^E;8?2JCSLV5\'4]#VRO*?B7X2V.=<L8_
ME/\ Q\HH[_WJ]6J.:))X7BE4-&ZE64]"#7JU::J1Y6?$8+%SPM95(?/S1\P4
M5TOC3PO)X;U8A%)LIR6A;T_V3]*YJO&G%PDXL_0J%>%>FJD'HPHHHJ38****
M -SPIXCF\-ZPERI+6[_+-&/XE]?J*^@+2ZAO;6*YMW#Q2*&5@>HKYCKT/X;>
M+?L%RNC7K_Z/*W[EC_ WI]#79A:_*^1['SN>9=[6/UBFO>6_FO\ @'L-%&:*
M],^./#/B<FSQE+_M1(?TKCJ[CXJ1E?%:OV>!?TKAZ\6O_%D?HF5N^#I^@444
M5D=X4444 >O_  B_Y =__P!? _\ 017HE>=_"'_D!W__ %\#_P!!%>B5[.'_
M (43\\S7_?:GK_D+1116QYXE!HK(\2ZU%H&ASWTA^8#;&/5STI-I*[*IPE4D
MH16K/.?BEXA^TWB:-;M^[@(:8@]7[#\*\YJ2>>2YN))YF+22,68D]2:CKQ:M
M1SDY,_1L%A8X:A&FOGZA11169UA1Z44?2@1U7@#0?[:\1QM(N;:VQ))D<$]A
M^?\ *O>  !@=!7+^ M _L/P[$)%Q<W'[V4^A/0?@*ZFO8PU/DAYL^ S;&?6<
M0VOA6B%HHHK<\P2O*/BKX?\ +EBUN!/E<B.? []C7J]4M6TZ'5M+N+&<925"
MN?0]C656G[2#B=F Q3PU>-1;=?0^::*LZC8RZ;J$]G.NV2)RK"JU>*U9V9^B
MQDI14H[,****"@KTCX6>(O(NI-$G;]W+F2 D]&[K^/6O-ZEMKF:SNHKFW<I+
M$P9&'8BM*51TYJ1R8W"QQ5"5)_+U/IZBLKP[K,6O:+;W\1&77#C^ZPZBM6O:
M3NKH_.9PE"3A+="T444R0KSKXN_\@2P_Z^#_ .@UZ+7G/Q=_Y EA_P!?!_\
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MY3PN'<$^1;+HC<_X3+Q%_P!!:X_[ZH_X3+Q%_P!!:X_[ZK#HI>TGW+^J8?\
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M"O.OB[_R!+#_ *^#_P"@UZ(:\[^+O_($L?\ KX/_ *#6.(_A,]#*O]\I^O\
MF>04445XQ^AB4M%% !1110 =**** "BBB@ HHHH **** "BBB@ HHH- !10,
M Y(S6UHU]H=K,C:II<MR >JRX'Y=Z<5=[V,JM1PBY*+?H5]&T#4=>NU@L8&;
MGYI",(GU->Z>%O"]IX8T_P B ^9,YW2S,.6./T''2JWAKQ)X;O8%M=*>&V('
M$! 0_P#UZZ:O4P]&$%S)W9\5FN8XBO+V<X\L5T_S%HHHKJ/&/!/B+_R/5_\
M2/\ ]!6N5[?A75_$7_D>K_\ [9_^@BN5[?A7B5OXDC](R_\ W6GZ(.])VI>]
M';\*S.L**/7_ #ZT4 =7X:\"7?B?3'O8+R*%5E,15T)R0 <]?]JMK_A4.I?]
M!.W_ ._9_P :Z+X2_P#(J7'_ %^/_P"@)7>5Z=+#4Y03:/C,;F^+I8B<(RT3
M['D/_"H=2_Z"=O\ ]^S_ (T?\*AU+_H)V_\ W[/^->OT5?U6EV.7^W,;_-^!
MY!_PJ'4O^@G;_P#?L_XT?\*AU+_H)V__ '[/^->OT4?5:78/[<QO\WX'D'_"
MH=2_Z"=O_P!^S_C1_P *AU+_ *"=O_W[/^->OT4?5:78/[<QO\WX'D'_  J'
M4O\ H)V__?L_XT?\*AU+_H)V_P#W[/\ C7K]%'U6EV#^W,;_ #?@>0?\*AU+
M_H)V_P#W[/\ C1_PJ'4O^@G;_P#?L_XUZ_11]5I=@_MS&_S?@>0?\*AU+_H)
MV_\ W[/^->J:?;-9Z;:VK,&:&)(RP[D #^E6J*TITH4_A.7%8^OBK*J[V.'U
M/X8Z7J>IW%\UU<1M.^]E7& 3UQ53_A4>E_\ /_=?I5SQCXWN_"VI0VZ6$4T4
MT>Y79R#D'D?RKG?^%OW?_0*A_P"_AK";P\9-26IZF'CFU2E&5*3Y>FJ-;_A4
M>E_\_P!=?I1_PJ/2_P#G^NOTK)_X7!=_] J'_OLT?\+@N_\ H%0_]_#4<V%-
MO8YSW?WHUO\ A4>E_P#/]=?I_A1_PJ/2O^?ZZ_2LG_A<%W_T"H?^_AH_X7!=
M_P#0*A_[^&GS84/8YUW?WHZ31OAQ8Z+JT.H6][<-)"<A6Q@^U=K7DP^+]UGG
M2H<?]=#7INEZC;ZMIT%[;.&CE4'@]#W'UK>C.D]*9Y>84,9%J>*]+EVBBBMS
MS0HHHH **** "BBB@ HHHH 0\UP=Y\+=.OKZ>ZEO[KS)G+MT[FNC\2^((/#F
MCR7LN&<<1QYP78]J\_\ ^%OW?_0*A_[^&N>M.E\-0]3+\/CFG4PNBV-;_A4>
ME_\ /]=?I1_PJ+2O^?ZZ_2LG_A<%W_T"H?\ OLT?\+@N_P#H%0_]_#6/-ACT
MO8YSW?WHUO\ A4>E_P#/]=?I1_PJ/2_^?^Z_3_"LG_A<%W_T"H?^_AH_X6_=
M_P#0*A_[^&CFPH>QSKN_O1K?\*CTK_G_ +K]*UO#O@&P\.:E]N@N)I9-A0!\
M8&>]<G_PN"[_ .@5#_W\-=AX+\53^*K>ZFEM4@$+A1M8G.:NFZ#DN1:G-BXY
MI3HMUY>[UU1U->=?%[_D"V'_ %\G_P!!->BUYU\7O^0+8?\ 7R?_ $$UKB/X
M;.'*O]\I^IY#1117C'Z(%%%% !72^ #CQII_^\?Y5S5=%X$;;XSTXX_C(_2M
M*7\1')CM<+4]&?05%%%>V?FX4444 >._$GPE_9]T=8LH_P#1IC^^4?P-Z_0U
MY[7TY=VL-]:2VUQ&'BE4JRGG(-?/_BOPY-X:UA[9@6MW^:"0_P 2^GU%>9BJ
M'*^>.Q]CD>8^UC["H_>6WFO^ 8=%%%<9]$%%%% !74>"/%#^'-6 E8FQG(65
M?0]FKEZ*J$W"2DC'$4(5Z;ISV9Z;\4=0L-2L;"2SO(9RCG(1\D BO,J**JK4
M]I+F9E@L*L+25).]@HHHK,ZPHHHH ]?^$/\ R [_ /Z^!_Z"*]$KSSX1?\@.
M_P#^O@?^@BO0Z]G#_P *)^>9K_OM3U_1!2$X!)X ZTM<?\0O$/\ 8N@M!"^+
MNZ&Q,=0.YK2<E"+DSDP]&5>K&G'=GFWC[Q"==U]UB;-K;$QQ^_J:Y6CW/?O1
M7B3DYR<F?I&'H1H4HTH[(****DV"BBB@ HHHH **** "BBB@ HHHH **** "
MBCBB@ HHHH *Z[X>^(?[%\0+#*^+2[(C?/0-_"?Z5R%+[@X-5";A)21AB:$:
M]*5*6S/J('(SVI:Y3P#XA_MWP_&LK W5M^ZE'<^A_$5U=>W"2E'F1^<5Z,J-
M1TY;H6O.OB[_ ,@.Q_Z^#_Z#7HM>=?%W_D!6/_7P?_0:SQ'\*1UY5_OM/U_S
M/(#1117C'Z&%%)2T %%%7M&TUM7U>VT])!&T[;0Q&0.,TTFW9$SFH1<I;(HT
M5Z3_ ,*AO/\ H)Q?]^S_ (TG_"H;W_H)P_\ ?L_XUM]6J]CS?[9P7\YYO17H
M_P#PJ&^_Z"4/_?L_XTG_  J&_P#^@E!_WP?\:/JU7L/^V,%_.><T5Z-_PJ'4
M/^@E!_WP:3_A46H_]!&#_O@T?5JO8/[8P7\YYU17HO\ PJ+4O^@C;_\ ?!I/
M^%1:E_T$;?\ [X-'U:KV'_:^"_Y^'G=%>AGX1ZG@XU"W/']TUR>N>&=5\/2A
M;^WQ&QPLR<HWX]C42HU(J[1K1S##5I<E.:;,BBBBLSM"BBB@!5)5@5)!'0@X
M(KU/P'X^EN;B/2-8D+R2-MMY\=3C[K?T/O7E= )5@RL58'((X(-:4JLJ<KHX
M\;@J>+IN$UKT?8^HZ*P?!VLG7/#%G=N<S!?+F_WUX)_'K^-%>U&2DKH_.ZM-
MTYN$MT>2?$7_ )'J_P#^V?\ Z"*Y3M^%=7\1?^1ZO_\ MG_Z"*Y3M^%>+6_B
M2/T3+_\ =:?HOR%[T#I^%'>@=/PK,[ ]?\^M'K1_G^='>@#V?X2_\BI<?]?C
M_P#H"5WE<'\)?^14G_Z_'_\ 0$KO*]JA_#CZ'YSF/^]U/5BT445J<04444 %
M%%% !1110 4444 %%%% '!?%+1VOO#Z7T29DLFW-CJ4/!_H?PKQBOI^:%)X7
MBD4,C@JRGN*\<U/X6:O'J$JZ;Y,EIG,;22;6 ].E<&*HMOFBCZC(\RITZ;HU
MI6MJK_D<'178_P#"L/$W_/*U_P"__P#]:C_A6'B;_GE:_P#?[_ZU<GL*G8][
M^TL)_P _%]YQU%=C_P *P\3?\\K7_O\ ?_6H_P"%8>)O^>5K_P!__P#ZU'L:
MG8/[2P?_ #\7WG'5M>'_ !5JGAR4FSES"QR\$G*,:U_^%8>)O^>5K_W^_P#K
M4?\ "L/$W_/*U_[_ '_UJ<:5:+NDS.KC<!5CR5)Q:.HL/B]:.H%_ILL;8^]"
MP8'\#C'YUHK\5= (R4NQ_P!LQ_C7#?\ "L/$W_/*U_[_ /\ ]:C_ (5AXF_Y
MY6O_ '^_^M70JN)73\#R98+*).ZJ6^?_  #NO^%J^'_[MU_W['^-'_"U?#_]
MVZ_[]C_&N%_X5AXF_P">5K_W_P#_ *U'_"L/$W_/*U_[_?\ UJ?M<1_*3]1R
MC_GY^/\ P#NO^%J^'_[MU_W['^-'_"U?#_\ =NO^_8_QKA?^%8>)O^>5K_W^
M_P#K4?\ "L/$W_/*U_[_ '_UJ/:XC^4/J.4?\_/Q_P" =U_PM7P__=NO^_8_
MQH_X6KX?_NW7_?L?XUPO_"L/$W_/*U_[_P#_ -:C_A6'B;_GE:_]_P#_ .M1
M[7$?RA]1RC_GY^/_  #N&^*V@*,B.[;V$8_QK*U#XNQ!2NG::['L\[X'Y#_&
MN<_X5AXF_P">5K_W^_\ K4?\*P\3?\\K7_O_ /\ UJ3JXE]/P*A@\HB[N:?S
M.?UG7-0UZ[^TW\[2,.%4<*@] *SJ['_A6'B;_GE:_P#?[_ZU'_"L/$W_ #RM
M?^_W_P!:N=TJK=VF>O#'8&G%1A4BDCCJ*['_ (5AXF_YY6O_ '^_^M1_PK#Q
M-_SRM?\ O]_]:E[&IV+_ +2P?_/Q?><=178_\*P\3?\ /*U_[_?_ %J/^%8>
M)O\ GE:_]_\ _P"M1["IV#^TL)_S\7WG'5[I\-],;3O"4+NN)+EC*<]<=!7$
MZ3\+M7?4X?[2\F.T#;I#')N)QVZ#K7L44:0Q)%&H5$ 55'0 5UX2C*+<I'S^
M>YA2JPC1I._5V']Z\Z^+W_(%L/\ KY/_ *":]%[UYU\7O^0+8?\ 7R?_ $$U
MTXC^&SR,K_WRGZGD-%%%>,?H@4444 %;O@QMOB[3O^NN*PJVO"7'BO3?^NPJ
MZ?QHYL6KX>:\F?15%%%>X?FH4444 )6%XJ\.P>)-'>U<!9E^:&3'*M_A6[12
MDE)69=.I*E-3@[-'S%>6D]A>2VMS&8YHF*LIJ&O8?B1X2_M&T.KV4?\ I<*_
MO54?ZQ/\17CU>-6I.G*Q^@Y?C8XNBIK?J%%%%9'>%%%% !1110 4444 %%%'
M:@#V#X1?\@*__P"O@?\ H(KT.O//A%_R [__ *^!_P"@BO0Z]G#_ ,*)^>9K
M_OM3U_1#9)$AC>21@J*"S$GH*^>_%^O/X@U^:YR?(0^7"N>BCO7I'Q-\1'3M
M*73+=\7%W]XCJJ=_SKQJN3&5;OD1[G#^"Y8O$S6^B"BBBN$^G"BBB@ HHKT3
M3/A3<WNG07-Q?^1)*H8Q^7G;G\:N%*53X3EQ.,HX9)U7:YYW17J'_"GV_P"@
MM_Y"_P#KT?\ "GV_Z"W_ )"_^O6OU6KV./\ MO!?S?@SR^BO4/\ A3[?]!8_
M]^O_ *]'_"GV_P"@L?\ OU_]>CZK5[!_;>"_F_!GE]%>H?\ "GV_Z"W_ )"_
M^O1_PI]O^@N?^_7_ ->CZK5[!_;>"_F_!GE]%>H?\*?;_H+'_OU_]>D_X4^W
M_06_\A?_ %Z/JM7L']MX+^;\&>845ZA_PI]O^@M_Y"_^O1_PI]O^@M_Y"_\
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M']^W'H/N445H\/"45%[(XZ>9UZ=:5:-N:6^A4_X53XD_OZ?_ -_V_P#B:/\
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E')M2;4HXT$ZQA-D@;.TOG^8HHHKIIP4(\J/(Q5>>(JNK/=G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>fonar_stock-graph.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_stock-graph.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1$ 17AI9@  34T *@    @ !0$2  ,
M   !  $   $[  (    .   (5H=I  0    !   (9)R=  $    <   0W.H<
M  <   @,    2@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M     $1A;FEE;"!#=6QV97(   60 P "    %   $+*0!  "    %   $,:2
MD0 "     S<U  "2D@ "     S<U  #J'  '   (#   "*8     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M.QAZJ+AKS-K3HUJ[^BU+U3DI:65_D]/ST/U2\WD@@\4+*&Z9K\:=8_X)0?\
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M\8O@EX<\%:?:ZU9PZ/J^HW-E&OV;3D:&.UBOK9(@7N&<LIZYX);-?=7[!/\
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M$%OVO?&7B7]KC]O>Y^)/Q%\8>(?"?PV\4&:PAUW6[F_M/#]E%>:T9!;I,[+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"41/@@21/PT4@!(#H5<9.&%9)^SY>35IR;OUYERV\K+9E-J=U/1625O7FO\
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M\2?C1_P3N_X+UZWX:_:(\#:?\+-0_:OMKC4I-(TF^@N=(74'GGFMIHVBN;@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2\5^\I3IPWDYM>FEO2[O9&6%7LYTY5=>514O-W=_72UV?C5\5OV?/"'[./\
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M\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]"#^T!_X(](_^6=?K]S[4<^U
M'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]"#^T!_X(](_^6=?K]S[4
M<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]"#^T!_X(](_^6=?K
M]S[4<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]"#^T!_X(](_^
M6=?K]S[4<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]"#^T!_X(
M](_^6=?K]S[4<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]"#^T
M!_X(](_^6=?K]S[4<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?LL?]
M"#^T!_X(](_^6=?K]S[4<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG1_Q&K?
MLL?]"#^T!_X(](_^6=?K]S[4<^U 'Y _\1JW[+'_ $(/[0'_ ((](_\ EG7/
M?%C_ (/4O@&WPN\2GP+X!^,'_":_V5=?\(__ &[HFG?V5_:/DO\ 9OM?DZGY
MOV?SMGF>7\^S=MYQ7[/\^U?/O_!6)3_PZV_:6/'_ "2KQ1V_ZA%U0!\!_P#$
M:I^RRO'_  @'Q_'_ ' ](_\ EG1_Q&K?LL?]"#^T!_X(](_^6=?KZB[5'3\J
M7GVH _('_B-6_98_Z$']H#_P1Z1_\LZ/^(U;]EC_ *$']H#_ ,$>D?\ RSK]
M?N?:CGVH _('_B-6_98_Z$']H#_P1Z1_\LZ/^(U;]EC_ *$']H#_ ,$>D?\
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M^U'/M0,_( _\'JO[+./^1!^/_P#X(](_^6=(?^#U3]ED_P#,@_'\?]P/2/\
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MK(!GE?EZ4+&5/6GT46%89L(&.,'BD\LCTXZ&I**8QJIM I2/3O2T4K ?G_\
M\%]/^;*_^SJ? _\ [?5]_I]P?2O@'_@OKU_8K_[.I\#_ /M]7W\GW!]*8"T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7S_ /\ !6+_ )1:?M+?]DJ\4?\ IHNJ^@*^?_\ @K%_RBT_
M:6_[)5XH_P#31=4 ?0"]!10O044 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X!_P33_Y-U\1_P#9
M5?B/_P"IQKM>_P!> ?\ !-/_ )-U\1_]E5^(_P#ZG&NT >_T444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5\_\ [97_ "<3^R?_ -E5OO\ U!_%=?0%?/\ ^V5_R<3^R?\ ]E5O
MO_4'\5T ?0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%,FG2!"SD*HZD]!0 XN%/--$ZE21DXX([BOFG]OO_@K?
M\!/^"<'AUY?BEXXLK'6I8?-MO#5@!?:W> C(VVR$E5;H))2D>?XZ_$_]I_\
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MH **** "BBB@ HHHH **** "OG__ (*Q?\HM/VEO^R5>*/\ TT75?0%?/_\
MP5B_Y1:?M+?]DJ\4?^FBZH ^@%Z"BA>@HH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP#_@FG_R;
MKXC_ .RJ_$?_ -3C7:]_KP#_ ()I_P#)NOB/_LJOQ'_]3C7: /?Z*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^?\ ]LK_ ).)_9/_ .RJWW_J#^*Z^@*^?_VRO^3B?V3_ /LJ
MM]_Z@_BN@#Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC=SW_B2%[KQ#JF_#&1;-BLH+G.7N'B.3N"MC!_HC_P""<?\ P3>^'W_!,/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %?/\ _P %8O\ E%I^TM_V2KQ1_P"FBZKZ KY__P""L7_*+3]I
M;_LE7BC_ --%U0!] +T%%"]!10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@'_!-/_DW7Q'_ -E5
M^(__ *G&NU[_ %X!_P $T_\ DW7Q'_V57XC_ /J<:[0![_1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^&5/AA_T3CP%_P"""T_^-T?\,J?##_HG'@+_ ,$%I_\ &Z .]W#W_*C</?\
M*N"_X94^&'_1./ 7_@@M/_C='_#*GPP_Z)QX"_\ !!:?_&Z .]W#W_*C</?\
MJX+_ (94^&'_ $3CP%_X(+3_ .-T?\,J?##_ *)QX"_\$%I_\;H [W</?\J-
MP]_RK@O^&5/AA_T3CP%_X(+3_P"-T?\ #*GPP_Z)QX"_\$%I_P#&Z .]W#W_
M "HW#W_*N"_X94^&'_1./ 7_ ((+3_XW1_PRI\,/^B<> O\ P06G_P ;H [W
M</?\J-P]_P JX+_AE3X8?]$X\!?^""T_^-T?\,J?##_HG'@+_P $%I_\;H [
MW</?\J-P]_RK@O\ AE3X8?\ 1./ 7_@@M/\ XW1_PRI\,/\ HG'@+_P06G_Q
MN@#O=P]_RHW#W_*N"_X94^&'_1./ 7_@@M/_ (W1_P ,J?##_HG'@+_P06G_
M ,;H [W</?\ *C</?\JX+_AE3X8?]$X\!?\ @@M/_C='_#*GPP_Z)QX"_P#!
M!:?_ !N@#O=P]_RHW#W_ "K@O^&5/AA_T3CP%_X(+3_XW1_PRI\,/^B<> O_
M  06G_QN@#O=P]_RHW#W_*N"_P"&5/AA_P!$X\!?^""T_P#C='_#*GPP_P"B
M<> O_!!:?_&Z .]W#W_*C</?\JX+_AE3X8?]$X\!?^""T_\ C='_  RI\,/^
MB<> O_!!:?\ QN@#O=P]_P J-P]_RK@O^&5/AA_T3CP%_P"""T_^-T?\,J?#
M#_HG'@+_ ,$%I_\ &Z .]W#W_*C</?\ *N"_X94^&'_1./ 7_@@M/_C='_#*
MGPP_Z)QX"_\ !!:?_&Z .\,H'KZ=*\!_X)IL/^&=?$?7_DJOQ'[?]3OKM>@'
M]E/X8E@?^%<^ _3_ )%^TZ?]^_\ .37A/_!.;]FKX=:U^S[XAFO/ '@JZF3X
MG_$* /-HEL[+''XTUN.- 2F=JHJJHZ!5 &  * /K7</?\J-P]_RK@O\ AE3X
M8?\ 1./ 7_@@M/\ XW1_PRI\,/\ HG'@+_P06G_QN@#O=P]_RHW#W_*N"_X9
M4^&'_1./ 7_@@M/_ (W1_P ,J?##_HG'@+_P06G_ ,;H [W</?\ *C</?\JX
M+_AE3X8?]$X\!?\ @@M/_C='_#*GPP_Z)QX"_P#!!:?_ !N@#O=P]_RHW#W_
M "K@O^&5/AA_T3CP%_X(+3_XW1_PRI\,/^B<> O_  06G_QN@#O=P]_RHW#W
M_*N"_P"&5/AA_P!$X\!?^""T_P#C='_#*GPP_P"B<> O_!!:?_&Z .]W#W_*
MC</?\JX+_AE3X8?]$X\!?^""T_\ C='_  RI\,/^B<> O_!!:?\ QN@#O=P]
M_P J-P]_RK@O^&5/AA_T3CP%_P"""T_^-T?\,J?##_HG'@+_ ,$%I_\ &Z .
M]W#W_*C</?\ *N"_X94^&'_1./ 7_@@M/_C='_#*GPP_Z)QX"_\ !!:?_&Z
M.]W#W_*C</?\JX+_ (94^&'_ $3CP%_X(+3_ .-T?\,J?##_ *)QX"_\$%I_
M\;H [W</?\J-P]_RK@O^&5/AA_T3CP%_X(+3_P"-T?\ #*GPP_Z)QX"_\$%I
M_P#&Z .]W#W_ "HW#W_*N"_X94^&'_1./ 7_ ((+3_XW1_PRI\,/^B<> O\
MP06G_P ;H [W</?\J-P]_P JX+_AE3X8?]$X\!?^""T_^-T?\,J?##_HG'@+
M_P $%I_\;H [W</?\J-P]_RK@O\ AE3X8?\ 1./ 7_@@M/\ XW1_PRI\,/\
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M* "BBB@ KY__ &RO^3B?V3_^RJWW_J#^*Z^@*^?_ -LK_DXG]D__ +*K??\
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MV(:Z91@//(Q,D[X_CE=G]6.:]0 P** (H(&A/WL@Y)Y/)))/\ZEHHH ****
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M0 5\_P#_  5B_P"46G[2W_9*O%'_ *:+JOH"OG__ (*Q?\HM/VEO^R5>*/\
MTT75 'T O044+T%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^E? '_!?7_FRO_LZGP/_ .WU??Z?<'TI@+1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?/_ /P5B_Y1
M:?M+?]DJ\4?^FBZKZ KY_P#^"L7_ "BT_:6_[)5XH_\ 31=4 ?0"]!10O044
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-'N_"MKK$_CV^M8YY;J*>>8EK6,M:S1H\.#M9,@-EEV_C9_P6[\??'3]B?\
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M\I(^3V!/ZQA2?Y5M>]*$I;M:_>TOPLS))*K-+;3_ -)3?XW/@+_@OF=Q_8L
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MO^%/>(?^BJ^/O_ 31/\ Y7T?\*>\0_\ 15?'W_@)HG_ROH [W/L:,^QK@O\
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M\!-$_P#E?1_PI[Q#_P!%5\??^ FB?_*^@#O<^QHS[&N"_P"%/>(?^BJ^/O\
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ME_X.OOVO/'UW<)X7\7:9X)TUBZQ+'HFFWUV%/ #2R6P4L 3RD2]1P.M?2_\
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MK7R0 O88&>PJ89 [UP?_  I[Q#_T57Q]_P" FB?_ "OH_P"%/>(?^BJ^/O\
MP$T3_P"5] '>Y]C1GV-<%_PI[Q#_ -%5\??^ FB?_*^C_A3WB'_HJOC[_P !
M-$_^5] '>Y]C1GV-<%_PI[Q#_P!%5\??^ FB?_*^C_A3WB'_ **KX^_\!-$_
M^5] '>Y]C1GV-<%_PI[Q#_T57Q]_X":)_P#*^C_A3WB'_HJOC[_P$T3_ .5]
M '>Y]C1GV-<%_P *>\0_]%5\??\ @)HG_P KZ/\ A3WB'_HJOC[_ ,!-$_\
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MN/B)\0_B!\0KJ(@O#9+!H5A-R/O1H)9AWZ3CK7[&);E7!+;L9QGMGZU,!@4
M?)_[/W_!#?\ 9._9D$#^%?@3X!>ZMR'CO-;LVUVZ1QC#K+>M,Z-GNI&.<8!(
MKZEL='@TG3XK6TA@M;>%=L<42!$C'95 X ]L8]JMT4 11VVQNN<#&3U_^MT'
M2I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWDF@AO8A%<VLD4TD$T,B@E=Z2Q2(<%E8IE2RD,0#ULW"@#J<^@R?KBA[A8V
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M\2/B% 928[#6==6VMEB!&Q&-G%!(Q  YW@'T%?JG%$R 9QGN0?\ /?-2 8%
M'B/[/'_!.+X&_LEBW;X;?"?P!X0N[9=JW]CH\7V]AC^*Y8-,Y[$LY)]>U>S+
M:N)F)92I QZ_3VZ9SW_ 58HH BC@*G+-N/N.GY8J4# HHH **;)*(R,ACDXX
M&:03!NG3ZB@!]%,\X<\,,=<C%#S"/J&_!2?Y4 /HKA?BS^T_\-O@)"9/'/Q
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MT&_9"^&9C;6[/XA^/W7EAK?B(P1L<CM91VYP!D8)/#'.>,?5WP<_X(U?LL_
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M !1110 4444 %%%% !1110 4444 %%(6"^O'M2&4*>AY]J '45$;M X7/+'
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MMY7D=D"N74A6+Y4 $ ?U :;X<@T'28;#3H;>PLK6)8;:"",1Q6Z* %1%7 5
M!C [=,4^+0;>&_:Z6& 731B#SM@$IB4DJA;J5!9B >!GIGD@'\B=O_P78_;_
M /B?<Q16?Q3^(6HO?N#&FF>&[5&D(^8A!!:@D8!R!P0I]Z_I7_X)!?%#XO\
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M]<]J^@_.7=M!!.,X!YKY_P#^":\ZQ_LZ>(\G_FJGQ'/7K_Q6^NT >_K%M7&
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M;]G\.^&H'Z@C;NO!<N#TY# @CMD@^>QZS_P47_X*"Q?NI_VH/'&D:B,,;?\
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M+X3?\&7/[//AQ[:;Q7\0_BSXIFC/SQVT]GI=K<=<AD%O)*!CTE!]Z_8RXX
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M$'4C<.#G0_#]I;@,HZ VEJ@&>XQVH _KV,BQGGJ<]%//? ]:\!_X*M3K<_\
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M3_M&_!=BZ[@UOXOL;F/KC!>.1E!]B:IO_P %K/V2$_YN+^$!/3'_  DUK_\
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M-T"[".^9RJ@Y.U6;'0$\4 ?6DBLZ@*0/?\/3O3%MMK#D  =O_K_XUPZ_&+Q
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M6>//_ O1?_EA1_PN'Q!_T2SQY_X%Z+_\L* .]HK@O^%P^(/^B6>//_ O1?\
MY84?\+A\0?\ 1+/'G_@7HO\ \L* .]HK@O\ A</B#_HEGCS_ ,"]%_\ EA1_
MPN'Q!_T2SQY_X%Z+_P#+"@#O:*X+_A</B#_HEGCS_P "]%_^6%'_  N'Q!_T
M2SQY_P"!>B__ "PH [VBN"_X7#X@_P"B6>//_ O1?_EA1_PN'Q!_T2SQY_X%
MZ+_\L* .]HK@O^%P^(/^B6>//_ O1?\ Y84?\+A\0?\ 1+/'G_@7HO\ \L*
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M^B6>//\ P+T7_P"6% '>T5P7_"X?$'_1+/'G_@7HO_RPH_X7#X@_Z)9X\_\
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M%_PN'Q!_T2SQY_X%Z+_\L*/^%P^(/^B6>//_  +T7_Y84 =[17!?\+A\0?\
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MW?+MSGC-?T1&+)SD@CISFOGW_@K#;C_AUO\ M*DX;'PK\4$9SQ_Q*+KWXZ4
M?E$?VD?VM_@PY^W:S\8]-$7S-_;=E=7('?):XC91^(K:\+_\%L_VA/#GR7GB
M32]<1#M87^C6IQ[%H(X\_0\^]?N*(SC@G!]S6+XJ^&/AWQRA76]!T76%9=I%
M]8Q7((]/G4T ?D]X3_X.&/B3I[)'K/@GP3J42CG[&+JQD8>O,D@'Y8KTOPE_
MP<9:3.@&L_"Z_@5>#)8:VERI_P"^XD /U:OLOQ5_P3K^!OC($7OPJ\$)D<FT
MTN.R)/KF$)S[]:\T\5_\$2_V>?$I9H?">IZ0[?Q66N7G'OB21Q^E '&>%O\
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M;]/RHV_3\J8+I"P&<$]CP?R//_ZJ#=()-I(SC=U'3UH ?M^GY4;?I^5()58
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M4 %?/_\ P5B_Y1:?M+?]DJ\4?^FBZKZ KY__ ."L7_*+3]I;_LE7BC_TT75
M'T O044+T%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMT@K<SW$$[R6/B/4K)W"B%TPSV[,.<@,*_=ROG__ ()JKN_9U\1_]E5^(_\
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M/_0J:3_X/+3_ ..4?\.1OVB?^A4TG_P=VG_QROW)\L>B_E1Y8]%_*@#\-O\
MAR-^T3_T*FD_^#NT_P#CE'_#D;]HG_H5-)_\'=I_\<K]R?+'HOY4>6/1?RH
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MZ_Q4 >O^&_\ @LE^SMXCPO\ PGCV$IS\EYHU]"!C&?G\G9W[-7H/AO\ ;_\
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MU^-7AS_@X'^,6DA5U#0?A]JB=-[6=Q;R'_@2W 7'_ :]$\-?\'&FK6^T:O\
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MBBB@ HHHH .]?D#_ ,&5/_*++Q]_V574?_31H]?K]WK\@?\ @RI_Y19>/O\
MLJNH_P#IHT>@#]?J*** "BBB@ HHHH **** "BBB@ HHHH **** /@#_ (+Z
M]?V*_P#LZGP/_P"WU??R?<'TKX!_X+Z]?V*_^SJ? _\ [?5]_)]P?2@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KY_\ ^"L7_*+3]I;_ +)5XH_]-%U7T!7S_P#\%8O^46G[2W_9
M*O%'_IHNJ /H!>@HH7H** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\ _P"":?\ R;KXC_[*K\1_
M_4XUVO?Z\ _X)I_\FZ^(_P#LJOQ'_P#4XUV@#W^BBB@ HHHH **** "BBB@
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M/ OQ MM)=([Z;PUKUIJR6;."460P2.$+!6(#8SM/I7YJ_P#!P%\(_BC^T/\
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M"_\ Z*1X!_\ "@M/_CE'_#5?PO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\
MZ*1X!_\ "@M/_CE'_#5?PO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X
M!_\ "@M/_CE'_#5?PO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\
M"@M/_CE'_#5?PO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\ "@M/
M_CE'_#5?PO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\ "@M/_CE'
M_#5?PO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\ "@M/_CE'_#5?
MPO\ ^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\ "@M/_CE'_#5?PO\
M^BD> ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\ "@M/_CE'_#5?PO\ ^BD>
M ?\ PH+3_P".4 =[17!?\-5_"_\ Z*1X!_\ "@M/_CE'_#5?PO\ ^BD> ?\
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MCP#_ .%!:?\ QRC_ (:K^%__ $4CP#_X4%I_\<H [VBN"_X:K^%__12/ /\
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M%(\ _P#A06G_ ,<H [VBN"_X:K^%_P#T4CP#_P"%!:?_ !RC_AJOX7_]%(\
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MEW_P95R*O_!+?Q\FX;O^%J:@V,\X_LC1^U '[ "BBB@ I&7/I@TM% 'Y%_\
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MXY_LGZ9\=_AIX:^%_@3]DA8[I]9@\3VFLW'CZ^MXX([:6"" 9M4W6D3LLN"
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MW8^7%?8P3'>E084#FEK23YOZZ=!1C:^NK=WZL_/_ /X+YC#?L6'KG]JGP/\
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M]*\"_P"":9/_  SKXCX'_)5?B-W_ .IWUVOH"O /^":?_)NOB/\ [*K\1_\
MU.-=H ]_Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]
MJ.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]
MJ.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J.?:BB@ Y]J^??VRP?^&B?V4.G_)5+
M['/_ %)'BNOH*OG_ /;*_P"3B?V3_P#LJM]_Z@_BN@#W]1M4# P.*7GVHHH
M.?:CGVHHH .?:CGVHHH .?:CGVHHH .?:CGVHHH .?:CGVHHH .?:CGVHHH
M.?:CGVHHH .?:CGVHHH .?:CGVHHH .?:CGVHHH .?:CGVHHH .?:CGVHHH
M.?:CGVHHH .?:CGVHHH 9+'Y@P0#[$\'V-?D%_P961[O^"6_CYLG_DJFH#&3
MC_D$Z/VZ5^P'>OR!_P"#*G_E%EX^_P"RJZC_ .FC1Z /U^HHHH **** $P<^
MU&T[<4M%  *,9HHHL C+FC'/TI:* L'6C'-%%%@"BBB@#X _X+Z]?V*_^SJ?
M _\ [?5]_)]P?2O@'_@OKU_8K_[.I\#_ /M]7W\GW!]* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"OG_ /X*Q?\ *+3]I;_LE7BC_P!-%U7T!7S_ /\ !6+_ )1:?M+?]DJ\4?\
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M*** "BBB@ HHHH **** "OG_ /X*Q?\ *+3]I;_LE7BC_P!-%U7T!7S_ /\
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M/^":?_)NOB/_ +*K\1__ %.-=KW^O /^":?_ ";KXC_[*K\1_P#U.-=H ]_H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KY_\ VRO^3B?V3_\ LJM]_P"H/XKKZ KY_P#VRO\
MDXG]D_\ [*K??^H/XKH ^@**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .]?D#_ ,&5/_*++Q]_
MV574?_31H]?K]WK\@?\ @RI_Y19>/O\ LJNH_P#IHT>@#]?J*** $+8J.X<"
M)B2!@9I[G'O45W(L,3NV=B*2=JEC^ ')_#FLZEW%V!;W/Q&U'_@OU^U7\:OC
MYH7CKX/_  GT#Q/\$S-K\6G>#+2.>^\4^-;/3;K3X+B]1HHV>&91>1M%$BX
M^T^8LVV)J_:KP7XD'C+PAI>KI::A8)JEK%=K;7ULUM=6XD0,$EB<!HY%SAD8
M J00>17\WW[5_@OX9?"#]HZZ_:)_8.^..I^$EMM(\6^*-<T^[MIH=/LK[3GT
MQKG3HK2[ABDB6Y%VG[N5)$9DC5=J[0G] _[%GQCU?]H?]D3X8^//$&EIHNM^
M,_"^FZU?V**RI:SW%M'-(BAB6"AG. QR!C/.:UH)/#Q?:U_G?[T[/^F*OI7T
M5D[V^5M_-7/3UXQ7S'_P5J_X*)6W_!,S]D'4?B"FC+XF\27M];:'X:T9YO)3
M4]2N&(C1G )5%19)&Z$K$5!!((^FL_IZU^5G_!VWIL\/["/PS\0,CC2/"WQ1
MTF_U2=58BT@\B[C\U@!T#.J]#RX&,FLG;FC&3LG**;\FTF7!:2?5*37JDVOQ
M/3?V/_\ @I9\=O#7_!0/3/V;?VHO"/PQT?QEXT\,-XK\)ZSX N+U],GCCW^;
M97"7;,_VA!%,Q=6V?(  0P<_5?[<_P"UMH?["'[)/CKXM>(;>2]TWP5IC7GV
M.-]CW\Y81P6X<AMIEF>./<00-^<8!K\_/VK;JV^+O_!T)^RM'X=GMK\^%OA[
MJFMZG<6L@D\FTN+:_2$N0I 5F=,9/(E!&-RY[_\ X.%OB/X7_:=_X(P_M!6/
MP[\5^&/&U[X,GL(]=M]$U6"_DTB2WU.V>:*X6)F,,D:H[,C[2 C9'%3B)R6%
MC-:2=_N4W&_W!AXJ6*Y):KW?O:NU_7<YC]GC_@L+^T1X(^/GP T_]I#X?_"O
M1O '[4T.[P7>^#+J]DU#P_.\<<L%OJ8N&:-WD$\"YAVA=Y.3M957]HK_ (+"
M_M"^,_CK^T!:_LX> ?A5KWP]_97A'_":WOBZZODU'Q!<1I)+=6NF+ 52.2,0
M3IF8,I:,,,Y5#X1^V_XFTWXX6G_!)70O#%Y;:GJNHZSHFNP&V.Z:.SM8=,:>
M3;M)50$?)88!A.1\IPG[ GBS2_@?J?\ P5ETOQ5<V>GW^E:OJVM3V=VWEB2T
MFCU5HI!N'S+('C P"?WB<98"M,1>$9RCO#GLN]G!*_?XG]Q.'?,J;DOBY+^5
M^:_I\*]+^9^LG["G[7.C?MU?LD>!/BSH-K/8:=XVTU;T6<K!WLI0S1S0E@ &
M\N5)$W8&[;G SBO6PX(S7P7_ ,&S_@;4O!'_  18^"\&II)#+>VVI:A%&X Q
M#/J=W-$1P#AHW5AG/WNN,5]YJ0J@=JZL5!0JRC'N<^&DY4U?_A_,^ O^"^O7
M]BO_ +.I\#_^WU??R?<'TKX _P""^9W']BO_ +.I\#_^WU??RMA1P>E<YT#J
M*3/L:7/L: "BC/L:,^QH **,^QHS[&@ HHS[&C/L: "BC/L:,^QH **,^QHS
M[&@ HHS[&C/L: "BC/L:,^QH **,^QHS[&@ HHS[&C/L: "BC/L:,^QH **,
M^QHS[&@ HHS[&C/L: "BC/L:,^QH *^?_P#@K%_RBT_:6_[)5XH_]-%U7T!G
MV-?/W_!6$Y_X):_M*C!R?A5XH_\ 31=4 ?0*]!13$E!)'.5ZTX'(Z&@!:*,^
MQHS[&@ HHS[&C/L: "BC/L:,^QH **,^QHS[&@ HHS[&C/L: "BC/L:,^QH
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MXMWWCSX7_"?0_"_BV_1XSJ(NKN\>U1\[UMUN)9$M@P8J1 $RIVGCBF_M7?\
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M?\."?^"IO_1Z8_\ #O>+O_D2OW_HH _ #_AP3_P5-_Z/3'_AWO%W_P B4?\
M#@G_ (*F_P#1Z8_\.]XN_P#D2OW_ ** /P _X<$_\%3?^CTQ_P"'>\7?_(E'
M_#@G_@J;_P!'IC_P[WB[_P"1*_?^B@#\ #_P0+_X*F?]'I_^9>\7?_(E-;_@
M@=_P5,49_P"&T_\ S+WB[_Y$K]_7;:WIFOS=_P""FOQS\;^!/^"UW[$'A30O
M%_BC1/"_BRYU\:WH]AJMQ;V&LB.WA,8N8$<1S["25WJVTDD5/-^\A3_F=OPO
M^@2]V$JG\JN?$O\ PX,_X*F'_F]/_P R]XN_^1*4?\$"O^"IA_YO4'_AWO%W
M_P B5^N7[.7_  4T\!_M,?M+?&KX5:#I/BVU\0_ B>&WUZXO[6WCL[QI1+M-
MJR3N[C]RV?,2/J.O;Q)/^#B?X)M_P3ON_P!IC_A&/BB/ =EXI_X1*2P_LZP_
MM<W6%.\1_;/*\KYASYN[@_+4NHK7Z637HW9/YL:3V>][?-*]ONU/SY_X<&?\
M%3,_\GJ?^9>\7?\ R)5'Q7_P;P_\%-_'GA;4M"UW]L'3M:T36K66PU#3[_XK
M>*[FUOK>5"DL,L3V922-T9E9&!5@Q!!!K]+_ (*_\%]/@K\;OVK?"?PF@T#X
MK>&;_P"(5M]K\':_XC\*OIFA^+XMA</8S._FRHP#!9#$L;%<*YRNZ#]IO_@O
MY\&?V:_C9XL\$Q^%_C!\1Y/AP$/CG6?!'A1M6T?P,&YW:C<>8@C"J'+% ^WR
MY%/SJ5%]4N]_PW)CKM_5S\YC_P $#O\ @J8#_P GI_\ F7O%W/\ Y*4UO^""
M'_!4O=C_ (;3Z_\ 57O%W_R)7[K_  :^,GAK]H3X5Z!XV\&ZO:Z[X7\3V4>H
M:;?P9V7$+C*M@@,I[%6 92"" 00/BG]MK]@_XZ?M0_M3^)O$_B[]IGQ3\$_V
M<O"_AUI]$L_AOXCET#6H[U(T::ZU.X:'RW@4"9L>80%6/ C/F.\U).F[35K7
MNWTL532G'FB[]O.Y^?[?\$#?^"IB_P#-Z?\ YE[Q=_\ (E)_PX._X*EX!_X;
M3)![_P#"WO%W_P B56\.?\%L?C]<_P#!!--<_P"$OU"3QMJ?Q;7X76'Q&FM$
M6[;3&@%U]M ("FX"AH-[#.T[MWFJ7'U%^S3\5?B!_P $U_\ @N%X4_9;UCXR
M_$?XV?#OXN>"VU^PN/'FJ_VKK.A:A$EV[;;DKN:&064V$(50)4ZE"S[*FW4Y
M.^WG[O-\M']^A$VXQYNVK\ES<M_O_#4^:%_X(%_\%3&&?^&T_P#S+WB[_P"1
M*/\ AP3_ ,%3?^CTQ_X=[Q=_\B5^_L8 08Z4ZH*1^ '_  X)_P""IO\ T>F/
M_#O>+O\ Y$H_X<$_\%3?^CTQ_P"'>\7?_(E?O_10!^ '_#@G_@J;_P!'IC_P
M[WB[_P"1*/\ AP3_ ,%3?^CTQ_X=[Q=_\B5^_P#10!^ '_#@G_@J;_T>F/\
MP[WB[_Y$H_X<$_\ !4W_ */3'_AWO%W_ ,B5^_\ 10!^ '_#@G_@J;_T>F/_
M  [WB[_Y$H_X<$_\%3?^CTQ_X=[Q=_\ (E?O_10!^ '_  X)_P""IO\ T>F/
M_#O>+O\ Y$H_X<$_\%3?^CTQ_P"'>\7?_(E?O_10!^ '_#@G_@J;_P!'IC_P
M[WB[_P"1*/\ AP3_ ,%3?^CTQ_X=[Q=_\B5^_P#10!^ '_#@G_@J;_T>F/\
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M&D<)O&YI=I!(ZS4-M4OFW9?B59N/-'7?\%=GE:_\$#_^"I;=/VU/_,O>+O\
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M#\ /^'!/_!4W_H],?^'>\7?_ ")1_P ."?\ @J;_ -'IC_P[WB[_ .1*_?\
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M*K M"Q66(@LFX*3(J[MNY@,D>F#"J"2OTHXW8ROM5UFY14;VM_F*DN2?-O\
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MC1LP92*_I5VC&,9Z<4B)P#@ $<\9S6B;^]R?_@33_"Q"NE;LHKYQO_F?._\
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M9VJ06MO'V1(D 55YZ  5BX7I3@]VFK^3:?Z)%JHE4A)+1--KT5M/6]S^<_\
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MG@KPEX9O/%UVU_KT^E:/;V4NM7!+$S7+1HIGD)=R6D+$[FYYK)^%'[(?PH^
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M[&>UUSQU<6KZOH^F7 #[;&\T];:4R"3:F/F^8.2$;RW _,_X%_L??$#]L?\
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M&>$]-\;^(H4MM6\0VND6\.JZG$@4)'/<J@EE50B !V( 1<=!5S2;=EO[2_\
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MI%12^2L[_<OO(L^=SW<FV_PM^IW=%%%!84444 %%%% !1110 A7K1MXQ2T4
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M_C&7]HO7/&L6H>+O$]UKES</XCL9[R[CDLKB%Y?*:$^3",!06 .[(P4^SO\
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MGMDX.*_$S_@H[\!/VFOV(?V/?B5^TO\ %C]L/QQHWQ?TSQ#"_A+PWX-UUX?
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MQ&\$6_P_^*_PBU]O#_BG2;21GM1+ND"M&&9G0AX949"SC,88.0^%ZK_@K?\
M\%2=%_X):? 32]??PY?^.?&_C#4DT/PGX6L9-D^KWC<G)"LXC4%02B.Q=XD
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M+=;T#P;\0O!'BW7?##F/6-.T77;6_N])8.4*W$43L\)W*RX<#E2.H-4OB/\
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M+<6U[!(I1XI8W!5T925*L"""01@FO$6_X*O_ ++C)E/VDO@&Q'8?$#23]/\
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MKHRTM9-]$WM^1,'S4U476_X6O^9^[PE!(QSGTH,@ Z&OR1_X+$_MG?M5R_\
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MHH **** $QS33&6Z_G3Z*5N@=;C%B*D8P!Z4QK8.#D#GK[U-10E96%;J,$1
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MW]H#P;+X<\=^$_#7C3P[<R)++I>OZ9!J5G*Z'<C-#,K(2IP02,@CC!K\V_\
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M'/'-DVC"#5/L%K=A/M%Y;QS?NIXY(CN21QRAQGC! ->H?$;_ (*@_"3]BO\
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M9I6=^1;KH.ZMSO;O]Q]7BBD0Y4=12TRT%%%% !1110 4444 %%%% !11030
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M$OQ)F-QXDDM=5O6L]3E\QI!(;-YFMHV#R2$&.-2OF.!@,P/IOQ5^$WAKXX^
M-4\*>,M!TCQ1X:UN$P7^EZG:I<VMTF0=KHX(." 1QP5!&" :*\G*<*T5K&SM
MTNEJO3L13BHJ=-ZJ7,K];/\ 774^5/C-_P %^OV4_@_=>![6V^*NA^/;_P >
MZG!IEC9^"IH_$%U9F4 "6YBMV9X5#,B["/.9GPL;%6V_('CSX=^#/VK?^#IO
MQ3X.^/VCZ)XE\->&?AQ;2_#K0/$D*S:9J#NEM)/(EO-F*>0/)?<%3_J"<$Q
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MN?"'@;QS-9:;<>&]7TG4/[)NO%&MM;1-,M]<P;7G9+E2,3.H5R8CPYC/Z2_
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MK1<JSJ*UFW]UEKZWW^1ZE$P9>#G%.J.!'"?-M![;3Q4G2K&%% .:* "BBD+
M&@!:*0L ,YI!,I/WA0 ZBDW#U%+D>HH **3</6C>* %HH!S10 4444 %%%%
M%:_G,2Y^?:O+;< XP>^17X"_\%-?^#43X[_M=?MU?$GXF^"?B3\,[O0?'6LR
MZS"OB;4-0M=0L3*=S6VV&TG0Q1'Y8V#CY%7*BOW\N(7DE!5E 'JN3^>:C2TE
M0DATR>2=AR?UHL^XN5]S^8[_ (@N?VHD!9O'WP$^@UO5CGG/7^S?KTK]I/\
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MZ]>:]=ZW<OIWG/I^G^<L48M[=I55RF(?,)*)\\TO'.:^6?\ @JWX$T;XI_\
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M;>B5K?UZ"FG*C*G'1R4D_G:S/6H?]4OTIU(@VK@4M!2V"BBB@84444 %%%%
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JT]:-FS)HHI$K>PNWD=*39@\444+8'H@7+4I&"***.H HP*6BBF"V/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>fonr-20210630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOa+HiaP9wZ93CekhsGRwbfm6fy4sBjrX4Coj7HGG0bcL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:FONR="http://fonar.com/20210630" elementFormDefault="qualified" targetNamespace="http://fonar.com/20210630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" id="ConsolidatedStatementsOfIncomeParenthetical">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
	  <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" id="Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources">
	  <link:definition>00000008 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" id="Note2-SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
	  <link:definition>00000010 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilities" id="Note4ContractAssetsAndLiabilities">
	  <link:definition>00000011 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5Inventories" id="Note5Inventories">
	  <link:definition>00000012 - Disclosure - NOTE 5 &#8211; INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-PropertyAndEquipment" id="Note6-PropertyAndEquipment">
	  <link:definition>00000013 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7OperatingFinancingLeases" id="Note7OperatingFinancingLeases">
	  <link:definition>00000014 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets" id="Note8-OtherIntangibleAssets">
	  <link:definition>00000015 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-CapitalStock" id="Note9-CapitalStock">
	  <link:definition>00000016 - Disclosure - NOTE 9 - CAPITAL STOCK</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" id="Note10ControllingAndNoncontrollingInterests">
	  <link:definition>00000017 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" id="Note11-Long-termDebtNotesPayableAndCapitalLeases">
	  <link:definition>00000018 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxes" id="Note12-IncomeTaxes">
	  <link:definition>00000019 - Disclosure - NOTE 12 - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities" id="Note13-OtherCurrentLiabilities">
	  <link:definition>00000020 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note14-CommitmentsAndContingencies" id="Note14-CommitmentsAndContingencies">
	  <link:definition>00000021 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformation" id="Note15-SupplementalCashFlowInformation">
	  <link:definition>00000022 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note16RelatedPartyTransactions" id="Note16RelatedPartyTransactions">
	  <link:definition>00000023 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation" id="Note17-SegmentAndRelatedInformation">
	  <link:definition>00000024 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note18Acquistion" id="Note18Acquistion">
	  <link:definition>00000025 - Disclosure - NOTE 18 &#8211; ACQUISTION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" id="Note19AllowanceForDoubtfulAccounts">
	  <link:definition>00000026 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData" id="Note20-QuarterlyFinancialData">
	  <link:definition>00000027 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note21SubsequentEvents" id="Note21SubsequentEvents">
	  <link:definition>00000028 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" id="Note2-SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" id="Note2-SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
	  <link:definition>00000031 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" id="Note4ContractAssetsAndLiabilitiesTables">
	  <link:definition>00000032 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5InventoriesTables" id="Note5InventoriesTables">
	  <link:definition>00000033 - Disclosure - NOTE 5 &#8211; INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentTables" id="Note6-PropertyAndEquipmentTables">
	  <link:definition>00000034 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesTables" id="Note7OperatingFinancingLeasesTables">
	  <link:definition>00000035 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" id="Note8-OtherIntangibleAssetsTables">
	  <link:definition>00000036 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" id="Note10ControllingAndNoncontrollingInterestsTables">
	  <link:definition>00000037 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" id="Note11-Long-termDebtNotesPayableAndCapitalLeasesTables">
	  <link:definition>00000038 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxesTables" id="Note12-IncomeTaxesTables">
	  <link:definition>00000039 - Disclosure - NOTE 12 - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" id="Note13-OtherCurrentLiabilitiesTables">
	  <link:definition>00000040 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" id="Note17-SegmentAndRelatedInformationTables">
	  <link:definition>00000041 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note18AcquistionTables" id="Note18AcquistionTables">
	  <link:definition>00000042 - Disclosure - NOTE 18 &#8211; ACQUISTION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" id="Note19AllowanceForDoubtfulAccountsTables">
	  <link:definition>00000043 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" id="Note20-QuarterlyFinancialDataTables">
	  <link:definition>00000044 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" id="Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative">
	  <link:definition>00000045 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" id="Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details">
	  <link:definition>00000046 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" id="Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details">
	  <link:definition>00000047 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
	  <link:definition>00000048 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000049 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
	  <link:definition>00000050 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails">
	  <link:definition>00000051 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
	  <link:definition>00000052 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" id="Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details">
	  <link:definition>00000053 - Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" id="Note5-Inventories-InventoriesDetails">
	  <link:definition>00000054 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" id="Note6-PropertyAndEquipment-PropertyAndEquipmentDetails">
	  <link:definition>00000055 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" id="Note6-PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000056 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" id="Note7-OperatingFinancingLeases-LeasePaymentsDetails">
	  <link:definition>00000057 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" id="Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails">
	  <link:definition>00000058 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" id="Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails">
	  <link:definition>00000059 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" id="Note7OperatingFinancingLeasesDetailsNarrative">
	  <link:definition>00000060 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
	  <link:definition>00000061 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" id="Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details">
	  <link:definition>00000062 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" id="Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details">
	  <link:definition>00000063 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" id="Note8-OtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000064 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" id="Note9-CapitalStockDetailsNarrative">
	  <link:definition>00000065 - Disclosure - NOTE 9 - CAPITAL STOCK (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" id="Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails">
	  <link:definition>00000066 - Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" id="Note10ControllingAndNoncontrollingInterestsDetailsNarrative">
	  <link:definition>00000067 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" id="Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details">
	  <link:definition>00000068 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" id="Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details">
	  <link:definition>00000069 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" id="Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails">
	  <link:definition>00000070 - Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" id="Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details">
	  <link:definition>00000071 - Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" id="Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details">
	  <link:definition>00000072 - Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" id="Note12-IncomeTaxesDetailsNarrative">
	  <link:definition>00000073 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
	  <link:definition>00000074 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" id="Note14-CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000075 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" id="Note15-SupplementalCashFlowInformationDetailsNarrative">
	  <link:definition>00000076 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" id="Note16RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000077 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" id="Note17-SegmentAndRelatedInformation-SumarizedSegments-Details">
	  <link:definition>00000078 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" id="Note17-SegmentAndRelatedInformation-ForeignProductSales-Details">
	  <link:definition>00000079 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" id="Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details">
	  <link:definition>00000080 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" id="Note17-SegmentAndRelatedInformationDetailsNarrative">
	  <link:definition>00000081 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" id="Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails">
	  <link:definition>00000082 - Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" id="Note18-Acquistion-NetAssetsAcquiredDetails">
	  <link:definition>00000083 - Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" id="Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd">
	  <link:definition>00000084 - Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" id="Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details">
	  <link:definition>00000085 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" id="Note21SubsequentEventsDetailsNarrative">
	  <link:definition>00000086 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredMember" name="ClassANonVotingPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassCCommonStockMember" name="ClassCCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMMember" name="HDMMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipmentMember" name="DiagnosticEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" name="ResearchDeveopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticImagingFacilityMember" name="DiagnosticImagingFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" name="NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_N2010StockBonusPlanMember" name="N2010StockBonusPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassBMember" name="ClassBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMEquityMember" name="HDMEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassAMember" name="ClassAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OutsideInvestorsMember" name="OutsideInvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable1Member" name="NotePayable1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable2Member" name="NotePayable2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable3Member" name="NotePayable3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ABillingCompanyMember" name="ABillingCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BensonhurstMRILimitedPartnershipMember" name="BensonhurstMRILimitedPartnershipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" name="ManufacturingAndServicingOfMedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RocklandManagementGroupMember" name="RocklandManagementGroupMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CovenantNotToCompeteMember" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableMember" name="ManagementAndOtherFeesReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" name="ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivablesMember" name="MedicalReceivablesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_QuarterlyFinancialDataMember" name="QuarterlyFinancialDataMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" name="StockIssuedToEmployeesUnderStockBonusPlansValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" name="PaymentsOnNotesReceivableFromEmployeeStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CompensatoryElementOfStockIssuances" name="CompensatoryElementOfStockIssuances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInContractLiabilities" name="IncreaseDecreaseInContractLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfImagingCenter" name="PurchaseOfImagingCenter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureNote7OperatingFinancingLeasesAbstract" name="DisclosureNote7OperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureNote9CapitalStockAbstract" name="DisclosureNote9CapitalStockAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalStockAndOptionsDisclosureTextblock" name="CapitalStockAndOptionsDisclosureTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" name="AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShippingsAndHandlingCostPolicyTextBlock" name="ShippingsAndHandlingCostPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesPolicyTextBlock" name="CustomerAdvancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment" name="EstimatedUsefulLifeInYearsForPropertyAndEquipment" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" name="LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportProductSales" name="ExportProductSales" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportServiceRevenues" name="ExportServiceRevenues" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ImperialContributionPercentage" name="ImperialContributionPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetPatientFeeRevenue" name="NetPatientFeeRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" name="ManagementAgreementsWithCompanyTotalMedicalPractices" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" name="ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" name="ScannersWithManagementWithCompanyLocatedInNewYorkState" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMinimum" name="ContractualFeesForServicesRenderedMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMaximum" name="ContractualFeesForServicesRenderedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShippingAndHandlingExpense" name="ShippingAndHandlingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" name="NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" name="TotalFacilitiesOwnedOrManagedAtBeginningOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedAcquisition" name="ManagedFacilitiesAddedAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedByInternalDevelopment" name="ManagedFacilitiesAddedByInternalDevelopment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesClosedDuringYear" name="ManagedFacilitiesClosedDuringYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" name="TotalFacilitiesOwnedOrManagedAtEndOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsIncurredOnUncompletedContracts" name="CostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedEarnings" name="EstimatedEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" name="CostsAndEstimatedEarningsOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BillingsToDate" name="BillingsToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" name="CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciationOfLeasedEquipment" name="DepreciationOfLeasedEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingCashFlowsFromOperatingLeases" name="OperatingCashFlowsFromOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingCashFlowsFromFinancingLeases" name="FinancingCashFlowsFromFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AmountsCapitalized" name="AmountsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareOrPatentsWrittenOff" name="SoftwareOrPatentsWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesRegistered" name="SharesRegistered" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OpeningMembersEquity" name="OpeningMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShareOfNetIncome" name="ShareOfNetIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Distributions" name="Distributions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EndingMembersEquity" name="EndingMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipPercentageAcquired" name="OwnershipPercentageAcquired" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfStandupMriCenters" name="PurchaseOfStandupMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfOtherMriCenters" name="PurchaseOfOtherMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationToOutsideInvestors" name="ConsiderationToOutsideInvestors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalPurchasePrice" name="TotalPurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" name="ConsiderationForNoncompetitionAndConsultingAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfInstallment" name="NumberOfInstallment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaturityDate" name="MaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BookValueOfBuilding" name="BookValueOfBuilding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" name="ReimbursementOfAlternativeMinimumTaxCreditsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AdditionalTaxes" name="AdditionalTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatementFromSuffolkCountyIda" name="PropertyTaxAbatementFromSuffolkCountyIda" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatement" name="PropertyTaxAbatement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EmployeeStockPurchasePlanEspp" name="EmployeeStockPurchasePlanEspp" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LitigationSettelementDescription" name="LitigationSettelementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RecordedSalesTaxObligationsInterestAndPenalties" name="RecordedSalesTaxObligationsInterestAndPenalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" name="StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SellingGeneralAndAdministrativeExpenses" name="SellingGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignProductSales" name="ForeignProductSales" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignServiceAndRepairFees" name="ForeignServiceAndRepairFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportSalesOfMedicalEquipmentPercentage" name="ExportSalesOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" name="ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" name="PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" name="PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClosingCostsExpensed" name="ClosingCostsExpensed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BusinessCombinationContingentConsiderationAsset1" name="BusinessCombinationContingentConsiderationAsset1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsAdditions" name="AllowanceForDoubtfulAccountsAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsDeductions" name="AllowanceForDoubtfulAccountsDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>fonr-20210630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20210630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20210630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20210630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20210630.xsd#Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilities" xlink:href="fonr-20210630.xsd#Note4ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5Inventories" xlink:href="fonr-20210630.xsd#Note5Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipment" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeases" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-CapitalStock" xlink:href="fonr-20210630.xsd#Note9-CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-CommitmentsAndContingencies" xlink:href="fonr-20210630.xsd#Note14-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformation" xlink:href="fonr-20210630.xsd#Note15-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note16RelatedPartyTransactions" xlink:href="fonr-20210630.xsd#Note16RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18Acquistion" xlink:href="fonr-20210630.xsd#Note18Acquistion" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" xlink:href="fonr-20210630.xsd#Note19AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note21SubsequentEvents" xlink:href="fonr-20210630.xsd#Note21SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20210630.xsd#Note4ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5InventoriesTables" xlink:href="fonr-20210630.xsd#Note5InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentTables" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesTables" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesTables" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18AcquistionTables" xlink:href="fonr-20210630.xsd#Note18AcquistionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20210630.xsd#Note19AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20210630.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20210630.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20210630.xsd#Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:href="fonr-20210630.xsd#Note5-Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" xlink:href="fonr-20210630.xsd#Note9-CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20210630.xsd#Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20210630.xsd#Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note16RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20210630.xsd#Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" xlink:href="fonr-20210630.xsd#Note18-Acquistion-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:href="fonr-20210630.xsd#Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note21SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="loc_us-gaapIncomeTaxReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapIncomeTaxReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="loc_us-gaapIncomeTaxCreditsAndAdjustments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeTaxCreditsAndAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CompensatoryElementOfStockIssuances" xlink:label="loc_FONRCompensatoryElementOfStockIssuances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRCompensatoryElementOfStockIssuances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfImagingCenter" xlink:label="loc_FONRPurchaseOfImagingCenter" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_FONRPurchaseOfImagingCenter" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000008 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4ContractAssetsAndLiabilities" xlink:title="00000011 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5Inventories" xlink:title="00000012 - Disclosure - NOTE 5 &#8211; INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipment" xlink:title="00000013 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeases" xlink:title="00000014 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets" xlink:title="00000015 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-CapitalStock" xlink:title="00000016 - Disclosure - NOTE 9 - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" xlink:title="00000017 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000018 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes" xlink:title="00000019 - Disclosure - NOTE 12 - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilities" xlink:title="00000020 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-CommitmentsAndContingencies" xlink:title="00000021 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note15-SupplementalCashFlowInformation" xlink:title="00000022 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note16RelatedPartyTransactions" xlink:title="00000023 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation" xlink:title="00000024 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18Acquistion" xlink:title="00000025 - Disclosure - NOTE 18 &#8211; ACQUISTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" xlink:title="00000026 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialData" xlink:title="00000027 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note21SubsequentEvents" xlink:title="00000028 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000031 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" xlink:title="00000032 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5InventoriesTables" xlink:title="00000033 - Disclosure - NOTE 5 &#8211; INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipmentTables" xlink:title="00000034 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeasesTables" xlink:title="00000035 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" xlink:title="00000036 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" xlink:title="00000037 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000038 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesTables" xlink:title="00000039 - Disclosure - NOTE 12 - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" xlink:title="00000041 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18AcquistionTables" xlink:title="00000042 - Disclosure - NOTE 18 &#8211; ACQUISTION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" xlink:title="00000043 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" xlink:title="00000044 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000045 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000046 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:title="00000047 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000048 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000050 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000051 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000052 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000053 - Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BillingsToDate" xlink:label="loc_FONRBillingsToDate" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="loc_FONRBillingsToDate" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:title="00000054 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000055 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" xlink:title="00000056 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000057 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:title="00000058 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:title="00000059 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" xlink:title="00000060 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000061 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:title="00000062 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000063 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" xlink:title="00000064 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" xlink:title="00000065 - Disclosure - NOTE 9 - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000066 - Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000067 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000068 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000069 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000070 - Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000071 - Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000072 - Disclosure - NOTE 12 - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000074 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000075 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000076 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" xlink:title="00000077 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000078 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000079 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000080 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000081 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000082 - Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" xlink:title="00000083 - Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:title="00000084 - Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:title="00000085 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>fonr-20210630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20210630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20210630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20210630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20210630.xsd#Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilities" xlink:href="fonr-20210630.xsd#Note4ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5Inventories" xlink:href="fonr-20210630.xsd#Note5Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipment" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeases" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-CapitalStock" xlink:href="fonr-20210630.xsd#Note9-CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-CommitmentsAndContingencies" xlink:href="fonr-20210630.xsd#Note14-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformation" xlink:href="fonr-20210630.xsd#Note15-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note16RelatedPartyTransactions" xlink:href="fonr-20210630.xsd#Note16RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18Acquistion" xlink:href="fonr-20210630.xsd#Note18Acquistion" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" xlink:href="fonr-20210630.xsd#Note19AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note21SubsequentEvents" xlink:href="fonr-20210630.xsd#Note21SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20210630.xsd#Note4ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5InventoriesTables" xlink:href="fonr-20210630.xsd#Note5InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentTables" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesTables" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesTables" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18AcquistionTables" xlink:href="fonr-20210630.xsd#Note18AcquistionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20210630.xsd#Note19AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20210630.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20210630.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20210630.xsd#Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:href="fonr-20210630.xsd#Note5-Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" xlink:href="fonr-20210630.xsd#Note9-CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20210630.xsd#Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20210630.xsd#Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note16RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20210630.xsd#Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" xlink:href="fonr-20210630.xsd#Note18-Acquistion-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:href="fonr-20210630.xsd#Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note21SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_70" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_70" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_70" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_70" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_70" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_70" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_70" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_70" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_70" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_70" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_70" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_70" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_70" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_70" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_70" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_70" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_70" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_70" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_70" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_70" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_70" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountReceivableRelatedParties_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagementAndOtherFees_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="loc_us-gaapIncomeTaxReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIncomeTaxReceivable_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="51" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRProductSalesNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesNet_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToProductSales_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapCostsAndExpenses_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract" xlink:label="loc_us-gaapOtherExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherExpensesAbstract_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted_90" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassANonVotingPreferredMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassCCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:label="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000008 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4ContractAssetsAndLiabilities" xlink:title="00000011 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5Inventories" xlink:title="00000012 - Disclosure - NOTE 5 &#8211; INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipment" xlink:title="00000013 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeases" xlink:title="00000014 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets" xlink:title="00000015 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-CapitalStock" xlink:title="00000016 - Disclosure - NOTE 9 - CAPITAL STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" xlink:title="00000017 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000018 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes" xlink:title="00000019 - Disclosure - NOTE 12 - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilities" xlink:title="00000020 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-CommitmentsAndContingencies" xlink:title="00000021 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note15-SupplementalCashFlowInformation" xlink:title="00000022 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note16RelatedPartyTransactions" xlink:title="00000023 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation" xlink:title="00000024 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18Acquistion" xlink:title="00000025 - Disclosure - NOTE 18 &#8211; ACQUISTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" xlink:title="00000026 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialData" xlink:title="00000027 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note21SubsequentEvents" xlink:title="00000028 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000031 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" xlink:title="00000032 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5InventoriesTables" xlink:title="00000033 - Disclosure - NOTE 5 &#8211; INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipmentTables" xlink:title="00000034 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeasesTables" xlink:title="00000035 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" xlink:title="00000036 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" xlink:title="00000037 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000038 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesTables" xlink:title="00000039 - Disclosure - NOTE 12 - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" xlink:title="00000041 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18AcquistionTables" xlink:title="00000042 - Disclosure - NOTE 18 &#8211; ACQUISTION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" xlink:title="00000043 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" xlink:title="00000044 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000045 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ImperialContributionPercentage" xlink:label="loc_FONRImperialContributionPercentage_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRImperialContributionPercentage_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000046 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:title="00000047 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetPatientFeeRevenue_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000048 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:label="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShippingAndHandlingExpense" xlink:label="loc_FONRShippingAndHandlingExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRShippingAndHandlingExpense_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_120" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000050 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000051 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000052 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000053 - Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:title="00000054 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000055 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" xlink:title="00000056 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldDepreciationAndAmortization_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldDepreciationAndAmortization_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000057 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:title="00000058 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:title="00000059 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" xlink:title="00000060 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000061 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:title="00000062 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_50" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000063 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" xlink:title="00000064 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_80" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" xlink:title="00000065 - Disclosure - NOTE 9 - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000066 - Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapMinorityInterestTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000067 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassBMember" xlink:label="loc_FONRClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassAMember" xlink:label="loc_FONRClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OutsideInvestorsMember" xlink:label="loc_FONROutsideInvestorsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_FONROutsideInvestorsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OwnershipPercentageAcquired" xlink:label="loc_FONROwnershipPercentageAcquired_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONROwnershipPercentageAcquired_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_70" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000068 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable3Member" xlink:label="loc_FONRNotePayable3Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable3Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NumberOfInstallment" xlink:label="loc_FONRNumberOfInstallment_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRNumberOfInstallment_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_120" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000069 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000070 - Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000071 - Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000072 - Disclosure - NOTE 12 - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000074 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000075 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:label="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="loc_us-gaapEmployeeStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" xlink:to="loc_us-gaapEmployeeStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PropertyTaxAbatement" xlink:label="loc_FONRPropertyTaxAbatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRPropertyTaxAbatement_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EmployeeStockPurchasePlanEspp" xlink:label="loc_FONREmployeeStockPurchasePlanEspp_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONREmployeeStockPurchasePlanEspp_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_LitigationSettelementDescription" xlink:label="loc_FONRLitigationSettelementDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRLitigationSettelementDescription_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RecordedSalesTaxObligationsInterestAndPenalties" xlink:label="loc_FONRRecordedSalesTaxObligationsInterestAndPenalties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRRecordedSalesTaxObligationsInterestAndPenalties_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000076 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" xlink:title="00000077 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ABillingCompanyMember" xlink:label="loc_FONRABillingCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRABillingCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000078 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000079 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DO" xlink:label="loc_countryDO_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_countryCA_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR" xlink:label="loc_countryPR_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000080 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR" xlink:label="loc_countryPR_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH" xlink:label="loc_countryCH_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB" xlink:label="loc_countryGB_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_countryCA_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GR" xlink:label="loc_countryGR_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="loc_countryAU_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees_170" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000081 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000082 - Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" xlink:title="00000083 - Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember" xlink:label="loc_us-gaapCustomerListsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerListsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CovenantNotToCompeteMember" xlink:label="loc_FONRCovenantNotToCompeteMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRCovenantNotToCompeteMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClosingCostsExpensed" xlink:label="loc_FONRClosingCostsExpensed_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRClosingCostsExpensed_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaapGoodwillGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwillGross_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BusinessCombinationContingentConsiderationAsset1" xlink:label="loc_FONRBusinessCombinationContingentConsiderationAsset1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRBusinessCombinationContingentConsiderationAsset1_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:title="00000084 - Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivablesMember" xlink:label="loc_FONRMedicalReceivablesMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRMedicalReceivablesMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions_220" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:title="00000085 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_QuarterlyFinancialDataMember" xlink:label="loc_FONRQuarterlyFinancialDataMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRQuarterlyFinancialDataMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpenses_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_110" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:label="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromLoans_30" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>fonr-20210630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="FONR_ClassANonVotingPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredMember" xlink:to="FONR_ClassANonVotingPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredMember_lbl" xml:lang="en-US">Class A Non Voting Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassCCommonStockMember" xlink:label="FONR_ClassCCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassCCommonStockMember" xlink:to="FONR_ClassCCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassCCommonStockMember_lbl" xml:lang="en-US">Class C Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="FONR_HDMMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMMember_lbl" xml:lang="en-US">H D M [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="FONR_DiagnosticEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipmentMember_lbl" xml:lang="en-US">Diagnostic Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research Deveopment And Demonstration Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="FONR_DiagnosticImagingFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticImagingFacilityMember_lbl" xml:lang="en-US">Diagnostic Imaging Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other Revenue Source [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:label="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:to="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_lbl" xml:lang="en-US">Net Management Fee Receivables From Related Party Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="FONR_N2010StockBonusPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_N2010StockBonusPlanMember" xlink:to="FONR_N2010StockBonusPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_N2010StockBonusPlanMember_lbl" xml:lang="en-US">N 2010 Stock Bonus Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsByNameAxis" xlink:to="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xml:lang="en-US">Other Ownership Interests Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassBMember" xlink:label="FONR_ClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBMember" xlink:to="FONR_ClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassBMember_lbl" xml:lang="en-US">Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMEquityMember" xlink:label="FONR_HDMEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMEquityMember_lbl" xml:lang="en-US">H D M Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassAMember" xlink:label="FONR_ClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAMember" xlink:to="FONR_ClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassAMember_lbl" xml:lang="en-US">Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OutsideInvestorsMember" xlink:label="FONR_OutsideInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OutsideInvestorsMember" xlink:to="FONR_OutsideInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OutsideInvestorsMember_lbl" xml:lang="en-US">Outside Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Series [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable1Member" xlink:label="FONR_NotePayable1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable1Member_lbl" xml:lang="en-US">Note Payable 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable2Member" xlink:label="FONR_NotePayable2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable2Member" xlink:to="FONR_NotePayable2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable2Member_lbl" xml:lang="en-US">Note Payable 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable3Member" xlink:label="FONR_NotePayable3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable3Member" xlink:to="FONR_NotePayable3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable3Member_lbl" xml:lang="en-US">Note Payable 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockMember_lbl" xml:lang="en-US">Employee Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ABillingCompanyMember" xlink:label="FONR_ABillingCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ABillingCompanyMember" xlink:to="FONR_ABillingCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ABillingCompanyMember_lbl" xml:lang="en-US">A Billing Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xml:lang="en-US">Bensonhurst M R I Limited Partnership [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:to="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_lbl" xml:lang="en-US">Manufacturing And Servicing Of Medical Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DO" xlink:label="country_DO" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DO" xlink:to="country_DO_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DO_lbl" xml:lang="en-US">DOMINICAN REPUBLIC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="country_DE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US">GERMANY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR" xlink:label="country_PR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PR_lbl" xml:lang="en-US">PUERTO RICO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH" xlink:label="country_CH" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US">SWITZERLAND</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB" xlink:label="country_GB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GR" xlink:label="country_GR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GR" xlink:to="country_GR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GR_lbl" xml:lang="en-US">GREECE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RocklandManagementGroupMember" xlink:label="FONR_RocklandManagementGroupMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RocklandManagementGroupMember" xlink:to="FONR_RocklandManagementGroupMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RocklandManagementGroupMember_lbl" xml:lang="en-US">Rockland Management Group [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember" xlink:label="us-gaap_CustomerListsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerListsMember" xlink:to="us-gaap_CustomerListsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerListsMember_lbl" xml:lang="en-US">Customer Lists [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CovenantNotToCompeteMember" xlink:label="FONR_CovenantNotToCompeteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CovenantNotToCompeteMember" xlink:to="FONR_CovenantNotToCompeteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CovenantNotToCompeteMember_lbl" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="FONR_ManagementAndOtherFeesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableMember" xlink:to="FONR_ManagementAndOtherFeesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableMember_lbl" xml:lang="en-US">Management And Other Fees Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:to="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xml:lang="en-US">Management And Other Fees Receivable Related Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableMember" xlink:to="us-gaap_NotesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableMember_lbl" xml:lang="en-US">Notes Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivablesMember" xlink:label="FONR_MedicalReceivablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivablesMember" xlink:to="FONR_MedicalReceivablesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivablesMember_lbl" xml:lang="en-US">Medical Receivables [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_QuarterlyFinancialDataMember" xlink:label="FONR_QuarterlyFinancialDataMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_QuarterlyFinancialDataMember" xlink:to="FONR_QuarterlyFinancialDataMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_QuarterlyFinancialDataMember_lbl" xml:lang="en-US">Quarterly Financial Data [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">Accounts receivable &#8211; net of allowances for doubtful accounts of $442,270 and $514,561 at June 30, 2021 and 2020, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $15,786,878 and $11,063,233 at June 30, 2021 and 2020, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $4,184,399 and $3,322,055 at June 30, 2021 and 2020, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="us-gaap_ContractWithCustomerAssetGrossCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent_lbl" xml:lang="en-US">Contract assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="us-gaap_IncomeTaxReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReceivable" xlink:to="us-gaap_IncomeTaxReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReceivable_lbl" xml:lang="en-US">Income tax receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long-term debt and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Due to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 11,643 shares of common stock at June 30, 2021 and 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees &#8211; related party medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative, inclusive of compensatory element of stock issuances of $83,277 and $0 for the years ended June 30, 2021 and 2020 respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract" xlink:label="us-gaap_OtherExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpensesAbstract_lbl" xml:lang="en-US">Other Income and (Expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before provision for income taxes and noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income &#8211; Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income - Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted Average Basic and Diluted Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Beginning Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:to="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_lbl" xml:lang="en-US">Stock issued to employees under stock bonus plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock issued to employees under stock bonus plans, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:label="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:to="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders_lbl" xml:lang="en-US">Payments on notes receivable from employee stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_2_lbl" xml:lang="en-US">Ending Balance, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxCreditsAndAdjustments" xlink:to="us-gaap_IncomeTaxCreditsAndAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments_lbl" xml:lang="en-US">Income tax receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CompensatoryElementOfStockIssuances" xlink:label="FONR_CompensatoryElementOfStockIssuances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CompensatoryElementOfStockIssuances" xlink:to="FONR_CompensatoryElementOfStockIssuances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CompensatoryElementOfStockIssuances_lbl" xml:lang="en-US">Compensatory element of stock issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock issued for costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:to="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_lbl" xml:lang="en-US">Abandoned patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:label="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_lbl" xml:lang="en-US">Contract assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="FONR_IncreaseDecreaseInContractLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xml:lang="en-US">Proceeds of Short term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfImagingCenter" xlink:label="FONR_PurchaseOfImagingCenter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfImagingCenter" xlink:to="FONR_PurchaseOfImagingCenter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PurchaseOfImagingCenter_lbl" xml:lang="en-US">Purchase of imaging center</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS &#8211; BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS &#8211; END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="us-gaap_RegulatedOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegulatedOperationsAbstract" xlink:to="us-gaap_RegulatedOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegulatedOperationsAbstract_lbl" xml:lang="en-US">Regulated Operations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:label="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:to="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_lbl" xml:lang="en-US">NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 5 &#8211; INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 6 - PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureNote7OperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureNote7OperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Note 7 Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 8 - OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote9CapitalStockAbstract" xlink:label="FONR_DisclosureNote9CapitalStockAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureNote9CapitalStockAbstract" xlink:to="FONR_DisclosureNote9CapitalStockAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureNote9CapitalStockAbstract_lbl" xml:lang="en-US">Note 9 - Capital Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:to="FONR_CapitalStockAndOptionsDisclosureTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock_lbl" xml:lang="en-US">NOTE 9 - CAPITAL STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:to="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xml:lang="en-US">NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 12 - INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">NOTE 13 - OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 14 - COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 16 &#8211; RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 17 - SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 18 &#8211; ACQUISTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">NOTE 21 &#8211; SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="us-gaap_InventoryWorkInProcessPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryWorkInProcessPolicy_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:to="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US">Acquired assets and assumed liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShippingsAndHandlingCostPolicyTextBlock" xlink:label="FONR_ShippingsAndHandlingCostPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShippingsAndHandlingCostPolicyTextBlock" xlink:to="FONR_ShippingsAndHandlingCostPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShippingsAndHandlingCostPolicyTextBlock_lbl" xml:lang="en-US">Shipping Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="FONR_CustomerAdvancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesPolicyTextBlock" xlink:to="FONR_CustomerAdvancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesPolicyTextBlock_lbl" xml:lang="en-US">Customer Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Short Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment" xlink:to="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment_lbl" xml:lang="en-US">Estimated Useful Life in Years for Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Patient Fee Revenue - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Receivables - Non Current - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Total Facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:to="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xml:lang="en-US">`Costs and Estimated Earnings on Uncompleted Contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:label="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:to="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_lbl" xml:lang="en-US">Reconciliation of operating and financing lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Components of lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xml:lang="en-US">Supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Other Intagible Assets - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule Of Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US">Class A And B Members' Equity (HDM Acquisition)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Maturities Of Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Components Of The Benefit Provision For Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Reconciliation Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Components Of Company's Deferred Tax Assets And Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Summarized Segment Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ExportProductSales" xlink:label="FONR_ExportProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportProductSales" xlink:to="FONR_ExportProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportProductSales_lbl" xml:lang="en-US">Export Product Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ExportServiceRevenues" xlink:label="FONR_ExportServiceRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportServiceRevenues" xlink:to="FONR_ExportServiceRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportServiceRevenues_lbl" xml:lang="en-US">Foreign Service and Repair Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xml:lang="en-US">Fair value assets and assumed liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US">Summary of Allowance For Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Quarterly Financial Data</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ImperialContributionPercentage" xlink:label="FONR_ImperialContributionPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ImperialContributionPercentage" xlink:to="FONR_ImperialContributionPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ImperialContributionPercentage_lbl" xml:lang="en-US">[custom:ImperialContributionPercentage-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NetPatientFeeRevenue" xlink:label="FONR_NetPatientFeeRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetPatientFeeRevenue_lbl" xml:lang="en-US">Net Patient Fee Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Basic Numerator: Net Income Available to Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic Denominator: Weighted Average Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Total Denominator for Diluted Earnings Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Income per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:to="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xml:lang="en-US">Cost of Property Repairs and Maintenance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xml:lang="en-US">[custom:ManagementAgreementsWithCompanyTotalMedicalPractices-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xml:lang="en-US">[custom:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xml:lang="en-US">[custom:ScannersWithManagementWithCompanyLocatedInNewYorkState-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xml:lang="en-US">[custom:ContractualFeesForServicesRenderedMinimum-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xml:lang="en-US">[custom:ContractualFeesForServicesRenderedMaximum-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShippingAndHandlingExpense" xlink:label="FONR_ShippingAndHandlingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShippingAndHandlingExpense" xlink:to="FONR_ShippingAndHandlingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShippingAndHandlingExpense_lbl" xml:lang="en-US">[custom:ShippingAndHandlingExpense]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xml:lang="en-US">[custom:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueOneToTwoYears" xlink:to="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFourToFiveYears" xlink:to="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at Beginning of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagedFacilitiesAddedAcquisition" xlink:label="FONR_ManagedFacilitiesAddedAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedAcquisition" xlink:to="FONR_ManagedFacilitiesAddedAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedAcquisition_lbl" xml:lang="en-US">Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xml:lang="en-US">Internal development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="FONR_ManagedFacilitiesClosedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_lbl" xml:lang="en-US">Managed Facilities Closed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at End of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">[custom:PercentageOfConsolidatedNetRevenueFromManagementFees]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="FONR_CostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Costs incurred on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EstimatedEarnings" xlink:label="FONR_EstimatedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedEarnings_lbl" xml:lang="en-US">Estimated earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_lbl" xml:lang="en-US">Costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BillingsToDate" xlink:label="FONR_BillingsToDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BillingsToDate_lbl" xml:lang="en-US">Less: Billings to date</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:label="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_lbl" xml:lang="en-US">Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and Equipment Before Accumulated depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation and amortization of property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and Equipment AfterAccumulated depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_lbl" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureNote7OperatingFinancingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureNote7OperatingFinancingLeasesAbstract_2_lbl" xml:lang="en-US">Note 7 - Operating Financing Leases - Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present Value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present Value discount, Financing Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureNote7OperatingFinancingLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="FONR_DisclosureNote7OperatingFinancingLeasesAbstract_3_lbl" xml:lang="en-US">Note 7 - Operating Financing Leases - Recent Accounting Pronouncements - Components Of Lease Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="FONR_FinanceLeaseCostsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCostsAbstract_lbl" xml:lang="en-US">Finance lease cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="FONR_DepreciationOfLeasedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciationOfLeasedEquipment_lbl" xml:lang="en-US">Depreciation of leased equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xml:lang="en-US">Interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_FinanceLeaseCost" xlink:label="FONR_FinanceLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCost_lbl" xml:lang="en-US">Total finance lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xml:lang="en-US">Operating cash flows from operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xml:lang="en-US">Financing cash flows from financing leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xml:lang="en-US">Operating leases(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_lbl" xml:lang="en-US">Financing leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating Lease, Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Other intangible assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_2_lbl" xml:lang="en-US">Balance - End of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AmountsCapitalized" xlink:label="FONR_AmountsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AmountsCapitalized" xlink:to="FONR_AmountsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AmountsCapitalized_lbl" xml:lang="en-US">Amounts capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="FONR_SoftwareOrPatentsWrittenOff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareOrPatentsWrittenOff" xlink:to="FONR_SoftwareOrPatentsWrittenOff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareOrPatentsWrittenOff_lbl" xml:lang="en-US">Software or patents written off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_3_lbl" xml:lang="en-US">Balance - End of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableNature" xlink:label="us-gaap_DividendsPayableNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableNature" xlink:to="us-gaap_DividendsPayableNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableNature_lbl" xml:lang="en-US">Dividends Payable, Nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:to="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xml:lang="en-US">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common Stock, Voting Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SharesRegistered" xlink:label="FONR_SharesRegistered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesRegistered" xlink:to="FONR_SharesRegistered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesRegistered_lbl" xml:lang="en-US">[custom:SharesRegistered-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other Selling, General and Administrative Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestTable_lbl" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OpeningMembersEquity" xlink:label="FONR_OpeningMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OpeningMembersEquity_lbl" xml:lang="en-US">Opening Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShareOfNetIncome" xlink:label="FONR_ShareOfNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShareOfNetIncome_lbl" xml:lang="en-US">Share of Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_Distributions" xlink:label="FONR_Distributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Distributions_lbl" xml:lang="en-US">Distributions</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EndingMembersEquity" xlink:label="FONR_EndingMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EndingMembersEquity_lbl" xml:lang="en-US">Ending Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OwnershipPercentageAcquired" xlink:label="FONR_OwnershipPercentageAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipPercentageAcquired" xlink:to="FONR_OwnershipPercentageAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipPercentageAcquired_lbl" xml:lang="en-US">[custom:OwnershipPercentageAcquired-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="FONR_PurchaseOfStandupMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfStandupMriCenters" xlink:to="FONR_PurchaseOfStandupMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfStandupMriCenters_lbl" xml:lang="en-US">[custom:PurchaseOfStandupMriCenters-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="FONR_PurchaseOfOtherMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfOtherMriCenters" xlink:to="FONR_PurchaseOfOtherMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfOtherMriCenters_lbl" xml:lang="en-US">[custom:PurchaseOfOtherMriCenters-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="FONR_ConsiderationToOutsideInvestors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationToOutsideInvestors" xlink:to="FONR_ConsiderationToOutsideInvestors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationToOutsideInvestors_lbl" xml:lang="en-US">[custom:ConsiderationToOutsideInvestors-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalPurchasePrice" xlink:label="FONR_TotalPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchasePrice" xlink:to="FONR_TotalPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalPurchasePrice_lbl" xml:lang="en-US">[custom:TotalPurchasePrice-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:to="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xml:lang="en-US">[custom:ConsiderationForNoncompetitionAndConsultingAgreements-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NumberOfInstallment" xlink:label="FONR_NumberOfInstallment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfInstallment" xlink:to="FONR_NumberOfInstallment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfInstallment_lbl" xml:lang="en-US">[custom:NumberOfInstallment]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MaturityDate" xlink:label="FONR_MaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaturityDate" xlink:to="FONR_MaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaturityDate_lbl" xml:lang="en-US">[custom:MaturityDate]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BookValueOfBuilding" xlink:label="FONR_BookValueOfBuilding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BookValueOfBuilding" xlink:to="FONR_BookValueOfBuilding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BookValueOfBuilding_lbl" xml:lang="en-US">[custom:BookValueOfBuilding-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Long Term Debt, Notes Payable and Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt Instrument, Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2_lbl" xml:lang="en-US">Current portion of Long Term Debt, Notes Payable and Capital Leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_2_lbl" xml:lang="en-US">Long Term Debt, Notes Payable and Capital Leases less Current Portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_lbl" xml:lang="en-US">Long-Term Debt Over Five Years and Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State deferred taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision (Benefit) for Income Taxes - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Taxes at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local income taxes (benefit), net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Non Controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Expiration of tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Return to provision adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in the valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Non-deductible accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_lbl" xml:lang="en-US">Other Operating Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xml:lang="en-US">Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:label="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:to="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription_lbl" xml:lang="en-US">[custom:ReimbursementOfAlternativeMinimumTaxCreditsDescription]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AdditionalTaxes" xlink:label="FONR_AdditionalTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AdditionalTaxes" xlink:to="FONR_AdditionalTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AdditionalTaxes_lbl" xml:lang="en-US">[custom:AdditionalTaxes]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Litigation accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:to="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable_lbl" xml:lang="en-US">Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xml:lang="en-US">[custom:PropertyTaxAbatementFromSuffolkCountyIda]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PropertyTaxAbatement" xlink:label="FONR_PropertyTaxAbatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatement_lbl" xml:lang="en-US">[custom:PropertyTaxAbatement]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EmployeeStockPurchasePlanEspp" xlink:label="FONR_EmployeeStockPurchasePlanEspp" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EmployeeStockPurchasePlanEspp" xlink:to="FONR_EmployeeStockPurchasePlanEspp_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EmployeeStockPurchasePlanEspp_lbl" xml:lang="en-US">[custom:EmployeeStockPurchasePlanEspp]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_LitigationSettelementDescription" xlink:label="FONR_LitigationSettelementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LitigationSettelementDescription" xlink:to="FONR_LitigationSettelementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LitigationSettelementDescription_lbl" xml:lang="en-US">[custom:LitigationSettelementDescription]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RecordedSalesTaxObligationsInterestAndPenalties" xlink:label="FONR_RecordedSalesTaxObligationsInterestAndPenalties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RecordedSalesTaxObligationsInterestAndPenalties" xlink:to="FONR_RecordedSalesTaxObligationsInterestAndPenalties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RecordedSalesTaxObligationsInterestAndPenalties_lbl" xml:lang="en-US">[custom:RecordedSalesTaxObligationsInterestAndPenalties-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xml:lang="en-US">[custom:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfLeasedAsset" xlink:label="us-gaap_AmortizationOfLeasedAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfLeasedAsset" xlink:to="us-gaap_AmortizationOfLeasedAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfLeasedAsset_lbl" xml:lang="en-US">Amortization of Leased Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SellingGeneralAndAdministrativeExpenses" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SellingGeneralAndAdministrativeExpenses" xlink:to="FONR_SellingGeneralAndAdministrativeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US">[custom:SellingGeneralAndAdministrativeExpenses]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xml:lang="en-US">Related Party Transaction, Description of Transaction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total Revenues - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Intersegment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_lbl" xml:lang="en-US">Compensatory element of stock issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Total identifiable assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignProductSales" xlink:label="FONR_ForeignProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignProductSales_lbl" xml:lang="en-US">[custom:ForeignProductSales]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="FONR_ForeignServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignServiceAndRepairFees_lbl" xml:lang="en-US">Foreign Service and Repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:to="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">[custom:ExportSalesOfMedicalEquipmentPercentage]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:to="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">[custom:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:label="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:to="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:label="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:to="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_lbl" xml:lang="en-US">Right to use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:label="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:to="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_lbl" xml:lang="en-US">Right to use liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xml:lang="en-US">Total purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClosingCostsExpensed" xlink:label="FONR_ClosingCostsExpensed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClosingCostsExpensed" xlink:to="FONR_ClosingCostsExpensed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClosingCostsExpensed_lbl" xml:lang="en-US">Closing costs - expensed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross" xlink:label="us-gaap_GoodwillGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillGross" xlink:to="us-gaap_GoodwillGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillGross_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BusinessCombinationContingentConsiderationAsset1" xlink:label="FONR_BusinessCombinationContingentConsiderationAsset1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BusinessCombinationContingentConsiderationAsset1" xlink:to="FONR_BusinessCombinationContingentConsiderationAsset1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BusinessCombinationContingentConsiderationAsset1_lbl" xml:lang="en-US">Cash Consideration Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xml:lang="en-US">Additions (Included in provision for bad debts)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xml:lang="en-US">Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_3_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_3_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:label="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:to="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings_lbl" xml:lang="en-US">Debtor-in-Possession Financing, Fee on Unused Borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans" xlink:label="us-gaap_ProceedsFromLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLoans" xlink:to="us-gaap_ProceedsFromLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLoans_lbl" xml:lang="en-US">Proceeds from Loans</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A Non Voting Preferred Stock Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_doc" xml:lang="en-US">Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountReceivableRelatedParties_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related MRI scanner customers; net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xml:lang="en-US">Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xml:lang="en-US">Costs related To Management and other fees - Related medical practices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:to="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_doc" xml:lang="en-US">Value of shares issued to an employee benefit plan, such as a defined contribution or defined benefit plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:to="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders_doc" xml:lang="en-US">Payments On Notes Receivable From Employee Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HDMMember_doc" xml:lang="en-US">HDM Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_doc" xml:lang="en-US">Minimum contractual fees for services rendered to the PC's.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticImagingFacilityMember_doc" xml:lang="en-US">Diagnostic Imaging Facility Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_doc" xml:lang="en-US">Maximum contractual fees for services rendered to the PC's.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShippingAndHandlingExpense" xlink:to="FONR_ShippingAndHandlingExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ShippingAndHandlingExpense_doc" xml:lang="en-US">Amount charged to shipping and handling expense for the period, which are expenses incurred with the objective of delivery of Fonar's products to its customers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_doc" xml:lang="en-US">Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticEquipmentMember_doc" xml:lang="en-US">MRI Diagnostic Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_doc" xml:lang="en-US">Research Deveopment And Demonstration Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedAcquisition" xlink:to="FONR_ManagedFacilitiesAddedAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesAddedAcquisition_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsIncurredOnUncompletedContracts_doc" xml:lang="en-US">Costs incurred on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EstimatedEarnings_doc" xml:lang="en-US">Estimated Earnings on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_doc" xml:lang="en-US">Costs and estimated earnings on uncompleted contracts in excess of billings means the current asset as of the closing date, as properly recorded on seller's balance sheet in accordance with GAAP, representing the amount, in the aggregate, earned on contracts but not yet invoiced to customers, as determined in accordance with GAAP.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BillingsToDate_doc" xml:lang="en-US">Amount within current period that has been billed to customer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBMember" xlink:to="FONR_ClassBMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassBMember_doc" xml:lang="en-US">The Class B Member havea 50.5% ownership interest of HDM.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HDMEquityMember_doc" xml:lang="en-US">HDM Equity Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAMember" xlink:to="FONR_ClassAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassAMember_doc" xml:lang="en-US">The Class A Member havea 49.5% ownership interest of HDM.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OpeningMembersEquity_doc" xml:lang="en-US">Opening Members Equity for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ShareOfNetIncome_doc" xml:lang="en-US">Share Of Net Income for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_Distributions_doc" xml:lang="en-US">Distributions to each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EndingMembersEquity_doc" xml:lang="en-US">Ending Members Equity for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NotePayable1Member_doc" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable2Member" xlink:to="FONR_NotePayable2Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NotePayable2Member_doc" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable3Member" xlink:to="FONR_NotePayable3Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NotePayable3Member_doc" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PropertyTaxAbatement_doc" xml:lang="en-US">The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_doc" xml:lang="en-US">The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EmployeeStockPurchasePlanEspp" xlink:to="FONR_EmployeeStockPurchasePlanEspp_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EmployeeStockPurchasePlanEspp_doc" xml:lang="en-US">The stockholders of the Company approved the 2000 Employee Stock Purchase Plan (ESPP) at the Companys annual stockholders meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect as of June 30, 2014.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RecordedSalesTaxObligationsInterestAndPenalties" xlink:to="FONR_RecordedSalesTaxObligationsInterestAndPenalties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RecordedSalesTaxObligationsInterestAndPenalties_doc" xml:lang="en-US">Recorded sales tax obligations of interest and penalties. Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. The reserves are included in Other current liabilities' in the consolidated balance sheets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ABillingCompanyMember" xlink:to="FONR_ABillingCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ABillingCompanyMember_doc" xml:lang="en-US">Company or entity owned by related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_doc" xml:lang="en-US">Bensonhurst MRI Limited Partnership.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:to="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_doc" xml:lang="en-US">Manufacturing And Servicing Of Medical Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">Intersegment net revenues are the transfer or exchange of goods for monetary compensation between the management and diagnostic imaging center segment and the manufacturing and service segment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignProductSales_doc" xml:lang="en-US">Foreign Product Sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignServiceAndRepairFees_doc" xml:lang="en-US">Foreign Service And Repair Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_doc" xml:lang="en-US">Allowance For Doubtful Accounts Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_doc" xml:lang="en-US">Allowance For Doubtful Accounts Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivablesMember" xlink:to="FONR_MedicalReceivablesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalReceivablesMember_doc" xml:lang="en-US">Medical Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_doc" xml:lang="en-US">Total Imaging Centers with management agreements with Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_doc" xml:lang="en-US">Number of management agreements with PC's owned by a relarted party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_doc" xml:lang="en-US">Number of management agreements with PC's owned by two unrelated radiologists.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_3_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxCreditsAndAdjustments" xlink:to="us-gaap_IncomeTaxCreditsAndAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments_2_lbl" xml:lang="en-US">Income Tax Credits and Adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:to="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Intangible Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Commodity Contract Assets and Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInContractLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfImagingCenter" xlink:to="FONR_PurchaseOfImagingCenter_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfImagingCenter_2_lbl" xml:lang="en-US">PurchaseOfImagingCenter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xml:lang="en-US">Inventory Work in Process, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_2_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_3_lbl" xml:lang="en-US">CostsAndEstimatedEarningsOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_2_lbl" xml:lang="en-US">CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_2_lbl" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_2_lbl" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_2_lbl" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillGross" xlink:to="us-gaap_GoodwillGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillGross_2_lbl" xml:lang="en-US">Goodwill, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>fonr-20210630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20210630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20210630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20210630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20210630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20210630.xsd#Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilities" xlink:href="fonr-20210630.xsd#Note4ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5Inventories" xlink:href="fonr-20210630.xsd#Note5Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipment" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeases" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-CapitalStock" xlink:href="fonr-20210630.xsd#Note9-CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-CommitmentsAndContingencies" xlink:href="fonr-20210630.xsd#Note14-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformation" xlink:href="fonr-20210630.xsd#Note15-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note16RelatedPartyTransactions" xlink:href="fonr-20210630.xsd#Note16RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18Acquistion" xlink:href="fonr-20210630.xsd#Note18Acquistion" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" xlink:href="fonr-20210630.xsd#Note19AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note21SubsequentEvents" xlink:href="fonr-20210630.xsd#Note21SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20210630.xsd#Note4ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5InventoriesTables" xlink:href="fonr-20210630.xsd#Note5InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentTables" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesTables" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesTables" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18AcquistionTables" xlink:href="fonr-20210630.xsd#Note18AcquistionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20210630.xsd#Note19AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20210630.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20210630.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20210630.xsd#Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20210630.xsd#Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:href="fonr-20210630.xsd#Note5-Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20210630.xsd#Note6-PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:href="fonr-20210630.xsd#Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note7OperatingFinancingLeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note8-OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" xlink:href="fonr-20210630.xsd#Note9-CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20210630.xsd#Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20210630.xsd#Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note12-IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20210630.xsd#Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20210630.xsd#Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20210630.xsd#Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note16RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20210630.xsd#Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20210630.xsd#Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" xlink:href="fonr-20210630.xsd#Note18-Acquistion-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:href="fonr-20210630.xsd#Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:href="fonr-20210630.xsd#Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" xlink:href="fonr-20210630.xsd#Note21SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReceivable" xlink:label="loc_us-gaapIncomeTaxReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIncomeTaxReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract" xlink:label="loc_us-gaapOtherExpensesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassANonVotingPreferredMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:label="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="loc_us-gaapIncomeTaxCreditsAndAdjustments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeTaxCreditsAndAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CompensatoryElementOfStockIssuances" xlink:label="loc_FONRCompensatoryElementOfStockIssuances" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRCompensatoryElementOfStockIssuances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfImagingCenter" xlink:label="loc_FONRPurchaseOfImagingCenter" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_FONRPurchaseOfImagingCenter" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000008 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4ContractAssetsAndLiabilities" xlink:title="00000011 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_us-gaapScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5Inventories" xlink:title="00000012 - Disclosure - NOTE 5 &#8211; INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipment" xlink:title="00000013 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeases" xlink:title="00000014 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets" xlink:title="00000015 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-CapitalStock" xlink:title="00000016 - Disclosure - NOTE 9 - CAPITAL STOCK">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote9CapitalStockAbstract" xlink:label="loc_FONRDisclosureNote9CapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:label="loc_FONRCapitalStockAndOptionsDisclosureTextblock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote9CapitalStockAbstract" xlink:to="loc_FONRCapitalStockAndOptionsDisclosureTextblock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterests" xlink:title="00000017 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000018 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="loc_us-gaapDebtAndCapitalLeasesDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapDebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes" xlink:title="00000019 - Disclosure - NOTE 12 - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilities" xlink:title="00000020 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-CommitmentsAndContingencies" xlink:title="00000021 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note15-SupplementalCashFlowInformation" xlink:title="00000022 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note16RelatedPartyTransactions" xlink:title="00000023 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation" xlink:title="00000024 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18Acquistion" xlink:title="00000025 - Disclosure - NOTE 18 &#8211; ACQUISTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19AllowanceForDoubtfulAccounts" xlink:title="00000026 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialData" xlink:title="00000027 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaapQuarterlyFinancialInformationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapQuarterlyFinancialInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note21SubsequentEvents" xlink:title="00000028 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="loc_us-gaapInventoryWorkInProcessPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:label="loc_FONRAcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRAcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShippingsAndHandlingCostPolicyTextBlock" xlink:label="loc_FONRShippingsAndHandlingCostPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRShippingsAndHandlingCostPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="loc_FONRCustomerAdvancesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRCustomerAdvancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment" xlink:label="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000031 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables" xlink:title="00000032 - Disclosure - NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5InventoriesTables" xlink:title="00000033 - Disclosure - NOTE 5 &#8211; INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipmentTables" xlink:title="00000034 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeasesTables" xlink:title="00000035 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:label="loc_FONRLesseeOperatingLeaseLiabilityMaturityTableTextBlockc" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRLesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssetsTables" xlink:title="00000036 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables" xlink:title="00000037 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000038 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesTables" xlink:title="00000039 - Disclosure - NOTE 12 - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformationTables" xlink:title="00000041 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ExportProductSales" xlink:label="loc_FONRExportProductSales" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ExportServiceRevenues" xlink:label="loc_FONRExportServiceRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportServiceRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18AcquistionTables" xlink:title="00000042 - Disclosure - NOTE 18 &#8211; ACQUISTION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables" xlink:title="00000043 - Disclosure - NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialDataTables" xlink:title="00000044 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000045 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ImperialContributionPercentage" xlink:label="loc_FONRImperialContributionPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRImperialContributionPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000046 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details" xlink:title="00000047 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetPatientFeeRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000048 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:label="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShippingAndHandlingExpense" xlink:label="loc_FONRShippingAndHandlingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRShippingAndHandlingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000050 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000051 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagedFacilitiesAddedAcquisition" xlink:label="loc_FONRManagedFacilitiesAddedAcquisition" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="loc_FONRManagedFacilitiesAddedByInternalDevelopment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedByInternalDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="loc_FONRManagedFacilitiesClosedDuringYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesClosedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000052 - Disclosure - NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000053 - Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BillingsToDate" xlink:label="loc_FONRBillingsToDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRBillingsToDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-Inventories-InventoriesDetails" xlink:title="00000054 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000055 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative" xlink:title="00000056 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000057 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:title="00000058 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="loc_FONRFinanceLeaseCostsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinanceLeaseCostsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="loc_FONRDepreciationOfLeasedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRDepreciationOfLeasedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaapFinanceLeaseInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_us-gaapFinanceLeaseInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_FinanceLeaseCost" xlink:label="loc_FONRFinanceLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRFinanceLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:title="00000059 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="loc_FONROperatingCashFlowsFromOperatingLeases" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONROperatingCashFlowsFromOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="loc_FONRFinancingCashFlowsFromFinancingLeases" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinancingCashFlowsFromFinancingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative" xlink:title="00000060 - Disclosure - NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote7OperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote7OperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000061 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:title="00000062 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000063 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AmountsCapitalized" xlink:label="loc_FONRAmountsCapitalized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRAmountsCapitalized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="loc_FONRSoftwareOrPatentsWrittenOff" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRSoftwareOrPatentsWrittenOff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative" xlink:title="00000064 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-CapitalStockDetailsNarrative" xlink:title="00000065 - Disclosure - NOTE 9 - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DisclosureNote9CapitalStockAbstract" xlink:label="loc_FONRDisclosureNote9CapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureNote9CapitalStockAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000066 - Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapMinorityInterestLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000067 - Disclosure - NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassBMember" xlink:label="loc_FONRClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClassAMember" xlink:label="loc_FONRClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OutsideInvestorsMember" xlink:label="loc_FONROutsideInvestorsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_FONROutsideInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_OwnershipPercentageAcquired" xlink:label="loc_FONROwnershipPercentageAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONROwnershipPercentageAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000068 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NotePayable3Member" xlink:label="loc_FONRNotePayable3Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_NumberOfInstallment" xlink:label="loc_FONRNumberOfInstallment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRNumberOfInstallment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000069 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000070 - Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000071 - Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000072 - Disclosure - NOTE 12 - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:label="loc_FONRReimbursementOfAlternativeMinimumTaxCreditsDescription" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRReimbursementOfAlternativeMinimumTaxCreditsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaapTaxCreditCarryforwardAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapTaxCreditCarryforwardAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AdditionalTaxes" xlink:label="loc_FONRAdditionalTaxes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRAdditionalTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000074 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000075 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:label="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="loc_us-gaapEmployeeStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" xlink:to="loc_us-gaapEmployeeStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PropertyTaxAbatement" xlink:label="loc_FONRPropertyTaxAbatement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRPropertyTaxAbatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_EmployeeStockPurchasePlanEspp" xlink:label="loc_FONREmployeeStockPurchasePlanEspp" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONREmployeeStockPurchasePlanEspp" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_LitigationSettelementDescription" xlink:label="loc_FONRLitigationSettelementDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRLitigationSettelementDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RecordedSalesTaxObligationsInterestAndPenalties" xlink:label="loc_FONRRecordedSalesTaxObligationsInterestAndPenalties" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRRecordedSalesTaxObligationsInterestAndPenalties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresLineItems" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000076 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfLeasedAsset" xlink:label="loc_us-gaapAmortizationOfLeasedAsset" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapAmortizationOfLeasedAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_SellingGeneralAndAdministrativeExpenses" xlink:label="loc_FONRSellingGeneralAndAdministrativeExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_FONRSellingGeneralAndAdministrativeExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative" xlink:title="00000077 - Disclosure - NOTE 16 &#8211; RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ABillingCompanyMember" xlink:label="loc_FONRABillingCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRABillingCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000078 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000079 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DO" xlink:label="loc_countryDO" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000080 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH" xlink:label="loc_countryCH" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GR" xlink:label="loc_countryGR" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000081 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="loc_FONRExportSalesOfMedicalEquipmentPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportSalesOfMedicalEquipmentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000082 - Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:label="loc_us-gaapPublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapPublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:label="loc_FONRPublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_FONRPublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:label="loc_FONRPublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_FONRPublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAsset" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAsset" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails" xlink:title="00000083 - Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember" xlink:label="loc_us-gaapCustomerListsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerListsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_CovenantNotToCompeteMember" xlink:label="loc_FONRCovenantNotToCompeteMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRCovenantNotToCompeteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ClosingCostsExpensed" xlink:label="loc_FONRClosingCostsExpensed" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRClosingCostsExpensed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaapGoodwillGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwillGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_BusinessCombinationContingentConsiderationAsset1" xlink:label="loc_FONRBusinessCombinationContingentConsiderationAsset1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRBusinessCombinationContingentConsiderationAsset1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd" xlink:title="00000084 - Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_MedicalReceivablesMember" xlink:label="loc_FONRMedicalReceivablesMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRMedicalReceivablesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:title="00000085 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20210630.xsd#FONR_QuarterlyFinancialDataMember" xlink:label="loc_FONRQuarterlyFinancialDataMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRQuarterlyFinancialDataMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note21SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - NOTE 21 &#8211; SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:label="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromLoans" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>9
<FILENAME>fonar_exhibit-21.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
21.1&#9;Subsidiaries of the Registrant</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Imperial
Management Services, LLC (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Health
Diagnostic Management, LLC d/b/a Health Management Company of America (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Health
Management Corporation of America (Delaware)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Fair
Haven Services, Inc. (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">HMCM,
Inc. (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Raymond
V. Damadian, M.D. MR Scanning Center Management Company (Delaware)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Dynamic
Services, Inc. (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Central
Health Care Management Company, Inc. (Delaware)</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>10
<FILENAME>fonar_exhibit-23.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Independent
Registered Public Accounting Firm&rsquo;s Consent</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">We
consent to the incorporation by reference in the Registration Statement of FONAR Corporation and Subsidiaries on Form S-8 File No. 333-168771
of our report dated October 12, 2021 with respect to our audits of the financial statements of FONAR Corporation and Subsidiaries as
of June 30, 2021 and 2020 and for each of the two years in the period ended June 30, 2021 appearing in this Annual Report on Form 10-K
of FONAR Corporation and Subsidiaries for the year ended June 30, 2021.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Marcum llp</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Marcum
llp</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">New
York, New York</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">October
12, 2021</FONT></P>
<P></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>11
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I,
Timothy R. Damadian certify that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I,
Raymond V. Damadian, certify that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.I
have reviewed this annual report on Form 10-K of Fonar Corporation;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.Based
on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements made, not misleading with respect
to the period covered by this annual report; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.Based
on my knowledge, the financial statements, and other financial information, included in this annual report, fairly present in
all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this annual report.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.I
am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financialreporting (as defined in Exchange Act Rules 13a-15(f) and 15(f)for the registrant
and I have:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under my supervision, to provide reasonable assurance regarding the reliability of financial statements for external purposes
in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the
registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;
and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.I
have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">a)
all significant deficiencies and material weakness in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial data;
and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Date:October
12, 2021</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
Timothy R. Damadian</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
R. Damadian,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">President
and Principal Executive Officer</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
Raymond V. Damadian</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Raymond
V. Damadian,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal
Financial Officer,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Chairman
of the Board and Treasurer</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
connection with the Annual Report of Fonar Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10K for the fiscal
year ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;),
I, Timothy Damadian, President and Principal Executive Officer of the Company, and I, Dr. Raymond V. Damadian, Principal Financial
Officer and Chairman of the Board of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
Timothy R. Damadian</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
R. Damadian,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">President
and Principal Executive Officer</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
Raymond V. Damadian</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Raymond
V. Damadian,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal
Financial Officer,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Chairman
of the Board and Treasurer</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Date:October
12, 2021</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained
by Fonar Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>fonar_10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20210630"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20210630.xsd" xlink:type="simple"/>
    <context id="From2020-07-01to2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-15_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-15</instant>
        </period>
    </context>
    <context id="AsOf2021-09-15_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-15</instant>
        </period>
    </context>
    <context id="AsOf2021-09-15_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-15</instant>
        </period>
    </context>
    <context id="AsOf2021-09-15_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-15</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember550836687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember550836687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_HDMMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_DiagnosticImagingFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-04-23</instant>
        </period>
    </context>
    <context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-08-10</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_ClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_ClassAMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="From2013-02-012013-02-13_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-01</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:OutsideInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-01</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2013-03-05_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-03-05</instant>
        </period>
    </context>
    <context id="AsOf2015-01-08_custom_ClassAMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-08</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NotePayable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NotePayable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_NotePayable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-01-012028-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2028-12-31</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_EmployeeStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ABillingCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:ABillingCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_BensonhurstMRILimitedPartnershipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_MedicalReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:MedicalReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_MedicalReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:MedicalReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_MedicalReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:MedicalReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="From2021-08-012021-08-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="N">
        <measure>FONR:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-07-01to2021-06-30">0000355019</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-07-01to2021-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2020-07-01to2021-06-30">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-07-01to2021-06-30">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0071"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReceivable
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2020-06-30"
      id="xdx2ixbrl0138"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0186"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0188"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PaymentsOnNotesReceivableFromEmployeeStockholders
      contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PaymentsOnNotesReceivableFromEmployeeStockholders
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PaymentsOnNotesReceivableFromEmployeeStockholders
      contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CompensatoryElementOfStockIssuances
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0539"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfImagingCenter
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0762"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0795"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesAddedAcquisition
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0877"
      unitRef="N"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0880"
      unitRef="N"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2020-07-01to2021-06-30"
      id="xdx2ixbrl0882"
      unitRef="N"
      xsi:nil="true"/>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1030"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1033"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:FinanceLeaseCost
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1036"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases
      contextRef="From2020-07-01to2021-06-30"
      id="xdx2ixbrl1049"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1105"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1110"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1120"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-06-30_custom_NotePayable3Member"
      id="xdx2ixbrl1270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2020-06-30_custom_NotePayable3Member"
      id="xdx2ixbrl1272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1371"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:TaxesPayableCurrent
      contextRef="AsOf2020-06-30"
      id="xdx2ixbrl1448"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1556"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      id="xdx2ixbrl1596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1598"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember"
      id="xdx2ixbrl1721"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      id="xdx2ixbrl1731"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      id="xdx2ixbrl1739"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1745"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1747"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      id="xdx2ixbrl1778"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2019-06-30_custom_MedicalReceivablesMember"
      id="xdx2ixbrl1782"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2019-07-012020-06-30_custom_MedicalReceivablesMember"
      id="xdx2ixbrl1786"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2020-07-01to2021-06-30">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2020-07-01to2021-06-30">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2020-07-01to2021-06-30">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-07-01to2021-06-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2020-07-01to2021-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2020-07-01to2021-06-30">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2020-07-01to2021-06-30">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-07-01to2021-06-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-07-01to2021-06-30">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-07-01to2021-06-30">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-07-01to2021-06-30">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-07-01to2021-06-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-07-01to2021-06-30">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-07-01to2021-06-30">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-07-01to2021-06-30">694-2929</dei:LocalPhoneNumber>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-07-01to2021-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-07-01to2021-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2020-07-01to2021-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-07-01to2021-06-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2020-07-01to2021-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-07-01to2021-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-07-01to2021-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2020-07-01to2021-06-30">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">110000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-09-15_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-09-15_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-09-15_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-09-15_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">44460411</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">36802342</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">32177</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">31884</us-gaap:ShortTermInvestments>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4525435</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4312999</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">11977</FONR:AccountReceivableRelatedParties>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">5988</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">17900489</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">16171782</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">30947863</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">27437768</FONR:ManagementAndOtherFees>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7814250</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">6896482</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">152833</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1663419</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1648770</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:IncomeTaxReceivable contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">671185</us-gaap:IncomeTaxReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1227463</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1757499</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">108583484</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">95889532</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2879946</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">2730071</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15958961</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">18809757</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">21850139</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">21364034</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">30133285</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">31392458</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1126990</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1325870</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">3985397</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4109129</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">666514</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">653132</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">189506195</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">180259380</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">173206</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">108379</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1866035</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1965259</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9162118</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">8185098</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3533656</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">3370149</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">202741</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">74699</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4365825</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4105265</us-gaap:DeferredRevenueCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">731101</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">854579</FONR:CustomerDeposits>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">14739</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">20049421</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">18663428</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2800522</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">2655605</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">234106</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">92663</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">92663</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">28975132</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">30104464</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1048431</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1251171</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">760254</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">865416</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">171331</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">150311</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">34086649</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">35353736</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54136070</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">54017164</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6565853</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6459106</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6447463</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">657</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">647</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">185100976</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">183076888</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-46007663</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-56215251</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">675390</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">675390</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">138418649</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">126186963</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3048524</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">55253</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">135370125</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">126242216</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">189506195</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">180259380</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">23307389</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">22495260</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1288483</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">297613</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">7638608</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">8055490</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">46609449</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">44565405</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">10975836</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">10166694</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">89929765</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">85690462</us-gaap:Revenues>
    <FONR:CostsRelatedToProductSales
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1032676</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">745375</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2740625</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2731397</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">39466</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">37298</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">10917635</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">10880265</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">25384557</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">22951301</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">6341168</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5951189</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1635979</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2025376</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">83277</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">24740044</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">26717345</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">72832150</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">72039546</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">17097615</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">13650916</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">248665</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">74321</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">311931</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">502145</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">504450</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">70771</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">17665331</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">14149511</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">3991520</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2444778</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">13673811</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">11704733</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">3466223</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">3464528</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">10207588</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">8240205</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">9592134</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7735650</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30_us-gaap_PreferredClassAMember"
      decimals="0"
      unitRef="USD">458710</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30_us-gaap_PreferredClassAMember"
      decimals="0"
      unitRef="USD">376055</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">156744</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">128500</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">6505283</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">6443713</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6632787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6571217</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="AsOf2019-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6357482</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">638</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671"
      decimals="INF"
      unitRef="Shares">89981</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember550836671"
      decimals="0"
      unitRef="USD">9</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember550836687"
      decimals="INF"
      unitRef="Shares">6447463</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember550836687"
      decimals="0"
      unitRef="USD">647</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687"
      decimals="INF"
      unitRef="Shares">106747</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember550836687"
      decimals="0"
      unitRef="USD">10</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember550836687"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember550836687"
      decimals="0"
      unitRef="USD">657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">181086517</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-64455456</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">8240205</us-gaap:ProfitLoss>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1990371</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">183076888</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-56215251</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">10207588</us-gaap:ProfitLoss>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2024088</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">185100976</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-46007663</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">2155725</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">118112103</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">3464528</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">11704733</us-gaap:ProfitLoss>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1990380</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">5565000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5565000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">55253</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">126242216</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">3466223</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">13673811</us-gaap:ProfitLoss>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2024098</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">6570000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">6570000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-3048524</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">135370125</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">13673811</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">11704733</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">4081687</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">3908648</us-gaap:OtherDepreciationAndAmortization>
    <FONR:ProvisionForBadDebts
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">5585989</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5695420</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2855006</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2118829</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxCreditsAndAdjustments
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">671185</us-gaap:IncomeTaxCreditsAndAdjustments>
    <us-gaap:IncomeTaxCreditsAndAdjustments
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">528815</us-gaap:IncomeTaxCreditsAndAdjustments>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1458053</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1005560</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:CompensatoryElementOfStockIssuances
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">83277</FONR:CompensatoryElementOfStockIssuances>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1940821</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1990380</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-534</us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">12110859</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">10797456</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-46944</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-28889</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-152833</us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-372277</us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">14649</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-149396</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-526425</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">133287</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">18087</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">161350</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-99224</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">104032</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1382497</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">3556437</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-123478</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">55928</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-965825</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">159657</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">74698</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">14739</FONR:IncreaseDecreaseInContractLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">21020</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">115855</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">19088001</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">20402763</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">3533091</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">7522997</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">293</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-15062932</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <FONR:PurchaseOfImagingCenter
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1122508</FONR:PurchaseOfImagingCenter>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">163705</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">117522</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-4819597</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">7422413</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">103335</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">4957936</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">63000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5618089</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">6570000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5565000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-6610335</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4904847</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">7658069</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">22920329</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">36802342</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">13882013</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">44460411</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">36802342</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_801_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zSrIMiBonpE6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82C_z6jXO2zr5IN2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FONAR
Corporation (the &#x201c;Company&#x201d; or &#x201c;FONAR&#x201d;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#x201c;MRI&#x201d;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#x201c;HMCA&#x201d;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
&lt;span id="xdx_900_ecustom--ImperialContributionPercentage_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z0Km41pjoJHf"&gt;24.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z976zDP9yjm6"&gt;45.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
in HDM, and the original investors in HDM retained a &lt;span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z9llCzq97kXe"&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted
by HDM.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel to travel
for marketing purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and
the Company has been steadily recovering to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able
to enact certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases
in scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#x2018;PPP&#x2019;) program
and Medicare advances/stimulus payments. Although we are unable to predict if there will be additional consequences on our operations
from the continuing global pandemic of COVID-19 and the new variants, the Company believes with the positive cash flows, low debt and
cash on hand, it will be able to continue operations going forward.&lt;/span&gt;&lt;/p&gt;






















</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <FONR:ImperialContributionPercentage
      contextRef="AsOf2015-07-01_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:ImperialContributionPercentage>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2015-07-01_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.458</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2015-07-01_custom_HDMMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Pure">0.300</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zYulH27BVNMd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_821_zVDO5JLtNpz2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zLtLsqmwhe23" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zxPf8p16bxF8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zBqSjqTontc6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zcH5SNBobXa4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Use
of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zvuNP967cxF2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zYqIXvW9FN3d" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zIbbGTvGSA3h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zAHENb4dKiq1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and equipment procured in the normal course of business is stated at cost. Property and equipment purchased in connection with an acquisition
is stated at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting
purposes using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter
of the useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses
totaled approximately $&lt;span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20200701__20210630_pp0p0"&gt;2,051,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20190701__20200630_pp0p0"&gt;1,870,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for the
years ended June 30, 2021 and 2020 respectively. The estimated useful lives in years are generally as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated
Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
and fixtures&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
improvements&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





















&lt;p id="xdx_848_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zZz8Q5RcxKQf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_ztuPuSG6wJ2g" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-Lived
Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaSg3dJzIcK1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zfJcFT8xxeee" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1)
Patents and Copyrights&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight-line basis over &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyj86MpWUw6f"&gt;15
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2)
Non-Competition Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
non-competition agreements are being amortized on the straight line basis over the length of the agreement (&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zXlMLHrL1Fg3"&gt;7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3)
Customer Relationships&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight line basis over &lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zW7GgkeyX1q9"&gt;20
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--GoodwillDisclosureTextBlock_zpRTJLmWQx53" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zPbmbZCubsO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing the
reporting unit&#x2019;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount of the reporting
unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure the amount of impairment
loss, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zkKMC3wi5Hra" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86A_zzDdrzGNAwc5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Acquired
assets and assumed liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Pursuant
to ASC No. 805-10-25, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, but during the allowed measurement period not to exceed one year from the acquisition date, the Company adjusts
the provisional amounts recognized at the acquisition date by means of adjusting the amount recognized for goodwill.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_z7pbiOEpTgY2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_zuVgzj3IKn35" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on sales contracts for scanners, included in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type
and Production-Type Contracts&#x201d;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
from product sales (upgrades and supplies) is recognized upon shipment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2021, the Company has twenty
two &lt;span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20210630_zcSncm0bFo95"&gt;22 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;management
agreements of which three &lt;span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20210630_zwDV9ROkB2Uj"&gt;3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;are with
PC&#x2019;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (&#x201c;the Related medical practices&#x201d;) and nineteen
&lt;span id="xdx_905_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20210630_zASamHcSk18a"&gt;19&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;are
with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by two unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$&lt;span id="xdx_904_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_za2HOkZvPstc"&gt;77,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;to $&lt;span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_z3UgKWymxQM4"&gt;522,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts
for estimated uncollectible fees, which is reflected in other operating expenses on the Statement of Operations. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
July 1, 2018, the Company adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board
(&#x201c;FASB&#x201d;) and codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#x2019;s revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company applied the modified retrospective approach to all contracts when adopting ASC 606. As a result, at the adoption of ASC 606 the
majority of what was previously classified as the provision for bad debts in the statement of operations is now reflected as implicit
price concessions (as defined in ASC 606) and therefore included as a reduction to net operating revenues in 2019. For changes in credit
issues not assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the
statement of operations.&lt;/span&gt;&lt;/p&gt;






























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition
standards that required it to be presented separately as a component of net operating revenues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2021 and 2020 are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,100,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,545,987&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;968,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,038,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,011,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,028,737&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,227,783&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;882,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,307,389&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,495,260&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_z8WrJQIPxgf1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_867_zAFh41uMKkSg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVXAGHqj5Gw3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_zprP5qeyBaw6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
costs are expensed as incurred. Advertising expense approximated $&lt;span id="xdx_904_eus-gaap--AdvertisingExpense_c20200701__20210630_pp0p0"&gt;633,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_c20190701__20200630_pp0p0"&gt;566,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and for
the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zxSiwQ5y1MAi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_z0SYCump33c7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Shipping
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s shipping and handling costs are included in revenue from product sales and the related expense included in costs related
to product sales is $&lt;span id="xdx_90C_ecustom--ShippingAndHandlingExpense_c20200701__20210630_pp0p0"&gt;8,215&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
$&lt;span id="xdx_906_ecustom--ShippingAndHandlingExpense_c20190701__20200630_pp0p0"&gt;12,056 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for
the years ended June 30, 2021 and 2020 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zA5xsR1rShAh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86D_zQ9eRVz29CBl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Income
Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--CustomerAdvancesPolicyTextBlock_zaq3qTpC6NKd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zdANIG3i80mf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zmWFhyEeRnsl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86B_za9HiphMAcj8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the
Two-Class Method&#x201d;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2021 and 2020, diluted EPS for common shareholders
includes &lt;span id="xdx_90C_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20190701__20200630_pdd"&gt;127,504
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;



























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BF_zClNNIkWZL8a"&gt;&lt;span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,207,588&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,592,134&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;156,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,632,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,240,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,735,650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;128,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.28&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.34&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" style="text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0795"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,571,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.34&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A8_zzHEmSqwJ6E6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFXANRH7PhBg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zGeYtXpuQ5a4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zCYsOhXUbqbf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zXSCVqo92S6c" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short
Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short
term investments include certificates of deposit with original maturities of greater than 90 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zMEReFdwkn94" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zCZ12RgmjCLa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2021, the Company had cash on deposit of approximately $&lt;span id="xdx_90C_eus-gaap--Cash_c20210630_pp0p0"&gt;42,609,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;in excess
of federally insured limits of $&lt;span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20210630_pp0p0"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Related
Parties: Net revenues from related parties accounted for approximately &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zPMBJMQeMLx7"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zrOkxu7pQv2g"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively. Net management fee receivables from the related
party medical practices accounted for approximately &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zHvSLpgsqtMl"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zPb9MQN8nj7i"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated accounts receivable for the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;See
Note 3 regarding the Company&#x2019;s concentrations in the healthcare industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOyVwEzJJY21" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_ztzpkTwsHCm9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
financial statements include various estimated fair value information at June 30, 2021 and 2020, as required by ASC topic 820, &#x201c;Disclosures
about Fair Value of Financial Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short
term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;All
of the Company&#x2019;s financial instruments are held for purposes other than trading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zhx4jgMFiT22" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zYdBpS4sSaS6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
December 2019, the FASB issued ASU 2019-12 (&#x201c;ASU 2019-12&#x201d;), Income Taxes (Topic 740). ASU 2019-12 removes certain exceptions
related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition
of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12
was effective beginning in the first quarter of 2021. Certain amendments in this update must be applied on a prospective basis, certain
amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through
a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. The adoption of this update did not have a material
impact on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
January 2017, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2017-04, Intangibles &#x2013; Goodwill and Other (Topic
350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required
the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the
procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The
amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning
after December 15, 2019. The Company adopted the Standard on July 1, 2020 and the impact of adopting this guidance had no material impact
on our Consolidated Financial Statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2021
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those pronouncements will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;


















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zLtLsqmwhe23" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zxPf8p16bxF8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zBqSjqTontc6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zcH5SNBobXa4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Use
of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:InventoryWorkInProcessPolicy contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zvuNP967cxF2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zYqIXvW9FN3d" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryWorkInProcessPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zIbbGTvGSA3h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zAHENb4dKiq1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and equipment procured in the normal course of business is stated at cost. Property and equipment purchased in connection with an acquisition
is stated at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting
purposes using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter
of the useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses
totaled approximately $&lt;span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20200701__20210630_pp0p0"&gt;2,051,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20190701__20200630_pp0p0"&gt;1,870,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for the
years ended June 30, 2021 and 2020 respectively. The estimated useful lives in years are generally as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated
Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
and fixtures&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
improvements&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





















</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2051000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1870000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated
Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
and fixtures&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
improvements&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MinimumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MaximumMember">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_custom_ResearchDeveopmentAndDemonstrationEquipmentMember_srt_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_LeaseholdImprovementsMember_srt_MaximumMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember">P28Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_848_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zZz8Q5RcxKQf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_ztuPuSG6wJ2g" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-Lived
Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaSg3dJzIcK1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zfJcFT8xxeee" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1)
Patents and Copyrights&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight-line basis over &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyj86MpWUw6f"&gt;15
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2)
Non-Competition Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
non-competition agreements are being amortized on the straight line basis over the length of the agreement (&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zXlMLHrL1Fg3"&gt;7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3)
Customer Relationships&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight line basis over &lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zW7GgkeyX1q9"&gt;20
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_IntellectualPropertyMember">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_848_eus-gaap--GoodwillDisclosureTextBlock_zpRTJLmWQx53" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zPbmbZCubsO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing the
reporting unit&#x2019;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount of the reporting
unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure the amount of impairment
loss, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_848_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zkKMC3wi5Hra" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86A_zzDdrzGNAwc5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Acquired
assets and assumed liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Pursuant
to ASC No. 805-10-25, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, but during the allowed measurement period not to exceed one year from the acquisition date, the Company adjusts
the provisional amounts recognized at the acquisition date by means of adjusting the amount recognized for goodwill.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_z7pbiOEpTgY2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_zuVgzj3IKn35" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on sales contracts for scanners, included in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type
and Production-Type Contracts&#x201d;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
from product sales (upgrades and supplies) is recognized upon shipment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2021, the Company has twenty
two &lt;span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20210630_zcSncm0bFo95"&gt;22 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;management
agreements of which three &lt;span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20210630_zwDV9ROkB2Uj"&gt;3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;are with
PC&#x2019;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (&#x201c;the Related medical practices&#x201d;) and nineteen
&lt;span id="xdx_905_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20210630_zASamHcSk18a"&gt;19&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;are
with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by two unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$&lt;span id="xdx_904_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_za2HOkZvPstc"&gt;77,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;to $&lt;span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_z3UgKWymxQM4"&gt;522,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts
for estimated uncollectible fees, which is reflected in other operating expenses on the Statement of Operations. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
July 1, 2018, the Company adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board
(&#x201c;FASB&#x201d;) and codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#x2019;s revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company applied the modified retrospective approach to all contracts when adopting ASC 606. As a result, at the adoption of ASC 606 the
majority of what was previously classified as the provision for bad debts in the statement of operations is now reflected as implicit
price concessions (as defined in ASC 606) and therefore included as a reduction to net operating revenues in 2019. For changes in credit
issues not assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the
statement of operations.&lt;/span&gt;&lt;/p&gt;






























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition
standards that required it to be presented separately as a component of net operating revenues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2021 and 2020 are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,100,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,545,987&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;968,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,038,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,011,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,028,737&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,227,783&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;882,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,307,389&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,495,260&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <FONR:ManagementAgreementsWithCompanyTotalMedicalPractices contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">22</FONR:ManagementAgreementsWithCompanyTotalMedicalPractices>
    <FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">3</FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty>
    <FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">19</FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState>
    <FONR:ContractualFeesForServicesRenderedMinimum
      contextRef="AsOf2021-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      unitRef="USD">77000</FONR:ContractualFeesForServicesRenderedMinimum>
    <FONR:ContractualFeesForServicesRenderedMaximum
      contextRef="AsOf2021-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      unitRef="USD">522000</FONR:ContractualFeesForServicesRenderedMaximum>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,100,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,545,987&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;968,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,038,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,011,111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" style="text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,028,737&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,227,783&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;882,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,307,389&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,495,260&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      unitRef="USD">4100440</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2019-07-012020-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      unitRef="USD">4545987</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      unitRef="USD">968055</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2019-07-012020-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      unitRef="USD">1038288</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      unitRef="USD">15011111</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2019-07-012020-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      unitRef="USD">16028737</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      unitRef="USD">3227783</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2019-07-012020-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      unitRef="USD">882248</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">23307389</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">22495260</FONR:NetPatientFeeRevenue>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_z8WrJQIPxgf1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_867_zAFh41uMKkSg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVXAGHqj5Gw3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_zprP5qeyBaw6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
costs are expensed as incurred. Advertising expense approximated $&lt;span id="xdx_904_eus-gaap--AdvertisingExpense_c20200701__20210630_pp0p0"&gt;633,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_c20190701__20200630_pp0p0"&gt;566,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and for
the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">633000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">566000</us-gaap:AdvertisingExpense>
    <FONR:ShippingsAndHandlingCostPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_844_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zxSiwQ5y1MAi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_z0SYCump33c7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Shipping
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s shipping and handling costs are included in revenue from product sales and the related expense included in costs related
to product sales is $&lt;span id="xdx_90C_ecustom--ShippingAndHandlingExpense_c20200701__20210630_pp0p0"&gt;8,215&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
$&lt;span id="xdx_906_ecustom--ShippingAndHandlingExpense_c20190701__20200630_pp0p0"&gt;12,056 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for
the years ended June 30, 2021 and 2020 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FONR:ShippingsAndHandlingCostPolicyTextBlock>
    <FONR:ShippingAndHandlingExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">8215</FONR:ShippingAndHandlingExpense>
    <FONR:ShippingAndHandlingExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">12056</FONR:ShippingAndHandlingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zA5xsR1rShAh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86D_zQ9eRVz29CBl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Income
Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <FONR:CustomerAdvancesPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_845_ecustom--CustomerAdvancesPolicyTextBlock_zaq3qTpC6NKd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zdANIG3i80mf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FONR:CustomerAdvancesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zmWFhyEeRnsl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86B_za9HiphMAcj8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the
Two-Class Method&#x201d;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2021 and 2020, diluted EPS for common shareholders
includes &lt;span id="xdx_90C_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20190701__20200630_pdd"&gt;127,504
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;



























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BF_zClNNIkWZL8a"&gt;&lt;span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,207,588&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,592,134&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;156,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,632,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,240,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,735,650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;128,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.28&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.34&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" style="text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0795"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,571,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.34&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A8_zzHEmSqwJ6E6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BF_zClNNIkWZL8a"&gt;&lt;span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,207,588&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,592,134&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;156,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,505,283&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,632,787&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,240,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,735,650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;128,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.28&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.34&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted average
    shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" style="text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,443,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0795"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,571,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted income
    per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.34&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">10207588</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">9592134</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">156744</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">6505283</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6505283</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="USDPShares">1.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6505283</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">127504</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6632787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">8240205</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7735650</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">128500</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">6443713</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6443713</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">1.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.20</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.34</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6443713</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">127504</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6571217</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012020-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFXANRH7PhBg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zGeYtXpuQ5a4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zCYsOhXUbqbf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zXSCVqo92S6c" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short
Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short
term investments include certificates of deposit with original maturities of greater than 90 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zMEReFdwkn94" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zCZ12RgmjCLa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2021, the Company had cash on deposit of approximately $&lt;span id="xdx_90C_eus-gaap--Cash_c20210630_pp0p0"&gt;42,609,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;in excess
of federally insured limits of $&lt;span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20210630_pp0p0"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Related
Parties: Net revenues from related parties accounted for approximately &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zPMBJMQeMLx7"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zrOkxu7pQv2g"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively. Net management fee receivables from the related
party medical practices accounted for approximately &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zHvSLpgsqtMl"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zPb9MQN8nj7i"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated accounts receivable for the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;See
Note 3 regarding the Company&#x2019;s concentrations in the healthcare industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:Cash contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">42609000</us-gaap:Cash>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012020-06-30_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012020-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOyVwEzJJY21" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_ztzpkTwsHCm9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
financial statements include various estimated fair value information at June 30, 2021 and 2020, as required by ASC topic 820, &#x201c;Disclosures
about Fair Value of Financial Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short
term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.&lt;/span&gt;&lt;/p&gt;























&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;All
of the Company&#x2019;s financial instruments are held for purposes other than trading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zhx4jgMFiT22" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_zYdBpS4sSaS6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
December 2019, the FASB issued ASU 2019-12 (&#x201c;ASU 2019-12&#x201d;), Income Taxes (Topic 740). ASU 2019-12 removes certain exceptions
related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition
of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12
was effective beginning in the first quarter of 2021. Certain amendments in this update must be applied on a prospective basis, certain
amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through
a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. The adoption of this update did not have a material
impact on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
January 2017, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2017-04, Intangibles &#x2013; Goodwill and Other (Topic
350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required
the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the
procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The
amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning
after December 15, 2019. The Company adopted the Standard on July 1, 2020 and the impact of adopting this guidance had no material impact
on our Consolidated Financial Statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2021
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those pronouncements will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;


















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_804_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zCLMPZEgKfec" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_82A_zea6mcqT0vBk"&gt;NOTE
3 &#x2013; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long
Term Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following four years at June 30, 2021 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoBFjbafe4G9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_z38JyVFkWP0a" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivables
    - Non Current - net&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210630_zuHAmvvH42O6" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pp0p0_maARBFLzg6L_zQnwfqZLr0fb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,020,140&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_maARBFLzg6L_zIFq4Asfjxqd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,020,140&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_maARBFLzg6L_z1E8DF4fWvr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;599,545&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_maARBFLzg6L_zioLAlunrAD1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;160,697&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pp0p0_mtARBFLzg6L_zpQKMbMNJrNj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,800,522&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s receivables from the related and non-related professional corporations (&#x201c;PCs&#x201d;) substantially consist of fees
outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third party
medical reimbursement organizations, principally insurance companies and health management organizations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Payment
of the management fee receivables from the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_90B_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20210630_zwU20bZAzQyk"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_903_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20190701__20200630_zS8V3puKjQHe"&gt;66&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%,
respectively, of the PCs&#x2019; 2021 and 2020 net revenues were derived from no-fault and personal injury protection claims. The Company
considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#x2019;s expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
revenues from management and other fees charged to the related party medical practices accounted for approximately &lt;span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20210630_zYtXfSBRIwUi"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_90C_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20190701__20200630_zYeh3N6eWUH4"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%,
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related party medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company,
which have arisen under each individual management agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following table sets forth the number of our facilities for the years ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zqieCF8R7qc8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B0_zzzGG3b2SDtk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20200701__20210630_zZQlJWUvrOl3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20190701__20200630_ztsqqEiy72Jj" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_uN_znGr62zMQxE9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at Beginning of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Facilities
    Added by:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--ManagedFacilitiesAddedAcquisition_uN_zRoaEaKANBvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0877"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--ManagedFacilitiesAddedByInternalDevelopment_uN_zXRGLSNcSI11" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Internal
    development&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0880"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--ManagedFacilitiesClosedDuringYear_uN_zHHJ2Z6ihqVk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Managed
    Facilities Closed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0882"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_uN_zGJjal9NGXx2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at End of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoBFjbafe4G9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_z38JyVFkWP0a" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivables
    - Non Current - net&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210630_zuHAmvvH42O6" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pp0p0_maARBFLzg6L_zQnwfqZLr0fb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,020,140&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_maARBFLzg6L_zIFq4Asfjxqd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,020,140&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_maARBFLzg6L_z1E8DF4fWvr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;599,545&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_maARBFLzg6L_zioLAlunrAD1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;160,697&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pp0p0_mtARBFLzg6L_zpQKMbMNJrNj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,800,522&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <us-gaap:ContractReceivableDueOneToTwoYears contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1020140</us-gaap:ContractReceivableDueOneToTwoYears>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1020140</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">599545</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:ContractReceivableDueFourToFiveYears contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">160697</us-gaap:ContractReceivableDueFourToFiveYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2800522</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.65</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.66</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zqieCF8R7qc8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B0_zzzGG3b2SDtk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20200701__20210630_zZQlJWUvrOl3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20190701__20200630_ztsqqEiy72Jj" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_uN_znGr62zMQxE9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at Beginning of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Facilities
    Added by:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--ManagedFacilitiesAddedAcquisition_uN_zRoaEaKANBvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0877"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--ManagedFacilitiesAddedByInternalDevelopment_uN_zXRGLSNcSI11" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Internal
    development&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0880"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--ManagedFacilitiesClosedDuringYear_uN_zHHJ2Z6ihqVk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Managed
    Facilities Closed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0882"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_uN_zGJjal9NGXx2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at End of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="N">25</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="N">26</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:ManagedFacilitiesAddedAcquisition
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="N">1</FONR:ManagedFacilitiesAddedAcquisition>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="N">1</FONR:ManagedFacilitiesAddedByInternalDevelopment>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="N">-1</FONR:ManagedFacilitiesClosedDuringYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="N">27</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="N">25</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_803_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_zhJ1WWO5fEQh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_823_z93nS4bFuySh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
4 &#x2013; CONTRACT ASSETS AND LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Information
relating to uncompleted contracts as of June 30, 2021 and 2020 about contract assets and contract (liabilities) is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zlhn1AN11dV" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-top: 0; padding-right: 0"&gt;&lt;span id="xdx_8BB_zwtFauVdJpP5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;`Costs
    and Estimated Earnings on Uncompleted Contracts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20210630_zxPyr040yaSh" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20200630_z6tLCJpz5K42" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzX6u_z9fo0QQbVcUb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Costs
    incurred on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;294,783&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;448,437&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzX6u_zWePQjsPMiO7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated
    earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;567,978&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;309,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzX6u_maCAEEIz60s_zXtcV4aEcssc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Costs
    and estimated earnings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;862,761&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;757,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz60s_zo5aWfzTjK22" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Billings to date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;877,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;604,852&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz60s_z3DkGDjrfMti" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Costs
    and estimated earnings in excess of billings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(14,739&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;152,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock>
    <us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zlhn1AN11dV" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-top: 0; padding-right: 0"&gt;&lt;span id="xdx_8BB_zwtFauVdJpP5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;`Costs
    and Estimated Earnings on Uncompleted Contracts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20210630_zxPyr040yaSh" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20200630_z6tLCJpz5K42" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzX6u_z9fo0QQbVcUb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Costs
    incurred on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;294,783&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;448,437&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzX6u_zWePQjsPMiO7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated
    earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;567,978&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;309,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzX6u_maCAEEIz60s_zXtcV4aEcssc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Costs
    and estimated earnings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;862,761&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;757,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz60s_zo5aWfzTjK22" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Billings to date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;877,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;604,852&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz60s_z3DkGDjrfMti" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Costs
    and estimated earnings in excess of billings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(14,739&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;152,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">294783</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">448437</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:EstimatedEarnings contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">567978</FONR:EstimatedEarnings>
    <FONR:EstimatedEarnings contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">309248</FONR:EstimatedEarnings>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">862761</FONR:CostsAndEstimatedEarningsOnUncompletedContracts>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContracts contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">757685</FONR:CostsAndEstimatedEarningsOnUncompletedContracts>
    <FONR:BillingsToDate contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">877500</FONR:BillingsToDate>
    <FONR:BillingsToDate contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">604852</FONR:BillingsToDate>
    <FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-14739</FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts>
    <FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">152833</FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_805_eus-gaap--InventoryDisclosureTextBlock_z2bhGtPO2vgl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_823_zzuPqy0yPFJf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
5 &#x2013; INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
included in the accompanying consolidated balance sheets consist of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEZlWDlLOQva" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zyPaFYGMnLZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20210630_z9YOyYUuJnVb" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20200630_zfDZsGiiNszj" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWz0L2_zoKmIuMutIOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,393,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,544,036&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWz0L2_zuuS48pQnW8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;270,090&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;104,734&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWz0L2_zVe2OZvxW0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,663,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,648,770&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEZlWDlLOQva" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zyPaFYGMnLZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20210630_z9YOyYUuJnVb" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20200630_zfDZsGiiNszj" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWz0L2_zoKmIuMutIOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,393,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,544,036&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWz0L2_zuuS48pQnW8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;270,090&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;104,734&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWz0L2_zVe2OZvxW0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,663,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,648,770&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1393329</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1544036</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">270090</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">104734</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1663419</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1648770</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNC6esK4vxh9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span id="xdx_821_zga6IPHNiRqh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;NOTE
6 - PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2021 and 2020, is comprised of:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwUO3RV0kjm8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zkCxt8jO2F4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,826,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28,434,063&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,029,551&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,901,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,450,664&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,291,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,961,887&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,736,825&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,277,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20200630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;51,373,184&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20210630_zvVIPqA3ouae" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;33,427,461&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20200630_zuNN7xmynn1h" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,009,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,850,139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,364,034&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
and amortization of property and equipment for the years ended June 30, 2021 and 2020 was $&lt;span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSoldDepreciationAndAmortization_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"&gt;3,696,986
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90E_eus-gaap--CostOfGoodsAndServicesSoldDepreciationAndAmortization_c20190701__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"&gt;3,144,580&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;















</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwUO3RV0kjm8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zkCxt8jO2F4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,826,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28,434,063&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,029,551&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,901,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,450,664&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,291,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,961,887&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,736,825&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,277,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20200630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;51,373,184&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20210630_zvVIPqA3ouae" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;33,427,461&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20200630_zuNN7xmynn1h" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,009,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,850,139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,364,034&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">29826829</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">28434063</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">6029551</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-06-30_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">5901961</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">3450664</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">3291666</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">12961887</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">10736825</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-06-30_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">55277600</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">51373184</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">33427461</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">30009150</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">21850139</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">21364034</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">3696986</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="From2019-07-012020-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">3144580</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_805_eus-gaap--LesseeOperatingLeasesTextBlock_zXV6cHCPDnx8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_823_zfNxIgBcMGec" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
7 &#x2013; OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases
as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase by the
lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line
basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with
a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less will be accounted for similar
to existing guidance for operating leases. The standard was effective for us beginning July 1, 2019. We have elected the optional transition
method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented
in the consolidated financial statements. We have also elected the transition package of thee practical expedients permitted within the
standard which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and indirect
costs. The adoption of this guidance had a material impact on the Company&#x2019;s balance sheet by virtue of including the present value
of its future operating lease payments as a liability of $&lt;span id="xdx_900_eus-gaap--OperatingLeasePayments_pp0n3_dm_c20200701__20210630_zxPuq0Ogikvc"&gt;33.3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million
and related right-to-use lease assets as of July 1, 2019. At the time of adoption of this guidance we had no significant financing leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as
of June 30, 2021 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zMDOU8DTqM0l" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_8BF_zEcB5YqbzAxl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
    of operating and financing lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Year
    Ending&lt;br/&gt;
    June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease&lt;br/&gt;
    Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,077,656&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,172,157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,837,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,725,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,285,124&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,950,126&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;162,898&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Present
    value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PresentValueDiscount_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(8,539,725&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PresentValueDiscountFinancingLease_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount, Financing Lease"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(133,441&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseLiability_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;32,508,788&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,251,172&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases - years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zyiKeR8aFeId" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9.4&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease - years&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zHyDciq5j3Od" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted Average
    Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zX3jn1iTNo2j" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zLJKkgRcvkFi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_zvb9V3irp98k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
components of lease expense were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zNBBitWNGn5a" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zsnyY55tolR" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20200701__20210630_zz0TZKPAK4Sh" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20190701__20200630_zjPNhS75wov1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,145,701&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,135,604&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,881&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1030"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Interest
    on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;47,472&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1033"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;246,353&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1036"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Supplemental
cash flow information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zxciqAwBS698" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_zlpYDIrDrba8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Supplemental
    cash flow information related to leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20200701__20210630_zI5AZPQZsM68" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20190701__20200630_zG5ySzJR2yw2" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
    paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,970,934&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,170,977&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;130,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right-of-use
    &amp;amp; equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_F42_zfwrmZn7BRha"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases(1)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,531,889&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;34,786,611&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_zqRFsh9v7ux" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1049"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,325,871&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F0E_z1lTZArbGDC8" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F14_zlPnT2lvPHtl" style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
  for the year ended June 30, 2020 include the transition adjustment for the adoption of topic 842 of $31,651,110.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



















</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">33300000</us-gaap:OperatingLeasePayments>
    <FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zMDOU8DTqM0l" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_8BF_zEcB5YqbzAxl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
    of operating and financing lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Year
    Ending&lt;br/&gt;
    June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease&lt;br/&gt;
    Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,077,656&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,172,157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,837,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,725,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,285,124&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,950,126&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;162,898&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Present
    value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PresentValueDiscount_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(8,539,725&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PresentValueDiscountFinancingLease_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount, Financing Lease"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(133,441&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseLiability_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;32,508,788&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,251,172&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases - years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zyiKeR8aFeId" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9.4&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease - years&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zHyDciq5j3Od" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted Average
    Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zX3jn1iTNo2j" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zLJKkgRcvkFi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5077656</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5172157</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4837900</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4725550</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4285124</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16950126</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">162898</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-8539725</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-133441</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">32508788</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1251172</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-06-30">P9Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-06-30">P5Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">0.055</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zNBBitWNGn5a" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zsnyY55tolR" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20200701__20210630_zz0TZKPAK4Sh" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20190701__20200630_zjPNhS75wov1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,145,701&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,135,604&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,881&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1030"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Interest
    on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;47,472&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1033"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;246,353&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1036"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">6145701</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5135604</us-gaap:OperatingLeaseCost>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">47472</us-gaap:FinanceLeaseInterestExpense>
    <FONR:FinanceLeaseCost
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">246353</FONR:FinanceLeaseCost>
    <FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zxciqAwBS698" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B8_zlpYDIrDrba8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Supplemental
    cash flow information related to leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20200701__20210630_zI5AZPQZsM68" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20190701__20200630_zG5ySzJR2yw2" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
    paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,970,934&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,170,977&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;130,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right-of-use
    &amp;amp; equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_F42_zfwrmZn7BRha"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases(1)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,531,889&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;34,786,611&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_zqRFsh9v7ux" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1049"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,325,871&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">4970934</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">4170977</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">130038</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      id="Fact001046"
      unitRef="USD">1531889</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      id="Fact001047"
      unitRef="USD">34786611</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1325871</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_zsaTfRi9NyKl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82B_zQMXwypJdeZ3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
8 - OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
intangible assets, net of accumulated amortization, at June 30, 2021 and 2020 are comprised of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbXy2181BX2g" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zILyUXvgO2Gb" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intagible Assets - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,244,892&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,081,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-competition
    agreements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,800,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,299,739&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;19,986,568&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20210630_zTn2YN4m0lY2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,262,140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,877,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iI_pp0p0_c20210630_zCuIGUHQA6gi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIntangibleAssetsNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,109,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
estimated amortization of other intangible assets for the five years ending June 30, 2026 and thereafter is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zBuqZYKbMIwk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zB5P59yB77f9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    Of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20210630_zeJIn3QGdWfj" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zSxXkzAjN876" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zGDhhxG9qfoa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjs3UftClBE5" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years&lt;br/&gt;
    Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and Copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-
    &lt;br/&gt; competition&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;423,209&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;185,709&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;37,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;389,168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;189,168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;388,867&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;188,867&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;383,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;183,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1110"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;373,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;173,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,079,223&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;765,056&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,314,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_z5Jw5o8TSqsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,685,932&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;37,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,314,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
weighted average amortization period for other intangible assets is &lt;span id="xdx_906_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20200701__20210630_zBl64AhToYm3"&gt;11.4
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years
and they have no expected residual value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Information
related to the above intangible assets for the years ended June 30, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZJ5f4yVc1ta" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zmE4HPVTja7e" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_zJtB6wn9h7g9" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,109,129&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20190701__20200630_zz3zceFQ0pDa" style="width: 12%; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,755,675&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
    capitalized&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;313,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmountsCapitalized_c20190701__20200630_pp0p0" style="text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;117,522&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Software
    or patents written off&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pp0p0" style="text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_c20190701__20200630_pp0p0" style="text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1141"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(384,701&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AdjustmentForAmortization_c20190701__20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(764,068&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; End of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_zFrPxUK9UwN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20190701__20200630_zpoSwOBJRgX6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,109,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of patents and copyrights for the years ended June 30, 2021 and 2020 amounted to $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0"&gt;179,701
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0"&gt;183,592&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
software development costs were fully amortized as of June 30, 2018.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of non-competition agreements for the years ended June 30, 2021 and 2020 amounted to $&lt;span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"&gt;12,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"&gt;390,476&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of customer relationships for the years ended June 30, 2021 and 2020 amounted to $&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"&gt;192,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"&gt;190,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbXy2181BX2g" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zILyUXvgO2Gb" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intagible Assets - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,244,892&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,081,721&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-competition
    agreements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,800,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,299,739&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630_pp0p0" style="text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;19,986,568&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20210630_zTn2YN4m0lY2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,262,140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,877,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iI_pp0p0_c20210630_zCuIGUHQA6gi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherIntangibleAssetsNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,109,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">5244892</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">5081721</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">4100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">20299739</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">19986568</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16262140</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">15877439</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4109129</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zBuqZYKbMIwk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zB5P59yB77f9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    Of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20210630_zeJIn3QGdWfj" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zSxXkzAjN876" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zGDhhxG9qfoa" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjs3UftClBE5" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years&lt;br/&gt;
    Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and Copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-
    &lt;br/&gt; competition&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;423,209&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;185,709&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;37,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;389,168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;189,168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;388,867&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;188,867&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;383,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;183,912&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1110"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;373,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;173,220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,079,223&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;765,056&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,314,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_z5Jw5o8TSqsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,685,932&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;37,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,314,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">423209</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">185709</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">37500</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">389168</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">189168</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">388867</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">188867</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">383912</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">183912</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">373220</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">173220</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2079223</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">765056</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">1314167</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">1685932</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">37500</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">2314167</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2020-07-01to2021-06-30">P11Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZJ5f4yVc1ta" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zmE4HPVTja7e" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_zJtB6wn9h7g9" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,109,129&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20190701__20200630_zz3zceFQ0pDa" style="width: 12%; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,755,675&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
    capitalized&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;313,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AmountsCapitalized_c20190701__20200630_pp0p0" style="text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;117,522&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Software
    or patents written off&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pp0p0" style="text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_c20190701__20200630_pp0p0" style="text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1141"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(384,701&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AdjustmentForAmortization_c20190701__20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(764,068&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; End of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_zFrPxUK9UwN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20190701__20200630_zpoSwOBJRgX6" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,109,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4109129</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">4755675</us-gaap:OtherIntangibleAssetsNet>
    <FONR:AmountsCapitalized
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">313705</FONR:AmountsCapitalized>
    <FONR:AmountsCapitalized
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">117522</FONR:AmountsCapitalized>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-534</FONR:SoftwareOrPatentsWrittenOff>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-384701</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-764068</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4109129</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012021-06-30_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">179701</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-07-012020-06-30_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">183592</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">12500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-07-012020-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">390476</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">192500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-07-012020-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">190000</us-gaap:AmortizationOfIntangibleAssets>
    <FONR:CapitalStockAndOptionsDisclosureTextblock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_80A_ecustom--CapitalStockAndOptionsDisclosureTextblock_zuqPAGn0nYXe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_825_zlRKkpR0Jfbk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
9 - CAPITAL STOCK&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90E_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
B Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90D_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
B common stock is convertible into shares of common stock on a one-for-one basis.&lt;/span&gt; &lt;span id="xdx_900_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
B common stock has 10 votes per share&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
There
were &lt;/span&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7zfDcLZUZ73" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;146
&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;of
such shares outstanding at June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
C Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three
shares of Class C common stock for each share of the Company&#x2019;s outstanding Class B common stock. &lt;/span&gt;&lt;span id="xdx_907_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class C common stock has 25 votes per share&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
as compared to 10 votes per share for the Class B common stock and &lt;/span&gt;&lt;span id="xdx_908_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;one
vote per share for the common stock.&lt;/span&gt; &lt;span id="xdx_90B_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zj0iLxmvlPQ8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.&lt;/span&gt; &lt;span id="xdx_90C_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions.&lt;/span&gt; &lt;span id="xdx_90A_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zIZP2n6HBl6i" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
C common stock is convertible into shares of common stock on a three-for-one basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
A Non-Voting Preferred Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with
special dividend rights and the declaration of a stock dividend on the Company&#x2019;s common stock consisting of &lt;/span&gt;&lt;span id="xdx_904_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;one
share of Class A non-voting preferred stock for every five shares of common stock.&lt;/span&gt; &lt;span id="xdx_900_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zEmgKU33Vj45" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million
and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection
with the enforcement of five of the Company&#x2019;s patents in its patent lawsuits, less the revised special dividend payable on the
common stock with respect to one of the Company&#x2019;s patents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks
equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Stock
Bonus Plans&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve &lt;span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
of common stock. On August 10, 2010, the Company filed Form S-8 to register the &lt;span id="xdx_90E_ecustom--SharesRegistered_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares.
As of June 30, 2021, &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;450,177
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2021 and 2020, &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;106,747
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;89,981
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
were issued respectively, of which $&lt;span id="xdx_907_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20200701__20210630_zXhva5SmCQTa"&gt;83,277
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20190701__20200630_zlUj96hniVBb"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;were
expensed and included in selling, general and administrative expenses for the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Options&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company had stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and
consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of
time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board
of Directors, generally the fair value of the Company&#x2019;s common stock at the date of grant. The options must be exercised within
ten years from the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
















</FONR:CapitalStockAndOptionsDisclosureTextblock>
    <us-gaap:DividendsPayableNature contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.</us-gaap:DividendsPayableNature>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2020-07-012021-06-30_us-gaap_CommonClassBMember">Class
B common stock is convertible into shares of common stock on a one-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2020-07-012021-06-30_us-gaap_CommonClassBMember">Class
B common stock has 10 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember">The
Class C common stock has 25 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockVotingRights contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember">one
vote per share for the common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:DividendsPayableNature contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember">Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions.</us-gaap:DividendsPayableNature>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember">Class
C common stock is convertible into shares of common stock on a three-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2020-07-012021-06-30_us-gaap_PreferredClassAMember">one
share of Class A non-voting preferred stock for every five shares of common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:DividendsPayableNature contextRef="From2020-07-012021-06-30_us-gaap_PreferredClassAMember">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.</us-gaap:DividendsPayableNature>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <FONR:SharesRegistered
      contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">2000000</FONR:SharesRegistered>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">450177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">106747</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2019-07-012020-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">89981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">83277</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zZkWyEMq2DQ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82B_z7jLKZJpDuC6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
10 &#x2013; CONTROLLING AND NONCONTROLLING INTERESTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
February 13, 2013 the Company entered into an agreement with outside investors to acquire a &lt;span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember__srt--OwnershipAxis__custom--HDMEquityMember_z3jCRuZcsDS5"&gt;50.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
controlling interest in a newly formed limited liability company, Health Diagnostics Management LLC (HDM). According to the February
13, 2013 LLC operating agreement of HDM there are two classes of members; Class A members and one Class B member. The Class A members
have an ownership interest of &lt;span id="xdx_90C_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_zACopkDN6aOi"&gt;49.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of HDM. The Class B member (HMCA) has an ownership of &lt;span id="xdx_90D_ecustom--OwnershipPercentageAcquired_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember__srt--OwnershipAxis__custom--HDMEquityMember_zz6lUk9EkLci"&gt;50.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of
ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be allocated
among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be
allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions
of the operating agreement. The Company contributed $&lt;span id="xdx_905_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember_pp0p0"&gt;20,200,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;to HDM
and the group of outside investors contributed $&lt;span id="xdx_907_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OutsideInvestorsMember_pp0p0"&gt;19,800,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for its
non-controlling membership interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
March 5, 2013 HDM purchased from Health Diagnostics, LLC (&#x201c;HD&#x201d;) and certain of its subsidiaries, a business managing twelve
(&lt;span id="xdx_902_ecustom--PurchaseOfStandupMriCenters_iI_uN_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zbtIDdlBxJS2"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)
Stand-Up MRI Centers and two (&lt;span id="xdx_909_ecustom--PurchaseOfOtherMriCenters_iI_uN_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zyIQuekcC5Ee"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)
other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $&lt;span id="xdx_90F_ecustom--ConsiderationToOutsideInvestors_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zqdB35NzycNh"&gt;1.5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million
to outside investors) aggregating $&lt;span id="xdx_903_ecustom--TotalPurchasePrice_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkIIF4PChiCc"&gt;35.9
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million.
Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $&lt;span id="xdx_906_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zMzR7z1hBn09"&gt;4.1
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million.
The acquisition was accounted for using the purchase method in accordance with ASC 805, &#x201c;Business Combinations&#x201d;. The Company
recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair
value of the identified net assets acquired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
January 8, 2015, the Company purchased 20% of the Class A members ownership interest at a cost of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_pp0p0"&gt;4,971,094&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
The Company has a &lt;span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_z0J4trW8Vire"&gt;60.4&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
ownership interest in HDM after this transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amount
of each class of HDM members&#x2019; equity as of June 30, 2021 and 2020&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zO8VxsqLDxlb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_zIR8pg3tdXKi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    A And B Members' Equity (HDM Acquisition)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    B Member&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    B Member&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Opening
    Members&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,253&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;39,850,419&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,155,725&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;36,543,786&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Share of Net
    Income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,466,223&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,402,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,464,528&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,291,633&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(6,570,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(15,330,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(5,565,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(12,985,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Ending Members&#x2019;
    Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(3,048,524&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;41,923,380&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zokGHiJavRd3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,253&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zr22B74hWXZh" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;39,850,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
















</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_ClassBMember_custom_HDMEquityMember"
      decimals="INF"
      unitRef="Pure">0.505</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_ClassAMember_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.495</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <FONR:OwnershipPercentageAcquired
      contextRef="AsOf2013-02-13_custom_ClassBMember_custom_HDMEquityMember"
      decimals="INF"
      unitRef="Pure">0.505</FONR:OwnershipPercentageAcquired>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-012013-02-13_custom_HDMMember"
      decimals="0"
      unitRef="USD">20200000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember"
      decimals="0"
      unitRef="USD">19800000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <FONR:PurchaseOfStandupMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      unitRef="N">12</FONR:PurchaseOfStandupMriCenters>
    <FONR:PurchaseOfOtherMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      unitRef="N">2</FONR:PurchaseOfOtherMriCenters>
    <FONR:ConsiderationToOutsideInvestors
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="0"
      unitRef="USD">1500000</FONR:ConsiderationToOutsideInvestors>
    <FONR:TotalPurchasePrice
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="0"
      unitRef="USD">35900000</FONR:TotalPurchasePrice>
    <FONR:ConsiderationForNoncompetitionAndConsultingAgreements
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="0"
      unitRef="USD">4100000</FONR:ConsiderationForNoncompetitionAndConsultingAgreements>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2015-01-08_custom_ClassAMember_custom_HDMMember"
      decimals="0"
      unitRef="USD">4971094</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2015-01-08_custom_ClassAMember_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.604</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zO8VxsqLDxlb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_zIR8pg3tdXKi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    A And B Members' Equity (HDM Acquisition)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    B Member&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    B Member&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Opening
    Members&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,253&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;39,850,419&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,155,725&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;36,543,786&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Share of Net
    Income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,466,223&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,402,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,464,528&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,291,633&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(6,570,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(15,330,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(5,565,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(12,985,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Ending Members&#x2019;
    Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(3,048,524&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;41,923,380&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zokGHiJavRd3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,253&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zr22B74hWXZh" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;39,850,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">55253</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">39850419</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">2155725</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">36543786</FONR:OpeningMembersEquity>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">3466223</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">17402961</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">3464528</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">16291633</FONR:ShareOfNetIncome>
    <FONR:Distributions
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">-6570000</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">-15330000</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">-5565000</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">-12985000</FONR:Distributions>
    <FONR:EndingMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">-3048524</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">41923380</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">55253</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">39850419</FONR:EndingMembersEquity>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_80F_eus-gaap--DebtAndCapitalLeasesDisclosuresTextBlock_zOwgACrmdvz8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82A_z2f2Jf39Ekrf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt, notes payable and capital leases consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfDebtTableTextBlock_z8EditiZWPTf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_zKynI8lRFbah" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
    debt, notes payable and capital leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Note
    payable requiring monthly payments of interest at a rate of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zC0c6XA3xS68"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    until May 2009 followed by &lt;span id="xdx_90A_ecustom--NumberOfInstallment_uN_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zllq7TdCexnk"&gt;240
    &lt;/span&gt;&lt;/span&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;monthly
    &lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;payments
    of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"&gt;4,472
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;through
    &lt;span id="xdx_902_ecustom--MaturityDate_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRfWKu8kbBP6"&gt;October
    2026&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
    The loan is collateralized by a building with a net book value of $&lt;span id="xdx_90C_ecustom--BookValueOfBuilding_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"&gt;413,330
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;as
    of June 30, 2021.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;232,696&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;273,031&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;Note
    payable received under the Paycheck Protection Program (&#x2018;PPP&#x2019;) which was established as part of the Coronavirus Aid,
    Relief and Economic Security Act (&#x201c;Cares Act&#x2019;) that provides for loans to qualifying businesses for amounts up to 2.5
    times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds
    are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven
    portion of the PPP loan is payable over &lt;span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zn4ddeuwAEB9"&gt;5
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;five
    years at an interest rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdaRErAXaOH6"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%,
    with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note
    was forgiven in August 2021.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;700,764&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;700,764&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;The
    revolving credit note was extended to August 2021. The Company can borrow up to $&lt;span id="xdx_902_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zszCbI2JN9Sg"&gt;10,000,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zvYUPPkmTRD6"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line. See
    Note 21.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1270"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1272"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebtCurrent_c20210630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;933,460&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebtCurrent_c20200630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;973,795&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;173,206&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;108,379&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;760,254&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;865,416&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
maturities of debt over the next five years and thereafter are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z13f5Inpfas5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp;amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zUvG19y8jUs4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Maturities
    Of Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20200630_zrMZukqNhGb1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDACztt9_zTOCSVW27rL9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;173,206&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDACztt9_zN7k2APePLlf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;180,972&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_maLTDACztt9_zkPHvGBUAHWi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;183,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDACztt9_z6F16gNgf416" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;187,155&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_maLTDACztt9_zn5DgNIOzstg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;190,601&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_maLTDACztt9_z17A7qz8cCM6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,607&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_iTI_pp0p0_mtLTDACztt9_znBQguf7Gx0a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-Term
    Debt Over Five Years and Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;933,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfDebtTableTextBlock_z8EditiZWPTf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_zKynI8lRFbah" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
    debt, notes payable and capital leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Note
    payable requiring monthly payments of interest at a rate of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zC0c6XA3xS68"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    until May 2009 followed by &lt;span id="xdx_90A_ecustom--NumberOfInstallment_uN_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zllq7TdCexnk"&gt;240
    &lt;/span&gt;&lt;/span&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;monthly
    &lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;payments
    of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"&gt;4,472
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;through
    &lt;span id="xdx_902_ecustom--MaturityDate_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRfWKu8kbBP6"&gt;October
    2026&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
    The loan is collateralized by a building with a net book value of $&lt;span id="xdx_90C_ecustom--BookValueOfBuilding_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"&gt;413,330
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;as
    of June 30, 2021.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;232,696&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;273,031&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;Note
    payable received under the Paycheck Protection Program (&#x2018;PPP&#x2019;) which was established as part of the Coronavirus Aid,
    Relief and Economic Security Act (&#x201c;Cares Act&#x2019;) that provides for loans to qualifying businesses for amounts up to 2.5
    times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds
    are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven
    portion of the PPP loan is payable over &lt;span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zn4ddeuwAEB9"&gt;5
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;five
    years at an interest rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdaRErAXaOH6"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%,
    with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note
    was forgiven in August 2021.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;700,764&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;700,764&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;The
    revolving credit note was extended to August 2021. The Company can borrow up to $&lt;span id="xdx_902_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zszCbI2JN9Sg"&gt;10,000,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zvYUPPkmTRD6"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line. See
    Note 21.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1270"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1272"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebtCurrent_c20210630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;933,460&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebtCurrent_c20200630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;973,795&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;173,206&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;108,379&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;760,254&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;865,416&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-07-012021-06-30_custom_NotePayable1Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <FONR:NumberOfInstallment
      contextRef="From2020-07-012021-06-30_custom_NotePayable1Member"
      decimals="INF"
      unitRef="N">240</FONR:NumberOfInstallment>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="From2020-07-012021-06-30_custom_NotePayable1Member">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2020-07-012021-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">4472</us-gaap:DebtInstrumentPeriodicPayment>
    <FONR:MaturityDate contextRef="From2020-07-012021-06-30_custom_NotePayable1Member">October
    2026</FONR:MaturityDate>
    <FONR:BookValueOfBuilding
      contextRef="AsOf2021-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">413330</FONR:BookValueOfBuilding>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">232696</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2020-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">273031</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentTerm contextRef="From2020-07-012021-06-30_custom_NotePayable2Member">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-07-012021-06-30_custom_NotePayable2Member"
      decimals="INF"
      unitRef="Pure">0.01</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-06-30_custom_NotePayable2Member"
      decimals="0"
      unitRef="USD">700764</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2020-06-30_custom_NotePayable2Member"
      decimals="0"
      unitRef="USD">700764</us-gaap:LongTermDebtCurrent>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2020-07-012021-06-30_custom_NotePayable3Member"
      decimals="0"
      unitRef="USD">10000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-07-012021-06-30_custom_NotePayable3Member"
      decimals="INF"
      unitRef="Pure">0.040</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">933460</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">973795</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">173206</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">108379</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">760254</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">865416</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z13f5Inpfas5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp;amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zUvG19y8jUs4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Maturities
    Of Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20200630_zrMZukqNhGb1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDACztt9_zTOCSVW27rL9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;173,206&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDACztt9_zN7k2APePLlf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;180,972&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_maLTDACztt9_zkPHvGBUAHWi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;183,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDACztt9_z6F16gNgf416" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;187,155&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_maLTDACztt9_zn5DgNIOzstg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;190,601&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_maLTDACztt9_z17A7qz8cCM6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,607&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_iTI_pp0p0_mtLTDACztt9_znBQguf7Gx0a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-Term
    Debt Over Five Years and Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;933,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">173206</us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">180972</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">183919</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">187155</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">190601</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">17607</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">933460</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zye8e684ovI4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82B_z8upLoiDpZBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
12 - INCOME TAXES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#x201c;Interest expense, net. Penalties if incurred would be recognized as a component of &#x201c;Selling, general
and administrative&#x201d; expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2016 for federal
and 2015 for state.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has recorded a deferred tax asset of $&lt;span id="xdx_90F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20210630_zFrLyfiLZhWd"&gt;15,958,961
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and a
deferred tax liability of $&lt;span id="xdx_901_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20210630_pp0p0"&gt;238,316
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;as of
June 30, 2021, primarily relating to its net Federal operating loss carryforwards of approximately $&lt;span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0"&gt;35,574,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;available
to offset future taxable income through 2031. In addition the Company has state operating loss carryforwards of approximately $&lt;span id="xdx_90F_eus-gaap--OperatingIncomeLoss_iN_di_c20200701__20210630_zIeZ68hBeGta"&gt;7,094,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and city
operating loss carryforwards of approximately $&lt;span id="xdx_90C_eus-gaap--OtherOperatingIncome_c20200701__20210630_zJti3qAzLEU2"&gt;2,470,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of June 30, 2021, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which temporary
differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable income,
the regulatory environment of the industry, and tax planning strategies in making this assessment. At present, the Company believes that
it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
valuation allowance for deferred tax assets decreased during the year ended June 30, 2021, by approximately $&lt;span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20210630_pp0p0"&gt;3,547,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
The valuation allowance decreased by approximately $&lt;span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20200630_pp0p0"&gt;195,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;during
the year ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operation losses, temporary changes to prior and
future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security
taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and enhanced recoverability
of AMT tax credits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;At
the present time, the only impact of the CARES Act to the &lt;span id="xdx_901_ecustom--ReimbursementOfAlternativeMinimumTaxCreditsDescription_c20200701__20210630"&gt;Company
is allowing a full reimbursement of $1,342,370 of tax credits relating to the alternative minimum tax credits. The Company received the
first half payment in June 2020. The balance of alternative minimum tax credits of $671,185 was received in July 2020. Previously, these
credits were to be refunded over a 3 year period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
we continue to monitor tax implications of the CARES Act and other state and federal stimulus tax legislation, we may make adjustments
to our estimates and record additional amounts for tax assets and liabilities.&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
of the provision (benefit) for income taxes are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYT7CWqwymq" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt"&gt;&lt;span id="xdx_8B9_z4K8VtLimNF5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    Of The Benefit Provision For Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20200701__20210630_z4x9AAuSlfCd" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20190701__20200630_zk4oDg9F7dhl" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zVytMF3cwEcl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(187,255&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zzU5WvcCzqF3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,136,514&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;513,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzKST_maITEBzgpd_zMFOkPzHrjT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,136,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;325,949&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzjFJ_zXuyD9yVQX7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,718,046&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,953,349&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzjFJ_zGswvQaRXdfh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;136,960&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;165,480&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzjFJ_maITEBzgpd_zwUycu6NvH6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,855,006&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,118,829&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzgpd_zHbVbpnj7b8b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Provision
    (Benefit) for Income Taxes - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,991,520&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,444,778&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;A
reconciliation of the federal statutory income tax rate to the Company&#x2019;s effective tax rate as reported is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zVTM9VhrIY65" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z4to7WYmYz01" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
    Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20200701__20210630_zmI4FwNIjjWg" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20190701__20200630_zi05QEafvJz" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zESbB2xsLx14" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Taxes
    at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zzBlmvW5YL4b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    and local income taxes (benefit), net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zzg1GSyoBPN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non
    Controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zCry4Cxz3CK1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Expiration
    of tax credits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zbn8hWeq0LFb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Return
    to provision adjustments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zq3gQPwgrSM2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Change
    in the valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zh14IEcjuPL5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zsWYExNh9PD3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Effective
    income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
of June 30, 2021, the Company has net operating loss (&#x201c;NOL&#x201d;) carryforwards of approximately $35,574,000 that will be available
to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant
to Section 1502 of the Internal Revenue Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has, for federal income tax purposes, research and development tax credits and investments tax credits carryforwards aggregating
$&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_c20210630_pp0p0"&gt;3,733,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
However, the realization of these credits may be limited as a result of expiring prior to their utilization. These credits can only be
applied after all net operating losses have been used, which expire through 2031. As such, the Company has established a valuation reserve
for anticipated unused credits of $&lt;span id="xdx_909_eus-gaap--ValuationAllowancesAndReservesBalance_c20210630_pp0p0"&gt;890,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
addition, for New York State income tax purposes, the Company has tax credit carryforwards aggregating approximately $&lt;span id="xdx_908_eus-gaap--TaxCreditCarryforwardAmount_c20210630_pp0p0"&gt;11,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;which,
are accounted for under the flow-through method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company was also under audit with New York State for income tax and was assessed additional taxes of $&lt;span id="xdx_908_ecustom--AdditionalTaxes_c20200701__20210630_zeCqbPXooala"&gt;423,272
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;plus
interest and penalties. These amounts are accrued for at June 30, 2021 and included in other current liabilities and were paid in August
2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Significant
components of the Company&#x2019;s deferred tax assets and liabilities at June 30, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTJrnFRjjav6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zBhejEtOfbKg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    Of Company's Deferred Tax Assets And Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210630_zbRsvgODI2a9" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20200630_zaq807P4ffl2" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzcuf_zmvEX3bmoaA9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,827,382&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,946,801&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzcuf_zUaMTmMMobZg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-deductible
    accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;749,902&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;693,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzcuf_zE14Y8VOTrvc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    operating carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,285,163&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,720,637&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzcuf_zd0RTYzMxeMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tax
    credits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,732,650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,647,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzcuf_zGtEscVuBHm8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;66,316&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;69,940&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzcuf_zZJHJsOQKUB1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and equipment and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;187,632&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;168,371&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzcuf_maDTANzjWq_z5Cg3nyuUTac" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    Tax Assets - gross&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,849,045&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,246,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzjWq_zyfxNSxTwb52" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Valuation
    allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(890,084&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4,437,042&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzjWq_maDTALNzli5_ztJ0VLwWUDjh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,958,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,809,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzVX4_ztv7fFKyUCz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(238,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(234,106&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzVX4_msDTALNzli5_zD1fg6nC7Gy4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(238,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(234,106&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzli5_zTjFUCV8AYI7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,720,645&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,575,651&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15958961</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">35574000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">-7094000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherOperatingIncome
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2470000</us-gaap:OtherOperatingIncome>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3547000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">195000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <FONR:ReimbursementOfAlternativeMinimumTaxCreditsDescription contextRef="From2020-07-01to2021-06-30">Company
is allowing a full reimbursement of $1,342,370 of tax credits relating to the alternative minimum tax credits. The Company received the
first half payment in June 2020. The balance of alternative minimum tax credits of $671,185 was received in July 2020. Previously, these
credits were to be refunded over a 3 year period.</FONR:ReimbursementOfAlternativeMinimumTaxCreditsDescription>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYT7CWqwymq" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt"&gt;&lt;span id="xdx_8B9_z4K8VtLimNF5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    Of The Benefit Provision For Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20200701__20210630_z4x9AAuSlfCd" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20190701__20200630_zk4oDg9F7dhl" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zVytMF3cwEcl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(187,255&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zzU5WvcCzqF3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,136,514&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;513,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzKST_maITEBzgpd_zMFOkPzHrjT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,136,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;325,949&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzjFJ_zXuyD9yVQX7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,718,046&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,953,349&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzjFJ_zGswvQaRXdfh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;136,960&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;165,480&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzjFJ_maITEBzgpd_zwUycu6NvH6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,855,006&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,118,829&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzgpd_zHbVbpnj7b8b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Provision
    (Benefit) for Income Taxes - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,991,520&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,444,778&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-187255</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1136514</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">513204</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1136514</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">325949</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2718046</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1953349</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">136960</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">165480</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">2855006</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2118829</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">3991520</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2444778</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zVTM9VhrIY65" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z4to7WYmYz01" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
    Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_492_20200701__20210630_zmI4FwNIjjWg" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20190701__20200630_zi05QEafvJz" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zESbB2xsLx14" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Taxes
    at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zzBlmvW5YL4b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    and local income taxes (benefit), net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zzg1GSyoBPN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non
    Controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zCry4Cxz3CK1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Expiration
    of tax credits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zbn8hWeq0LFb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Return
    to provision adjustments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zq3gQPwgrSM2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Change
    in the valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(20.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zh14IEcjuPL5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zsWYExNh9PD3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Effective
    income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.033</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.049</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.061</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.061</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">-0.200</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.125</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.226</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.173</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3733000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">890000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">11000</us-gaap:TaxCreditCarryforwardAmount>
    <FONR:AdditionalTaxes
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">423272</FONR:AdditionalTaxes>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTJrnFRjjav6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zBhejEtOfbKg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    Of Company's Deferred Tax Assets And Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210630_zbRsvgODI2a9" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20200630_zaq807P4ffl2" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzcuf_zmvEX3bmoaA9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,827,382&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,946,801&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzcuf_zUaMTmMMobZg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-deductible
    accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;749,902&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;693,833&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzcuf_zE14Y8VOTrvc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    operating carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,285,163&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,720,637&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzcuf_zd0RTYzMxeMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tax
    credits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,732,650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,647,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzcuf_zGtEscVuBHm8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;66,316&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;69,940&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzcuf_zZJHJsOQKUB1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and equipment and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;187,632&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;168,371&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzcuf_maDTANzjWq_z5Cg3nyuUTac" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    Tax Assets - gross&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,849,045&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,246,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzjWq_zyfxNSxTwb52" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Valuation
    allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(890,084&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4,437,042&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzjWq_maDTALNzli5_ztJ0VLwWUDjh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,958,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,809,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzVX4_ztv7fFKyUCz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(238,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(234,106&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzVX4_msDTALNzli5_zD1fg6nC7Gy4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(238,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(234,106&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzli5_zTjFUCV8AYI7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,720,645&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,575,651&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3827382</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">3946801</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">749902</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">693833</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">8285163</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">13720637</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3732650</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4647217</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">66316</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">69940</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">187632</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">168371</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16849045</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">23246799</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">890084</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4437042</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15958961</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">18809757</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">234106</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">234106</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15720645</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">18575651</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z0nMoH7p0At4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82A_zdrj6p5ruTX6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
13 - OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Included
in other current liabilities are the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqXD9yhClk44" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B9_za7z03jDFjzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20210630_zg7zzsxnhNak" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20200630_zvqVfRqMuOMd" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOLCzdL8_zC97enrNuCle" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,406,982&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,491,941&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zqVlW8vYuwUc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Litigation
    accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;442,802&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOLCzdL8_zAyEEkYFc8zl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;644,623&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,353,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pp0p0_maOLCzdL8_zqd7NaqxgEy2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;774,234&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1448"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOLCzdL8_zT1rAwnUEQO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;37,827&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;112,867&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maOLCzdL8_zrKouvLUvxAh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,262&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;120,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--SelfInsuranceReserve_iI_pp0p0_maOLCzdL8_zV9TWuVLHdYc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;62,548&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;86,504&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0_maOLCzdL8_zxdCsbyQsbu2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;493,042&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;877,787&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zmuj7cg9j3a4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;715,600&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;699,997&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_mtOLCzdL8_zICACAUAwJe3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,162,118&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,185,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;













</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqXD9yhClk44" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B9_za7z03jDFjzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20210630_zg7zzsxnhNak" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20200630_zvqVfRqMuOMd" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOLCzdL8_zC97enrNuCle" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,406,982&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,491,941&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zqVlW8vYuwUc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Litigation
    accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;442,802&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOLCzdL8_zAyEEkYFc8zl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;644,623&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,353,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pp0p0_maOLCzdL8_zqd7NaqxgEy2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;774,234&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1448"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOLCzdL8_zT1rAwnUEQO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;37,827&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;112,867&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maOLCzdL8_zrKouvLUvxAh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,262&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;120,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--SelfInsuranceReserve_iI_pp0p0_maOLCzdL8_zV9TWuVLHdYc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;62,548&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;86,504&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0_maOLCzdL8_zxdCsbyQsbu2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;493,042&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;877,787&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zmuj7cg9j3a4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;715,600&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;699,997&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_mtOLCzdL8_zICACAUAwJe3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,162,118&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,185,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5406982</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4491941</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">900000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">442802</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">644623</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1353200</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">774234</us-gaap:TaxesPayableCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">37827</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">112867</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">127262</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">120000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">62548</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">86504</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">493042</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">877787</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">715600</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">699997</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9162118</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">8185098</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znFaJPRNRMRk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82F_z1cmcXPMVnBh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
14 - COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through
March 2030. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain
maintenance costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Rent
expense for operating leases approximated $&lt;span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20200701__20210630_pp0p0"&gt;6,146,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_900_eus-gaap--LeaseAndRentalExpense_c20190701__20200630_pp0p0"&gt;5,136,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
for the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company received approval from the Suffolk County IDA on February 29, 2016 of a &lt;span id="xdx_902_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20190101__20281231_z4Q5Ha62jtR9"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
property tax abatement, valued at $&lt;span id="xdx_900_ecustom--PropertyTaxAbatement_c20190101__20281231_pp0p0"&gt;440,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
over a 10 year period commencing January 2017.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Employee
Benefit Plans&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has a non-contributory 401(k) Plan (the &#x201c;401(k) Plan&#x201d;). The 401(k) Plan covers all non-union employees who are at
least 21 years of age with no minimum service requirements. There were $&lt;span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20200701__20210630_pp0p0"&gt;36,799
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20190701__20200630_pp0p0"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;employer
contributions to the Plan for the years ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_903_ecustom--EmployeeStockPurchasePlanEspp_c20200701__20210630__us-gaap--EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis__us-gaap--EmployeeStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) at the Company&#x2019;s annual stockholders&#x2019;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90E_ecustom--LitigationSettelementDescription_c20190701__20200630" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
September 2019, The Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course
of the arbitration proceedings. The Company is estimating the leasehold holdover charges to be approximately $900,000.&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
of June 30, 2021 this amount has been accrued for under other current liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_906_ecustom--LitigationSettelementDescription_c20200701__20210630" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900,000 was paid by the Company&#x2019;s insurance on September
15, 2020 with the remaining $315,000 paid by the Company on September 28, 2020.&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;The
Company is subject to other legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims besides the claim above. In the opinion of management, and with consultation with legal council,
the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial
position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has satisfied most of its delinquencies in filing sales tax returns for certain states, for which the Company has transacted
business. The Company has recorded tax obligations of approximately $&lt;span id="xdx_909_eus-gaap--SalesAndExciseTaxPayableCurrentAndNoncurrent_c20210630_pp0p0"&gt;645,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;plus
interest and penalties of approximately $&lt;span id="xdx_904_ecustom--RecordedSalesTaxObligationsInterestAndPenalties_c20210630_pp0p0"&gt;232,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;until
the remaining states have been resolved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_904_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_c20200701__20210630_pp0p0"&gt;110,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;per person
and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2021
and 2020, the Company had approximately $&lt;span id="xdx_904_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20210630_pp0p0"&gt;63,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_905_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20200630_pp0p0"&gt;87,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d;
in the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the years covered by this report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseAndRentalExpense
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">6146000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">5136000</us-gaap:LeaseAndRentalExpense>
    <FONR:PropertyTaxAbatementFromSuffolkCountyIda
      contextRef="From2019-01-012028-12-31"
      decimals="INF"
      unitRef="Pure">0.50</FONR:PropertyTaxAbatementFromSuffolkCountyIda>
    <FONR:PropertyTaxAbatement
      contextRef="From2019-01-012028-12-31"
      decimals="0"
      unitRef="USD">440000</FONR:PropertyTaxAbatement>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">36799</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <FONR:EmployeeStockPurchasePlanEspp contextRef="From2020-07-012021-06-30_us-gaap_EmployeeStockMember">The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) at the Company&#x2019;s annual stockholders&#x2019;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2021.</FONR:EmployeeStockPurchasePlanEspp>
    <FONR:LitigationSettelementDescription contextRef="From2019-07-012020-06-30">In
September 2019, The Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course
of the arbitration proceedings. The Company is estimating the leasehold holdover charges to be approximately $900,000.</FONR:LitigationSettelementDescription>
    <FONR:LitigationSettelementDescription contextRef="From2020-07-01to2021-06-30">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900,000 was paid by the Company&#x2019;s insurance on September
15, 2020 with the remaining $315,000 paid by the Company on September 28, 2020.</FONR:LitigationSettelementDescription>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">645000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <FONR:RecordedSalesTaxObligationsInterestAndPenalties contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">232000</FONR:RecordedSalesTaxObligationsInterestAndPenalties>
    <FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">63000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">87000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_808_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zW2tpuhqvagf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_821_z2WP7FkPc2mb" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
15 - SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the years ended June 30, 2021 and 2020 the Company paid $&lt;span id="xdx_906_eus-gaap--InterestPaid_c20200701__20210630_pp0p0"&gt;75,178&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90C_eus-gaap--InterestPaid_c20190701__20200630_pp0p0"&gt;137,200
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for interest,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the years ended June 30, 2021 and 2020 the Company paid $&lt;span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20200701__20210630_pp0p0"&gt;261,032
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_908_eus-gaap--IncomeTaxesPaid_c20190701__20200630_pp0p0"&gt;228,204
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for income
taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the years ended June 30, 2021 and 2020, the Company issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20200701__20210630_pdd"&gt;102,364
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20190701__20200630_pdd"&gt;89,981
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
of common stock for costs and expenses totaling $&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_pp0p0_c20200701__20210630_z7eRX6BZBc79"&gt;1,940,821
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20190701__20200630_pp0p0"&gt;1,990,380&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the year ended June 30, 2020 the Company entered into a capital lease for the purchase of equipment in the amount of $&lt;span id="xdx_904_eus-gaap--AmortizationOfLeasedAsset_c20200701__20210630_pp0p0"&gt;1,350,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the year, the Company resolved certain sales tax liabilities and was able to reverse accrued interest and penalties in the amount of
$&lt;span id="xdx_90C_ecustom--SellingGeneralAndAdministrativeExpenses_c20200701__20210630_zo2n4RLqGU9a"&gt;602,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;which
has been recorded under selling, general and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaid
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">75178</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">137200</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">261032</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">228204</us-gaap:IncomeTaxesPaid>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Shares">102364</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">89981</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1940821</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1990380</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AmortizationOfLeasedAsset
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">1350000</us-gaap:AmortizationOfLeasedAsset>
    <FONR:SellingGeneralAndAdministrativeExpenses
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">602000</FONR:SellingGeneralAndAdministrativeExpenses>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z6udcfPaMmY7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82E_zWZVmygsJMu7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
16 &#x2013; RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_909_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20200701__20210630__dei--LegalEntityAxis__custom--ABillingCompanyMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#x2019; Compensation claims of the Company&#x2019;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2021 for another year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20200701__20210630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2020-07-012021-06-30_custom_ABillingCompanyMember">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#x2019; Compensation claims of the Company&#x2019;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2021 for another year.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2020-07-012021-06-30_custom_BensonhurstMRILimitedPartnershipMember">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zP1Wk4JaEhD" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_823_zZU24sYETvXj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
17 - SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company provides segment data in accordance with the provisions of ASC topic 280, &#x201c;Disclosures about Segments of an Enterprise
and Related Information&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment
sales are market-based. The Company evaluates performance based on income or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summarized
financial information concerning the Company&#x2019;s reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zp3TRcW9zs84" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span id="xdx_8B1_zBC1GDej9gwl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summarized
    Segment Financial Information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Manufacturing
    and Servicing of Medical&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    of Diagnostic Imaging&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fiscal
    2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Center&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,037,091&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;80,892,674&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;89,929,765&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjWEe6ibgvM6" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;901,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zd6UUM6bPeE3" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1538"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____z1HeNFaEFOV3" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;901,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(3,410,189&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,507,804&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,097,615&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;264,830&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,816,857&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,081,687&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Compensatory
    element of stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;83,277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1556"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;83,277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24,592,582&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;164,913,613&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_c20210630_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;189,506,195&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;291,294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,405,502&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,696,796&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0 0 0 0pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&#160;Fiscal
    2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,463,103&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;77,227,359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20190701__20200630_pp0p0" style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;85,690,462&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span id="xdx_F4A_z2f1lgHdBOa5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____z1UtNFLi7ex4" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____z5k3P2XQRg2j" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1580"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630_fKg_____zvAtxyGLfSS1" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(6,425,411&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,076,327&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,650,916&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;368,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,540,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,908,648&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Compensatory
    element of stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1598"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20190701__20200630_zYrjZsbmjWf4" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,492,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;149,790,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20200630_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;180,283,510&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,440,640&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,981,773&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,422,413&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F05_zEREwuyQ0VD7" style="text-align: justify; padding-left: 11pt; text-indent: -11pt; width: 3pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F12_z53lLUQTqWb6" style="text-align: justify; padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
  eliminated in consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A2_z1sj9fDSkh29" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Export
Product Sales&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting
to &lt;span id="xdx_90E_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20200701__20210630_zcPiCn948zbd"&gt;69.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_904_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20190701__20200630_zy6Yr2rzfF6c"&gt;20.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of product sales revenues to third parties for the years ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ExportProductSales_z4Z2dMGvGDZ1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_z92wpdhnlKK3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Export
    Product Sales&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Dominican
    Republic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_zCNqWwICHib1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;67.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--DO_zbuHrPBs4Bic" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zXTLPwTWl7Eb" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zDfEYGapqgx9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zaUTjm7YMkhi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignProductSales_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_zkdxuozLYLOe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zJ4twkroHeV2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zaToq3FDmsff" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignProductSales_dp_c20200701__20210630_zXC9OYVV9YVd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;69.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignProductSales_dp_c20190701__20200630_zroALeKRx2ek" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Foreign
Service and Repair Fees&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair
of medical equipment amounting to &lt;span id="xdx_906_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20200701__20210630_zGsZoBcrc6kk"&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_900_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20190701__20200630_zv0zD1guyZ24"&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of consolidated net service and repair fees for the years ended June 30, 2021 and 2020 respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ExportServiceRevenues_z7IxUfVXDBAa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BD_zHJlKwDqPLCa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Foreign
    Service and Repair Fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zAOjZpSvEHFf" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zXZVn5akPBPk" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zwxPmRN7ETI2" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CH_zG2ngUskvLg" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zyYiiTRHkSB1" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_z70xhn2aRoXh" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;England&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_zdtuo3HGYI52" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GB_zyjcZPie06rd" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_z8F1YCdf3bs2" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zesJtEZtoB0h" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Greece&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zXuegxBIhZo" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GR_zTn5sOnOxVk3" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp0_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zLI9bng1yptl" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_z6BT6oIJTjTc" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zMNMHCtJnQXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630_zOdmbw7kYBZ2" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;The
Company does not have any material assets outside of the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zp3TRcW9zs84" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span id="xdx_8B1_zBC1GDej9gwl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summarized
    Segment Financial Information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Manufacturing
    and Servicing of Medical&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    of Diagnostic Imaging&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fiscal
    2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Center&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; width: 46%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,037,091&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;80,892,674&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;89,929,765&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjWEe6ibgvM6" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;901,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zd6UUM6bPeE3" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1538"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____z1HeNFaEFOV3" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;901,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(3,410,189&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,507,804&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,097,615&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;264,830&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,816,857&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,081,687&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Compensatory
    element of stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;83,277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1556"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;83,277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24,592,582&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;164,913,613&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_c20210630_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;189,506,195&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;291,294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,405,502&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,696,796&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0 0 0 0pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&#160;Fiscal
    2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,463,103&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;77,227,359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20190701__20200630_pp0p0" style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;85,690,462&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span id="xdx_F4A_z2f1lgHdBOa5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____z1UtNFLi7ex4" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____z5k3P2XQRg2j" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1580"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630_fKg_____zvAtxyGLfSS1" style="text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(6,425,411&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,076,327&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630_pp0p0" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,650,916&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;368,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,540,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630_pp0p0" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,908,648&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Compensatory
    element of stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1598"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20190701__20200630_zYrjZsbmjWf4" style="text-align: right" title="Compensatory element of stock issuances"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,492,757&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;149,790,753&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_c20200630_pp0p0" style="text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;180,283,510&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 20pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,440,640&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,981,773&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630_pp0p0" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,422,413&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F05_zEREwuyQ0VD7" style="text-align: justify; padding-left: 11pt; text-indent: -11pt; width: 3pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F12_z53lLUQTqWb6" style="text-align: justify; padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
  eliminated in consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">9037091</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">80892674</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">89929765</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      id="Fact001536"
      unitRef="USD">901250</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      id="Fact001540"
      unitRef="USD">901250</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">-3410189</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">20507804</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">17097615</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">264830</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">3816857</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">4081687</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">83277</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">83277</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:AssetsNet
      contextRef="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">24592582</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">164913613</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">189506195</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">291294</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">3405502</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-07-01to2021-06-30"
      decimals="0"
      unitRef="USD">3696796</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">8463103</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">77227359</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">85690462</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      id="Fact001578"
      unitRef="USD">875000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      id="Fact001582"
      unitRef="USD">875000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">-6425411</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">20076327</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">13650916</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">368498</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">3540150</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">3908648</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:AssetsNet
      contextRef="AsOf2020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">30492757</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">149790753</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">180283510</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-07-012020-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">2440640</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-07-012020-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4981773</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">7422413</us-gaap:PaymentsToAcquireProductiveAssets>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.693</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.202</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportProductSales contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ExportProductSales_z4Z2dMGvGDZ1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_z92wpdhnlKK3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Export
    Product Sales&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Dominican
    Republic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_zCNqWwICHib1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;67.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--DO_zbuHrPBs4Bic" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zXTLPwTWl7Eb" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zDfEYGapqgx9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zaUTjm7YMkhi" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignProductSales_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_zkdxuozLYLOe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zJ4twkroHeV2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zaToq3FDmsff" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignProductSales_dp_c20200701__20210630_zXC9OYVV9YVd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;69.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignProductSales_dp_c20190701__20200630_zroALeKRx2ek" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:ExportProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0.670</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2019-07-012020-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2019-07-012020-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.021</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2019-07-012020-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.202</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2019-07-012020-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.693</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.202</FONR:ForeignProductSales>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.045</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.056</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ExportServiceRevenues contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ExportServiceRevenues_z7IxUfVXDBAa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BD_zHJlKwDqPLCa" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Foreign
    Service and Repair Fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zAOjZpSvEHFf" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zXZVn5akPBPk" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zwxPmRN7ETI2" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CH_zG2ngUskvLg" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zyYiiTRHkSB1" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_z70xhn2aRoXh" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;England&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_zdtuo3HGYI52" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GB_zyjcZPie06rd" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_z8F1YCdf3bs2" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zesJtEZtoB0h" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Greece&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zXuegxBIhZo" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GR_zTn5sOnOxVk3" style="text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp0_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zLI9bng1yptl" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_z6BT6oIJTjTc" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zMNMHCtJnQXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630_zOdmbw7kYBZ2" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:ExportServiceRevenues>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.016</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_CH"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_CH"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_GB"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_GB"
      decimals="INF"
      unitRef="Pure">0.007</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_GR"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_GR"
      decimals="INF"
      unitRef="Pure">0.002</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0.010</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-01to2021-06-30"
      decimals="INF"
      unitRef="Pure">0.045</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">0.056</FONR:ForeignServiceAndRepairFees>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_80C_eus-gaap--BusinessCombinationDisclosureTextBlock_zj6eFgN8plob" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_827_zOehxc7sPdz4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
18 &#x2013; ACQUISTION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
March 29, 2021, the Company completed the acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company
used an incremental borrowing rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We
made a preliminary fair value determination of the acquired assets and assumed liabilities as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zXdJuyVSagVa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z6jPGMAKvh29" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
    value assets and assumed liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210329_zxfeHguUkri1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_zeqWo4kPhdwc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_zpPw0naz6u21" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right
    to use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;434,219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zyLV05W04Kce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--SecurityDeposit_iI_zrF1ibx6TGm1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Security
    Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;38,628&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_zSdLGpf7aCa9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right
    to use liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(434,219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--Goodwill_iI_zVEbHrQrgOi4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;283,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_zSvJXDE1DCPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,122,508&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC 805-10-25-1, Business Combinations &#x2013; Overall Recognition, the Company recorded the transaction as a business
combination. ASC 805-10-25-1 provides the requirements of recording the transaction by applying the acquisition method. The acquisition
method requires the Company to determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must
be determined if there is a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and you
must be able to recognized and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded
as a business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
net assets acquired and consideration is as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zPivPWwGYqbd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_zpnI1WtS9nI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210329_zCUgbAtbWGye" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    Improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_zzyOOWKnUiX2" style="width: 18%; text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;550,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_zrxAuUiyOWNg" style="text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    Lists&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zQ5RWzklSZge" style="text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Covenant
    Not to Compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_zIotqYfuDrnf" style="text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--SecurityDeposit_iI_zKk4Ycko5JMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Security
    Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;38,628&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--ClosingCostsExpensed_iI_zFJHgEbtC2ze" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Closing
    costs - expensed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,478&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--GoodwillGross_iI_zOzfAQbOY2Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;283,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--BusinessCombinationContingentConsiderationAsset1_iI_zbSEWojYvxyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
    Consideration Paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,125,986&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
results of operations of Rockland Management Group were diminutive and did not affect the pro forma results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zXdJuyVSagVa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_z6jPGMAKvh29" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
    value assets and assumed liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210329_zxfeHguUkri1" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_zeqWo4kPhdwc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_zpPw0naz6u21" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right
    to use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;434,219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zyLV05W04Kce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--SecurityDeposit_iI_zrF1ibx6TGm1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Security
    Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;38,628&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_zSdLGpf7aCa9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right
    to use liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(434,219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--Goodwill_iI_zVEbHrQrgOi4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;283,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_zSvJXDE1DCPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,122,508&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">650000</us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1>
    <FONR:PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">434219</FONR:PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">150000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:SecurityDeposit contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">38628</us-gaap:SecurityDeposit>
    <FONR:PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">-434219</FONR:PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1>
    <us-gaap:Goodwill contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">283880</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">1122508</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zPivPWwGYqbd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B7_zpnI1WtS9nI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210329_zCUgbAtbWGye" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    Improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_zzyOOWKnUiX2" style="width: 18%; text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;550,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_zrxAuUiyOWNg" style="text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    Lists&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zQ5RWzklSZge" style="text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Covenant
    Not to Compete&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_zIotqYfuDrnf" style="text-align: right" title="Intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--SecurityDeposit_iI_zKk4Ycko5JMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Security
    Deposit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;38,628&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--ClosingCostsExpensed_iI_zFJHgEbtC2ze" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Closing
    costs - expensed&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,478&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--GoodwillGross_iI_zOzfAQbOY2Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;283,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--BusinessCombinationContingentConsiderationAsset1_iI_zbSEWojYvxyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
    Consideration Paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,125,986&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:SecurityDeposit contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">38628</us-gaap:SecurityDeposit>
    <FONR:ClosingCostsExpensed contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">3478</FONR:ClosingCostsExpensed>
    <us-gaap:GoodwillGross contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">283880</us-gaap:GoodwillGross>
    <FONR:BusinessCombinationContingentConsiderationAsset1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">1125986</FONR:BusinessCombinationContingentConsiderationAsset1>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_80E_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zykeErPpT7Fl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82F_zCEHf9CxCB8j" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
19 &#x2013; ALLOWANCE FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following represents a summary of allowance for doubtful accounts for the years ended June 30, 2021 and 2020 respectively:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zerqICWYroB5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B9_zKV0Z4emBGC3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summary
    of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span id="xdx_F21_zT3MX0oVtua7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions
    (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zuGPhkmgJbrk" style="width: 10%; text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;514,561&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zAPq7TNWLFLk" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1721"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z1D6nWiS4d5h" style="width: 10%; text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;442,270&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEd0CAFZHqri" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,063,233&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zomO96pjBJGc" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,723,645&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBmFysJHP051" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,786,878&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zl351PL54CRf" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,322,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zW8wR0i7BDs8" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;862,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1739"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkaBXZwiYgH4" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,184,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zbbCCTfQrp3h" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zDuFC1AZDBq1" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1745"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1747"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zVVu0iBWB774" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zemU3sZSx1fj" style="width: 10%; text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;190,244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;380,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,683&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7sZGNZZ8Qne" style="width: 10%; text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;514,561&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zqOGS2IkEvQ8" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,404,944&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,526,742&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1,868,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zrnCJZhe17A6" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,063,233&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhEJUeMEVxKe" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,310,731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,011,324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1778"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkNJFjRIeU16" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,322,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zTY47H0LBznf" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1786"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zcUXU7sz30Vc" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F08_zfCQTmMiYeVd" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F15_zbz2USYUnRJ1" style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Included
  in provision for bad debts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zP04amakyl7g" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zerqICWYroB5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B9_zKV0Z4emBGC3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summary
    of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span id="xdx_F21_zT3MX0oVtua7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions
    (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zuGPhkmgJbrk" style="width: 10%; text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;514,561&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zAPq7TNWLFLk" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1721"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z1D6nWiS4d5h" style="width: 10%; text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;442,270&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEd0CAFZHqri" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,063,233&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zomO96pjBJGc" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,723,645&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBmFysJHP051" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,786,878&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zl351PL54CRf" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,322,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zW8wR0i7BDs8" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;862,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1739"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkaBXZwiYgH4" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,184,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zbbCCTfQrp3h" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zDuFC1AZDBq1" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1745"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1747"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zVVu0iBWB774" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zemU3sZSx1fj" style="width: 10%; text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;190,244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;380,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,683&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7sZGNZZ8Qne" style="width: 10%; text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;514,561&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zqOGS2IkEvQ8" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,404,944&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,526,742&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1,868,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zrnCJZhe17A6" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,063,233&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhEJUeMEVxKe" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,310,731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,011,324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1778"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkNJFjRIeU16" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,322,055&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zTY47H0LBznf" style="text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1786"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zcUXU7sz30Vc" style="text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F08_zfCQTmMiYeVd" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F15_zbz2USYUnRJ1" style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Included
  in provision for bad debts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">514561</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">72291</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">442270</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">11063233</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001729"
      unitRef="USD">4723645</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">15786878</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">3322055</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001737"
      unitRef="USD">862344</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4184399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2019-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">190244</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2019-07-012020-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">380000</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2019-07-012020-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">55683</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">514561</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">9404944</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">3526742</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">-1868453</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">11063233</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2019-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">2310731</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2019-07-012020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">1011324</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">3322055</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2019-07-012020-06-30_custom_MedicalReceivablesMember"
      decimals="0"
      unitRef="USD">777354</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_MedicalReceivablesMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_805_eus-gaap--QuarterlyFinancialInformationTextBlock_zip9jYPUHDVj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_82B_zXfWr7YNTiS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
20 - QUARTERLY FINANCIAL DATA (UNAUDITED)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(000&#x2019;s
omitted, except per share data)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_z33KCVI9QJEe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B4_zEkfJ54PT243" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Quarterly
    Financial Data&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zzeuI3PaBu9e" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zwmkSlA3CFsc" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zx6GVjWqt04l" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zdLGta2Dn3e6" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zVYpdzISdTB3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;December
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;March
    31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Revenues &#x2013; Net&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,979&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,164&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,090&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24,697&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;89,930&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,829&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,182&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,853&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72,832&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,251&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,299&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20190701__20190930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJgiPxxxFyxf" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20191001__20191231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvVGE27sjcIg" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20200101__20200331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvei2r7PuAq3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z1CXj7B8qNJ8" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20190701__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zbyL9jYtrAd9" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;December
    30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;March
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--Revenues_zIDIPJoGbZL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Revenues &#x2013; Net&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,747&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,451&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,686&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,806&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;85,690&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--CostsAndExpenses_zypLUvICwEp7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,261&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,430&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;19,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72,040&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ProfitLoss_znl4OZJzXxoj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,506&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,076&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EarningsPerShareBasic_zkN8CsWhxjxf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_zue1lAGxHVY4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_zUlIdy6oidwh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;













</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2020-07-01to2021-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_z33KCVI9QJEe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B4_zEkfJ54PT243" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Quarterly
    Financial Data&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zzeuI3PaBu9e" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zwmkSlA3CFsc" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zx6GVjWqt04l" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zdLGta2Dn3e6" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zVYpdzISdTB3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;December
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;March
    31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Revenues &#x2013; Net&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,979&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,164&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,090&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24,697&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;89,930&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,829&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,182&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,853&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72,832&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,251&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,299&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,196&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20190701__20190930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJgiPxxxFyxf" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20191001__20191231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvVGE27sjcIg" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20200101__20200331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvei2r7PuAq3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z1CXj7B8qNJ8" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20190701__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zbyL9jYtrAd9" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;December
    30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;March
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--Revenues_zIDIPJoGbZL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Revenues &#x2013; Net&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,747&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,451&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,686&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,806&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;85,690&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--CostsAndExpenses_zypLUvICwEp7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,261&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,430&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;19,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72,040&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--ProfitLoss_znl4OZJzXxoj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,506&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,076&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--EarningsPerShareBasic_zkN8CsWhxjxf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_zue1lAGxHVY4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    Net Income Per Common Share Available to Common Stockholders&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20979</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">21164</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">23090</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">24697</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">89930</us-gaap:Revenues>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">16829</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">16182</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">18968</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20853</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">72832</us-gaap:CostsAndExpenses>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">3251</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">3928</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">4299</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">2196</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">13674</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues
      contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">21747</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">21451</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">21686</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20806</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">85690</us-gaap:Revenues>
    <us-gaap:CostsAndExpenses
      contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">16261</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">16430</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">19071</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20278</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">72040</us-gaap:CostsAndExpenses>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">4506</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">4209</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">1914</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">1076</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">11705</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012019-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-10-012019-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-04-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012020-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-07-01to2021-06-30">&lt;p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zE2iSUI0bktc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_823_zy0vTOzkcnwe" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
21 &#x2013; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
August 2021 the Company amended their revolving credit agreement. The agreement was extended to August 2022.&#160;The interest rate on
borrowings remains at &lt;span id="xdx_908_eus-gaap--DebtorInPossessionFinancingFeeOnUnusedBorrowings_iI_dp_c20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQg4F74UgQw3"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
along with certain financial covenants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
loan of $&lt;span id="xdx_904_eus-gaap--ProceedsFromLoans_c20210801__20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSza1KTzoT81"&gt;700,764
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;received
under the Paycheck Protection Program was forgiven in August 2021.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings
      contextRef="AsOf2021-08-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.04</us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings>
    <us-gaap:ProceedsFromLoans
      contextRef="From2021-08-012021-08-31_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">700764</us-gaap:ProceedsFromLoans>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001046"
          xlink:label="Fact001046"
          xlink:type="locator"/>
        <link:footnote id="Footnote001051" xlink:label="Footnote001051" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  for the year ended June 30, 2020 include the transition adjustment for the adoption of topic 842 of $31,651,110.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001046"
          xlink:to="Footnote001051"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001047"
          xlink:label="Fact001047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001047"
          xlink:to="Footnote001051"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001536"
          xlink:label="Fact001536"
          xlink:type="locator"/>
        <link:footnote id="Footnote001613" xlink:label="Footnote001613" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001536"
          xlink:to="Footnote001613"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1538"
          xlink:label="xdx2ixbrl1538"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1538"
          xlink:to="Footnote001613"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001540"
          xlink:label="Fact001540"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001540"
          xlink:to="Footnote001613"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001578"
          xlink:label="Fact001578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001578"
          xlink:to="Footnote001613"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1580"
          xlink:label="xdx2ixbrl1580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1580"
          xlink:to="Footnote001613"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001582"
          xlink:label="Fact001582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001582"
          xlink:to="Footnote001613"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1721"
          xlink:label="xdx2ixbrl1721"
          xlink:type="locator"/>
        <link:footnote id="Footnote001789" xlink:label="Footnote001789" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
  in provision for bad debts.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1721"
          xlink:to="Footnote001789"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001729"
          xlink:label="Fact001729"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001729"
          xlink:to="Footnote001789"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001737"
          xlink:label="Fact001737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001737"
          xlink:to="Footnote001789"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1745"
          xlink:label="xdx2ixbrl1745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1745"
          xlink:to="Footnote001789"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169596098152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 15, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594659512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 44,460,411<span></span>
</td>
<td class="nump">$ 36,802,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investments</a></td>
<td class="nump">32,177<span></span>
</td>
<td class="nump">31,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable &#8211; net of allowances for doubtful accounts of $442,270 and $514,561 at June 30, 2021 and 2020, respectively</a></td>
<td class="nump">4,525,435<span></span>
</td>
<td class="nump">4,312,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">Accounts receivable &#8211; related party</a></td>
<td class="nump">11,977<span></span>
</td>
<td class="nump">5,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables - net</a></td>
<td class="nump">17,900,489<span></span>
</td>
<td class="nump">16,171,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $15,786,878 and $11,063,233 at June 30, 2021 and 2020, respectively</a></td>
<td class="nump">30,947,863<span></span>
</td>
<td class="nump">27,437,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $4,184,399 and $3,322,055 at June 30, 2021 and 2020, respectively</a></td>
<td class="nump">7,814,250<span></span>
</td>
<td class="nump">6,896,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Contract assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">152,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">1,663,419<span></span>
</td>
<td class="nump">1,648,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income tax receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">671,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,227,463<span></span>
</td>
<td class="nump">1,757,499<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">108,583,484<span></span>
</td>
<td class="nump">95,889,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">2,879,946<span></span>
</td>
<td class="nump">2,730,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">15,958,961<span></span>
</td>
<td class="nump">18,809,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment &#8211; net</a></td>
<td class="nump">21,850,139<span></span>
</td>
<td class="nump">21,364,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; operating leases</a></td>
<td class="nump">30,133,285<span></span>
</td>
<td class="nump">31,392,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; financing lease</a></td>
<td class="nump">1,126,990<span></span>
</td>
<td class="nump">1,325,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269,277<span></span>
</td>
<td class="nump">3,985,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">4,037,599<span></span>
</td>
<td class="nump">4,109,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">666,514<span></span>
</td>
<td class="nump">653,132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">189,506,195<span></span>
</td>
<td class="nump">180,259,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and capital leases</a></td>
<td class="nump">173,206<span></span>
</td>
<td class="nump">108,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,866,035<span></span>
</td>
<td class="nump">1,965,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">9,162,118<span></span>
</td>
<td class="nump">8,185,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability &#8211; current portion</a></td>
<td class="nump">3,533,656<span></span>
</td>
<td class="nump">3,370,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability &#8211; current portion</a></td>
<td class="nump">202,741<span></span>
</td>
<td class="nump">74,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">4,365,825<span></span>
</td>
<td class="nump">4,105,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">731,101<span></span>
</td>
<td class="nump">854,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">14,739<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">20,049,421<span></span>
</td>
<td class="nump">18,663,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">2,800,522<span></span>
</td>
<td class="nump">2,655,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">238,316<span></span>
</td>
<td class="nump">234,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent', window );">Due to related party medical practices</a></td>
<td class="nump">92,663<span></span>
</td>
<td class="nump">92,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">28,975,132<span></span>
</td>
<td class="nump">30,104,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">1,048,431<span></span>
</td>
<td class="nump">1,251,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">760,254<span></span>
</td>
<td class="nump">865,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">171,331<span></span>
</td>
<td class="nump">150,311<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">34,086,649<span></span>
</td>
<td class="nump">35,353,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">54,136,070<span></span>
</td>
<td class="nump">54,017,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">185,100,976<span></span>
</td>
<td class="nump">183,076,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(46,007,663)<span></span>
</td>
<td class="num">(56,215,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 11,643 shares of common stock at June 30, 2021 and 2020</a></td>
<td class="num">(675,390)<span></span>
</td>
<td class="num">(675,390)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">138,418,649<span></span>
</td>
<td class="nump">126,186,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(3,048,524)<span></span>
</td>
<td class="nump">55,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">135,370,125<span></span>
</td>
<td class="nump">126,242,216<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">189,506,195<span></span>
</td>
<td class="nump">180,259,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related MRI scanner customers; net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169595820888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,565,853<span></span>
</td>
<td class="nump">6,459,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,554,210<span></span>
</td>
<td class="nump">6,447,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593126536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 23,307,389<span></span>
</td>
<td class="nump">$ 22,495,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">1,288,483<span></span>
</td>
<td class="nump">297,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">7,638,608<span></span>
</td>
<td class="nump">8,055,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees &#8211; related parties &#8211; net</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">46,609,449<span></span>
</td>
<td class="nump">44,565,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees &#8211; related party medical practices &#8211; net</a></td>
<td class="nump">10,975,836<span></span>
</td>
<td class="nump">10,166,694<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">89,929,765<span></span>
</td>
<td class="nump">85,690,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">1,032,676<span></span>
</td>
<td class="nump">745,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">2,740,625<span></span>
</td>
<td class="nump">2,731,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees &#8211; related parties</a></td>
<td class="nump">39,466<span></span>
</td>
<td class="nump">37,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">10,917,635<span></span>
</td>
<td class="nump">10,880,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">25,384,557<span></span>
</td>
<td class="nump">22,951,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related party medical practices</a></td>
<td class="nump">6,341,168<span></span>
</td>
<td class="nump">5,951,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,635,979<span></span>
</td>
<td class="nump">2,025,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative, inclusive of compensatory element of stock issuances of $83,277 and $0 for the years ended June 30, 2021 and 2020 respectively</a></td>
<td class="nump">24,740,044<span></span>
</td>
<td class="nump">26,717,345<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">72,832,150<span></span>
</td>
<td class="nump">72,039,546<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income from Operations</a></td>
<td class="nump">17,097,615<span></span>
</td>
<td class="nump">13,650,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(248,665)<span></span>
</td>
<td class="num">(74,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">311,931<span></span>
</td>
<td class="nump">502,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">504,450<span></span>
</td>
<td class="nump">70,771<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes and noncontrolling interests</a></td>
<td class="nump">17,665,331<span></span>
</td>
<td class="nump">14,149,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(3,991,520)<span></span>
</td>
<td class="num">(2,444,778)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">13,673,811<span></span>
</td>
<td class="nump">11,704,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Noncontrolling Interests</a></td>
<td class="num">(3,466,223)<span></span>
</td>
<td class="num">(3,464,528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 10,207,588<span></span>
</td>
<td class="nump">$ 8,240,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,505,283<span></span>
</td>
<td class="nump">6,443,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 9,592,134<span></span>
</td>
<td class="nump">$ 7,735,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Share</a></td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Share</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,505,283<span></span>
</td>
<td class="nump">6,443,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,632,787<span></span>
</td>
<td class="nump">6,571,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 458,710<span></span>
</td>
<td class="nump">$ 376,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 156,744<span></span>
</td>
<td class="nump">$ 128,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Share</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Share</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted Average Basic and Diluted Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs related To Management and other fees - Related medical practices</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169595703208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Stock Issued During Period, Value, Employee Benefit Plan</a></td>
<td class="nump">$ 83,277<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589660472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Class A Non Voting Preferred [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Class C Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2019</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 638<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 181,086,517<span></span>
</td>
<td class="num">$ (64,455,456)<span></span>
</td>
<td class="num">$ (675,390)<span></span>
</td>
<td class="nump">$ 2,155,725<span></span>
</td>
<td class="nump">$ 118,112,103<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance, Shares at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,357,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,240,205<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,464,528<span></span>
</td>
<td class="nump">11,704,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue', window );">Stock issued to employees under stock bonus plans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,990,371<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,990,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued to employees under stock bonus plans, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PaymentsOnNotesReceivableFromEmployeeStockholders', window );">Payments on notes receivable from employee stockholders</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,565,000)<span></span>
</td>
<td class="num">(5,565,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2020</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">183,076,888<span></span>
</td>
<td class="num">(56,215,251)<span></span>
</td>
<td class="num">(675,390)<span></span>
</td>
<td class="nump">55,253<span></span>
</td>
<td class="nump">126,242,216<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,447,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,207,588<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,466,223<span></span>
</td>
<td class="nump">13,673,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue', window );">Stock issued to employees under stock bonus plans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,024,088<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,024,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued to employees under stock bonus plans, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,570,000)<span></span>
</td>
<td class="num">(6,570,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 185,100,976<span></span>
</td>
<td class="num">$ (46,007,663)<span></span>
</td>
<td class="num">$ (675,390)<span></span>
</td>
<td class="num">$ (3,048,524)<span></span>
</td>
<td class="nump">$ 135,370,125<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PaymentsOnNotesReceivableFromEmployeeStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments On Notes Receivable From Employee Stockholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PaymentsOnNotesReceivableFromEmployeeStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockIssuedToEmployeesUnderStockBonusPlansValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594990984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 13,673,811<span></span>
</td>
<td class="nump">$ 11,704,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,081,687<span></span>
</td>
<td class="nump">3,908,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="nump">5,585,989<span></span>
</td>
<td class="nump">5,695,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax - net</a></td>
<td class="nump">2,855,006<span></span>
</td>
<td class="nump">2,118,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxCreditsAndAdjustments', window );">Income tax receivable</a></td>
<td class="nump">671,185<span></span>
</td>
<td class="nump">528,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">1,458,053<span></span>
</td>
<td class="nump">1,005,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CompensatoryElementOfStockIssuances', window );">Compensatory element of stock issuances</a></td>
<td class="nump">83,277<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock issued for costs and expenses</a></td>
<td class="nump">1,940,821<span></span>
</td>
<td class="nump">1,990,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent', window );">Abandoned patents</a></td>
<td class="nump">534<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivables</a></td>
<td class="num">(12,110,859)<span></span>
</td>
<td class="num">(10,797,456)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">46,944<span></span>
</td>
<td class="nump">28,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities', window );">Contract assets</a></td>
<td class="nump">152,833<span></span>
</td>
<td class="nump">372,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(14,649)<span></span>
</td>
<td class="nump">149,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">526,425<span></span>
</td>
<td class="num">(133,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(18,087)<span></span>
</td>
<td class="num">(161,350)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(99,224)<span></span>
</td>
<td class="nump">104,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">1,382,497<span></span>
</td>
<td class="nump">3,556,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer advances</a></td>
<td class="num">(123,478)<span></span>
</td>
<td class="nump">55,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(965,825)<span></span>
</td>
<td class="nump">159,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(74,698)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncreaseDecreaseInContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">14,739<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other liabilities</a></td>
<td class="nump">21,020<span></span>
</td>
<td class="nump">115,855<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">19,088,001<span></span>
</td>
<td class="nump">20,402,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,533,091)<span></span>
</td>
<td class="num">(7,522,997)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Proceeds of Short term investment</a></td>
<td class="num">(293)<span></span>
</td>
<td class="nump">15,062,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PurchaseOfImagingCenter', window );">Purchase of imaging center</a></td>
<td class="num">(1,122,508)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(163,705)<span></span>
</td>
<td class="num">(117,522)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES</a></td>
<td class="num">(4,819,597)<span></span>
</td>
<td class="nump">7,422,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(103,335)<span></span>
</td>
<td class="num">(4,957,936)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt</a></td>
<td class="nump">63,000<span></span>
</td>
<td class="nump">5,618,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(6,570,000)<span></span>
</td>
<td class="num">(5,565,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(6,610,335)<span></span>
</td>
<td class="num">(4,904,847)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">7,658,069<span></span>
</td>
<td class="nump">22,920,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS &#8211; BEGINNING OF YEAR</a></td>
<td class="nump">36,802,342<span></span>
</td>
<td class="nump">13,882,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS &#8211; END OF YEAR</a></td>
<td class="nump">$ 44,460,411<span></span>
</td>
<td class="nump">$ 36,802,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CompensatoryElementOfStockIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CompensatoryElementOfStockIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfImagingCenter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfImagingCenter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxCreditsAndAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxCreditsAndAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the assets (liabilities) created through trading commodity-based derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169596033512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zSrIMiBonpE6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82C_z6jXO2zr5IN2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#8220;MRI&#8221;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_900_ecustom--ImperialContributionPercentage_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z0Km41pjoJHf">24.2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember_z976zDP9yjm6">45.8</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
in HDM, and the original investors in HDM retained a <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20150701__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z9llCzq97kXe">30.0</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted
by HDM.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
March 2020 the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies
which has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally
COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel to travel
for marketing purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and
the Company has been steadily recovering to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able
to enact certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases
in scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#8216;PPP&#8217;) program
and Medicare advances/stimulus payments. Although we are unable to predict if there will be additional consequences on our operations
from the continuing global pandemic of COVID-19 and the new variants, the Company believes with the positive cash flows, low debt and
cash on hand, it will be able to continue operations going forward.</span></p>






















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593820856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zYulH27BVNMd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_821_zVDO5JLtNpz2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zLtLsqmwhe23" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zxPf8p16bxF8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--UseOfEstimates_zBqSjqTontc6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_860_zcH5SNBobXa4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Use
of Estimates</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zvuNP967cxF2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zYqIXvW9FN3d" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zIbbGTvGSA3h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zAHENb4dKiq1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and Equipment</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment procured in the normal course of business is stated at cost. Property and equipment purchased in connection with an acquisition
is stated at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting
purposes using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter
of the useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses
totaled approximately $<span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20200701__20210630_pp0p0">2,051,000</span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20190701__20200630_pp0p0">1,870,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for the
years ended June 30, 2021 and 2020 respectively. The estimated useful lives in years are generally as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
Useful Life in Years for Property and Equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c">13</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
development and demonstration equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve">7</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
and equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd">7</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
and fixtures</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl">9</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
improvements</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22">10</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
<td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">28</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>





















<p id="xdx_848_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zZz8Q5RcxKQf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_ztuPuSG6wJ2g" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Lived
Assets</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaSg3dJzIcK1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zfJcFT8xxeee" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Intangible Assets</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1)
Patents and Copyrights</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight-line basis over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyj86MpWUw6f">15
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2)
Non-Competition Agreements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
non-competition agreements are being amortized on the straight line basis over the length of the agreement (<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zXlMLHrL1Fg3">7
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3)
Customer Relationships</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight line basis over <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zW7GgkeyX1q9">20
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--GoodwillDisclosureTextBlock_zpRTJLmWQx53" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zPbmbZCubsO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing the
reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount of the reporting
unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure the amount of impairment
loss, if any.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_848_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zkKMC3wi5Hra" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86A_zzDdrzGNAwc5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquired
assets and assumed liabilities</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to ASC No. 805-10-25, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, but during the allowed measurement period not to exceed one year from the acquisition date, the Company adjusts
the provisional amounts recognized at the acquisition date by means of adjusting the amount recognized for goodwill.</span></p>
























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_z7pbiOEpTgY2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zuVgzj3IKn35" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on sales contracts for scanners, included in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from product sales (upgrades and supplies) is recognized upon shipment.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2021, the Company has twenty
two <span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20210630_zcSncm0bFo95">22 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">management
agreements of which three <span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20210630_zwDV9ROkB2Uj">3
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are with
PC&#8217;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (&#8220;the Related medical practices&#8221;) and nineteen
<span id="xdx_905_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20210630_zASamHcSk18a">19</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$<span id="xdx_904_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_za2HOkZvPstc">77,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to $<span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_z3UgKWymxQM4">522,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts
for estimated uncollectible fees, which is reflected in other operating expenses on the Statement of Operations. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2018, the Company adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board
(&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company applied the modified retrospective approach to all contracts when adopting ASC 606. As a result, at the adoption of ASC 606 the
majority of what was previously classified as the provision for bad debts in the statement of operations is now reflected as implicit
price concessions (as defined in ASC 606) and therefore included as a reduction to net operating revenues in 2019. For changes in credit
issues not assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the
statement of operations.</span></p>






























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition
standards that required it to be presented separately as a component of net operating revenues.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2021 and 2020 are summarized in the following table.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,100,440</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,545,987</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">968,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,038,288</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,011,111</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,028,737</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,227,783</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">882,248</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,307,389</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,495,260</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_z8WrJQIPxgf1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_867_zAFh41uMKkSg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and Development Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.</span></p>
























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVXAGHqj5Gw3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zprP5qeyBaw6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
costs are expensed as incurred. Advertising expense approximated $<span id="xdx_904_eus-gaap--AdvertisingExpense_c20200701__20210630_pp0p0">633,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_c20190701__20200630_pp0p0">566,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and for
the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_844_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zxSiwQ5y1MAi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_z0SYCump33c7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shipping
Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s shipping and handling costs are included in revenue from product sales and the related expense included in costs related
to product sales is $<span id="xdx_90C_ecustom--ShippingAndHandlingExpense_c20200701__20210630_pp0p0">8,215</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_906_ecustom--ShippingAndHandlingExpense_c20190701__20200630_pp0p0">12,056 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
the years ended June 30, 2021 and 2020 respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zA5xsR1rShAh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86D_zQ9eRVz29CBl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
Taxes</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_845_ecustom--CustomerAdvancesPolicyTextBlock_zaq3qTpC6NKd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_869_zdANIG3i80mf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
Advances</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zmWFhyEeRnsl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86B_za9HiphMAcj8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the
Two-Class Method&#8221;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2021 and 2020, diluted EPS for common shareholders
includes <span id="xdx_90C_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20190701__20200630_pdd">127,504
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.</span></p>



























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BF_zClNNIkWZL8a"><span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
    Per Share</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,207,588</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,592,134</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">156,744</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.57</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.47</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,632,787</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.45</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,240,205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,735,650</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">128,500</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.28</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.20</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" style="text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0795">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,571,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p id="xdx_8A8_zzHEmSqwJ6E6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFXANRH7PhBg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zGeYtXpuQ5a4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>
























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zCYsOhXUbqbf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zXSCVqo92S6c" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
Term Investments</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zMEReFdwkn94" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zCZ12RgmjCLa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2021, the Company had cash on deposit of approximately $<span id="xdx_90C_eus-gaap--Cash_c20210630_pp0p0">42,609,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20210630_pp0p0">250,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zPMBJMQeMLx7">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zrOkxu7pQv2g">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively. Net management fee receivables from the related
party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zHvSLpgsqtMl">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zPb9MQN8nj7i">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOyVwEzJJY21" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_ztzpkTwsHCm9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2021 and 2020, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zhx4jgMFiT22" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_868_zYdBpS4sSaS6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Pronouncements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
December 2019, the FASB issued ASU 2019-12 (&#8220;ASU 2019-12&#8221;), Income Taxes (Topic 740). ASU 2019-12 removes certain exceptions
related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition
of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12
was effective beginning in the first quarter of 2021. Certain amendments in this update must be applied on a prospective basis, certain
amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through
a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. The adoption of this update did not have a material
impact on our financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2017-04, Intangibles &#8211; Goodwill and Other (Topic
350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required
the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the
procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The
amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning
after December 15, 2019. The Company adopted the Standard on July 1, 2020 and the impact of adopting this guidance had no material impact
on our Consolidated Financial Statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2021
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those pronouncements will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588536344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_804_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zCLMPZEgKfec" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_82A_zea6mcqT0vBk">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following four years at June 30, 2021 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoBFjbafe4G9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_z38JyVFkWP0a" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivables
    - Non Current - net</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210630_zuHAmvvH42O6" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pp0p0_maARBFLzg6L_zQnwfqZLr0fb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,020,140</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_maARBFLzg6L_zIFq4Asfjxqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,020,140</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_maARBFLzg6L_z1E8DF4fWvr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">599,545</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_maARBFLzg6L_zioLAlunrAD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">160,697</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pp0p0_mtARBFLzg6L_zpQKMbMNJrNj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,800,522</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s receivables from the related and non-related professional corporations (&#8220;PCs&#8221;) substantially consist of fees
outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third party
medical reimbursement organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90B_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20210630_zwU20bZAzQyk">65</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_903_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20190701__20200630_zS8V3puKjQHe">66</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
respectively, of the PCs&#8217; 2021 and 2020 net revenues were derived from no-fault and personal injury protection claims. The Company
considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#8217;s expectations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related party medical practices accounted for approximately <span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20210630_zYtXfSBRIwUi">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90C_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20190701__20200630_zYeh3N6eWUH4">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company,
which have arisen under each individual management agreement.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table sets forth the number of our facilities for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zqieCF8R7qc8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B0_zzzGG3b2SDtk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20200701__20210630_zZQlJWUvrOl3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20190701__20200630_ztsqqEiy72Jj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Year Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40F_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_uN_znGr62zMQxE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at Beginning of Year)</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">25</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">26</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Facilities
    Added by:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ManagedFacilitiesAddedAcquisition_uN_zRoaEaKANBvh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquisition</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0877">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--ManagedFacilitiesAddedByInternalDevelopment_uN_zXRGLSNcSI11" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Internal
    development</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0880">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ManagedFacilitiesClosedDuringYear_uN_zHHJ2Z6ihqVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
    Facilities Closed</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0882">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_uN_zGJjal9NGXx2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at End of Year)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">25</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593225976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock', window );">NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_zhJ1WWO5fEQh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_z93nS4bFuySh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; CONTRACT ASSETS AND LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
relating to uncompleted contracts as of June 30, 2021 and 2020 about contract assets and contract (liabilities) is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zlhn1AN11dV" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0; padding-right: 0"><span id="xdx_8BB_zwtFauVdJpP5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">`Costs
    and Estimated Earnings on Uncompleted Contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210630_zxPyr040yaSh" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20200630_z6tLCJpz5K42" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_407_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzX6u_z9fo0QQbVcUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    incurred on uncompleted contracts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">294,783</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">448,437</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzX6u_zWePQjsPMiO7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
    earnings</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">567,978</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">309,248</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzX6u_maCAEEIz60s_zXtcV4aEcssc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and estimated earnings on uncompleted contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">862,761</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">757,685</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz60s_zo5aWfzTjK22" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Billings to date</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">877,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">604,852</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz60s_z3DkGDjrfMti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and estimated earnings in excess of billings on uncompleted contracts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(14,739</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,833</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for detailed information about regulatory assets and liabilities, including current and noncurrent assets created when regulatory agencies permit the deferral of costs to the balance sheet that would otherwise be required to appear on the company's income statement and would be charged against current expenses or revenues, as well as current and noncurrent liabilities created when regulatory agencies permit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593957272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 &#8211; INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">NOTE 5 &#8211; INVENTORIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--InventoryDisclosureTextBlock_z2bhGtPO2vgl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zzuPqy0yPFJf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
5 &#8211; INVENTORIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying consolidated balance sheets consist of:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEZlWDlLOQva" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zyPaFYGMnLZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210630_z9YOyYUuJnVb" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200630_zfDZsGiiNszj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_408_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWz0L2_zoKmIuMutIOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,393,329</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,544,036</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWz0L2_zuuS48pQnW8i" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">270,090</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">104,734</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWz0L2_zVe2OZvxW0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,663,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,648,770</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587119304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">NOTE 6 - PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNC6esK4vxh9" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span id="xdx_821_zga6IPHNiRqh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
6 - PROPERTY AND EQUIPMENT</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2021 and 2020, is comprised of:&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwUO3RV0kjm8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zkCxt8jO2F4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and Equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,826,829</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">28,434,063</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,029,551</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,901,961</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,450,664</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,291,666</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,961,887</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,736,825</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,277,600</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20200630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">51,373,184</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated depreciation and amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20210630_zvVIPqA3ouae" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">33,427,461</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20200630_zuNN7xmynn1h" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,009,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,850,139</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,364,034</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
and amortization of property and equipment for the years ended June 30, 2021 and 2020 was $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSoldDepreciationAndAmortization_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0">3,696,986
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--CostOfGoodsAndServicesSoldDepreciationAndAmortization_c20190701__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0">3,144,580</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588556712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract', window );"><strong>Note 7 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--LesseeOperatingLeasesTextBlock_zXV6cHCPDnx8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zfNxIgBcMGec" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; OPERATING &amp; FINANCING LEASES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases
as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase by the
lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line
basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with
a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less will be accounted for similar
to existing guidance for operating leases. The standard was effective for us beginning July 1, 2019. We have elected the optional transition
method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented
in the consolidated financial statements. We have also elected the transition package of thee practical expedients permitted within the
standard which eliminates the requirements to reassess prior conclusions about lease identification, lease classification and indirect
costs. The adoption of this guidance had a material impact on the Company&#8217;s balance sheet by virtue of including the present value
of its future operating lease payments as a liability of $<span id="xdx_900_eus-gaap--OperatingLeasePayments_pp0n3_dm_c20200701__20210630_zxPuq0Ogikvc">33.3
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
and related right-to-use lease assets as of July 1, 2019. At the time of adoption of this guidance we had no significant financing leases.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as
of June 30, 2021 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zMDOU8DTqM0l" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_8BF_zEcB5YqbzAxl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    of operating and financing lease payments</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Year
    Ending<br/>
    June 30,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    Lease<br/>
    Payments</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,077,656</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,172,157</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,837,900</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,725,550</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,285,124</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,950,126</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">162,898</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PresentValueDiscount_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(8,539,725</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PresentValueDiscountFinancingLease_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount, Financing Lease"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(133,441</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32,508,788</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,251,172</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>





















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
Average Remaining Lease Term</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases - years</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zyiKeR8aFeId" style="font: normal 11pt Arial, Helvetica, Sans-Serif">9.4</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease - years</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_901_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zHyDciq5j3Od" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average
    Discount Rate</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zX3jn1iTNo2j" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.5</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zLJKkgRcvkFi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


<p id="xdx_8A7_zvb9V3irp98k" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
components of lease expense were as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zNBBitWNGn5a" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zsnyY55tolR" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    of lease expense</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20200701__20210630_zz0TZKPAK4Sh" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20190701__20200630_zjPNhS75wov1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease cost</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,145,701</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,135,604</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease cost:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    of leased equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,881</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1030">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    on lease liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47,472</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1033">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    finance lease cost</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">246,353</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1036">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
cash flow information related to leases was as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zxciqAwBS698" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_zlpYDIrDrba8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
    cash flow information related to leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20200701__20210630_zI5AZPQZsM68" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20190701__20200630_zG5ySzJR2yw2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    year ended</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,970,934</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,170,977</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    cash flows from financing leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">130,038</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"/><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    &amp; equipment assets obtained in exchange for lease obligations:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td id="xdx_F42_zfwrmZn7BRha"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases(1)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,531,889</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">34,786,611</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_zqRFsh9v7ux" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1049">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,325,871</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F0E_z1lTZArbGDC8" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
  <td id="xdx_F14_zlPnT2lvPHtl" style="padding-left: 11pt; text-indent: -11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  for the year ended June 30, 2020 include the transition adjustment for the adoption of topic 842 of $31,651,110.</span></td></tr>
</table>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote7OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588540296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">NOTE 8 - OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_zsaTfRi9NyKl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_zQMXwypJdeZ3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - OTHER INTANGIBLE ASSETS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, at June 30, 2021 and 2020 are comprised of:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbXy2181BX2g" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zILyUXvgO2Gb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intagible Assets - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,244,892</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,081,721</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-competition
    agreements</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,100,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,800,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,299,739</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">19,986,568</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20210630_zTn2YN4m0lY2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,262,140</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,877,439</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iI_pp0p0_c20210630_zCuIGUHQA6gi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--OtherIntangibleAssetsNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,109,129</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
estimated amortization of other intangible assets for the five years ending June 30, 2026 and thereafter is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zBuqZYKbMIwk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zB5P59yB77f9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    Of Other Intangible Assets</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49B_20210630_zeJIn3QGdWfj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zSxXkzAjN876" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zGDhhxG9qfoa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjs3UftClBE5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years<br/>
    Ending June 30,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and Copyrights</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-
    <br/> competition</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Relationships</span></td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">423,209</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">185,709</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37,500</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">389,168</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">189,168</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1100">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">388,867</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">188,867</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">383,912</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">183,912</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1110">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">373,220</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">173,220</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1115">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,079,223</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">765,056</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1120">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,314,167</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_z5Jw5o8TSqsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,685,932</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,314,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
weighted average amortization period for other intangible assets is <span id="xdx_906_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20200701__20210630_zBl64AhToYm3">11.4
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years
and they have no expected residual value.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
related to the above intangible assets for the years ended June 30, 2021 and 2020 is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZJ5f4yVc1ta" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zmE4HPVTja7e" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; Beginning of Year</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_zJtB6wn9h7g9" style="width: 12%; text-align: right" title="Balance - Beginning of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,109,129</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20190701__20200630_zz3zceFQ0pDa" style="width: 12%; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,755,675</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
    capitalized</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">313,705</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--AmountsCapitalized_c20190701__20200630_pp0p0" style="text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">117,522</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Software
    or patents written off</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pp0p0" style="text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(534</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_c20190701__20200630_pp0p0" style="text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1141">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(384,701</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AdjustmentForAmortization_c20190701__20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(764,068</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; End of Year</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_zFrPxUK9UwN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20190701__20200630_zpoSwOBJRgX6" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,109,129</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>





















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the years ended June 30, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0">179,701
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0">183,592</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
software development costs were fully amortized as of June 30, 2018.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of non-competition agreements for the years ended June 30, 2021 and 2020 amounted to $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0">12,500
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0">390,476</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the years ended June 30, 2021 and 2020 amounted to $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0">192,500
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190701__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0">190,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593437720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote9CapitalStockAbstract', window );"><strong>Note 9 - Capital Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CapitalStockAndOptionsDisclosureTextblock', window );">NOTE 9 - CAPITAL STOCK</a></td>
<td class="text"><p id="xdx_80A_ecustom--CapitalStockAndOptionsDisclosureTextblock_zuqPAGn0nYXe" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_825_zlRKkpR0Jfbk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 - CAPITAL STOCK</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90E_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B Common Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90D_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B common stock is convertible into shares of common stock on a one-for-one basis.</span> <span id="xdx_900_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B common stock has 10 votes per share</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
There
were </span><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7zfDcLZUZ73" style="font: normal 11pt Arial, Helvetica, Sans-Serif">146
</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">of
such shares outstanding at June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
C Common Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three
shares of Class C common stock for each share of the Company&#8217;s outstanding Class B common stock. </span><span id="xdx_907_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class C common stock has 25 votes per share</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
as compared to 10 votes per share for the Class B common stock and </span><span id="xdx_908_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">one
vote per share for the common stock.</span> <span id="xdx_90B_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zj0iLxmvlPQ8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</span> <span id="xdx_90C_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions.</span> <span id="xdx_90A_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zIZP2n6HBl6i" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
C common stock is convertible into shares of common stock on a three-for-one basis.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
A Non-Voting Preferred Stock</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with
special dividend rights and the declaration of a stock dividend on the Company&#8217;s common stock consisting of </span><span id="xdx_904_eus-gaap--CommonStockVotingRights_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">one
share of Class A non-voting preferred stock for every five shares of common stock.</span> <span id="xdx_900_eus-gaap--DividendsPayableNature_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zEmgKU33Vj45" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million
and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection
with the enforcement of five of the Company&#8217;s patents in its patent lawsuits, less the revised special dividend payable on the
common stock with respect to one of the Company&#8217;s patents.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks
equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
Bonus Plans</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">2,000,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock. On August 10, 2010, the Company filed Form S-8 to register the <span id="xdx_90E_ecustom--SharesRegistered_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">2,000,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares.
As of June 30, 2021, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">450,177
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2021 and 2020, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">106,747
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">89,981
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
were issued respectively, of which $<span id="xdx_907_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20200701__20210630_zXhva5SmCQTa">83,277
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20190701__20200630_zlUj96hniVBb">0
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">were
expensed and included in selling, general and administrative expenses for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Options</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company had stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and
consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of
time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board
of Directors, generally the fair value of the Company&#8217;s common stock at the date of grant. The options must be exercised within
ten years from the date of grant.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalStockAndOptionsDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalStockAndOptionsDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote9CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote9CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588500408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zZkWyEMq2DQ7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_z7jLKZJpDuC6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
February 13, 2013 the Company entered into an agreement with outside investors to acquire a <span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember__srt--OwnershipAxis__custom--HDMEquityMember_z3jCRuZcsDS5">50.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
controlling interest in a newly formed limited liability company, Health Diagnostics Management LLC (HDM). According to the February
13, 2013 LLC operating agreement of HDM there are two classes of members; Class A members and one Class B member. The Class A members
have an ownership interest of <span id="xdx_90C_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_zACopkDN6aOi">49.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. The Class B member (HMCA) has an ownership of <span id="xdx_90D_ecustom--OwnershipPercentageAcquired_iI_dp_c20130213__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember__srt--OwnershipAxis__custom--HDMEquityMember_zz6lUk9EkLci">50.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of
ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be allocated
among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be
allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions
of the operating agreement. The Company contributed $<span id="xdx_905_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember_pp0p0">20,200,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to HDM
and the group of outside investors contributed $<span id="xdx_907_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OutsideInvestorsMember_pp0p0">19,800,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for its
non-controlling membership interest.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 5, 2013 HDM purchased from Health Diagnostics, LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve
(<span id="xdx_902_ecustom--PurchaseOfStandupMriCenters_iI_uN_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zbtIDdlBxJS2">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
Stand-Up MRI Centers and two (<span id="xdx_909_ecustom--PurchaseOfOtherMriCenters_iI_uN_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zyIQuekcC5Ee">2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_90F_ecustom--ConsiderationToOutsideInvestors_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zqdB35NzycNh">1.5
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
to outside investors) aggregating $<span id="xdx_903_ecustom--TotalPurchasePrice_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkIIF4PChiCc">35.9
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $<span id="xdx_906_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pp0n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zMzR7z1hBn09">4.1
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business Combinations&#8221;. The Company
recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair
value of the identified net assets acquired.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
January 8, 2015, the Company purchased 20% of the Class A members ownership interest at a cost of $<span id="xdx_908_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_pp0p0">4,971,094</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The Company has a <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember__srt--OwnershipAxis__custom--HDMMember_z0J4trW8Vire">60.4</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in HDM after this transaction.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amount
of each class of HDM members&#8217; equity as of June 30, 2021 and 2020</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zO8VxsqLDxlb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B6_zIR8pg3tdXKi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A And B Members' Equity (HDM Acquisition)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Members</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Member</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Members</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Member</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Opening
    Members&#8217; Equity</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,253</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39,850,419</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,155,725</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">36,543,786</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Share of Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,466,223</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,402,961</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,464,528</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,291,633</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(6,570,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(15,330,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(5,565,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(12,985,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ending Members&#8217;
    Equity</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(3,048,524</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">41,923,380</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zokGHiJavRd3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,253</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zr22B74hWXZh" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39,850,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587142280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--DebtAndCapitalLeasesDisclosuresTextBlock_zOwgACrmdvz8" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82A_z2f2Jf39Ekrf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt, notes payable and capital leases consist of the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfDebtTableTextBlock_z8EditiZWPTf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zKynI8lRFbah" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    debt, notes payable and capital leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Note
    payable requiring monthly payments of interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zC0c6XA3xS68">7</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    until May 2009 followed by <span id="xdx_90A_ecustom--NumberOfInstallment_uN_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zllq7TdCexnk">240
    </span></span><span id="xdx_90A_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" style="font: normal 11pt Arial, Helvetica, Sans-Serif">monthly
    </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">payments
    of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0">4,472
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">through
    <span id="xdx_902_ecustom--MaturityDate_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRfWKu8kbBP6">October
    2026</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
    The loan is collateralized by a building with a net book value of $<span id="xdx_90C_ecustom--BookValueOfBuilding_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0">413,330
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    of June 30, 2021.</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">232,696</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">273,031</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;Note
    payable received under the Paycheck Protection Program (&#8216;PPP&#8217;) which was established as part of the Coronavirus Aid,
    Relief and Economic Security Act (&#8220;Cares Act&#8217;) that provides for loans to qualifying businesses for amounts up to 2.5
    times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds
    are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven
    portion of the PPP loan is payable over <span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zn4ddeuwAEB9">5
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">five
    years at an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdaRErAXaOH6">1</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
    with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note
    was forgiven in August 2021.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">700,764</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">700,764</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;The
    revolving credit note was extended to August 2021. The Company can borrow up to $<span id="xdx_902_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zszCbI2JN9Sg">10,000,000
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zvYUPPkmTRD6">4.0</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line. See
    Note 21.</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1270">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1272">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_c20210630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">933,460</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_c20200630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">973,795</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Current portion</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">173,206</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">108,379</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">760,254</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">865,416</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>





<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
maturities of debt over the next five years and thereafter are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z13f5Inpfas5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zUvG19y8jUs4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Maturities
    Of Long-Term Debt</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20200630_zrMZukqNhGb1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ending June 30,</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDACztt9_zTOCSVW27rL9" style="vertical-align: bottom; background-color: White">
    <td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">173,206</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDACztt9_zN7k2APePLlf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">180,972</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_maLTDACztt9_zkPHvGBUAHWi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">183,919</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDACztt9_z6F16gNgf416" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">187,155</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_maLTDACztt9_zn5DgNIOzstg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">190,601</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_maLTDACztt9_z17A7qz8cCM6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,607</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_iTI_pp0p0_mtLTDACztt9_znBQguf7Gx0a" style="vertical-align: bottom; background-color: White">
    <td style="color: White; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Term
    Debt Over Five Years and Thereafter</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">933,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589726968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">NOTE 12 - INCOME TAXES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zye8e684ovI4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_z8upLoiDpZBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - INCOME TAXES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net. Penalties if incurred would be recognized as a component of &#8220;Selling, general
and administrative&#8221; expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2016 for federal
and 2015 for state.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has recorded a deferred tax asset of $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20210630_zFrLyfiLZhWd">15,958,961
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and a
deferred tax liability of $<span id="xdx_901_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20210630_pp0p0">238,316
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as of
June 30, 2021, primarily relating to its net Federal operating loss carryforwards of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20210630_pp0p0">35,574,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">available
to offset future taxable income through 2031. In addition the Company has state operating loss carryforwards of approximately $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_iN_di_c20200701__20210630_zIeZ68hBeGta">7,094,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and city
operating loss carryforwards of approximately $<span id="xdx_90C_eus-gaap--OtherOperatingIncome_c20200701__20210630_zJti3qAzLEU2">2,470,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of June 30, 2021, no such changes in ownership have occurred.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which temporary
differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable income,
the regulatory environment of the industry, and tax planning strategies in making this assessment. At present, the Company believes that
it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
valuation allowance for deferred tax assets decreased during the year ended June 30, 2021, by approximately $<span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20210630_pp0p0">3,547,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The valuation allowance decreased by approximately $<span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20200630_pp0p0">195,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">during
the year ended June 30, 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operation losses, temporary changes to prior and
future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security
taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and enhanced recoverability
of AMT tax credits.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At
the present time, the only impact of the CARES Act to the <span id="xdx_901_ecustom--ReimbursementOfAlternativeMinimumTaxCreditsDescription_c20200701__20210630">Company
is allowing a full reimbursement of $1,342,370 of tax credits relating to the alternative minimum tax credits. The Company received the
first half payment in June 2020. The balance of alternative minimum tax credits of $671,185 was received in July 2020. Previously, these
credits were to be refunded over a 3 year period.</span></span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
we continue to monitor tax implications of the CARES Act and other state and federal stimulus tax legislation, we may make adjustments
to our estimates and record additional amounts for tax assets and liabilities.</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
of the provision (benefit) for income taxes are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYT7CWqwymq" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span id="xdx_8B9_z4K8VtLimNF5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of The Benefit Provision For Income Taxes</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20210630_z4x9AAuSlfCd" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20190701__20200630_zk4oDg9F7dhl" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_406_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zVytMF3cwEcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"/><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(187,255</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zzU5WvcCzqF3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,136,514</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">513,204</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzKST_maITEBzgpd_zMFOkPzHrjT3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,136,514</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">325,949</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzjFJ_zXuyD9yVQX7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
    deferred taxes</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,718,046</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,953,349</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzjFJ_zGswvQaRXdfh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    deferred taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">136,960</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">165,480</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzjFJ_maITEBzgpd_zwUycu6NvH6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,855,006</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,118,829</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzgpd_zHbVbpnj7b8b" style="vertical-align: bottom; background-color: White">
    <td style="color: White"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    (Benefit) for Income Taxes - Net</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,991,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,444,778</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
reconciliation of the federal statutory income tax rate to the Company&#8217;s effective tax rate as reported is as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zVTM9VhrIY65" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z4to7WYmYz01" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20200701__20210630_zmI4FwNIjjWg" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_490_20190701__20200630_zi05QEafvJz" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zESbB2xsLx14" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Taxes
    at federal statutory rate</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zzBlmvW5YL4b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    and local income taxes (benefit), net of federal benefit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zzg1GSyoBPN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non
    Controlling interest</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4.9</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(6.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zCry4Cxz3CK1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Expiration
    of tax credits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.2</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zbn8hWeq0LFb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Return
    to provision adjustments</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1371">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zq3gQPwgrSM2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Change
    in the valuation allowance</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(20.0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zh14IEcjuPL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(2.1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
<tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zsWYExNh9PD3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
    income tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2021, the Company has net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $35,574,000 that will be available
to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant
to Section 1502 of the Internal Revenue Code.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has, for federal income tax purposes, research and development tax credits and investments tax credits carryforwards aggregating
$<span id="xdx_902_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_c20210630_pp0p0">3,733,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
However, the realization of these credits may be limited as a result of expiring prior to their utilization. These credits can only be
applied after all net operating losses have been used, which expire through 2031. As such, the Company has established a valuation reserve
for anticipated unused credits of $<span id="xdx_909_eus-gaap--ValuationAllowancesAndReservesBalance_c20210630_pp0p0">890,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition, for New York State income tax purposes, the Company has tax credit carryforwards aggregating approximately $<span id="xdx_908_eus-gaap--TaxCreditCarryforwardAmount_c20210630_pp0p0">11,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which,
are accounted for under the flow-through method.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company was also under audit with New York State for income tax and was assessed additional taxes of $<span id="xdx_908_ecustom--AdditionalTaxes_c20200701__20210630_zeCqbPXooala">423,272
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">plus
interest and penalties. These amounts are accrued for at June 30, 2021 and included in other current liabilities and were paid in August
2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Significant
components of the Company&#8217;s deferred tax assets and liabilities at June 30, 2021 and 2020 are as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTJrnFRjjav6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zBhejEtOfbKg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of Company's Deferred Tax Assets And Liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210630_zbRsvgODI2a9" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20200630_zaq807P4ffl2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    tax assets:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzcuf_zmvEX3bmoaA9" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,827,382</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,946,801</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzcuf_zUaMTmMMobZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-deductible
    accruals</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">749,902</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">693,833</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzcuf_zE14Y8VOTrvc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    operating carryforwards</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,285,163</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,720,637</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzcuf_zd0RTYzMxeMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
    credits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,732,650</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,647,217</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzcuf_zGtEscVuBHm8" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventory</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">66,316</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">69,940</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzcuf_zZJHJsOQKUB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment and depreciation</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">187,632</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">168,371</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzcuf_maDTANzjWq_z5Cg3nyuUTac" style="vertical-align: bottom; background-color: White">
    <td style="color: White"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    Tax Assets - gross</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,849,045</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,246,799</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzjWq_zyfxNSxTwb52" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Valuation
    allowance</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(890,084</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4,437,042</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzjWq_maDTALNzli5_ztJ0VLwWUDjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,958,961</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,809,757</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzVX4_ztv7fFKyUCz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangibles</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(238,316</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(234,106</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzVX4_msDTALNzli5_zD1fg6nC7Gy4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(238,316</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(234,106</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzli5_zTjFUCV8AYI7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    deferred tax asset</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,720,645</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,575,651</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588512088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 - OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">NOTE 13 - OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z0nMoH7p0At4" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82A_zdrj6p5ruTX6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
13 - OTHER CURRENT LIABILITIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
in other current liabilities are the following:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqXD9yhClk44" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_za7z03jDFjzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20210630_zg7zzsxnhNak" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20200630_zvqVfRqMuOMd" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOLCzdL8_zC97enrNuCle" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,406,982</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,491,941</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zqVlW8vYuwUc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation
    accruals</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">900,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">442,802</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOLCzdL8_zAyEEkYFc8zl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">644,623</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,353,200</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pp0p0_maOLCzdL8_zqd7NaqxgEy2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">774,234</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1448">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOLCzdL8_zT1rAwnUEQO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37,827</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">112,867</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maOLCzdL8_zrKouvLUvxAh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,262</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">120,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--SelfInsuranceReserve_iI_pp0p0_maOLCzdL8_zV9TWuVLHdYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">62,548</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">86,504</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0_maOLCzdL8_zxdCsbyQsbu2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">493,042</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">877,787</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zmuj7cg9j3a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">715,600</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">699,997</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_mtOLCzdL8_zICACAUAwJe3" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other current
    liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,162,118</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,185,098</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>





<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>













<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593820856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 14 - COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">NOTE 14 - COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znFaJPRNRMRk" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82F_z1cmcXPMVnBh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
14 - COMMITMENTS AND CONTINGENCIES</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leases</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through
March 2030. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain
maintenance costs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Rent
expense for operating leases approximated $<span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20200701__20210630_pp0p0">6,146,000</span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_900_eus-gaap--LeaseAndRentalExpense_c20190701__20200630_pp0p0">5,136,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company received approval from the Suffolk County IDA on February 29, 2016 of a <span id="xdx_902_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20190101__20281231_z4Q5Ha62jtR9">50</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
property tax abatement, valued at $<span id="xdx_900_ecustom--PropertyTaxAbatement_c20190101__20281231_pp0p0">440,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
over a 10 year period commencing January 2017.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Employee
Benefit Plans</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has a non-contributory 401(k) Plan (the &#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at
least 21 years of age with no minimum service requirements. There were $<span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20200701__20210630_pp0p0">36,799
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20190701__20200630_pp0p0">0
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">employer
contributions to the Plan for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_903_ecustom--EmployeeStockPurchasePlanEspp_c20200701__20210630__us-gaap--EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis__us-gaap--EmployeeStockMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2021.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90E_ecustom--LitigationSettelementDescription_c20190701__20200630" style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
September 2019, The Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course
of the arbitration proceedings. The Company is estimating the leasehold holdover charges to be approximately $900,000.</span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2021 this amount has been accrued for under other current liabilities.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_906_ecustom--LitigationSettelementDescription_c20200701__20210630" style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900,000 was paid by the Company&#8217;s insurance on September
15, 2020 with the remaining $315,000 paid by the Company on September 28, 2020.</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
Company is subject to other legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims besides the claim above. In the opinion of management, and with consultation with legal council,
the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial
position or results of operations of the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has satisfied most of its delinquencies in filing sales tax returns for certain states, for which the Company has transacted
business. The Company has recorded tax obligations of approximately $<span id="xdx_909_eus-gaap--SalesAndExciseTaxPayableCurrentAndNoncurrent_c20210630_pp0p0">645,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">plus
interest and penalties of approximately $<span id="xdx_904_ecustom--RecordedSalesTaxObligationsInterestAndPenalties_c20210630_pp0p0">232,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">until
the remaining states have been resolved.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_904_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_c20200701__20210630_pp0p0">110,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">per person
and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2021
and 2020, the Company had approximately $<span id="xdx_904_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20210630_pp0p0">63,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_905_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20200630_pp0p0">87,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the consolidated balance sheets.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the years covered by this report.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169675228280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_808_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zW2tpuhqvagf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_821_z2WP7FkPc2mb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
15 - SUPPLEMENTAL CASH FLOW INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2021 and 2020 the Company paid $<span id="xdx_906_eus-gaap--InterestPaid_c20200701__20210630_pp0p0">75,178</span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90C_eus-gaap--InterestPaid_c20190701__20200630_pp0p0">137,200
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for interest,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2021 and 2020 the Company paid $<span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20200701__20210630_pp0p0">261,032
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_908_eus-gaap--IncomeTaxesPaid_c20190701__20200630_pp0p0">228,204
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for income
taxes, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2021 and 2020, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20200701__20210630_pdd">102,364
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20190701__20200630_pdd">89,981
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock for costs and expenses totaling $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_pp0p0_c20200701__20210630_z7eRX6BZBc79">1,940,821
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20190701__20200630_pp0p0">1,990,380</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the year ended June 30, 2020 the Company entered into a capital lease for the purchase of equipment in the amount of $<span id="xdx_904_eus-gaap--AmortizationOfLeasedAsset_c20200701__20210630_pp0p0">1,350,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the year, the Company resolved certain sales tax liabilities and was able to reverse accrued interest and penalties in the amount of
$<span id="xdx_90C_ecustom--SellingGeneralAndAdministrativeExpenses_c20200701__20210630_zo2n4RLqGU9a">602,000</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which
has been recorded under selling, general and administrative expenses.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587228472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 16 &#8211; RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">NOTE 16 &#8211; RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z6udcfPaMmY7" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82E_zWZVmygsJMu7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
16 &#8211; RELATED PARTY TRANSACTIONS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20200701__20210630__dei--LegalEntityAxis__custom--ABillingCompanyMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#8217; Compensation claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2021 for another year.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20200701__20210630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593775208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 17 - SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">NOTE 17 - SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zP1Wk4JaEhD" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zZU24sYETvXj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
17 - SEGMENT AND RELATED INFORMATION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company provides segment data in accordance with the provisions of ASC topic 280, &#8220;Disclosures about Segments of an Enterprise
and Related Information&#8221;.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment
sales are market-based. The Company evaluates performance based on income or loss from operations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zp3TRcW9zs84" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span id="xdx_8B1_zBC1GDej9gwl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
    Segment Financial Information</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
    and Servicing of Medical</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    of Diagnostic Imaging</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2021:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Center</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,037,091</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">80,892,674</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">89,929,765</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjWEe6ibgvM6" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">901,250</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zd6UUM6bPeE3" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1538">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____z1HeNFaEFOV3" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">901,250</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(3,410,189</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,507,804</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,097,615</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">264,830</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,816,857</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,081,687</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">83,277</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1556">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">83,277</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24,592,582</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">164,913,613</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsNet_c20210630_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">189,506,195</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">291,294</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,405,502</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,696,796</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;&#160;Fiscal
    2020:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,463,103</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">77,227,359</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--Revenues_c20190701__20200630_pp0p0" style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85,690,462</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span id="xdx_F4A_z2f1lgHdBOa5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____z1UtNFLi7ex4" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">875,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____z5k3P2XQRg2j" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1580">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630_fKg_____zvAtxyGLfSS1" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">875,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(6,425,411</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,076,327</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,650,916</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">368,498</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,540,150</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,908,648</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1598">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20190701__20200630_zYrjZsbmjWf4" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,492,757</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">149,790,753</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_c20200630_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">180,283,510</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,440,640</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,981,773</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,422,413</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F05_zEREwuyQ0VD7" style="text-align: justify; padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
  <td id="xdx_F12_z53lLUQTqWb6" style="text-align: justify; padding-left: 11pt; text-indent: -11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation</span></td></tr>
</table>


<p id="xdx_8A2_z1sj9fDSkh29" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
Product Sales</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting
to <span id="xdx_90E_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20200701__20210630_zcPiCn948zbd">69.3</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_904_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20190701__20200630_zy6Yr2rzfF6c">20.2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of product sales revenues to third parties for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ExportProductSales_z4Z2dMGvGDZ1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B6_z92wpdhnlKK3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
    Product Sales</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_zCNqWwICHib1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">67.0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--DO_zbuHrPBs4Bic" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zXTLPwTWl7Eb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zDfEYGapqgx9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zaUTjm7YMkhi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_zkdxuozLYLOe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">20.2</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zJ4twkroHeV2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zaToq3FDmsff" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp_c20200701__20210630_zXC9OYVV9YVd" style="font: normal 11pt Arial, Helvetica, Sans-Serif">69.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--ForeignProductSales_dp_c20190701__20200630_zroALeKRx2ek" style="font: normal 11pt Arial, Helvetica, Sans-Serif">20.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
Service and Repair Fees</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair
of medical equipment amounting to <span id="xdx_906_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20200701__20210630_zGsZoBcrc6kk">4.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_900_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20190701__20200630_zv0zD1guyZ24">5.6</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of consolidated net service and repair fees for the years ended June 30, 2021 and 2020 respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ExportServiceRevenues_z7IxUfVXDBAa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BD_zHJlKwDqPLCa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
    Service and Repair Fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zAOjZpSvEHFf" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zXZVn5akPBPk" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.6</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Switzerland</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zwxPmRN7ETI2" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CH_zG2ngUskvLg" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zyYiiTRHkSB1" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_z70xhn2aRoXh" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">England</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_zdtuo3HGYI52" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GB_zyjcZPie06rd" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.7</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_z8F1YCdf3bs2" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zesJtEZtoB0h" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Greece</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zXuegxBIhZo" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GR_zTn5sOnOxVk3" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.2</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Australia</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp0_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zLI9bng1yptl" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_z6BT6oIJTjTc" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zMNMHCtJnQXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630_zOdmbw7kYBZ2" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
Company does not have any material assets outside of the United States.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588543640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 18 &#8211; ACQUISTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">NOTE 18 &#8211; ACQUISTION</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--BusinessCombinationDisclosureTextBlock_zj6eFgN8plob" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_827_zOehxc7sPdz4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
18 &#8211; ACQUISTION</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 29, 2021, the Company completed the acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company
used an incremental borrowing rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We
made a preliminary fair value determination of the acquired assets and assumed liabilities as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zXdJuyVSagVa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z6jPGMAKvh29" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
    value assets and assumed liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210329_zxfeHguUkri1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_zeqWo4kPhdwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">650,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_zpPw0naz6u21" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right
    to use assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">434,219</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zyLV05W04Kce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangible
    assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">150,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--SecurityDeposit_iI_zrF1ibx6TGm1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Security
    Deposit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,628</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_zSdLGpf7aCa9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right
    to use liability</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(434,219</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--Goodwill_iI_zVEbHrQrgOi4" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">283,880</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_zSvJXDE1DCPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    purchase consideration</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,122,508</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 805-10-25-1, Business Combinations &#8211; Overall Recognition, the Company recorded the transaction as a business
combination. ASC 805-10-25-1 provides the requirements of recording the transaction by applying the acquisition method. The acquisition
method requires the Company to determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must
be determined if there is a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and you
must be able to recognized and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded
as a business combination.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
net assets acquired and consideration is as follow:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zPivPWwGYqbd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zpnI1WtS9nI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    assets acquired</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210329_zCUgbAtbWGye" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    Improvements</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_zzyOOWKnUiX2" style="width: 18%; text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">550,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    Equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_zrxAuUiyOWNg" style="text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Lists</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zQ5RWzklSZge" style="text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Covenant
    Not to Compete</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_zIotqYfuDrnf" style="text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--SecurityDeposit_iI_zKk4Ycko5JMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Security
    Deposit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,628</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--ClosingCostsExpensed_iI_zFJHgEbtC2ze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Closing
    costs - expensed</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,478</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--GoodwillGross_iI_zOzfAQbOY2Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">283,880</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--BusinessCombinationContingentConsiderationAsset1_iI_zbSEWojYvxyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    Consideration Paid</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,125,986</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
results of operations of Rockland Management Group were diminutive and did not affect the pro forma results of operations.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588920120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS</a></td>
<td class="text"><p id="xdx_80E_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zykeErPpT7Fl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82F_zCEHf9CxCB8j" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following represents a summary of allowance for doubtful accounts for the years ended June 30, 2021 and 2020 respectively:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zerqICWYroB5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_zKV0Z4emBGC3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summary
    of Allowance For Doubtful Accounts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span id="xdx_F21_zT3MX0oVtua7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions
    (1)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zuGPhkmgJbrk" style="width: 10%; text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">514,561</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zAPq7TNWLFLk" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1721">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72,291</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z1D6nWiS4d5h" style="width: 10%; text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">442,270</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEd0CAFZHqri" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,063,233</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zomO96pjBJGc" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,723,645</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBmFysJHP051" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,786,878</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zl351PL54CRf" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,322,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zW8wR0i7BDs8" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">862,344</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1739">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkaBXZwiYgH4" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,184,399</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zbbCCTfQrp3h" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zDuFC1AZDBq1" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1745">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1747">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zVVu0iBWB774" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zemU3sZSx1fj" style="width: 10%; text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">190,244</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">380,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,683</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7sZGNZZ8Qne" style="width: 10%; text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">514,561</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zqOGS2IkEvQ8" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,404,944</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,526,742</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1,868,453</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zrnCJZhe17A6" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,063,233</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhEJUeMEVxKe" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,310,731</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,011,324</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1778">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkNJFjRIeU16" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,322,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zTY47H0LBznf" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1782">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1786">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zcUXU7sz30Vc" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F08_zfCQTmMiYeVd" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
  <td id="xdx_F15_zbz2USYUnRJ1" style="padding-left: 11pt; text-indent: -11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
  in provision for bad debts.</span></td></tr>
</table>


<p id="xdx_8A6_zP04amakyl7g" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587161976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</a></td>
<td class="text"><p id="xdx_805_eus-gaap--QuarterlyFinancialInformationTextBlock_zip9jYPUHDVj" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_82B_zXfWr7YNTiS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(000&#8217;s
omitted, except per share data)</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_z33KCVI9QJEe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B4_zEkfJ54PT243" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Quarterly
    Financial Data</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zzeuI3PaBu9e" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zwmkSlA3CFsc" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zx6GVjWqt04l" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zdLGta2Dn3e6" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zVYpdzISdTB3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">December
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">March
    31, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,979</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,164</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,090</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24,697</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">89,930</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,829</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,182</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,968</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,853</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72,832</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,251</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,928</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,299</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,196</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,674</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.37</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.45</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.10</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.47</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.36</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.44</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.54</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.11</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.45</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20190701__20190930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJgiPxxxFyxf" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20191001__20191231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvVGE27sjcIg" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20200101__20200331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvei2r7PuAq3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z1CXj7B8qNJ8" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20190701__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zbyL9jYtrAd9" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">December
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">March
    31, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_40D_eus-gaap--Revenues_zIDIPJoGbZL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,747</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,451</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,686</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,806</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85,690</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--CostsAndExpenses_zypLUvICwEp7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,261</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,430</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">19,071</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,278</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72,040</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_znl4OZJzXxoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,506</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,209</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,914</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,076</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,705</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--EarningsPerShareBasic_zkN8CsWhxjxf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.48</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.45</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.18</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.20</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_zue1lAGxHVY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.47</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.44</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.18</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p id="xdx_8A7_zUlIdy6oidwh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>













<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL124452896-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588504584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 21 &#8211; SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">NOTE 21 &#8211; SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zE2iSUI0bktc" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_823_zy0vTOzkcnwe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
21 &#8211; SUBSEQUENT EVENTS</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
August 2021 the Company amended their revolving credit agreement. The agreement was extended to August 2022.&#160;The interest rate on
borrowings remains at <span id="xdx_908_eus-gaap--DebtorInPossessionFinancingFeeOnUnusedBorrowings_iI_dp_c20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQg4F74UgQw3">4</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
along with certain financial covenants.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
loan of $<span id="xdx_904_eus-gaap--ProceedsFromLoans_c20210801__20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSza1KTzoT81">700,764
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">received
under the Paycheck Protection Program was forgiven in August 2021.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169596048472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zLtLsqmwhe23" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zxPf8p16bxF8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--UseOfEstimates_zBqSjqTontc6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_860_zcH5SNBobXa4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Use
of Estimates</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessPolicy', window );">Inventories</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zvuNP967cxF2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zYqIXvW9FN3d" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zIbbGTvGSA3h" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zAHENb4dKiq1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and Equipment</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment procured in the normal course of business is stated at cost. Property and equipment purchased in connection with an acquisition
is stated at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting
purposes using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter
of the useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses
totaled approximately $<span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20200701__20210630_pp0p0">2,051,000</span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20190701__20200630_pp0p0">1,870,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for the
years ended June 30, 2021 and 2020 respectively. The estimated useful lives in years are generally as follows:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
Useful Life in Years for Property and Equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c">13</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
development and demonstration equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve">7</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
and equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd">7</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
and fixtures</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl">9</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
improvements</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22">10</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
<td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">28</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>





















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zZz8Q5RcxKQf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_ztuPuSG6wJ2g" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Lived
Assets</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zaSg3dJzIcK1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zfJcFT8xxeee" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Intangible Assets</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1)
Patents and Copyrights</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight-line basis over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyj86MpWUw6f">15
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2)
Non-Competition Agreements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
non-competition agreements are being amortized on the straight line basis over the length of the agreement (<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zXlMLHrL1Fg3">7
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years).</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3)
Customer Relationships</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight line basis over <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zW7GgkeyX1q9">20
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_848_eus-gaap--GoodwillDisclosureTextBlock_zpRTJLmWQx53" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zPbmbZCubsO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing the
reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount of the reporting
unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure the amount of impairment
loss, if any.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock', window );">Acquired assets and assumed liabilities</a></td>
<td class="text"><p id="xdx_848_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zkKMC3wi5Hra" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86A_zzDdrzGNAwc5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquired
assets and assumed liabilities</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to ASC No. 805-10-25, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, but during the allowed measurement period not to exceed one year from the acquisition date, the Company adjusts
the provisional amounts recognized at the acquisition date by means of adjusting the amount recognized for goodwill.</span></p>
























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_z7pbiOEpTgY2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zuVgzj3IKn35" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on sales contracts for scanners, included in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from product sales (upgrades and supplies) is recognized upon shipment.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2021, the Company has twenty
two <span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20210630_zcSncm0bFo95">22 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">management
agreements of which three <span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20210630_zwDV9ROkB2Uj">3
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are with
PC&#8217;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (&#8220;the Related medical practices&#8221;) and nineteen
<span id="xdx_905_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20210630_zASamHcSk18a">19</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$<span id="xdx_904_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_za2HOkZvPstc">77,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to $<span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20210630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_z3UgKWymxQM4">522,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts
for estimated uncollectible fees, which is reflected in other operating expenses on the Statement of Operations. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2018, the Company adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board
(&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company applied the modified retrospective approach to all contracts when adopting ASC 606. As a result, at the adoption of ASC 606 the
majority of what was previously classified as the provision for bad debts in the statement of operations is now reflected as implicit
price concessions (as defined in ASC 606) and therefore included as a reduction to net operating revenues in 2019. For changes in credit
issues not assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the
statement of operations.</span></p>






























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition
standards that required it to be presented separately as a component of net operating revenues.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2021 and 2020 are summarized in the following table.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,100,440</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,545,987</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">968,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,038,288</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,011,111</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,028,737</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,227,783</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">882,248</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,307,389</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,495,260</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_z8WrJQIPxgf1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_867_zAFh41uMKkSg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and Development Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.</span></p>
























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--AdvertisingCostsPolicyTextBlock_zVXAGHqj5Gw3" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zprP5qeyBaw6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
costs are expensed as incurred. Advertising expense approximated $<span id="xdx_904_eus-gaap--AdvertisingExpense_c20200701__20210630_pp0p0">633,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_c20190701__20200630_pp0p0">566,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and for
the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ShippingsAndHandlingCostPolicyTextBlock', window );">Shipping Costs</a></td>
<td class="text"><p id="xdx_844_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zxSiwQ5y1MAi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_z0SYCump33c7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shipping
Costs</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s shipping and handling costs are included in revenue from product sales and the related expense included in costs related
to product sales is $<span id="xdx_90C_ecustom--ShippingAndHandlingExpense_c20200701__20210630_pp0p0">8,215</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_906_ecustom--ShippingAndHandlingExpense_c20190701__20200630_pp0p0">12,056 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
the years ended June 30, 2021 and 2020 respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zA5xsR1rShAh" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86D_zQ9eRVz29CBl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
Taxes</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CustomerAdvancesPolicyTextBlock', window );">Customer Advances</a></td>
<td class="text"><p id="xdx_845_ecustom--CustomerAdvancesPolicyTextBlock_zaq3qTpC6NKd" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_869_zdANIG3i80mf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
Advances</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zmWFhyEeRnsl" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86B_za9HiphMAcj8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the
Two-Class Method&#8221;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2021 and 2020, diluted EPS for common shareholders
includes <span id="xdx_90C_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20190701__20200630_pdd">127,504
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.</span></p>



























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BF_zClNNIkWZL8a"><span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
    Per Share</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,207,588</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,592,134</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">156,744</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.57</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.47</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,632,787</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.45</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,240,205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,735,650</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">128,500</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.28</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.20</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" style="text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0795">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,571,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p id="xdx_8A8_zzHEmSqwJ6E6" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFXANRH7PhBg" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zGeYtXpuQ5a4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>
























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short Term Investments</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zCYsOhXUbqbf" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86A_zXSCVqo92S6c" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
Term Investments</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zMEReFdwkn94" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zCZ12RgmjCLa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2021, the Company had cash on deposit of approximately $<span id="xdx_90C_eus-gaap--Cash_c20210630_pp0p0">42,609,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_c20210630_pp0p0">250,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zPMBJMQeMLx7">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zrOkxu7pQv2g">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2021 and 2020, respectively. Net management fee receivables from the related
party medical practices accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zHvSLpgsqtMl">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20190701__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zPb9MQN8nj7i">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years ended June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOyVwEzJJY21" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_ztzpkTwsHCm9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2021 and 2020, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short
term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>























<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zhx4jgMFiT22" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_868_zYdBpS4sSaS6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Pronouncements</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
December 2019, the FASB issued ASU 2019-12 (&#8220;ASU 2019-12&#8221;), Income Taxes (Topic 740). ASU 2019-12 removes certain exceptions
related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition
of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12
was effective beginning in the first quarter of 2021. Certain amendments in this update must be applied on a prospective basis, certain
amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through
a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. The adoption of this update did not have a material
impact on our financial statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2017-04, Intangibles &#8211; Goodwill and Other (Topic
350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required
the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the
procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The
amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning
after December 15, 2019. The Company adopted the Standard on July 1, 2020 and the impact of adopting this guidance had no material impact
on our Consolidated Financial Statements.</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2021
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2021 or 2020, and it does not believe that any
of those pronouncements will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShippingsAndHandlingCostPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShippingsAndHandlingCostPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594399800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment', window );">Estimated Useful Life in Years for Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipment_z5jP4nqp1Vr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span id="xdx_8B7_zGwAHpuuvYQ2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
Useful Life in Years for Property and Equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MinimumMember_z5niI97JjqBe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember__srt--RangeAxis__srt--MaximumMember_zuLDBQ8Yzg2c">13</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
development and demonstration equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3OJpvNWKSOa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNyUKKHsgVve">7</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
and equipment</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zf4k4yrZcocg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zKYUGVdhY7Bd">7</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
and fixtures</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_znmPTeOXG65k" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z9Le3OXf75hl">9</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
improvements</span></td>
<td style="padding: 0; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_z0FRLJuJPrZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zF4O3KTYLa22">10</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0; width: 90%; line-height: 115%; text-indent: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
<td style="padding: 0; width: 10%; text-align: right; line-height: 115%; text-indent: 0"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zwjXXKYqyqBi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">28</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Patient Fee Revenue - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zeKVdAPZius4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B1_zl9hok3q1hcf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zVGtEhJLYsZa" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,100,440</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zfJDvblgx9Sd" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,545,987</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zSUh04QEVhnk" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">968,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_ztutsidQhaR3" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,038,288</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zxBOF2vA8ejb" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,011,111</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zdCWaef4EvE1" style="text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,028,737</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zIxZbhP4vi5k" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,227,783</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zZnuiWHLm3De" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">882,248</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_pp0p0_c20200701__20210630_zzhQNST8Sln6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,307,389</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20190701__20200630_zzbDqS8WX4B3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,495,260</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAhN0TCIgbXd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BF_zClNNIkWZL8a"><span id="xdx_86A_znJHOYIuitk2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
    Per Share</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630_zxKlKROqqB1d" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,207,588</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHIBHwe86eC1" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,592,134</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCBQWckyg1rh" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">156,744</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zdwM1m0BOAc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zA51S4HM3mok" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI1tHO26jKne" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zrtRDD2ITG0i" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.57</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7D79o5dAYhj" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.47</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNLkONh2fnud" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8JTKn0pwvpa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,505,283</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbEo8ucJ7rm5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLAF6BYoxrmc" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTlhHtD9Cgv1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKW6QiBAa8eb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,632,787</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxa2b35b9Ik7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPaJrHHC3F33" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.45</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMQ8aQRCPdLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630_zFef42buOXd7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,240,205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2gLQ9VUaozb" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,735,650</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zX6olqWoH4Rl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">128,500</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630_zJc4zHIyelUa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqKuv3Lm6Nfa" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrCChUjqDL7d" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630_zTOlEU8YNzyi" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.28</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z887Df5ep5nd" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.20</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0CVIdZSlj36" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted average
    shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znEiOKQZCoO4" style="text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,443,713</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHnuV77ecZ07" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6z7e3bVjTB5" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0fO5wpW55Ld" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0795">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zU2VYZDFSYC" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,571,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z35B7NWxbwS3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted income
    per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zV6azQiJh3h4" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--EarningsPerShareDiluted_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbMd6mpOjEK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588543080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Receivables - Non Current - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoBFjbafe4G9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_z38JyVFkWP0a" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivables
    - Non Current - net</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210630_zuHAmvvH42O6" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pp0p0_maARBFLzg6L_zQnwfqZLr0fb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,020,140</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_maARBFLzg6L_zIFq4Asfjxqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,020,140</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_maARBFLzg6L_z1E8DF4fWvr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">599,545</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_maARBFLzg6L_zioLAlunrAD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">160,697</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_iTI_pp0p0_mtARBFLzg6L_zpQKMbMNJrNj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,800,522</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Total Facilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zqieCF8R7qc8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B0_zzzGG3b2SDtk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20200701__20210630_zZQlJWUvrOl3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20190701__20200630_ztsqqEiy72Jj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Year Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40F_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_uN_znGr62zMQxE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at Beginning of Year)</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">25</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">26</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Facilities
    Added by:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ManagedFacilitiesAddedAcquisition_uN_zRoaEaKANBvh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquisition</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0877">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--ManagedFacilitiesAddedByInternalDevelopment_uN_zXRGLSNcSI11" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Internal
    development</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0880">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ManagedFacilitiesClosedDuringYear_uN_zHHJ2Z6ihqVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
    Facilities Closed</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0882">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_uN_zGJjal9NGXx2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at End of Year)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">25</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593602840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 &#8211; CONTRACT ASSETS AND LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock', window );">`Costs and Estimated Earnings on Uncompleted Contracts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zlhn1AN11dV" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0; padding-right: 0"><span id="xdx_8BB_zwtFauVdJpP5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">`Costs
    and Estimated Earnings on Uncompleted Contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210630_zxPyr040yaSh" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20200630_z6tLCJpz5K42" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_407_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzX6u_z9fo0QQbVcUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    incurred on uncompleted contracts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">294,783</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">448,437</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzX6u_zWePQjsPMiO7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated
    earnings</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">567,978</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">309,248</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzX6u_maCAEEIz60s_zXtcV4aEcssc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and estimated earnings on uncompleted contracts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">862,761</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">757,685</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz60s_zo5aWfzTjK22" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Billings to date</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">877,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">604,852</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz60s_z3DkGDjrfMti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and estimated earnings in excess of billings on uncompleted contracts</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(14,739</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,833</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-term contract or program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593495784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 &#8211; INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEZlWDlLOQva" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zyPaFYGMnLZj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210630_z9YOyYUuJnVb" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200630_zfDZsGiiNszj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_408_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWz0L2_zoKmIuMutIOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,393,329</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,544,036</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWz0L2_zuuS48pQnW8i" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">270,090</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">104,734</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWz0L2_zVe2OZvxW0Y7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,663,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,648,770</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587202536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwUO3RV0kjm8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zkCxt8jO2F4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and Equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,826,829</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">28,434,063</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,029,551</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,901,961</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,450,664</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,291,666</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,961,887</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,736,825</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,277,600</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20200630_pp0p0" style="text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">51,373,184</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated depreciation and amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20210630_zvVIPqA3ouae" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">33,427,461</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20200630_zuNN7xmynn1h" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,009,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,850,139</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,364,034</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169590113400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract', window );"><strong>Note 7 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc', window );">Reconciliation of operating and financing lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zMDOU8DTqM0l" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_8BF_zEcB5YqbzAxl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    of operating and financing lease payments</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Year
    Ending<br/>
    June 30,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    Lease<br/>
    Payments</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,077,656</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20210630_pp0p0" style="width: 26%; text-align: right" title="2022"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,172,157</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20210630_pp0p0" style="text-align: right" title="2023"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,837,900</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20210630_pp0p0" style="text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,725,550</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20210630_pp0p0" style="text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,285,124</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20210630_pp0p0" style="text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,950,126</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20210630_pp0p0" style="text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">162,898</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PresentValueDiscount_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(8,539,725</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PresentValueDiscountFinancingLease_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Present Value discount, Financing Lease"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(133,441</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32,508,788</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,251,172</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>





















<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
Average Remaining Lease Term</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases - years</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zyiKeR8aFeId" style="font: normal 11pt Arial, Helvetica, Sans-Serif">9.4</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease - years</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_901_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210630_zHyDciq5j3Od" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average
    Discount Rate</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zX3jn1iTNo2j" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.5</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20210630_zLJKkgRcvkFi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Components of lease expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zNBBitWNGn5a" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zsnyY55tolR" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    of lease expense</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20200701__20210630_zz0TZKPAK4Sh" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20190701__20200630_zjPNhS75wov1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease cost</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,145,701</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,135,604</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease cost:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    of leased equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,881</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1030">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    on lease liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47,472</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1033">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    finance lease cost</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">246,353</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1036">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zxciqAwBS698" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B8_zlpYDIrDrba8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
    cash flow information related to leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20200701__20210630_zI5AZPQZsM68" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20190701__20200630_zG5ySzJR2yw2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    year ended</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,970,934</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,170,977</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    cash flows from financing leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">130,038</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"/><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    &amp; equipment assets obtained in exchange for lease obligations:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td id="xdx_F42_zfwrmZn7BRha"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases(1)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,531,889</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">34,786,611</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases_zqRFsh9v7ux" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1049">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,325,871</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote7OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169702061672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Other Intagible Assets - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zbXy2181BX2g" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zILyUXvgO2Gb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intagible Assets - Net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,244,892</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,081,721</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-competition
    agreements</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,100,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,800,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,299,739</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200630_pp0p0" style="text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">19,986,568</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20210630_zTn2YN4m0lY2" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,262,140</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,877,439</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iI_pp0p0_c20210630_zCuIGUHQA6gi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--OtherIntangibleAssetsNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,109,129</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Of Other Intangible Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zBuqZYKbMIwk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zB5P59yB77f9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    Of Other Intangible Assets</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49B_20210630_zeJIn3QGdWfj" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zSxXkzAjN876" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zGDhhxG9qfoa" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjs3UftClBE5" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years<br/>
    Ending June 30,</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and Copyrights</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-
    <br/> competition</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Relationships</span></td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">423,209</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">185,709</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37,500</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">389,168</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">189,168</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1100">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">388,867</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">188,867</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">383,912</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">183,912</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1110">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">373,220</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">173,220</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1115">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,079,223</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">765,056</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1120">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,314,167</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_z5Jw5o8TSqsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,685,932</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,314,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zZJ5f4yVc1ta" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zmE4HPVTja7e" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; Beginning of Year</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_zJtB6wn9h7g9" style="width: 12%; text-align: right" title="Balance - Beginning of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,109,129</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20190701__20200630_zz3zceFQ0pDa" style="width: 12%; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,755,675</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
    capitalized</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">313,705</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--AmountsCapitalized_c20190701__20200630_pp0p0" style="text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">117,522</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Software
    or patents written off</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pp0p0" style="text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(534</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_c20190701__20200630_pp0p0" style="text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1141">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(384,701</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AdjustmentForAmortization_c20190701__20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(764,068</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; End of Year</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_zFrPxUK9UwN4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20190701__20200630_zpoSwOBJRgX6" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,109,129</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593276616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Class A And B Members' Equity (HDM Acquisition)</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zO8VxsqLDxlb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B6_zIR8pg3tdXKi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A And B Members' Equity (HDM Acquisition)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Members</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Member</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Members</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Member</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Opening
    Members&#8217; Equity</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,253</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39,850,419</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,155,725</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--OpeningMembersEquity_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">36,543,786</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Share of Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,466,223</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,402,961</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,464,528</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--ShareOfNetIncome_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,291,633</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(6,570,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--Distributions_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(15,330,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(5,565,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--Distributions_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(12,985,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ending Members&#8217;
    Equity</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(3,048,524</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">41,923,380</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zokGHiJavRd3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,253</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EndingMembersEquity_iI_pp0p0_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zr22B74hWXZh" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39,850,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587147384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term debt, notes payable and capital leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfDebtTableTextBlock_z8EditiZWPTf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zKynI8lRFbah" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    debt, notes payable and capital leases</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Note
    payable requiring monthly payments of interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zC0c6XA3xS68">7</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    until May 2009 followed by <span id="xdx_90A_ecustom--NumberOfInstallment_uN_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zllq7TdCexnk">240
    </span></span><span id="xdx_90A_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" style="font: normal 11pt Arial, Helvetica, Sans-Serif">monthly
    </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">payments
    of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0">4,472
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">through
    <span id="xdx_902_ecustom--MaturityDate_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRfWKu8kbBP6">October
    2026</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
    The loan is collateralized by a building with a net book value of $<span id="xdx_90C_ecustom--BookValueOfBuilding_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0">413,330
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    of June 30, 2021.</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">232,696</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" style="width: 12%; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">273,031</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;Note
    payable received under the Paycheck Protection Program (&#8216;PPP&#8217;) which was established as part of the Coronavirus Aid,
    Relief and Economic Security Act (&#8220;Cares Act&#8217;) that provides for loans to qualifying businesses for amounts up to 2.5
    times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds
    are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven
    portion of the PPP loan is payable over <span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zn4ddeuwAEB9">5
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">five
    years at an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zdaRErAXaOH6">1</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
    with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note
    was forgiven in August 2021.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">700,764</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">700,764</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;The
    revolving credit note was extended to August 2021. The Company can borrow up to $<span id="xdx_902_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zszCbI2JN9Sg">10,000,000
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200701__20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zvYUPPkmTRD6">4.0</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line. See
    Note 21.</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LongTermDebtCurrent_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1270">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_c20200630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1272">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_c20210630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">933,460</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LongTermDebtCurrent_c20200630_pp0p0" style="text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">973,795</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Current portion</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">173,206</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20200630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">108,379</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">760,254</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">865,416</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Maturities Of Long-Term Debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z13f5Inpfas5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zUvG19y8jUs4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Maturities
    Of Long-Term Debt</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20200630_zrMZukqNhGb1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ending June 30,</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDACztt9_zTOCSVW27rL9" style="vertical-align: bottom; background-color: White">
    <td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 43%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">173,206</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDACztt9_zN7k2APePLlf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">180,972</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_maLTDACztt9_zkPHvGBUAHWi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">183,919</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDACztt9_z6F16gNgf416" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">187,155</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_maLTDACztt9_zn5DgNIOzstg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">190,601</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_maLTDACztt9_z17A7qz8cCM6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,607</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_iTI_pp0p0_mtLTDACztt9_znBQguf7Gx0a" style="vertical-align: bottom; background-color: White">
    <td style="color: White; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Term
    Debt Over Five Years and Thereafter</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">933,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594368088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components Of The Benefit Provision For Income Taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYT7CWqwymq" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span id="xdx_8B9_z4K8VtLimNF5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of The Benefit Provision For Income Taxes</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20210630_z4x9AAuSlfCd" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20190701__20200630_zk4oDg9F7dhl" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_406_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zVytMF3cwEcl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"/><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(187,255</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_maCITEBzKST_zzU5WvcCzqF3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,136,514</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">513,204</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzKST_maITEBzgpd_zMFOkPzHrjT3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,136,514</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">325,949</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzjFJ_zXuyD9yVQX7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
    deferred taxes</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,718,046</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,953,349</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzjFJ_zGswvQaRXdfh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    deferred taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">136,960</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">165,480</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzjFJ_maITEBzgpd_zwUycu6NvH6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,855,006</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,118,829</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzgpd_zHbVbpnj7b8b" style="vertical-align: bottom; background-color: White">
    <td style="color: White"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    (Benefit) for Income Taxes - Net</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,991,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,444,778</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zVTM9VhrIY65" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z4to7WYmYz01" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_492_20200701__20210630_zmI4FwNIjjWg" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_490_20190701__20200630_zi05QEafvJz" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zESbB2xsLx14" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Taxes
    at federal statutory rate</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zzBlmvW5YL4b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    and local income taxes (benefit), net of federal benefit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zzg1GSyoBPN7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non
    Controlling interest</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4.9</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(6.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zCry4Cxz3CK1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Expiration
    of tax credits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.2</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zbn8hWeq0LFb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Return
    to provision adjustments</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1371">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zq3gQPwgrSM2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Change
    in the valuation allowance</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(20.0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zh14IEcjuPL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(2.1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
<tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zsWYExNh9PD3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
    income tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components Of Company's Deferred Tax Assets And Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTJrnFRjjav6" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zBhejEtOfbKg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of Company's Deferred Tax Assets And Liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210630_zbRsvgODI2a9" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20200630_zaq807P4ffl2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    tax assets:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzcuf_zmvEX3bmoaA9" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,827,382</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,946,801</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzcuf_zUaMTmMMobZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-deductible
    accruals</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">749,902</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">693,833</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzcuf_zE14Y8VOTrvc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    operating carryforwards</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,285,163</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,720,637</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzcuf_zd0RTYzMxeMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
    credits</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,732,650</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,647,217</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzcuf_zGtEscVuBHm8" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventory</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">66,316</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">69,940</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzcuf_zZJHJsOQKUB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment and depreciation</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">187,632</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">168,371</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzcuf_maDTANzjWq_z5Cg3nyuUTac" style="vertical-align: bottom; background-color: White">
    <td style="color: White"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    Tax Assets - gross</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,849,045</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,246,799</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzjWq_zyfxNSxTwb52" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Valuation
    allowance</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(890,084</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4,437,042</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzjWq_maDTALNzli5_ztJ0VLwWUDjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,958,961</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,809,757</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzVX4_ztv7fFKyUCz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangibles</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(238,316</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(234,106</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzVX4_msDTALNzli5_zD1fg6nC7Gy4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax liabilities</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(238,316</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(234,106</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzli5_zTjFUCV8AYI7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    deferred tax asset</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,720,645</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,575,651</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589905064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 - OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zqXD9yhClk44" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_za7z03jDFjzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20210630_zg7zzsxnhNak" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20200630_zvqVfRqMuOMd" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOLCzdL8_zC97enrNuCle" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,406,982</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,491,941</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zqVlW8vYuwUc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation
    accruals</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">900,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">442,802</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOLCzdL8_zAyEEkYFc8zl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">644,623</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,353,200</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--TaxesPayableCurrent_iI_pp0p0_maOLCzdL8_zqd7NaqxgEy2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">774,234</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1448">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOLCzdL8_zT1rAwnUEQO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">37,827</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">112,867</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maOLCzdL8_zrKouvLUvxAh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,262</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">120,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--SelfInsuranceReserve_iI_pp0p0_maOLCzdL8_zV9TWuVLHdYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">62,548</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">86,504</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0_maOLCzdL8_zxdCsbyQsbu2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">493,042</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">877,787</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0_maOLCzdL8_zmuj7cg9j3a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">715,600</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">699,997</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_mtOLCzdL8_zICACAUAwJe3" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other current
    liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,162,118</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,185,098</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589106104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Segment Financial Information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zp3TRcW9zs84" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span id="xdx_8B1_zBC1GDej9gwl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
    Segment Financial Information</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
    and Servicing of Medical</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    of Diagnostic Imaging</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2021:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Equipment</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Center</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; width: 46%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,037,091</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">80,892,674</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="width: 11%; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">89,929,765</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjWEe6ibgvM6" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">901,250</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zd6UUM6bPeE3" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1538">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____z1HeNFaEFOV3" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">901,250</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(3,410,189</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,507,804</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,097,615</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">264,830</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,816,857</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,081,687</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">83,277</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1556">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">83,277</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24,592,582</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsNet_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">164,913,613</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsNet_c20210630_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">189,506,195</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">291,294</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,405,502</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,696,796</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;&#160;Fiscal
    2020:</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,463,103</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">77,227,359</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--Revenues_c20190701__20200630_pp0p0" style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85,690,462</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span id="xdx_F4A_z2f1lgHdBOa5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____z1UtNFLi7ex4" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">875,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____z5k3P2XQRg2j" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1580">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_pp0p0_c20190701__20200630_fKg_____zvAtxyGLfSS1" style="text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">875,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(6,425,411</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,076,327</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_c20190701__20200630_pp0p0" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,650,916</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">368,498</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,540,150</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_c20190701__20200630_pp0p0" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,908,648</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compensatory
    element of stock issuances</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1598">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20190701__20200630_zYrjZsbmjWf4" style="text-align: right" title="Compensatory element of stock issuances"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,492,757</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--AssetsNet_c20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">149,790,753</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_c20200630_pp0p0" style="text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">180,283,510</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 20pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,440,640</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,981,773</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_c20190701__20200630_pp0p0" style="text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,422,413</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F05_zEREwuyQ0VD7" style="text-align: justify; padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
  <td id="xdx_F12_z53lLUQTqWb6" style="text-align: justify; padding-left: 11pt; text-indent: -11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation</span></td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ExportProductSales', window );">Export Product Sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ExportProductSales_z4Z2dMGvGDZ1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8B6_z92wpdhnlKK3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
    Product Sales</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_zCNqWwICHib1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">67.0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--DO_zbuHrPBs4Bic" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zXTLPwTWl7Eb" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zDfEYGapqgx9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zaUTjm7YMkhi" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.1</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_zkdxuozLYLOe" style="font: normal 11pt Arial, Helvetica, Sans-Serif">20.2</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zJ4twkroHeV2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp0_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zaToq3FDmsff" style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp_c20200701__20210630_zXC9OYVV9YVd" style="font: normal 11pt Arial, Helvetica, Sans-Serif">69.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--ForeignProductSales_dp_c20190701__20200630_zroALeKRx2ek" style="font: normal 11pt Arial, Helvetica, Sans-Serif">20.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ExportServiceRevenues', window );">Foreign Service and Repair Fees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ExportServiceRevenues_z7IxUfVXDBAa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BD_zHJlKwDqPLCa" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
    Service and Repair Fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zAOjZpSvEHFf" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--PR_zXZVn5akPBPk" style="width: 12%; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.6</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Switzerland</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zwxPmRN7ETI2" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CH_zG2ngUskvLg" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zyYiiTRHkSB1" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--DE_z70xhn2aRoXh" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">England</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_zdtuo3HGYI52" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GB_zyjcZPie06rd" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.7</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_z8F1YCdf3bs2" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--CA_zesJtEZtoB0h" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Greece</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zXuegxBIhZo" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--GR_zTn5sOnOxVk3" style="text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.2</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Australia</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ForeignServiceAndRepairFees_dp0_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zLI9bng1yptl" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_z6BT6oIJTjTc" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zMNMHCtJnQXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ForeignServiceAndRepairFees_dp_c20190701__20200630_zOdmbw7kYBZ2" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign Service and Repair fees"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportServiceRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportServiceRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594481304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 18 &#8211; ACQUISTION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Fair value assets and assumed liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zXdJuyVSagVa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_z6jPGMAKvh29" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
    value assets and assumed liabilities</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210329_zxfeHguUkri1" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_zeqWo4kPhdwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">650,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_zpPw0naz6u21" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right
    to use assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">434,219</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zyLV05W04Kce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangible
    assets</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">150,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--SecurityDeposit_iI_zrF1ibx6TGm1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Security
    Deposit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,628</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_zSdLGpf7aCa9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right
    to use liability</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(434,219</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--Goodwill_iI_zVEbHrQrgOi4" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">283,880</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_zSvJXDE1DCPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    purchase consideration</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,122,508</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Net assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zPivPWwGYqbd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zpnI1WtS9nI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    assets acquired</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210329_zCUgbAtbWGye" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    Improvements</span></td><td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_zzyOOWKnUiX2" style="width: 18%; text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">550,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    Equipment</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_zrxAuUiyOWNg" style="text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Lists</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zQ5RWzklSZge" style="text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Covenant
    Not to Compete</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_zIotqYfuDrnf" style="text-align: right" title="Intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--SecurityDeposit_iI_zKk4Ycko5JMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Security
    Deposit</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,628</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--ClosingCostsExpensed_iI_zFJHgEbtC2ze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Closing
    costs - expensed</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,478</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--GoodwillGross_iI_zOzfAQbOY2Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">283,880</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--BusinessCombinationContingentConsiderationAsset1_iI_zbSEWojYvxyk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    Consideration Paid</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,125,986</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587176168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 19 &#8211; ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Summary of Allowance For Doubtful Accounts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zerqICWYroB5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_zKV0Z4emBGC3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summary
    of Allowance For Doubtful Accounts</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span id="xdx_F21_zT3MX0oVtua7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions
    (1)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zuGPhkmgJbrk" style="width: 10%; text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">514,561</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zAPq7TNWLFLk" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1721">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72,291</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z1D6nWiS4d5h" style="width: 10%; text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">442,270</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEd0CAFZHqri" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,063,233</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zomO96pjBJGc" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,723,645</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBmFysJHP051" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,786,878</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zl351PL54CRf" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,322,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zW8wR0i7BDs8" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">862,344</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1739">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkaBXZwiYgH4" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,184,399</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zbbCCTfQrp3h" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zDuFC1AZDBq1" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1745">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1747">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zVVu0iBWB774" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zemU3sZSx1fj" style="width: 10%; text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">190,244</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">380,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pp0p0" style="width: 10%; text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,683</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7sZGNZZ8Qne" style="width: 10%; text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">514,561</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zqOGS2IkEvQ8" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,404,944</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,526,742</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1,868,453</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zrnCJZhe17A6" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,063,233</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhEJUeMEVxKe" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,310,731</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,011,324</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1778">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zkNJFjRIeU16" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,322,055</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zTY47H0LBznf" style="text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1782">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_pp0p0" style="text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1786">&#8212;</span></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20190701__20200630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--MedicalReceivablesMember_zcUXU7sz30Vc" style="text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
  <td id="xdx_F08_zfCQTmMiYeVd" style="padding-left: 11pt; text-indent: -11pt; width: 3pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
  <td id="xdx_F15_zbz2USYUnRJ1" style="padding-left: 11pt; text-indent: -11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
  in provision for bad debts.</span></td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587188552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Data</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_z33KCVI9QJEe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B4_zEkfJ54PT243" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Quarterly
    Financial Data</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zzeuI3PaBu9e" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zwmkSlA3CFsc" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zx6GVjWqt04l" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zdLGta2Dn3e6" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zVYpdzISdTB3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">December
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">March
    31, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,979</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,164</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,090</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24,697</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">89,930</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,829</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,182</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,968</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,853</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72,832</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,251</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,928</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,299</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,196</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,674</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.37</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.45</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.10</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.47</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.36</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.44</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.54</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.11</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.45</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20190701__20190930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJgiPxxxFyxf" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49A_20191001__20191231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvVGE27sjcIg" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20200101__20200331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvei2r7PuAq3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20200401__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z1CXj7B8qNJ8" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20190701__20200630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zbyL9jYtrAd9" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">December
    30, 2019</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">March
    31, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
<tr id="xdx_40D_eus-gaap--Revenues_zIDIPJoGbZL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,747</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,451</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,686</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,806</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85,690</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--CostsAndExpenses_zypLUvICwEp7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,261</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,430</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">19,071</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,278</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72,040</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_znl4OZJzXxoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,506</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,209</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,914</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,076</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,705</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--EarningsPerShareBasic_zkN8CsWhxjxf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.48</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.45</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.18</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.20</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_zue1lAGxHVY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.47</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.44</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.18</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588600952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - H D M [Member]<br></strong></div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ImperialContributionPercentage', window );">[custom:ImperialContributionPercentage-0]</a></td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ImperialContributionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ImperialContributionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169685606552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember', window );">Research Deveopment And Demonstration Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember', window );">Research Deveopment And Demonstration Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">28 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594224296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 23,307,389<span></span>
</td>
<td class="nump">$ 22,495,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">4,100,440<span></span>
</td>
<td class="nump">4,545,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">968,055<span></span>
</td>
<td class="nump">1,038,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">15,011,111<span></span>
</td>
<td class="nump">16,028,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other Revenue Source [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 3,227,783<span></span>
</td>
<td class="nump">$ 882,248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetPatientFeeRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetPatientFeeRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594902024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 10,207,588<span></span>
</td>
<td class="nump">$ 8,240,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">6,505,283<span></span>
</td>
<td class="nump">6,443,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 1.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 9,592,134<span></span>
</td>
<td class="nump">$ 7,735,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">6,505,283<span></span>
</td>
<td class="nump">6,443,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">6,505,283<span></span>
</td>
<td class="nump">6,443,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">6,632,787<span></span>
</td>
<td class="nump">6,571,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 156,744<span></span>
</td>
<td class="nump">$ 128,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169590149192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfPropertyRepairsAndMaintenance', window );">Cost of Property Repairs and Maintenance</a></td>
<td class="nump">$ 2,051,000<span></span>
</td>
<td class="nump">$ 1,870,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices', window );">[custom:ManagementAgreementsWithCompanyTotalMedicalPractices-0]</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty', window );">[custom:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty-0]</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState', window );">[custom:ScannersWithManagementWithCompanyLocatedInNewYorkState-0]</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="nump">$ 633,000<span></span>
</td>
<td class="nump">566,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ShippingAndHandlingExpense', window );">[custom:ShippingAndHandlingExpense]</a></td>
<td class="nump">8,215<span></span>
</td>
<td class="nump">$ 12,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders', window );">[custom:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders] | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">42,609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC Insured Amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember', window );">Net Management Fee Receivables From Related Party Medical Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember', window );">Diagnostic Imaging Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMinimum', window );">[custom:ContractualFeesForServicesRenderedMinimum-0]</a></td>
<td class="nump">$ 77,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMaximum', window );">[custom:ContractualFeesForServicesRenderedMaximum-0]</a></td>
<td class="nump">$ 522,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual fees for services rendered to the PC's.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum contractual fees for services rendered to the PC's.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Imaging Centers with management agreements with Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAgreementsWithCompanyTotalMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of management agreements with PC's owned by a relarted party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of management agreements with PC's owned by two unrelated radiologists.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShippingAndHandlingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to shipping and handling expense for the period, which are expenses incurred with the objective of delivery of Fonar's products to its customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShippingAndHandlingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfPropertyRepairsAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfPropertyRepairsAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589073864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueOneToTwoYears', window );">2023</a></td>
<td class="nump">$ 1,020,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2024</a></td>
<td class="nump">1,020,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2025</a></td>
<td class="nump">599,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFourToFiveYears', window );">2026</a></td>
<td class="nump">160,697<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 2,800,522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFourToFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFourToFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueOneToTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueOneToTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353855&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593975336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details) - Integer<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear', window );">Total Facilities Owned or Managed (at Beginning of Year)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedAcquisition', window );">Acquisition</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedByInternalDevelopment', window );">Internal development</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagedFacilitiesClosedDuringYear', window );">Managed Facilities Closed</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear', window );">Total Facilities Owned or Managed (at End of Year)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedByInternalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedByInternalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesClosedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesClosedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588951864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims]</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">[custom:PercentageOfConsolidatedNetRevenueFromManagementFees]</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594365544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsIncurredOnUncompletedContracts', window );">Costs incurred on uncompleted contracts</a></td>
<td class="nump">$ 294,783<span></span>
</td>
<td class="nump">$ 448,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EstimatedEarnings', window );">Estimated earnings</a></td>
<td class="nump">567,978<span></span>
</td>
<td class="nump">309,248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsOnUncompletedContracts', window );">Costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">862,761<span></span>
</td>
<td class="nump">757,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_BillingsToDate', window );">Less: Billings to date</a></td>
<td class="nump">877,500<span></span>
</td>
<td class="nump">604,852<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="num">$ (14,739)<span></span>
</td>
<td class="nump">$ 152,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BillingsToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount within current period that has been billed to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BillingsToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs and estimated earnings on uncompleted contracts in excess of billings means the current asset as of the closing date, as properly recorded on seller's balance sheet in accordance with GAAP, representing the amount, in the aggregate, earned on contracts but not yet invoiced to customers, as determined in accordance with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Earnings on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169706204808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 5 - INVENTORIES - Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 1,393,329<span></span>
</td>
<td class="nump">$ 1,544,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">270,090<span></span>
</td>
<td class="nump">104,734<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">$ 1,663,419<span></span>
</td>
<td class="nump">$ 1,648,770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594666232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">$ 55,277,600<span></span>
</td>
<td class="nump">$ 51,373,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization of property and equipment</a></td>
<td class="nump">33,427,461<span></span>
</td>
<td class="nump">30,009,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment AfterAccumulated depreciation and amortization</a></td>
<td class="nump">21,850,139<span></span>
</td>
<td class="nump">21,364,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">29,826,829<span></span>
</td>
<td class="nump">28,434,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">6,029,551<span></span>
</td>
<td class="nump">5,901,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">2,069,055<span></span>
</td>
<td class="nump">2,069,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">3,450,664<span></span>
</td>
<td class="nump">3,291,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">12,961,887<span></span>
</td>
<td class="nump">10,736,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">$ 939,614<span></span>
</td>
<td class="nump">$ 939,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588500088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Cost, Depreciation and Amortization</a></td>
<td class="nump">$ 3,696,986<span></span>
</td>
<td class="nump">$ 3,144,580<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169595688136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract', window );"><strong>Note 7 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 5,077,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">5,172,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">4,837,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">4,725,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">4,285,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">16,950,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">162,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present Value discount</a></td>
<td class="num">(8,539,725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present Value discount, Financing Lease</a></td>
<td class="num">(133,441)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">32,508,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease liability</a></td>
<td class="nump">$ 1,251,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">5.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote7OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589161288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract', window );"><strong>Note 7 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 6,145,701<span></span>
</td>
<td class="nump">$ 5,135,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DepreciationOfLeasedEquipment', window );">Depreciation of leased equipment</a></td>
<td class="nump">198,881<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">47,472<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 246,353<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciationOfLeasedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciationOfLeasedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote7OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594546184">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract', window );"><strong>Note 7 Operating Financing Leases</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OperatingCashFlowsFromOperatingLeases', window );">Operating cash flows from operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,970,934<span></span>
</td>
<td class="nump">$ 4,170,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_FinancingCashFlowsFromFinancingLeases', window );">Financing cash flows from financing leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">130,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases', window );">Operating leases(1)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,531,889<span></span>
</td>
<td class="nump">34,786,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases', window );">Financing leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,325,871<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  for the year ended June 30, 2020 include the transition adjustment for the adoption of topic 842 of $31,651,110.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote7OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinancingCashFlowsFromFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinancingCashFlowsFromFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OperatingCashFlowsFromOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OperatingCashFlowsFromOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169587157480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract', window );"><strong>Note 7 Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">$ 33,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureNote7OperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureNote7OperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594854568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">$ 20,299,739<span></span>
</td>
<td class="nump">$ 19,986,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">16,262,140<span></span>
</td>
<td class="nump">15,877,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets - net</a></td>
<td class="nump">4,037,599<span></span>
</td>
<td class="nump">4,109,129<span></span>
</td>
<td class="nump">$ 4,755,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">7,004,847<span></span>
</td>
<td class="nump">7,004,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">5,244,892<span></span>
</td>
<td class="nump">5,081,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">4,150,000<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589833208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 423,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">389,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">388,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">383,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">373,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,079,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">4,037,599<span></span>
</td>
<td class="nump">$ 4,109,129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">185,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">189,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">188,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">183,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">173,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">765,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">1,685,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,314,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">$ 2,314,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593842008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - End of Year</a></td>
<td class="nump">$ 4,109,129<span></span>
</td>
<td class="nump">$ 4,755,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AmountsCapitalized', window );">Amounts capitalized</a></td>
<td class="nump">313,705<span></span>
</td>
<td class="nump">117,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SoftwareOrPatentsWrittenOff', window );">Software or patents written off</a></td>
<td class="num">(534)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="num">(384,701)<span></span>
</td>
<td class="num">(764,068)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - End of Year</a></td>
<td class="nump">$ 4,037,599<span></span>
</td>
<td class="nump">$ 4,109,129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AmountsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AmountsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareOrPatentsWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareOrPatentsWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169686943464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">11 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 179,701<span></span>
</td>
<td class="nump">$ 183,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">390,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 192,500<span></span>
</td>
<td class="nump">$ 190,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589748648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - CAPITAL STOCK (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Aug. 10, 2010</div></th>
<th class="th"><div>Apr. 23, 2010</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Other Selling, General and Administrative Expense</a></td>
<td class="nump">$ 83,277<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember', window );">N 2010 Stock Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SharesRegistered', window );">[custom:SharesRegistered-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">450,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</a></td>
<td class="nump">106,747<span></span>
</td>
<td class="nump">89,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">Class
C common stock is convertible into shares of common stock on a three-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">one
vote per share for the common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,554,210<span></span>
</td>
<td class="nump">6,447,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">Class
B common stock is convertible into shares of common stock on a one-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">Class
B common stock has 10 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">The
Class C common stock has 25 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">one
share of Class A non-voting preferred stock for every five shares of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesRegistered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesRegistered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21550-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593139208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details) - H D M Equity [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">$ 55,253<span></span>
</td>
<td class="nump">$ 2,155,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">3,466,223<span></span>
</td>
<td class="nump">3,464,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="num">(6,570,000)<span></span>
</td>
<td class="num">(5,565,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="num">(3,048,524)<span></span>
</td>
<td class="nump">55,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">39,850,419<span></span>
</td>
<td class="nump">36,543,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">17,402,961<span></span>
</td>
<td class="nump">16,291,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="num">(15,330,000)<span></span>
</td>
<td class="num">(12,985,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">$ 41,923,380<span></span>
</td>
<td class="nump">$ 39,850,419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Distributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Distributions to each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Distributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EndingMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ending Members Equity for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EndingMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OpeningMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opening Members Equity for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OpeningMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShareOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Of Net Income for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShareOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588757432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 13, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 08, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2013 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">H D M [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PurchaseOfStandupMriCenters', window );">[custom:PurchaseOfStandupMriCenters-0] | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PurchaseOfOtherMriCenters', window );">[custom:PurchaseOfOtherMriCenters-0] | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ConsiderationToOutsideInvestors', window );">[custom:ConsiderationToOutsideInvestors-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_TotalPurchasePrice', window );">[custom:TotalPurchasePrice-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements', window );">[custom:ConsiderationForNoncompetitionAndConsultingAgreements-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMMember', window );">H D M [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Proceeds from Contributions from Affiliates</a></td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMMember', window );">H D M [Member] | Outside Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Proceeds from Contributions from Affiliates</a></td>
<td class="nump">$ 19,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBMember', window );">Class B [Member] | H D M Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</a></td>
<td class="nump">50.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipPercentageAcquired', window );">[custom:OwnershipPercentageAcquired-0]</a></td>
<td class="nump">50.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAMember', window );">Class A [Member] | H D M [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</a></td>
<td class="nump">49.50%<span></span>
</td>
<td class="nump">60.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,971,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationForNoncompetitionAndConsultingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationToOutsideInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationToOutsideInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipPercentageAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipPercentageAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfOtherMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfOtherMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfStandupMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfStandupMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_OutsideInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_OutsideInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593347720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 933,460<span></span>
</td>
<td class="nump">$ 973,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">173,206<span></span>
</td>
<td class="nump">108,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long Term Debt, Notes Payable and Capital Leases less Current Portion</a></td>
<td class="nump">$ 760,254<span></span>
</td>
<td class="nump">865,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NumberOfInstallment', window );">[custom:NumberOfInstallment] | Integer</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt Instrument, Frequency of Periodic Payment</a></td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="nump">$ 4,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MaturityDate', window );">[custom:MaturityDate]</a></td>
<td class="text">October
    2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_BookValueOfBuilding', window );">[custom:BookValueOfBuilding-0]</a></td>
<td class="nump">$ 413,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 232,696<span></span>
</td>
<td class="nump">273,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 700,764<span></span>
</td>
<td class="nump">700,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable3Member', window );">Note Payable 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from Lines of Credit</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BookValueOfBuilding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BookValueOfBuilding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfInstallment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfInstallment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593379208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 173,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">180,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">183,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">187,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">190,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">17,607<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-Term Debt Over Five Years and Thereafter</a></td>
<td class="nump">$ 933,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593908392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (187,255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State</a></td>
<td class="nump">$ 1,136,514<span></span>
</td>
<td class="nump">513,204<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">1,136,514<span></span>
</td>
<td class="nump">325,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred taxes</a></td>
<td class="nump">2,718,046<span></span>
</td>
<td class="nump">1,953,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred taxes</a></td>
<td class="nump">136,960<span></span>
</td>
<td class="nump">165,480<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">2,855,006<span></span>
</td>
<td class="nump">2,118,829<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (Benefit) for Income Taxes - Net</a></td>
<td class="nump">$ 3,991,520<span></span>
</td>
<td class="nump">$ 2,444,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594388072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Taxes at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (benefit), net of federal benefit</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Non Controlling interest</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="num">(6.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Expiration of tax credits</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Return to provision adjustments</a></td>
<td class="nump">6.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in the valuation allowance</a></td>
<td class="num">(20.00%)<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">22.60%<span></span>
</td>
<td class="nump">17.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594138312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 3,827,382<span></span>
</td>
<td class="nump">$ 3,946,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Non-deductible accruals</a></td>
<td class="nump">749,902<span></span>
</td>
<td class="nump">693,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating carryforwards</a></td>
<td class="nump">8,285,163<span></span>
</td>
<td class="nump">13,720,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">3,732,650<span></span>
</td>
<td class="nump">4,647,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">66,316<span></span>
</td>
<td class="nump">69,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment and depreciation</a></td>
<td class="nump">187,632<span></span>
</td>
<td class="nump">168,371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets - gross</a></td>
<td class="nump">16,849,045<span></span>
</td>
<td class="nump">23,246,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(890,084)<span></span>
</td>
<td class="num">(4,437,042)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">15,958,961<span></span>
</td>
<td class="nump">18,809,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(238,316)<span></span>
</td>
<td class="num">(234,106)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(238,316)<span></span>
</td>
<td class="num">(234,106)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 15,720,645<span></span>
</td>
<td class="nump">$ 18,575,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594111576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="nump">$ 15,958,961<span></span>
</td>
<td class="nump">$ 18,809,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</a></td>
<td class="nump">238,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">35,574,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">7,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Other Operating Income</a></td>
<td class="nump">2,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital', window );">Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital</a></td>
<td class="nump">$ 3,547,000<span></span>
</td>
<td class="nump">$ 195,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription', window );">[custom:ReimbursementOfAlternativeMinimumTaxCreditsDescription]</a></td>
<td class="text">Company
is allowing a full reimbursement of $1,342,370 of tax credits relating to the alternative minimum tax credits. The Company received the
first half payment in June 2020. The balance of alternative minimum tax credits of $671,185 was received in July 2020. Previously, these
credits were to be refunded over a 3 year period.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Deferred Tax Assets, Tax Credit Carryforwards, Research</a></td>
<td class="nump">$ 3,733,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AdditionalTaxes', window );">[custom:AdditionalTaxes]</a></td>
<td class="nump">$ 423,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AdditionalTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AdditionalTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169684286904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 5,406,982<span></span>
</td>
<td class="nump">$ 4,491,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Litigation accruals</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">442,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">644,623<span></span>
</td>
<td class="nump">1,353,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">State income taxes payable</a></td>
<td class="nump">774,234<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">37,827<span></span>
</td>
<td class="nump">112,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">127,262<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">62,548<span></span>
</td>
<td class="nump">86,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">493,042<span></span>
</td>
<td class="nump">877,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">715,600<span></span>
</td>
<td class="nump">699,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 9,162,118<span></span>
</td>
<td class="nump">$ 8,185,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593108552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">120 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2028</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems', window );"><strong>Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="nump">$ 6,146,000<span></span>
</td>
<td class="nump">$ 5,136,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda', window );">[custom:PropertyTaxAbatementFromSuffolkCountyIda]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PropertyTaxAbatement', window );">[custom:PropertyTaxAbatement]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</a></td>
<td class="nump">$ 36,799<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_LitigationSettelementDescription', window );">[custom:LitigationSettelementDescription]</a></td>
<td class="text">In
September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which
was scheduled for arbitration. The settlement was for $1.2 million of which $900,000 was paid by the Company&#8217;s insurance on September
15, 2020 with the remaining $315,000 paid by the Company on September 28, 2020.<span></span>
</td>
<td class="text">In
September 2019, The Company was notified by one of its landlords that it was required to vacate the premises within 180 days under the
demolition clause in the lease. The Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated
in February 2018. The Company is in the process of relocating to a new location but the original lease provided for penalty payments
in the event that the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course
of the arbitration proceedings. The Company is estimating the leasehold holdover charges to be approximately $900,000.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Sales and Excise Tax Payable</a></td>
<td class="nump">$ 645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_RecordedSalesTaxObligationsInterestAndPenalties', window );">[custom:RecordedSalesTaxObligationsInterestAndPenalties-0]</a></td>
<td class="nump">232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims', window );">[custom:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims]</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth', window );">Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health</a></td>
<td class="nump">$ 63,000<span></span>
</td>
<td class="nump">$ 87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=us-gaap_EmployeeStockMember', window );">Employee Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems', window );"><strong>Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EmployeeStockPurchasePlanEspp', window );">[custom:EmployeeStockPurchasePlanEspp]</a></td>
<td class="text">The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EmployeeStockPurchasePlanEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The stockholders of the Company approved the 2000 Employee Stock Purchase Plan (ESPP) at the Companys annual stockholders meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect as of June 30, 2014.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EmployeeStockPurchasePlanEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LitigationSettelementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LitigationSettelementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatementFromSuffolkCountyIda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RecordedSalesTaxObligationsInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded sales tax obligations of interest and penalties. Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RecordedSalesTaxObligationsInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. The reserves are included in Other current liabilities' in the consolidated balance sheets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593987704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</a></td>
<td class="nump">$ 75,178<span></span>
</td>
<td class="nump">$ 137,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="nump">$ 261,032<span></span>
</td>
<td class="nump">$ 228,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">102,364<span></span>
</td>
<td class="nump">89,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">$ 1,940,821<span></span>
</td>
<td class="nump">$ 1,990,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfLeasedAsset', window );">Amortization of Leased Asset</a></td>
<td class="nump">1,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SellingGeneralAndAdministrativeExpenses', window );">[custom:SellingGeneralAndAdministrativeExpenses]</a></td>
<td class="nump">$ 602,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfLeasedAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense charged against earnings for the periodic recognition of capitalized leases. This element may apply to energy companies that lease mineral producing properties and to other enterprises that capitalize property, plant, or equipment obtained through capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123406127&amp;loc=d3e45031-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfLeasedAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588579976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 16 &#8211; RELATED PARTY TRANSACTIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_ABillingCompanyMember', window );">A Billing Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related Party Transaction, Description of Transaction</a></td>
<td class="text">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#8217; Compensation claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2021 for another year.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember', window );">Bensonhurst M R I Limited Partnership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related Party Transaction, Description of Transaction</a></td>
<td class="text">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123395306&amp;loc=d3e36975-112693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919370-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918703-209980<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123417830&amp;loc=SL77919784-209982<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_ABillingCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_ABillingCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169589930888">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 89,929,765<span></span>
</td>
<td class="nump">$ 85,690,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">901,250<span></span>
</td>
<td class="nump">875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,097,615<span></span>
</td>
<td class="nump">13,650,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,081,687<span></span>
</td>
<td class="nump">3,908,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83,277<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">189,506,195<span></span>
</td>
<td class="nump">180,283,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,696,796<span></span>
</td>
<td class="nump">7,422,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember', window );">Manufacturing And Servicing Of Medical Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,037,091<span></span>
</td>
<td class="nump">8,463,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">901,250<span></span>
</td>
<td class="nump">875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,410,189)<span></span>
</td>
<td class="num">(6,425,411)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">264,830<span></span>
</td>
<td class="nump">368,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83,277<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,592,582<span></span>
</td>
<td class="nump">30,492,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">291,294<span></span>
</td>
<td class="nump">2,440,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,892,674<span></span>
</td>
<td class="nump">77,227,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,507,804<span></span>
</td>
<td class="nump">20,076,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,816,857<span></span>
</td>
<td class="nump">3,540,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">164,913,613<span></span>
</td>
<td class="nump">149,790,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,405,502<span></span>
</td>
<td class="nump">$ 4,981,773<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intersegment net revenues are the transfer or exchange of goods for monetary compensation between the management and diagnostic imaging center segment and the manufacturing and service segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593532104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">[custom:ForeignProductSales]</a></td>
<td class="nump">69.30%<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DO', window );">DOMINICAN REPUBLIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">[custom:ForeignProductSales]</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">[custom:ForeignProductSales]</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">[custom:ForeignProductSales]</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">[custom:ForeignProductSales]</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Product Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169593948440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GR', window );">GREECE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Service And Repair Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588544200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ExportSalesOfMedicalEquipmentPercentage', window );">[custom:ExportSalesOfMedicalEquipmentPercentage]</a></td>
<td class="nump">69.30%<span></span>
</td>
<td class="nump">20.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage', window );">[custom:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage]</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportSalesOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportSalesOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594559640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 29, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1', window );">Right to use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1', window );">Right to use liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,219)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,269,277<span></span>
</td>
<td class="nump">283,880<span></span>
</td>
<td class="nump">$ 3,985,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,122,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition adjustments included in property, plant and equipment (PPE) for utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169594066808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 18 - ACQUISTION - Net assets acquired (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 29, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="nump">38,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ClosingCostsExpensed', window );">Closing costs - expensed</a></td>
<td class="nump">3,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">283,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_BusinessCombinationContingentConsiderationAsset1', window );">Cash Consideration Paid</a></td>
<td class="nump">1,125,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Customer Lists [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Covenant Not To Compete [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BusinessCombinationContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BusinessCombinationContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ClosingCostsExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ClosingCostsExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169682043752">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 514,561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 190,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">380,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,291<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">55,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">442,270<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">514,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember', window );">Management And Other Fees Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,063,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,404,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,723,645<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,526,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,868,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,786,878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,063,233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember', window );">Management And Other Fees Receivable Related Medical Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,322,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,310,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">862,344<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,011,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,184,399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,322,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">777,354<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">777,354<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">777,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_MedicalReceivablesMember', window );">Medical Receivables [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 777,354<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">777,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 777,354<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
  in provision for bad debts.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Additions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Deductions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_MedicalReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_MedicalReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169588760728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,929,765<span></span>
</td>
<td class="nump">$ 85,690,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,832,150<span></span>
</td>
<td class="nump">72,039,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,673,811<span></span>
</td>
<td class="nump">11,704,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_QuarterlyFinancialDataMember', window );">Quarterly Financial Data [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">$ 24,697<span></span>
</td>
<td class="nump">$ 23,090<span></span>
</td>
<td class="nump">$ 21,164<span></span>
</td>
<td class="nump">$ 20,979<span></span>
</td>
<td class="nump">$ 20,806<span></span>
</td>
<td class="nump">$ 21,686<span></span>
</td>
<td class="nump">$ 21,451<span></span>
</td>
<td class="nump">$ 21,747<span></span>
</td>
<td class="nump">89,930<span></span>
</td>
<td class="nump">85,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">20,853<span></span>
</td>
<td class="nump">18,968<span></span>
</td>
<td class="nump">16,182<span></span>
</td>
<td class="nump">16,829<span></span>
</td>
<td class="nump">20,278<span></span>
</td>
<td class="nump">19,071<span></span>
</td>
<td class="nump">16,430<span></span>
</td>
<td class="nump">16,261<span></span>
</td>
<td class="nump">72,832<span></span>
</td>
<td class="nump">72,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 2,196<span></span>
</td>
<td class="nump">$ 4,299<span></span>
</td>
<td class="nump">$ 3,928<span></span>
</td>
<td class="nump">$ 3,251<span></span>
</td>
<td class="nump">$ 1,076<span></span>
</td>
<td class="nump">$ 1,914<span></span>
</td>
<td class="nump">$ 4,209<span></span>
</td>
<td class="nump">$ 4,506<span></span>
</td>
<td class="nump">$ 13,674<span></span>
</td>
<td class="nump">$ 11,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_QuarterlyFinancialDataMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_QuarterlyFinancialDataMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140169695677288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 21 &#8211; SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings', window );">Debtor-in-Possession Financing, Fee on Unused Borrowings</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Proceeds from Loans</a></td>
<td class="nump">$ 700,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fee on unused borrowings under debtor-in-possession financing arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>100
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MI\T)  #X+@  &    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;+6:6V_;.A*
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MD##S3:NBZ?Y'#UM9/$+3==-6R^U@T&"9EYN_V;>M(W8&$!X80+<#Z+$#V'8
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M:22]]=7 2+D^H)ZO&)//"SV2%"/HZ!]02P,$%     @ P)9,4^2AA+?M!P
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M+#:HQ0^A;F21*3E'RZR!\GHW&F%/ 8[@;Q#,NV9O8DDVL23!6"ZS"H2CU(M
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MSP5/*C!4D$3IX3O\7@W$$<#L A@5P)  AM$!,"N *6? '0"K E@RP.X T I
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MIR7PT:(L;$@# X'GA5X41@VD%CL_\KA*?!O2\(0T?".R*Y'G,'O'F8V_ T?
MY-JPA@8&&GH>R$P#J\6.D#"DD1UK=,(:.;&.-43(!I$^Q8N-=0U%QOA^  "\
M!DS3S*-A2#P[2H(U$6,GSOY9<B*ED4J NG+5W1<"Q44A[)EPZ/4<#^%>B#W6
MP&TSQ-CS_)9<(&<20IS(!W(+NXHB+F7^@D"@%0L@N4(@7LDWE!;%/LX284=/
M#% AHT%SP;D!J*W.1;&+$W'5@15?B/Q)=*Z1@T$(U;Y1IV_SDP^0[6I9)K(
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MX@IUNHT?%<LE %;D5KBF='4)H=3#37)S#_OCG,"T"+(W1!!*V"I]VNM"9I-
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M7S#K;NK[[B]Q#CN# LAU!5WB3P$$-Z^OD.N74NZJ6]B%+*$"K1[7(EZ*7!G
M[RLIR^.+&N!TD7_]#U!+ P04    " # EDQ3(Q?CWXT'   8$0  &    'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;+U8VVX;.1)][Z\@M)A%!I!ULY,X$]N
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MQP(51HXW8'UMD1WM"ROH_QER\5]02P,$%     @ P)9,4_$4!6%^&P  _$T
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M9T/*8C6*VFM]ASEV8G86]"-8*+.&<&U5M^H3U81OHF7E:RX5]ZF1*SQ_AB1
M(;QNFQXM?0/J7* >"DD%\\TBSECKCWGSA1GY7/5;&:B-DAJ'J8^!^7:0T;VB
M=D"6U*.0MYTM\@CDLQTS"Y/9C NGE;A;:)VSH^0$&D348V=$(>VW*]^9/V''
M&G*<>SW"9^/D?/B,@Q,I#.&DB 5'2<$S!++3H11671%;,<0QS7.*]D-)@#UY
MR%#5 GKF/OM#;4P]@D9C_=\LMOS'H6M$96_^/^"*^]$$D1FU,TB:Q=V5B6Y7
MN?A&TG(/2O7?WLS$;69R9#.^-3VL_1?V=&>,>@\XI2?],MR#2RWS6.!]>>G
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MVKN#T32QW8UQ*BAN<W822SH0&J/'0V].G8HL0E\I[W#9Y5)$HI0-!P*B4W:
MLCIU'2<.0B![%RD8Z5+"$O5Z;6KND;^1KLM/:?.%"A?V!CG3^_I:M-@JG[--
MUAH_;,ZFW_J0SIGD8<O,PXL82N2(V YT1CXGG!^6H5_!L>TUMNWRA5Y56ZIM
M)G%FQ@?",V@9GMK@K(QPI.OG$9GE/?50B9)?=C'9GFV*]F@OL_GV)-?.3$<"
M?NRDH3-4;FU9B',45>U2%"4W:!ZE6'F*-WW<P4RR%C7N@.X;U>_XN1@Q!UR:
MM53W&3\X].M0I]$O<I'8\.^.\6^3E*W\.)?_UO^TV97\HE=X77X7[5U*4D>]
M1PL,'0XNIH]T+;\U)A_::L._[S6KVK9:\Y\KDV:FIA?P?%$!\]H/M(#_P;>?
M_A]02P,$%     @ P)9,4_F-?B,9"0  IA4  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&ULS5A9C]M&$G[GKV@H!VQ ,SKFL#T7H)$UFUEX#LR,LU@$
M>6B1+;%CDDUW-R4KOSY?59,4E<A&\K# /G@LDE75=7SU59$7:V,_N50I+[[D
M6>$N>ZGWY=E@X.)4Y=(=FE(5>+(P-I<>EW8Y<*55,F&E/!N,A\/302YUT;NZ
MX'N/]NK"5#[3A7JTPE5Y+NWF6F5F?=D;]9H;3WJ9>KHQN+HHY5(]*_^Q?+2X
M&K16$IVKPFE3"*L6E[W)Z.SZF.19X&>MUJ[S6U D<V,^T<5M<MD;DD,J4[$G
M"Q+_K=1491D9@AN?:YN]]DA2[/YNK-]P[(AE+IV:FNP_.O'I9>]M3R1J(:O,
M/YGU3ZJ.YX3LQ29S_%>L:]EA3\25\R:OE>%!KHOPO_Q2Y^'O*(QKA3'['0YB
M+]]++Z\NK%D+2]*P1C\X5-:&<[J@HCQ[BZ<:>O[J_N%E)H[$C]^]'8]&YV(R
MG3Y\O']Y%D^SZ>SVY\GUAUE?W,W>WTXG'SKWQ.3^O;B;W$_^-;N;W;_PY</+
M3[,G<3.;=94O!AY.TE&#N';H.C@T_HI#H[&X,X5/G9@5B4IV#0P071OBN GQ
M>OQ-B_^NBD-Q-.R+\7 \^H:]HS9E1VSO]"OVGE2L]$K.,^7$+Y.Y\Q;0^O4;
MAH];P\=L^.C_IQ;?=(@(X<R5,E:7/72\4W:E>E>"W(S^=VZ*21R;JO NVB9:
M3*U*M(^L=I_0(#X%'[@2C2V\$3[%<Y.7LMBP3V_.'9H]V(!<:\.J3'J5D$II
M35)!VTDJHBP20<'I6/%OJTJIK5@H/--.9#K7I)=4JCXN"HVIK)#)2A:Q:LZ!
M5&FUL8U;L<E!8+'"'R_,@AE*E,H2F4*6#B.QN<Z0^B5)R#SX#0/-(7#0@33G
M!](YE<\S32Y;.(&8,P7/#L7S5[R'&!O'6<2 (J?.RC8"'GZNI/7*X@*DIEWK
M2YU)D1CH%\8CAL+K K$C:2N=D)^0<ZI)F8OT8F^^YPH>0DTZ3[D[%"\=\V35
M@KM$S)45>RN[S^K"FGQ/M2*.UZ?65,M4:-\:5BN959(G  * NZ[?/.+"XA)9
MT=Y8BHQ%DLK6J,"8<Z; N1OA4F,I&5DS3Y"\W.T&55?61:98&C)7'R0K#VW]
M.[OAD!A(P?D_P9!3 BHAS $O"KI"%T@#JO4U>%*!0UT(!A]P;O0"O]H>$IT>
M@J=1X^D:H!!+52B+EH#%E:(*<VXS&#F@X/HH?W$0$[ZSC"TT'KJZA^C8?:XU
MR#@4-Y5',ML#H#97$:IIEH7^G5"Y0A,1[!9(K%E3SA:FLF*C).'>"Y"W:LF;
M,H->"++NK$,0+CH0]RC*M+*6>NU %,I'T#D2WXM1?S@>]D?'0[IQO'MY(D[>
MO>N?')_0Q:D8G0[[I^_>1"_&RPRJX_[;X;!_,L900B5CF75)J;EE.P.!"D)$
M46%X<8T.4.N#)D?;!'*J?:HM& .-".S(C;$ HZOBE(),C2LUG,"M)66I8 YQ
M)0!D"!FIDIE/XQH 2RMSUX]*( QB+0UF:HDP" K8@[A"B8:W'GAF!VIY%.JY
MPB"3Z'29X2'^<%6:N@7J#&6O5:A/ QOH0MQD@'<BN1LB^&0W]"!P&;$:V<I#
MMKJ]K,D*.@#AS'%H0>>:-0$.&B@^%C3J-H>%I\"&F'=#FRO0"O[IG!!<G]&R
M)[0CQC@QV%PU?4M-TFW81!'0,?7<]FC"EVTK5<%CF?P&*LXY:LIA530T0$&T
M)$7+(?,L\9=>Z%C()=* LK0WN,A=$M'.52KX*U*Y(M)4N)O@+"C4(Z(U7*MG
M& 1DKJ83$DFU(P:C_*HOH"%-4X?Z1TG R6%^'8J[-HD1J3P@85;<$(OL)XDV
MU5U\U[C=3E,R13S17 .,"Y L/&/DV=+8VL]79' \/'^<.OXU.G]-8ZT#.R0=
MHX@10^P6X26"GC+*0D-M@8#D6L6_@-Y'N6E&+/G6U6NF>*+P'I.P4-&M (!'
M*G"J.?8OO1EMH:OS>65=/<_M4A8-J?=I\!>Q+CD07;C*,HYCSJ6NYTEHVFX4
M.T;:0**F9[:"\&Q_(1ZG;:%RN2&PZYQ8.#0526A,,)UID$QMMJ-">T9(!O6Q
M%.@GA0!P,&9#!&'0>1-^-SEJ+WG1E8ZK3-K=)( 1-"TR,3$94T.%U<; *P7P
M'/ [%">(%J0@F*-<CM,2 ? Z=\W^1?,)2"CKDL>;N-GAK%X:S'^4NPAOJP&$
M5GVND(YM_\;*>KRN"L,=D&C'O8]\A8,.Q:0$BK\PLR".TQ/Q W?,Z:GXH1_5
M^PF6O6S3WV;4U2D-@XK$\6-(8ZAA42?6BJ8#,D"+(B=R)WCTK6./=?%;93?4
M2KY&:>-9A[PB[I:$LL74MZPW2-I]]BU."+BANWJ'ZQ#TEGB)_!)3S?VBREH[
MNZP9]@;"N9>?T*8T+7C2T.1821V6!>=5N8NO'7]@<UJO809[+0UV9V+-',)[
M8""9W<G:K#KL)0(*.S8F8H;I \UH :RC"Y%#$(#OU)S)=<N2M/82T]))L+-G
MOA"-QK[IRWML$VT9N7)=)H+]@"7ND#B5=AG>,[I$&3JEZ:62A@OM2$V.ZZ#D
M#O3P,AR@1S_Z#2MT(]X%&%D@B; ^$=\E?]J@&F#V11?'J"]R(E-ZPU#1G5S"
M*L;5DR(\$BIN<\977SQ.^N*9N%5\+,7=TRV!Y]K$4CQ);PIZSD?LB/PH\_)<
MO-<P:QS9G?)ZR\*O"#Q[4Q2U*7J]NPY+L<2["X;&9CL#0#W@Y0HW*>WK5,<,
M((P4"W0U"HKF%<[;I557RS/ Y(;!N_M:V8^"!(-(XE4%R GSB,>KQJ0!+&E5
MV#>?PE:T77!]: _EN5XUTHLJG\,>LDGK[T+&1-CZ'Y7T,&RMT4VK'-T8YG#Q
M7RB'[RFM;L2ZI/<7-?&P+FCAL/7*D*!*7EPK(*"H288,OA;8GL>GW?,F2<)C
MYRR:Q"!=[!U$7J/PK6!\'MU2'<%P40+$9J;D1&T?U\=U79F"'6"REA"O1N+U
MW_1W1EW9>OJ&G-WWC6;0^7:&E^TE?R%TO#/[\!FMO=M^A)R$;V];\? %\PY]
MCZ$'+EQ =7CXYJ1',REM+[PI^4O<W'B,/_Z)C0 X(@$\7Q@0?GU!![2?9J_^
M %!+ P04    " # EDQ33//G,@H#  #*!@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6RU5=V/XC80?\]?,4JKZDZ*-A\$DMT"$G!4I=K;72U<^U!5
MJDD&L"ZQ4]LYMO]]QPYDJ;2+^M(7&#OS^YAQ/!D?I?JJ#X@&7NI*Z(E_,*:Y
M"T-='+!F^D8V*.C)3JJ:&5JJ?:@;A:QTH+H*DR@:A37CPI^.W=Z3FHYE:RHN
M\$F!;NN:J;_G6,GCQ(_]\\8SWQ^,W0BGXX;M<8WF2_.D:!7V+"6O46@N!2C<
M3?Q9?#=/;;Y+^)7C45_$8"O92OG5+E;EQ(^L(:RP,):!T=\W7&!562*R\=>)
MT^\E+? R/K/_Y&JG6K9,XT)6O_'2'"9^[D.).]96YED>?\93/4/+5\A*NU\X
M=KDI*1:M-K(^@6E=<]']LY=3'RX >?0.(#D!$N>[$W(N/S'#IF,ECZ!L-K'9
MP)7JT&2."WLH:Z/H*2><F3X\;I:0P@_?Y4D<_PB+QX?-\VRQ@=EZO=RL8?;P
M">Y7L_GJ?K59+=?CT)"F18;%B7_>\2?O\,<)?);"'#0L18GEOPE",ML[3LZ.
MY\E5QE]:<0.#*( D2N(K?(.^ P/'-WJ'[QGW;<4,EO#8H&+V7='P^VRKC:)7
MYH\K"FFOD#J%P?_6XZO\]M[>Z885./'I8FI4W]!WHMY_%H65Z"XX5>\II'YP
ML0<CH16%K)L*;7\*.DC;$PU,@]P!G03V)P%,E#:(@&WI\O?)E*O10L0K 7RH
M.-ORBAN.^B-P1[B3%4T(?>?]N9#::,\"EMKPVIW-DBE!EDA7P)<+3XNS)V^F
MO0M/GO-D_7@='1=%JQ0AB.#MHKZ'Y#8-LGQ 49KF03K(O-Z AV<#PU$6W&8Y
MB=P&29I[KVZQ=XL7;M\6RT=)D(UBR(99,,J'WCUJ*GW.J\KAJ/,E,4&>9<$P
MBF 4I4$^3*Z+<0'X4A"1/9SMF>I*O1]BJG=P"Q\ICH=)D \&\-;['E[,EQK5
MWDU1352M,-VHZ7?[03WKYM-K>C?E/S.UYW3!*MP1-+K)ACZH;G)V"R,;-ZVV
MTM#L<^&!/C:H; (]WTEIS@LKT'^^IO\ 4$L#!!0    ( ,"63%,J'R SH (
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M ,,(;F5K*@WKMN3E:P ?HQM#C$XA7D=O(O[4MU<0!Q2B( K?P(O'E&.'EUW
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M*WQ/ML]AK<)LV#DD((,DSQ6CDYII?UOJ[1OV#%:&IJ!>+'2F28QG.,@3=8^
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MM47#!G2^U=H=%QS@]'Z/_P%02P,$%     @ P)9,4\V34& ;!P  XQ   !D
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MOW2@)LT:]X]:V(W0$UQJU#_>8C#JP<<+I"]1A4?R\Y;"E0:V,'9_M?4FL,7
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M/^*@1_(5DQ&PO,X&;%SAVQ)I) HP7">"_HHXWFB+V-!GV!0:IEGY_GN,YKU
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M*M,UW@#7EQ5@<?L%!_!O:_[E_P!02P,$%     @ P)9,4\"/NT7)!   _0L
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M[JM8#_.-@WM[4W]G)$->EW[P-."'BW8ZZTZ[V7;4CG3/S]O!^(KII9 &*KY
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M+(IA)H79:DA%COG/  &UV?0:O_0ZB4\B_K47%] -.Q"'<70"K]O,KNOP!K_
M6V"&_-GU!_\F*VT4W;'_3@#W&N"> ^Z^ ?@/F-/EG>Z50F'($FB.S?(DH'W9
M-WK',ASY]'0UJF?TVU6\(U4\FE(7?H.H$\9A)^J%UM'[V>Q#__JZT^_UK3&
M:!!V!M>7WE(:5E!JW+D*PTX_CN'$4/K-4/HGAU*!WK&,%]QPU,>F<!+A^!0<
MK/<*Z]%C]\P6X1]DJKIZ0!<'[<6Q74;V]H3>_]/@X2 H4BJ8,4%JEL,9,S#!
M#1>"BPW(M0,\!YI9/&C72W);8O7]QDNRKWNNN5.KJ'J2\7OO7AA4@HKE^$P:
MNBOM";UNU^7:5*:%U 191\!9!.=OY$OMMIA>6K+'3BYHZ4V):N-454,F]\)4
MTM-X&^%.*KUZ#:]4?\84C4A#@6M*#2\NZ0A5I:258>3.J==*&M)"M]S2QP>5
M#:#]M93FQ; %FL_9^ =02P,$%     @ P)9,4_Q)U>#7 @  (08  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&ULE55M;],P$/Z>7W$*"($4+>]--MI*
M;2FB:&S36N #0L)-KFU$8@?;6<>_YYRTH4A;);XT9^>>E[O:E^%>R)]JAZCA
ML2JY&MD[K>LKUU79#BNF+D2-G-YLA*R8IJ7<NJJ6R/(65)5NX'D#MV(%M\?#
M=N].CH>BT67!\4Z":JJ*R=]3+,5^9/OV<>.^V.ZTV7#'PYIM<8GZ<WTG:>7V
M+'E1(5>%X"!Q,[(G_M4T,OEMPI<"]^HD!E/)6HB?9K'(1[9G#&&)F38,C!X/
M.,.R-$1DX]>!T^XE#? T/K*_;VNG6M9,X4R47XM<[T9V:D..&]:4^E[L/^"A
MGMCP9:)4[2_LN]PXMB%KE!;5 4P.JH)W3_9XZ,,)(/6> 00'0-#Z[H1:E^^8
M9N.A%'N0)IO83-"6VJ+)7,'-G[+4DMX6A-/CF]O5'")X]2(-?/\MS&YO5O>3
MV0HFR^5\M83)S3NX7DRFB^O%:C%?PNL56Y>HW@Q=3>*&PLT.0M-.*'A&R _@
MD^!ZIV#.<\S_)7#)=6\].%J?!F<9/S;\ D+/@< +_#-\8=^*L.4;/,-WC]NF
M9!ISN*U1,G-H%'R;K)66=':^GU&(>H6H50B?4?@Q$THK8#R'N=)%U8K-F>0%
MWRJ@,_J99Z*J2S3[,^J6$59/]?JLCKG(5ZIF&8YLNJD*Y0/:!W'K/\6MB;+$
M!JC7:'IMF5Z;AGM61U?PK)&2$$30G!!D1P)X"<%EY"1I2%$4I4X4)E9OP,*C
M@7B0.)=)2B*73A"EUE^WV+O%$[=/BZ6#P$D&/B1QX@S2V+I&I:ZL:5&6+4X+
MR(D)TB1Q8L^#@1<Y:1R<%RLXX&-&1$"-6!^ISM3[VJ=ZPTMX0[$?!TX:AO#4
MZ7%/KFV%<ML.)T54#=?=#>YW^_DWZ:[]W_1N>'YB<EO0<2UQ0U#O(J%Q([N!
MU"VTJ-LAL!::1DH;[FB&HS0)]'XCA#XNC$#_51C_ 5!+ P04    " # EDQ3
MC#2SF7H"   .!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6R%5-MN
MVS ,??=7$-XP;(!;7W-IEP1(N@S+@+9!V[4/PQX4FXF%RI(GR4W[]Y/DQ,N
M-GN)28GG\) A-=H*^:A*1 W/%>-J[)=:U^=AJ/(2*Z).18W<W*R%K(@VKMR$
MJI9("@>J6)A$43^L".7^9.3.EG(R$HUFE.-2@FJJBLB7&3*Q'?NQOS^XH9M2
MVX-P,JK)!F]1_ZB7TGAAQU+0"KFB@H/$]=B?QN>SS,:[@'N*6W5@@ZUD)<2C
M=1;%V(^L(&28:\M S.<)+Y Q2V1D_-YQ^EU*"SRT]^Q?7>VFEA51>"'8 RUT
M.?:'/A2X)@W3-V+[#7?U]"Q?+IARO[!M8]/$A[Q16E0[L%%04=Y^R?.N#P>
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M3EGY @  408  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULC55MC])
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MT 99+[!:T&)?+8V5T+2"JN..=CY*XT#VC1#Z)!B"]E]D^!M02P,$%     @
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MM+TP7,*+6!A_ /;G6KN'B7<PO+&/_@502P,$%     @ P)9,4X=P9; Y P
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MKY[G$#(-_HQA5BK@M@_@.N5H.SG:SF^@W<-X*SP#;L0GL/N*Q+O0.*Q V3E
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M-&8S>5P#0^HT"_#]4@C],C &\CO"_G]02P,$%     @ P)9,4VP'XOUE @
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M2+O O%\*H5\+>P'4UW?\%U!+ P04    " # EDQ3\D9HT?P"  !G"   &0
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M>#\&'W[Y.#"EFI&.:X;K[.=E=KPG^^<\/0$6_ 0PQ*C#_>)P=[CM;JHZ5,7
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M5#YT+AS(<$WJ0BWY]@.V]5B#*2^D?<*VR0U]!]):*EZV8.V@I*QYDZ?V'/8
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MWD0S"IJ-XI7MIA57NC?M,M?3$X5)T-_7G*O=Q@AT\SC^#5!+ P04    " #
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M_P4?J=@63.(MR9""<Q7A513-K&T$3-!,GP>N<):998Z_)R"T >YG'%M?*^@
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M@8-$(_;&4;RT MMRI>5JS5S?#R!,@-[?<3W&UC$$W8T3_P502P,$%     @
MP)9,4[:O9D^! P  S P  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N>&UL
MO5??;]HZ%/Y7K.@^;-+:V/F="I H=!M3QZK2[3Y<W0<#!["6Q%S;E&U__6PG
M#0%2+IJJ]J'$Y'SG?.?[G!/3V7+Q7:X %/J19X7L.BNEUE>N*V<KR*F\Y&LH
M])T%%SE5>BF6KEP+H',+RC/7PSAR<\H*I]>QW]V)7H=O5,8*N!-(;O*<BI_7
MD/%MUR'.TQ?W;+E2Y@NWUUG3)4Q ?5W?";URZRQSED,A&2^0@$77Z9.K(8D-
MP$9\8["5C6MD6IER_MTL1O.N@PTCR&"F3 JJ/QYA %EF,FD>_U5)G;JF 3:O
MG[*_M\WK9J94PH!G?[.Y6G6=Q$%S6-!-IN[Y]B-4#84FWXQGTOY'VRH6.VBV
MD8KG%5@SR%E1?M(?E1 -  F> 7@5P#L7X%< _UQ 4 $"JTS9BM5A2!7M=03?
M(F&B=39S8<6T:-T^*XSO$R7T7:9QJC?^\G"#$G2!OCQ\O+E'H_%#?_QA='U[
M@_J3R<W#Q-Q1*Q!H5"BZ9-,,4%]*4!*-]:;D"]3/N6"*_:+6QC=#4)1E\JW&
M?9T,T9N_WG9<I7F::NZLXG1=<O*>X?1I4UPB'[]#'O9("WQP/ARWP(=GPTFZ
M#W>UN+7"7JVP9_-%S^1[SPJFX.)6;^^Y5;'8D_&?6QV/1@IR^>^):GY=S;?5
M_&>JE6:Q71E:EKE 2\&E;#.C3!C8A&9,//:T<&D:^[K[QZ;LQX$D39,HC)(Z
M<(]S4',.3G*^!2FO4'\VV^2;C"HM$]6;ZFE/M5$N\X5-)I$7>23 !Y1; L,D
MCH-&;WN4PYIR^(<R%Z#:&(='1 +LQV%ZJ'%+',$I\0[BAN&1%T$<AE$<MO<5
MU7U%)_N:\(7:4J'[*>:H7@SA4;\@UGK<*S3@TNS:SY!/09S:L7%=,GZ%YR.I
MJR4O_7PD1Y;$& =)$!]8]_]Q>XS3FG%ZDO&=?B**\R0G>#?U\2N(3AIO&?+2
MLE<9FWJ&7A DJ7>@>UL@3DALWAUMPI/=Y";>2=9C7LQXO@:EA5D*@/QL(W;C
MFOBO8<1NU)+3L_9/C#@>H@$)L?X[-*(M$.\%[K/>35MR>MP.[$%($[^'S+X4
MY(JMSW-B-_E(]!I.[,8>B5_<B?AHZOLI;G.B)3!I<\)MG!S-.?\S%4M62)3!
M0B/Q9:Q]$>71N5PHOK:'R2E7VA%[N=(_-T"8 'U_P;EZ6ICS:?T#IO<;4$L#
M!!0    ( ,"63%-?Z9='300   <4   9    >&PO=V]R:W-H965T<R]S:&5E
M=#8R+GAM;+V877/:.!2&_XK&LQ?MS#:V)/R5 6;RU2V=-,D$VE[L[(6  WCJ
M#U86H?OO5S*.1<:RG' 1+D"V]>H].I8>) WW!?]5;@ $^IVE>3ER-D)LSUVW
M7&P@8^59L85</ED5/&-"7O*U6VXYL&4ERE*7>%[@9BS)G?&PNO? Q\-B)](D
MAP>.REV6,?[?):3%?N1@Y_G&8[+>"'7#'0^W; U3$-^W#UQ>N4TKRR2#O$R*
M''%8C9P+?'Y% R6H:OQ(8%\>E9'JRKPH?JF+R7+D>"HB2&$A5!-,_CS!%:2I
M:DG&\6_=J--X*N%Q^;GUSU7G96?FK(2K(OV9+,5FY$0.6L**[5+Q6.R_0-TA
M7[6W*-*R^D;[NJ[GH,6N%$56BV4$69(??MGO.A%' CSH$)!:0%XKH+6 5AT]
M1%9UZYH)-A[R8H^XJBU;4X4J-Y5:]B;)U6N<"BZ?)E(GQG?WLQL4H4_H?O;E
MYA%-[F87=W]-+F]OT,5T>C.;RB<R77O&E^A6OHLD7Z.I'$K+70JH6*%[L0&.
M)KE@^3J9RWL790FBE*H/UR!8DI8?9?G[]!I]^./CT!4R8N7K+NKH+@_1D8[H
MON[R,T2]/Q'Q"#;(KUXO]U[*79FG)EFD21:IV@LZVON<Y(F 3[=RX"T-G?[[
M5M9'$P%9^8_%C39NM'*C'6XR:&)*V4$UJ%1JECZ-!X02+QZZ3P:W0>,VZ'.C
M)K>#RC]RHU&,@\CLYC=N?I_;P.3F&]RB* C-;D'C%O2Y^2:WP.!&8TS,;F'C
M%O:Y!2:WL.T64J(&ILDM:MPBJ]M,3D!@*P'<Y!FU/(D7QD2]:I-IW)C&5M/#
MM$_T#&#/TSX'88HC;L4Q\&CHQWK0'N9SW![;V)-OI&-P8T]CSK-&_, $Y&J.
M?H-L#MPV/_$1._$[\ !K_&!R$A%JV7%Z<>2'74C FD"X%T%&*-2REX;=5, :
M0KB70D8NX#:&L 4,6',(]X+(B ;<)A&VL %K%.%>%AGI@-LPPA8\8$TC;,>1
M'1"X3:4P\#T_Z+#56,)V+KT9$;C-*CF@_)AVI5S#"MMI=5?DBR+;@I S<\T!
MLM>2@&B\$.\=2$ T>0@^B02U[.6?C.]U#")RM/#I)8\1!':9VH.<EUNV@)$C
M-QDE\"=PQLB6 8TFTHLF(RGLLA,BTNPBO>PRHL0N.R$B#3?2"S<C:^RR$R+2
M]"-V^MEA9!>?$)>&)+%#\LVT(J;57/=$T]@D=FQ>55L^&<LCI$QM=,M-LGT=
MK#0/2?P>VQ@-1VI?>W5N9#S#ZE1]S$FDFHZTEXY&6M$V':V&&H^T%X]&&-'V
MPLQJ>+0U[*6?D36TO3"S&FJXT5ZX&5%"VPLSJZ%F%[6SRTX*:EB>43S 70M"
MJ@E%[81Z,PGJ]H[W+,08BGMT2J..R+XQOD[R$J6PDDKO+)2]X8=3I\.%*+;5
MP<V\$)()57$#; E<59#/5T4AGB_465!S]C?^'U!+ P04    " # EDQ3LZ"I
MA L#  #_!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6RM5=]OTS 0
M_E>LB <FP?*K2;JIK=1N90S!-JT;""$>W.326G/L8+L+\-=S3K)0NK3PP$MS
M9]]]]]WY>C>JI'K0:P!#OA=<Z+&S-J8\=5V=KJ&@^EB6(/ FEZJ@!E6U<G6I
M@&:U4\'=P/-BMZ!,.)-1?7:C)B.Y,9P)N%%$;XJ"JA\SX+(:.[[S='#+5FMC
M#]S)J*0K6("Y+V\4:FZ'DK$"A&92$ 7YV)GZIV=#:U\;?&10Z2V9V$R64CY8
MY3(;.YXE!!Q28Q$H?A[A##BW0$CC6XOI="&MX[;\A/ZFSAUS65(-9Y)_8IE9
MCYVA0S+(Z8:;6UF]A3:?R.*EDNOZEU2MK>>0=*.-+%IG9% PT7SI][8.6PY^
MO,<A:!V"78?!'H>P=0CK1!MF=5KGU-#)2,F**&N-:%:H:U-[8S9,V%=<&(6W
M#/W,Y.KZ;DZ&Y#6YOGL[OR675W?3JXO+V?LYF2X6\[L%WBRP<[(-!W*=DTMA
MJ%BA/-4:C,;;E^=@*./Z".7[Q3EY^>)HY!ID9O'=M&4Q:U@$>UCX ?D@A5EK
M,A<99'\"N)A2EU?PE-<L.(CX;B..2>B](H$7^#V$SO[=W3M )^S*'-9X\1Z\
M"RFSBG%.J,C:(K+E[S*>,YURJ3<*R)?I4AN%W?WU0-A!%W90APWWA)U13D4*
M^#185R)S\AFHZGN>!F90P]@__N-DX'LG?G R<A^WJ]9CET11G$2=W1\\HXYG
M=)#GM) ;@75(:<D,Y>SG;@\T+!N0:"MZZ(>)%^V0?&[F^TD4!/T<XXYC?)#C
M0N:FHOA"4I&2&K!\*\4,2EC9O(]O_(S(ZR@<[+ ]&-4.\5-=TA3&#DYI#>H1
MG DYT!I)ET[RMY(KPWY2.TS[N"?/N8?#0>+Y._1[[))XX,7#_FH/.WK#_].Y
MP^<=Z85)=++;N3UV.QW>\'2W9FD!:E6O&.Q,VZ#-^.E.NRTVK8?WSOD,MUNS
MC'[#-*OQ U4K)C3AD".D=YQ@]52S;AK%R+*>V$MI</[7XAHW-"AK@/>YE.9)
ML0&ZG3_Y!5!+ P04    " # EDQ32E?=P2L#  #A"0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6R]5MMRVC 0_94=3Q^:F32^<<T ,T!H2R>AF9"T
M#YD^"+R )K)$)3DT_?I*LN/0Q+A]:/,"NNR><W977JFW$_).;1 U_$@95WUO
MH_7VU/?5<H,I42=BB]SLK(1,B393N?;55B))G%/*_"@(6GY**/<&/;=V*0<]
MD6E&.5Y*4%F:$ODP0B9V?2_T'A>NZ'JC[8(_Z&W)&N>H;[:7TLS\$B6A*7)%
M!0>)J[XW#$_'86P=G,47BCNU-P8;RD*(.SN9)GTOL(J0X5);"&+^[G&,C%DD
MH^-[ >J5G-9Q?_R(_MX%;X)9$(5CP;[21&_Z7L>#!%<D8_I*[#YB$5#3XBT%
M4^X7=KEM._!@F2DMTL+9*$@IS__)CR(1>PY1ZX!#5#A$SQS"Q@&'N'!PF?-S
M92ZL,Z+)H"?%#J2U-FAVX'+CO$TTE-LRSK4TN]3XZ<'L\_4$.O ./E]_G%S!
M='8]G'V8CLXG,)S/)]=S>'N&FE"F8$:D)#;G1\;Z9GX&;]\<]7QM-%@D?UGP
MC7*^Z !?&,&%X'JC8,(33'X'\(WX,H+H,8)15(OX*>,G$ ?'$ 516"%H_/?N
M08V<N$QH[/!:!_#>4TXUOCLWB4I@RC7A:[I@"$.E4"NX/3?V,-68JF\U;(V2
MK>'8X@-LP^7WC$K#5-"R:MIC^.K.L]D;WJ,TWR?<*%QE#,[I"JNJ6$\;AO"
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M@.L&ZOV"J?(6-[J#\DBG]S]02P,$%     @ P)9,4W4W[U*7 @  O 8  !D
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MWJ#64\;DVT2WO/J#U?T/4$L#!!0    ( ,"63%-[0?V(&@,  .,(   9
M>&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;)U6:V^;,!3]*Q;:AU9:"^85J))(
M>;1:)_6AIMTF3?O@P$UB%7!FFZ3]][,-I5D@6;4O8)M[[CGW&GSH;QE_%BL
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MA E!QF7YSUZJ0'Q$(*H$HH\*="N![CN!\/2 0*\2Z/G(E*[X.(R899?G6JU
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M*N=DN3"R<+-I)PU-.O>8TJ<%*FM YWLIS65A ]0?*^-_ %!+ P04    " #
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MX98F'+?.KZOXO"-\$_2"<"'2M* D!^$K1Q3## 3*6409@#@! X*7%P/Q.B?
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MN-(EM=M,CWH0YH(^WW.NCH8)T/QYC/\"4$L#!!0    ( ,"63%-;AX;T[ (
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MG @] =ZO.5>'CB[\S8?!^!]02P,$%     @ P)9,4Y?6C;M# P  :PL  !D
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M>9,F^]/N_0V+U]EQ[CQF+ ZSRQ4E'DV$ 7^_B#F[Y#<B0?$WA\%_4$L#!!0
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MA85H1FW:GV%ZW;1]?;&QN,S9DN7CIJMG$]>,;,-&;2YPV$5NW!5&,!^/A1'
ML#B8 LS'>V%Q_J7Y]-'Y> S3U@\B?=2GC_IXKQ R=C<6)^R3V2L\TRQ+DC3%
M5G0\#BH88^N6IO )LV':P .+ Y%^;ZWQ;.,5LK\.L)SNJQ!LIG@E8C/%UQJ0
M\+J!1Y:%LXW% 0\L"UCM0/QP'*BIL$^20%8Q;=@.QI$LPQ"HQ7"-IBFR.BG<
MX?Q@NR1)LBR, !96D"08 KL11S %H %#DL2=@SOG4;P^I^+-?S"CGU!+ P04
M    " # EDQ3EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_
MQ=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+
MJ1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D
M5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@
M2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/
M['X 4$L#!!0    ( ,"63%.53$> 4@8  &DY   /    >&PO=V]R:V)O;VLN
M>&ULQ9M=<Z,V%$#_BL8/G71F4YMODB:9P1@G3#%X :?-TPZQ\899#!X@2;N_
MOA(>=Z4FNMD77YX<P,''0M*Y]TJ^>JV;;X]U_8W\O2NK]GKTU'7[R_&X73_E
MNZS]K=[G%;VRK9M=UM'#YNNXW3=YMFF?\KS;E6-U,C''NZRH1C=7QWLMFS%_
M4'?YNBOJBIYD)^Z+_+7]<9T=DI>B+1Z+LNC^N1[U?Y?YB.R*JM@5W_/-]6@R
M(NU3_7I7-\7WNNJR,EDW=5E>CY3#A?N\Z8KUF],)@TRSQ[8_TV6/<49!KD?F
MA-YP6S1MU[^COW]&&5]R^N;#T7-7SXNRRYM9UN6W3?V\+ZJO[#;T6XRYK]&W
MP_'UT(B7S<\T8[W=%NM\5J^?=WG5'=JQR4L&6+5/Q;X=D2K;Y=<CMW[)&_9]
MZ ?XF\-WZR@4UU+-94$O-/ZFQSLA2A0F4>#/G-2;D:D3.*'KD>3.\]*$ U0!
M0'4P0'*VS#A(#8#4$"&3E+XLO) "1G/BAV[$0>H I#X@Y!>5@S0 2&,PR"2-
M7 [2!"#-P2!=)[GC("T TCHM9!BE'E'(.9EYB1O[R]2/0D8X725^Z/&CVP8@
M;01(E4(FJ\7"B1_ZY^S?AO[<=YTPY2 O ,@+!$B-?"&.ZT8K]J!CS_7\>V<:
M>)_(@I_()]!,/D' U"DF[9YI[+@I<9*$39-..".!SV."PCFQ<7I,@V+ZX3T=
M-5'L"YU1@5RCG%@V/9M)N^,RCI9>G#[T;>=]7OE+-L)Y3,@VRHEUTV-:M D9
MI)/ZX2WY)=OM?R=S/Z1^9,<\*N0<Y<32Z5%MVJ)1>N?%])FG3GCKTX%SZ)P\
M)F0=Y<3:Z3$O**;K+/W4"7K9_,'30;I13NR;PU0^.0[M* C8(V9=,XS$\$*!
MA*.@&(<I)XC"V_/4BQ=4/M/T$V%7A$$.*4?!<(["I,-BLX5'4N<OD0YRC8(A
M&T7[;\2XJSBF4P^=P)VI+\SB*B0;%4,VBLY&3+18^.DA &)=DG51 1.2C8HA
M&\7H XSE,NCC-#JZ691&Y@$_<E0PQ\'PCF+2 1Y[01]5+AUF'ZKQ,''XJ%>%
MO*-B>$>Q6&MZMZPI^P=^1!8>.N0<%<,YBMT';%3="8M\>39(-"J&:)0+QA8$
MT9]]-CN/8C*+5M-TON(Q(>.H&,91)_1)?U[1GNC%P<,QN*##9\9C0L91,8RC
M*K0UD]4TH7$:ZY,>"RN%Z@5D&W7(#$?(NE5(.RJ&=J28&E]F@;2C86A'EHH)
MK:E!VM$PM"-+Q41,2#L:AG;^EXJ1LS2C%.VO/"186L.0CBPG$]L2DHZ&(1TH
M)Q-1(0=I& Z2Y60B)N0@;<BL1\2$'*0-F?6(F)"'M$&RGG='.^0A;<CT1VA-
M'?*0CI+^2")A$1/RD(Z2_HB1\'N/7(<LI*,D/Y*06&Q+R$,ZAH=D(;&("2[R
MH"0_DK*_B DY2,=PD#3>U'E,R$$Z2AXDPS1X3,A!.DH>),,T>4S(0?J@N9#%
M8T(.TG'6>\X_7N\Q( <9.+G0^YCB>B[D( /#0=*4C<\L#<A"!H:%#O7,#U;/
M#,A"!H:%C#Z*^Y&RT:/JA?Y?S6\J,2 +&1@6DB9MPD,'-QM@6$B*R5O(@"QD
M8%B(!9L_M=YG0"8R,$P$H8H3$V0C \-&(*K03R$C&1A& HL+/*H)6<G$L)*T
MN"!@0E8R,:PDQ>1'O@E9R<2PDA23CS]-R$HFAI6DF'S\:4)6,C&L]&:5GYS-
M\BXKRI;'A*QDHJP138ZQ"+#<;X*;X :MSPDC'3*2.6A]3L"$;&2BU.=DF,*$
M!)G(1*G/O2DCGI,X7]?5FM_Z"%G(0JG/O8.9%%^K8LMC0A:R4.IS[V"Z]6Y?
M5SPF9"$+I4+WMG;\=MZT( M9*-L39+5C?J1;D(4LE J=9.N,$!Y;D(4L% M)
MMLZ(F)"%+!0+2;;.B)C@9FP4"\D6#(2^"5G(0K&0#).WD 59R$*QD R3#XMM
MR$+VH*M$?%AL0Q:RD5:)SOE5HG,RSXJ&O&0ECPE9R$:QT!O,D'Y<UK8YCPE9
MR$:Q$,LR/MKA94,6LC$L)%W.XB<D&[*0C;).].X.+Q9_\)B0A>S>0N/^S>W-
MU2;?%E6^">E'M/3\.BO7RX:P%W8G1=4-M@=X^UR6+CT754&=;8Z_%#S^RO'F
M7U!+ P04    " # EDQ34C7&HXH"  "Y,@  &@   'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QSS=I-;J- $(;AJU@<(.VNZJKNC.*L9I/M*!= 3OM'L8T%
MC":Y_5C.PO[0+&83\:U0@RC>#8\0\/2K'MIQWYV&W?X\+#Z.A].P:G;C>/X1
MPK#>U6,[/'3G>KH<V73]L1TORWX;SNWZO=W6(,NEA_Y^1O/\=#]S\?IYKO\S
ML=ML]NOZLUO_/M;3^(_!X4_7OP^[6L=F\=KVVSJNFO!QN.T>PG43'RZ3F\7+
MVZKI7]YB$^8.$@B2^8,4@G3^H 1!:?X@@R";/\@AR.</RA"4YP\J$%3F#WJ$
MH,?Y@^(295P2)$VP)M Z(M>1P.N(8$<"L2.2'0G,CHAV)% [(MN1P.V(<$<"
MN2/2'0GLCHAW)-!;4&\AT%M0;R'06R8/VP1Z"^HM!'H+ZBT$>@OJ+01Z"^HM
M!'H+ZBT$>@OJ+01Z"^HM!'HKZJT$>BOJK01Z*^JM!'KKY&4)@=Z*>BN!WHIZ
M*X'>BGHK@=Z*>BN!WHIZ*X'>BGHK@=X)]4X$>B?4.Q'HG5#O1*!W0KT3@=YI
M\K*;0.^$>B<"O1/JG0CT3JAW(M [H=Z)0.^$>B<"O0WU-@*]#?4V KT-]38"
MO0WU-@*]#?4V KUM\K&20&]#O8U ;T.]C4!O0[V-0&]#O8U ;T>]G4!O1[V=
M0&]'O9U ;T>]G4!O1[V=0&]'O9U ;Y_\;$*@MZ/>3J"WH]Y.H+>CWDZ@=T:]
M,X'>&?7.!'IGU#L3Z)U1[TR@=T:],X'>&?7.!'IGU#L3Z)TG/PL2Z)U1[TR@
M=T:],X'>!?4N!'H7U+L0Z%U0[T*@=T&]"X'>!?4N!'H7U+L0Z%U0[_*=>@_C
MYZ$.MYZO-5[_.ZD>+^?6V^6ORZ^=DWO\BG.XKQB>_P)02P,$%     @ P)9,
M4X/1K $N @  1#$  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS=M-;MLP$(;A
MJQC:!I8L4J34(LZF[;;-HA=@)3H6K#^03.K<OI2<!&B1&@E<H._&@DUROA$'
M>':^_OXX6;\Z]MW@M\D^A.ECEOEZ;WOCTW&R0US9C:XW(7YU=]EDZH.YLYG8
M;'16CT.P0UB'N49R<_W9[LQ]%U9?CO%GWX[#-G&V\\GJTVGCG+5-S#1U;6U"
M7,\>AN:/E/530AI/+GO\OIW\5=R09*\FS"M_#W@Z]^W!.M<V=G5K7/AJ^K@K
M.W:9#X^=]>GY$J_T..YV;6V;L;[OXY'43\Z:QN^M#7V7GHI>G4\.\8;MZ3._
M.'\I<RXP[KQUX^3CQ)Q]?]SS2.;3ZRD6LBZTYU_Q)3&6OOC][#SMQC9OS([7
M^W-TAV4>/EL>E]_Q[S-^J?_./@2D#PGIHX#TH2!]:$@?):2/"M+'!T@?^8;2
M"$74G$)J3C$UIZ":4U3-*:SF%%=S"JPY159!D5509!44605%5D&155!D%119
M!45609%54&25%%DE159)D5529)44625%5DF155)DE119)476@B)K09&UH,A:
M4&0M*+(6%%D+BJP%1=:"(FM!D5519%44615%5D6155%D5119%45619%54615
M%%DU159-D5539-44635%5DV155-DU119-45639&UI,A:4F0M*;*6%%E+BJPE
M1=:2(FM)D;6DR%I29*THLE8462N*K!5%UHHB:T61M?J?LOX8Q\,_CE^>:6_:
MX3D_6_X\<?,+4$L! A0#%     @ P)9,4P=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " # EDQ39$IU
M/N\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " # EDQ3F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,"63%/Z8MT!C@4  (,8
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " # EDQ3;F/!I\T)  #X+@  &               @('2#0
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ P)9,4P5)YEEX
M P  C@X  !@              ("!U1<  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( ,"63%/DH82W[0<  'XC   8              "
M@8,;  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " # EDQ3
M<J=G?U\"   N!0  &               @(&F(P  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ P)9,4Z#5*ZJS!0  JQT  !@
M     ("!.R8  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M ,"63%,+6RF1%0@  -0?   8              " @20L  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " # EDQ3(Q?CWXT'   8$0  &
M            @(%O-   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ P)9,4_$4!6%^&P  _$T  !@              ("!,CP  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( ,"63%/YC7XC&0D  *85
M   9              " @>97  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ P)9,4TSSYS(* P  R@8  !D              ("!-F$
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " # EDQ3*A\@
M,Z "  " !0  &0              @(%W9   >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( ,"63%.X[\L">0,  &4'   9
M  " @4YG  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
MP)9,4S^4B]O]"   LA4  !D              ("!_FH  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " # EDQ3-0-YABX%  !U#   &0
M            @($R=   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( ,"63%/2HM'";0<  % 3   9              " @9=Y  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ P)9,4P&=D"@5!P
M A   !D              ("!.X$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " # EDQ3AFAX\RP&  #>#   &0              @(&'
MB   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( ,"63%-)
MLC-C"0X  *4B   9              " @>J.  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ P)9,4WI2\BA3 P  NP8  !D
M     ("!*IT  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,"63%-R@9/;&04  'H+   9              "
M@:&Y  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ P)9,
M4R4;:VN[ P  ?0@  !D              ("!\;X  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " # EDQ3^8PR8:,#  "E"   &0
M        @('CP@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( ,"63%-ZM[\-[0(  #D&   9              " @;W&  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ P)9,4[K?[J(C'0  N5D
M !D              ("!X<D  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " # EDQ3P(^[1<D$  #]"P  &0              @($[YP
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( ,"63%-W 6SR
M!@,  -H&   9              " @3OL  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ P)9,4_Q)U>#7 @  (08  !D
M ("!>.\  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #
MEDQ3C#2SF7H"   .!0  &0              @(&&\@  >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( ,"63%,OP64K'0,  #4&   9
M          " @3?U  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#
M%     @ P)9,4[6_FKZ2!   V@H  !D              ("!B_@  'AL+W=O
M<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " # EDQ3NC)AC$0$  #U
M"0  &0              @(%4_0  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM
M;%!+ 0(4 Q0    ( ,"63%,$T$Y9^0(  %$&   9              " @<\!
M 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ P)9,4Z7%
M!E(8!@  K@P  !D              ("!_P0! 'AL+W=O<FMS:&5E=',O<VAE
M970S."YX;6Q02P$"% ,4    " # EDQ3 PWOMR8%  #*"P  &0
M    @(%."P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M ,"63%/X#BFS0 ,  %T&   9              " @:L0 0!X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ P)9,4\DK=-/^!   ;PL  !D
M             ("!(A0! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " # EDQ3AW!EL#D#   >!P  &0              @(%7&0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( ,"63%.*N?GW=0,
M +P'   9              " @<<< 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ P)9,4\UC[E2' P  / @  !D              ("!
M<R ! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " # EDQ3
M.105ZE4"  ""!0  &0              @($Q) $ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( ,"63%.JT19YUP,  .04   9
M      " @;TF 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ P)9,4^NC)ITG P  ,@D  !D              ("!RRH! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " # EDQ3[^&M:7@$   5$@
M&0              @($I+@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( ,"63%.,E#V>904  "\4   9              " @=@R 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ P)9,4VP'XOUE
M @  R@4  !D              ("!=#@! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " # EDQ3\D9HT?P"  !G"   &0
M@($0.P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( ,"6
M3%.88NTCK0(  )8&   9              " @4,^ 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ P)9,4_8< 574 @  I <  !D
M         ("!)T$! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
M    " # EDQ3D1D%.V "  "^!0  &0              @($R1 $ >&PO=V]R
M:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( ,"63%.=0Z+^Q@,  'T0
M   9              " @<E& 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL
M4$L! A0#%     @ P)9,4]7A<"5M @  FP4  !D              ("!QDH!
M 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " # EDQ3E[/%
MZ:0#  #)#0  &0              @(%J30$ >&PO=V]R:W-H965T<R]S:&5E
M=#4W+GAM;%!+ 0(4 Q0    ( ,"63%,83=Q__P(  !L(   9
M  " @451 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
MP)9,4SL?AIQ4 P  _ @  !D              ("!>U0! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " # EDQ3(YC)OS "  !]!   &0
M            @($&6 $ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( ,"63%.VKV9/@0,  ,P,   9              " @6U: 0!X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ P)9,4U_IET=-!
M!Q0  !D              ("!)5X! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q02P$"% ,4    " # EDQ3LZ"IA L#  #_!P  &0              @(&I
M8@$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( ,"63%-*
M5]W!*P,  .$)   9              " @>ME 0!X;"]W;W)K<VAE971S+W-H
M965T-C0N>&UL4$L! A0#%     @ P)9,4REJ)6HZ!@  81<  !D
M     ("!36D! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,"63%-[0?V(&@,  .,(   9              "
M@7!_ 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ P)9,
M4PID=4"* P  /0L  !D              ("!P8(! 'AL+W=O<FMS:&5E=',O
M<VAE970W,2YX;6Q02P$"% ,4    " # EDQ3V)!4:+T#  #Y"P  &0
M        @(&"A@$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0
M   ( ,"63%-$3,HI@P0  ,4,   9              " @7:* 0!X;"]W;W)K
M<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ P)9,4Q+--9"; P  N@H
M !D              ("!,(\! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q0
M2P$"% ,4    " # EDQ3U:*G-=(&  "#$@  &0              @($"DP$
M>&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( ,"63%-S7Z[+
M9P,  -\(   9              " @0N: 0!X;"]W;W)K<VAE971S+W-H965T
M-S8N>&UL4$L! A0#%     @ P)9,4Y GB@2] P  N @  !D
M ("!J9T! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " #
MEDQ3>9$L!G(%  #L%0  &0              @(&=H0$ >&PO=V]R:W-H965T
M<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( ,"63%/S50D*%@,   T,   9
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M970X,RYX;6Q02P$"% ,4    " # EDQ3PE2AH"\%  !_&   &0
M    @(&HMP$ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    (
M ,"63%-\:3<*S00  .\3   9              " @0Z] 0!X;"]W;W)K<VAE
M971S+W-H965T.#4N>&UL4$L! A0#%     @ P)9,4\ M'Q!E @  , 4  !D
M             ("!$L(! 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"
M% ,4    " # EDQ34PY2-1P#  "0$0  #0              @ &NQ $ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,"63%.7BKL<P    !,"   +
M      "  ?7' 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,"63%.53$> 4@8
M &DY   /              "  =[( 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " # EDQ34C7&HXH"  "Y,@  &@              @ %=SP$ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " # EDQ3@]&L 2X"  !$
M,0  $P              @ $?T@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    7@!> ,D9  !^U $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>206</ContextCount>
  <ElementCount>495</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources</Role>
      <ShortName>NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - NOTE 4 ??? CONTRACT ASSETS AND LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4ContractAssetsAndLiabilities</Role>
      <ShortName>NOTE 4 ??? CONTRACT ASSETS AND LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - NOTE 5 ??? INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5Inventories</Role>
      <ShortName>NOTE 5 ??? INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-PropertyAndEquipment</Role>
      <ShortName>NOTE 6 - PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - NOTE 7 ??? OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7OperatingFinancingLeases</Role>
      <ShortName>NOTE 7 ??? OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherIntangibleAssets</Role>
      <ShortName>NOTE 8 - OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - NOTE 9 - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-CapitalStock</Role>
      <ShortName>NOTE 9 - CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - NOTE 10 ??? CONTROLLING AND NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10ControllingAndNoncontrollingInterests</Role>
      <ShortName>NOTE 10 ??? CONTROLLING AND NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases</Role>
      <ShortName>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - NOTE 12 - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxes</Role>
      <ShortName>NOTE 12 - INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-OtherCurrentLiabilities</Role>
      <ShortName>NOTE 13 - OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note14-CommitmentsAndContingencies</Role>
      <ShortName>NOTE 14 - COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note15-SupplementalCashFlowInformation</Role>
      <ShortName>NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - NOTE 16 ??? RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note16RelatedPartyTransactions</Role>
      <ShortName>NOTE 16 ??? RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note17-SegmentAndRelatedInformation</Role>
      <ShortName>NOTE 17 - SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - NOTE 18 ??? ACQUISTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note18Acquistion</Role>
      <ShortName>NOTE 18 ??? ACQUISTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - NOTE 19 ??? ALLOWANCE FOR DOUBTFUL ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note19AllowanceForDoubtfulAccounts</Role>
      <ShortName>NOTE 19 ??? ALLOWANCE FOR DOUBTFUL ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note20-QuarterlyFinancialData</Role>
      <ShortName>NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - NOTE 21 ??? SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note21SubsequentEvents</Role>
      <ShortName>NOTE 21 ??? SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - NOTE 4 ??? CONTRACT ASSETS AND LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables</Role>
      <ShortName>NOTE 4 ??? CONTRACT ASSETS AND LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4ContractAssetsAndLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - NOTE 5 ??? INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5InventoriesTables</Role>
      <ShortName>NOTE 5 ??? INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note5Inventories</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-PropertyAndEquipmentTables</Role>
      <ShortName>NOTE 6 - PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-PropertyAndEquipment</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - NOTE 7 ??? OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7OperatingFinancingLeasesTables</Role>
      <ShortName>NOTE 7 ??? OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7OperatingFinancingLeases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherIntangibleAssetsTables</Role>
      <ShortName>NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note8-OtherIntangibleAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - NOTE 10 ??? CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables</Role>
      <ShortName>NOTE 10 ??? CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note10ControllingAndNoncontrollingInterests</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables</Role>
      <ShortName>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - NOTE 12 - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxesTables</Role>
      <ShortName>NOTE 12 - INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note12-IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables</Role>
      <ShortName>NOTE 13 - OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note13-OtherCurrentLiabilities</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note17-SegmentAndRelatedInformationTables</Role>
      <ShortName>NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note17-SegmentAndRelatedInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - NOTE 18 ??? ACQUISTION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note18AcquistionTables</Role>
      <ShortName>NOTE 18 ??? ACQUISTION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note18Acquistion</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - NOTE 19 ??? ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables</Role>
      <ShortName>NOTE 19 ??? ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note19AllowanceForDoubtfulAccounts</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note20-QuarterlyFinancialDataTables</Role>
      <ShortName>NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note20-QuarterlyFinancialData</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative</Role>
      <ShortName>NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>NOTE 3 ??? ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details</Role>
      <ShortName>NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-Inventories-InventoriesDetails</Role>
      <ShortName>NOTE 5 - INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails</Role>
      <ShortName>NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-PropertyAndEquipmentTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>NOTE 7 - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails</Role>
      <ShortName>NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails</Role>
      <ShortName>NOTE 7 - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - NOTE 7 ??? OPERATING &amp; FINANCING LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative</Role>
      <ShortName>NOTE 7 ??? OPERATING &amp; FINANCING LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7OperatingFinancingLeasesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details</Role>
      <ShortName>NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details</Role>
      <ShortName>NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note8-OtherIntangibleAssetsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - NOTE 9 - CAPITAL STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-CapitalStockDetailsNarrative</Role>
      <ShortName>NOTE 9 - CAPITAL STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note9-CapitalStock</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails</Role>
      <ShortName>NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - NOTE 10 ??? CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative</Role>
      <ShortName>NOTE 10 ??? CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details</Role>
      <ShortName>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details</Role>
      <ShortName>NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName>NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details</Role>
      <ShortName>NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details</Role>
      <ShortName>NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative</Role>
      <ShortName>NOTE 12 - INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note12-IncomeTaxesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note14-CommitmentsAndContingencies</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note15-SupplementalCashFlowInformation</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - NOTE 16 ??? RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>NOTE 16 ??? RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note16RelatedPartyTransactions</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details</Role>
      <ShortName>NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details</Role>
      <ShortName>NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative</Role>
      <ShortName>NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note17-SegmentAndRelatedInformationTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails</Role>
      <ShortName>NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails</Role>
      <ShortName>NOTE 18 - ACQUISTION - Net assets acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd</Role>
      <ShortName>NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details</Role>
      <ShortName>NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note20-QuarterlyFinancialDataTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - NOTE 21 ??? SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note21SubsequentEventsDetailsNarrative</Role>
      <ShortName>NOTE 21 ??? SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note21SubsequentEvents</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="fonar_10-k.htm">fonar_10-k.htm</File>
    <File>fonar_exhibit-21.htm</File>
    <File>fonar_exhibit-23.htm</File>
    <File>fonar_exhibit-31.htm</File>
    <File>fonar_exhibit-32.htm</File>
    <File>fonr-20210630.xsd</File>
    <File>fonr-20210630_cal.xml</File>
    <File>fonr-20210630_def.xml</File>
    <File>fonr-20210630_lab.xml</File>
    <File>fonr-20210630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar-logo.jpg</File>
    <File>fonar_stock-graph.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>105
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fonar_10-k.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 206,
   "dts": {
    "calculationLink": {
     "local": [
      "fonr-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fonar_10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20210630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20210630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fonr-20210630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 632,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 46,
    "http://fonar.com/20210630": 33,
    "http://xbrl.sec.gov/dei/2021": 4,
    "total": 83
   },
   "keyCustom": 101,
   "keyStandard": 394,
   "memberCustom": 30,
   "memberStandard": 39,
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://fonar.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "role": "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "shortName": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - NOTE 4 \u2013 CONTRACT ASSETS AND LIABILITIES",
     "role": "http://fonar.com/role/Note4ContractAssetsAndLiabilities",
     "shortName": "NOTE 4 \u2013 CONTRACT ASSETS AND LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - NOTE 5 \u2013 INVENTORIES",
     "role": "http://fonar.com/role/Note5Inventories",
     "shortName": "NOTE 5 \u2013 INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT",
     "role": "http://fonar.com/role/Note6-PropertyAndEquipment",
     "shortName": "NOTE 6 - PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - NOTE 7 \u2013 OPERATING & FINANCING LEASES",
     "role": "http://fonar.com/role/Note7OperatingFinancingLeases",
     "shortName": "NOTE 7 \u2013 OPERATING & FINANCING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS",
     "role": "http://fonar.com/role/Note8-OtherIntangibleAssets",
     "shortName": "NOTE 8 - OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:CapitalStockAndOptionsDisclosureTextblock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - NOTE 9 - CAPITAL STOCK",
     "role": "http://fonar.com/role/Note9-CapitalStock",
     "shortName": "NOTE 9 - CAPITAL STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:CapitalStockAndOptionsDisclosureTextblock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS",
     "role": "http://fonar.com/role/Note10ControllingAndNoncontrollingInterests",
     "shortName": "NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "role": "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases",
     "shortName": "NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - NOTE 12 - INCOME TAXES",
     "role": "http://fonar.com/role/Note12-IncomeTaxes",
     "shortName": "NOTE 12 - INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://fonar.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES",
     "role": "http://fonar.com/role/Note13-OtherCurrentLiabilities",
     "shortName": "NOTE 13 - OTHER CURRENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES",
     "role": "http://fonar.com/role/Note14-CommitmentsAndContingencies",
     "shortName": "NOTE 14 - COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION",
     "role": "http://fonar.com/role/Note15-SupplementalCashFlowInformation",
     "shortName": "NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - NOTE 16 \u2013 RELATED PARTY TRANSACTIONS",
     "role": "http://fonar.com/role/Note16RelatedPartyTransactions",
     "shortName": "NOTE 16 \u2013 RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION",
     "role": "http://fonar.com/role/Note17-SegmentAndRelatedInformation",
     "shortName": "NOTE 17 - SEGMENT AND RELATED INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - NOTE 18 \u2013 ACQUISTION",
     "role": "http://fonar.com/role/Note18Acquistion",
     "shortName": "NOTE 18 \u2013 ACQUISTION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - NOTE 19 \u2013 ALLOWANCE FOR DOUBTFUL ACCOUNTS",
     "role": "http://fonar.com/role/Note19AllowanceForDoubtfulAccounts",
     "shortName": "NOTE 19 \u2013 ALLOWANCE FOR DOUBTFUL ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)",
     "role": "http://fonar.com/role/Note20-QuarterlyFinancialData",
     "shortName": "NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - NOTE 21 \u2013 SUBSEQUENT EVENTS",
     "role": "http://fonar.com/role/Note21SubsequentEvents",
     "shortName": "NOTE 21 \u2013 SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30_custom_ClassANonVotingPreferredStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "role": "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "shortName": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - NOTE 4 \u2013 CONTRACT ASSETS AND LIABILITIES (Tables)",
     "role": "http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables",
     "shortName": "NOTE 4 \u2013 CONTRACT ASSETS AND LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - NOTE 5 \u2013 INVENTORIES (Tables)",
     "role": "http://fonar.com/role/Note5InventoriesTables",
     "shortName": "NOTE 5 \u2013 INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://fonar.com/role/Note6-PropertyAndEquipmentTables",
     "shortName": "NOTE 6 - PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - NOTE 7 \u2013 OPERATING & FINANCING LEASES (Tables)",
     "role": "http://fonar.com/role/Note7OperatingFinancingLeasesTables",
     "shortName": "NOTE 7 \u2013 OPERATING & FINANCING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://fonar.com/role/Note8-OtherIntangibleAssetsTables",
     "shortName": "NOTE 8 - OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "role": "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables",
     "shortName": "NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "role": "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables",
     "shortName": "NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - NOTE 12 - INCOME TAXES (Tables)",
     "role": "http://fonar.com/role/Note12-IncomeTaxesTables",
     "shortName": "NOTE 12 - INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES (Tables)",
     "role": "http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables",
     "shortName": "NOTE 13 - OTHER CURRENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)",
     "role": "http://fonar.com/role/Note17-SegmentAndRelatedInformationTables",
     "shortName": "NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - NOTE 18 \u2013 ACQUISTION (Tables)",
     "role": "http://fonar.com/role/Note18AcquistionTables",
     "shortName": "NOTE 18 \u2013 ACQUISTION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - NOTE 19 \u2013 ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)",
     "role": "http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables",
     "shortName": "NOTE 19 \u2013 ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)",
     "role": "http://fonar.com/role/Note20-QuarterlyFinancialDataTables",
     "shortName": "NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2015-07-01_custom_HDMMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ImperialContributionPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "role": "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
     "shortName": "NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2015-07-01_custom_HDMMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ImperialContributionPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MinimumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipment",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-012021-06-30_custom_DiagnosticEquipmentMember_srt_MinimumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:NetPatientFeeRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:NetPatientFeeRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsPerBasicShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "role": "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "shortName": "NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "N",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "role": "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails",
     "shortName": "NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "N",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "role": "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "shortName": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:CostsIncurredOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)",
     "role": "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details",
     "shortName": "NOTE 4 - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:CostsIncurredOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - NOTE 5 - INVENTORIES - Inventories (Details)",
     "role": "http://fonar.com/role/Note5-Inventories-InventoriesDetails",
     "shortName": "NOTE 5 - INVENTORIES - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)",
     "role": "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails",
     "shortName": "NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)",
     "role": "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative",
     "shortName": "NOTE 6 - PROPERTY AND EQUIPMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - NOTE 7 - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "role": "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails",
     "shortName": "NOTE 7 - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - NOTE 7 - OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)",
     "role": "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails",
     "shortName": "NOTE 7 - OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - NOTE 7 - OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)",
     "role": "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails",
     "shortName": "NOTE 7 - OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2019-06-30_custom_ClassANonVotingPreferredMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2019-06-30_custom_ClassANonVotingPreferredMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - NOTE 7 \u2013 OPERATING & FINANCING LEASES (Details Narrative)",
     "role": "http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative",
     "shortName": "NOTE 7 \u2013 OPERATING & FINANCING LEASES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "role": "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "shortName": "NOTE 8 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)",
     "role": "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
     "shortName": "NOTE 8 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)",
     "role": "http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details",
     "shortName": "NOTE 8 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "FONR:AmountsCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "role": "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative",
     "shortName": "NOTE 8 - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "FONR:CapitalStockAndOptionsDisclosureTextblock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherSellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - NOTE 9 - CAPITAL STOCK (Details Narrative)",
     "role": "http://fonar.com/role/Note9-CapitalStockDetailsNarrative",
     "shortName": "NOTE 9 - CAPITAL STOCK (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "FONR:CapitalStockAndOptionsDisclosureTextblock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherSellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OpeningMembersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)",
     "role": "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
     "shortName": "NOTE 10 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OpeningMembersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PurchaseOfStandupMriCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "N",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "role": "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative",
     "shortName": "NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PurchaseOfStandupMriCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "N",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)",
     "role": "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details",
     "shortName": "NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE & CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)",
     "role": "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details",
     "shortName": "NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE & CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2019-07-012020-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)",
     "role": "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails",
     "shortName": "NOTE 12 - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2019-07-012020-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "role": "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
     "shortName": "NOTE 12 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "role": "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
     "shortName": "NOTE 12 - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - NOTE 12 - INCOME TAXES (Details Narrative)",
     "role": "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative",
     "shortName": "NOTE 12 - INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "role": "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "shortName": "NOTE 13 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "NOTE 14 - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "role": "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative",
     "shortName": "NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-012021-06-30_custom_ABillingCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - NOTE 16 \u2013 RELATED PARTY TRANSACTIONS (Details Narrative)",
     "role": "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative",
     "shortName": "NOTE 16 \u2013 RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-012021-06-30_custom_ABillingCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "role": "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details",
     "shortName": "NOTE 17 - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "FONR:IntersegmentNetRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportProductSales",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignProductSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)",
     "role": "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
     "shortName": "NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportProductSales",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignProductSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "role": "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources",
     "shortName": "NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportServiceRevenues",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignServiceAndRepairFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)",
     "role": "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details",
     "shortName": "NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportServiceRevenues",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignServiceAndRepairFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure - NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "role": "http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative",
     "shortName": "NOTE 17 - SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)",
     "role": "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
     "shortName": "NOTE 18 - ACQUISTION - Fair value assets and assumed liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000083 - Disclosure - NOTE 18 - ACQUISTION - Net assets acquired (Details)",
     "role": "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails",
     "shortName": "NOTE 18 - ACQUISTION - Net assets acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "lang": null,
      "name": "FONR:ClosingCostsExpensed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30_us-gaap_AccountsReceivableMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000084 - Disclosure - NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)",
     "role": "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd",
     "shortName": "NOTE 19 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2019-06-30_us-gaap_AccountsReceivableMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000085 - Disclosure - NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)",
     "role": "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
     "shortName": "NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-08-31_us-gaap_SubsequentEventMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000086 - Disclosure - NOTE 21 \u2013 SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative",
     "shortName": "NOTE 21 \u2013 SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-08-31_us-gaap_SubsequentEventMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies",
     "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2020-07-01to2021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 74,
   "tag": {
    "FONR_ABillingCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company or entity owned by related party.",
        "label": "A Billing Company [Member]"
       }
      }
     },
     "localname": "ABillingCompanyMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_AccountReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from service and repair fees of Related MRI scanner customers; net of allowances for doubtful accounts.",
        "label": "Accounts receivable \u2013 related party"
       }
      }
     },
     "localname": "AccountReceivableRelatedParties",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term"
       }
      }
     },
     "localname": "AccountsReceivableNetLongTerm",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable - net - Current from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts.",
        "label": "Accounts receivable \u2013 net of allowances for doubtful accounts of $442,270 and $514,561 at June 30, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableServiceAndRepairFees",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired assets and assumed liabilities"
       }
      }
     },
     "localname": "AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_AdditionalTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AdditionalTaxes]"
       }
      }
     },
     "localname": "AdditionalTaxes",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AllowanceForDoubtfulAccountsAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts Additions",
        "label": "Additions (Included in provision for bad debts)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsAdditions",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AllowanceForDoubtfulAccountsDeductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts Deductions",
        "label": "Deductions"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsDeductions",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AmountsCapitalized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts capitalized"
       }
      }
     },
     "localname": "AmountsCapitalized",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BensonhurstMRILimitedPartnershipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bensonhurst MRI Limited Partnership.",
        "label": "Bensonhurst M R I Limited Partnership [Member]"
       }
      }
     },
     "localname": "BensonhurstMRILimitedPartnershipMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_BillingsToDate": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 2.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount within current period that has been billed to customer.",
        "label": "Less: Billings to date"
       }
      }
     },
     "localname": "BillingsToDate",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BookValueOfBuilding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:BookValueOfBuilding-0]"
       }
      }
     },
     "localname": "BookValueOfBuilding",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BusinessCombinationContingentConsiderationAsset1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Consideration Paid"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset1",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CapitalStockAndOptionsDisclosureTextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOTE 9 - CAPITAL STOCK"
       }
      }
     },
     "localname": "CapitalStockAndOptionsDisclosureTextblock",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Class A Member havea 49.5% ownership interest of HDM.",
        "label": "Class A [Member]"
       }
      }
     },
     "localname": "ClassAMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassANonVotingPreferredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Non Voting Preferred Stock Member",
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredStockMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Class B Member havea 50.5% ownership interest of HDM.",
        "label": "Class B [Member]"
       }
      }
     },
     "localname": "ClassBMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassCCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock [Member]"
       }
      }
     },
     "localname": "ClassCCommonStockMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClosingCostsExpensed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing costs - expensed"
       }
      }
     },
     "localname": "ClosingCostsExpensed",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance Managed Care Member",
        "label": "Commercial Insurance Managed Care [Member]"
       }
      }
     },
     "localname": "CommercialInsuranceManagedCareMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CompensatoryElementOfStockIssuances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensatory element of stock issuances"
       }
      }
     },
     "localname": "CompensatoryElementOfStockIssuances",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ConsiderationForNoncompetitionAndConsultingAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ConsiderationForNoncompetitionAndConsultingAgreements-0]"
       }
      }
     },
     "localname": "ConsiderationForNoncompetitionAndConsultingAgreements",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ConsiderationToOutsideInvestors": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ConsiderationToOutsideInvestors-0]"
       }
      }
     },
     "localname": "ConsiderationToOutsideInvestors",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ContractualFeesForServicesRenderedMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum contractual fees for services rendered to the PC's.",
        "label": "[custom:ContractualFeesForServicesRenderedMaximum-0]"
       }
      }
     },
     "localname": "ContractualFeesForServicesRenderedMaximum",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ContractualFeesForServicesRenderedMinimum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum contractual fees for services rendered to the PC's.",
        "label": "[custom:ContractualFeesForServicesRenderedMinimum-0]"
       }
      }
     },
     "localname": "ContractualFeesForServicesRenderedMinimum",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
        "totalLabel": "Costs and estimated earnings in excess of billings on uncompleted contracts"
       }
      }
     },
     "localname": "CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsAndEstimatedEarningsOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 1.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs and estimated earnings on uncompleted contracts in excess of billings means the current asset as of the closing date, as properly recorded on seller's balance sheet in accordance with GAAP, representing the amount, in the aggregate, earned on contracts but not yet invoiced to customers, as determined in accordance with GAAP.",
        "label": "CostsAndEstimatedEarningsOnUncompletedContracts",
        "totalLabel": "Costs and estimated earnings on uncompleted contracts"
       }
      }
     },
     "localname": "CostsAndEstimatedEarningsOnUncompletedContracts",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsIncurredOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 1.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred on uncompleted contracts.",
        "label": "Costs incurred on uncompleted contracts"
       }
      }
     },
     "localname": "CostsIncurredOnUncompletedContracts",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFees",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs related To Management and other fees - Related medical practices",
        "label": "Costs related to management and other fees \u2013 related party medical practices"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToProductSales": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "localname": "CostsRelatedToProductSales",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFees",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees \u2013 related parties"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CovenantNotToCompeteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Covenant Not To Compete [Member]"
       }
      }
     },
     "localname": "CovenantNotToCompeteMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CustomerAdvancesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Advances"
       }
      }
     },
     "localname": "CustomerAdvancesPolicyTextBlock",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_CustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDeposits",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DepreciationOfLeasedEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of leased equipment"
       }
      }
     },
     "localname": "DepreciationOfLeasedEquipment",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DiagnosticEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MRI Diagnostic Equipment",
        "label": "Diagnostic Equipment [Member]"
       }
      }
     },
     "localname": "DiagnosticEquipmentMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_DiagnosticImagingFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Imaging Facility Member",
        "label": "Diagnostic Imaging Facility [Member]"
       }
      }
     },
     "localname": "DiagnosticImagingFacilityMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_DisclosureNote7OperatingFinancingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 7 Operating Financing Leases",
        "terseLabel": "Note 7 - Operating Financing Leases - Recent Accounting Pronouncements - Components Of Lease Expense",
        "verboseLabel": "Note 7 - Operating Financing Leases - Lease Payments"
       }
      }
     },
     "localname": "DisclosureNote7OperatingFinancingLeasesAbstract",
     "nsuri": "http://fonar.com/20210630",
     "xbrltype": "stringItemType"
    },
    "FONR_DisclosureNote9CapitalStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 9 - Capital Stock"
       }
      }
     },
     "localname": "DisclosureNote9CapitalStockAbstract",
     "nsuri": "http://fonar.com/20210630",
     "xbrltype": "stringItemType"
    },
    "FONR_Distributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions to each class of members equity as of June 30.",
        "label": "Distributions"
       }
      }
     },
     "localname": "Distributions",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_EmployeeStockPurchasePlanEspp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The stockholders of the Company approved the 2000 Employee Stock Purchase Plan (ESPP) at the Companys annual stockholders meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect as of June 30, 2014.",
        "label": "[custom:EmployeeStockPurchasePlanEspp]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanEspp",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_EndingMembersEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ending Members Equity for each class of members equity as of June 30.",
        "label": "Ending Members Equity"
       }
      }
     },
     "localname": "EndingMembersEquity",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_EstimatedEarnings": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 2.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Earnings on uncompleted contracts.",
        "label": "Estimated earnings"
       }
      }
     },
     "localname": "EstimatedEarnings",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note4-ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Useful Life in Years for Property and Equipment"
       }
      }
     },
     "localname": "EstimatedUsefulLifeInYearsForPropertyAndEquipment",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ExportProductSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Export Product Sales"
       }
      }
     },
     "localname": "ExportProductSales",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ExportSalesOfMedicalEquipmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExportSalesOfMedicalEquipmentPercentage]"
       }
      }
     },
     "localname": "ExportSalesOfMedicalEquipmentPercentage",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ExportServiceRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Service and Repair Fees"
       }
      }
     },
     "localname": "ExportServiceRevenues",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_FinanceLeaseCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_FinanceLeaseCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease cost:"
       }
      }
     },
     "localname": "FinanceLeaseCostsAbstract",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_FinancingCashFlowsFromFinancingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing cash flows from financing leases"
       }
      }
     },
     "localname": "FinancingCashFlowsFromFinancingLeases",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ForeignProductSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Product Sales",
        "label": "[custom:ForeignProductSales]"
       }
      }
     },
     "localname": "ForeignProductSales",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage]"
       }
      }
     },
     "localname": "ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ForeignServiceAndRepairFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Service And Repair Fees",
        "label": "Foreign Service and Repair fees"
       }
      }
     },
     "localname": "ForeignServiceAndRepairFees",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_HDMEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HDM Equity Member",
        "label": "H D M Equity [Member]"
       }
      }
     },
     "localname": "HDMEquityMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_HDMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HDM Member",
        "label": "H D M [Member]"
       }
      }
     },
     "localname": "HDMMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ImperialContributionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ImperialContributionPercentage-0]"
       }
      }
     },
     "localname": "ImperialContributionPercentage",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_IncreaseDecreaseInContractLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInContractLiabilities",
        "verboseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractLiabilities",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer advances"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInFinancingLiabilities",
        "negatedLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IntersegmentNetRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intersegment net revenues are the transfer or exchange of goods for monetary compensation between the management and diagnostic imaging center segment and the manufacturing and service segment.",
        "label": "Intersegment net revenues"
       }
      }
     },
     "localname": "IntersegmentNetRevenues",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of operating and financing lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_LitigationSettelementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:LitigationSettelementDescription]"
       }
      }
     },
     "localname": "LitigationSettelementDescription",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_ManagedFacilitiesAddedAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Acquisition"
       }
      }
     },
     "localname": "ManagedFacilitiesAddedAcquisition",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_ManagedFacilitiesAddedByInternalDevelopment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Internal development"
       }
      }
     },
     "localname": "ManagedFacilitiesAddedByInternalDevelopment",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_ManagedFacilitiesClosedDuringYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Managed Facilities Closed"
       }
      }
     },
     "localname": "ManagedFacilitiesClosedDuringYear",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_ManagementAgreementsWithCompanyTotalMedicalPractices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Imaging Centers with management agreements with Company.",
        "label": "[custom:ManagementAgreementsWithCompanyTotalMedicalPractices-0]"
       }
      }
     },
     "localname": "ManagementAgreementsWithCompanyTotalMedicalPractices",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "FONR_ManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net of allowances for doubtful accounts of $15,786,878 and $11,063,233 at June 30, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "ManagementAndOtherFees",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesNet",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable [Member]"
       }
      }
     },
     "localname": "ManagementAndOtherFeesReceivableMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable Related Medical Practices [Member]"
       }
      }
     },
     "localname": "ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 related party medical practices \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management Of Diagnostic Imaging Centers",
        "label": "Management Of Diagnostic Imaging Centers [Member]"
       }
      }
     },
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management of, and other fees receivable from MRI Centers owned by related parties - net of allowances for doubtful accounts.",
        "label": "Management and other fees receivable \u2013 related party medical practices \u2013 net of allowances for doubtful accounts of $4,184,399 and $3,322,055 at June 30, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManufacturingAndServicingOfMedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing And Servicing Of Medical Equipment",
        "label": "Manufacturing And Servicing Of Medical Equipment [Member]"
       }
      }
     },
     "localname": "ManufacturingAndServicingOfMedicalEquipmentMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_MaturityDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:MaturityDate]"
       }
      }
     },
     "localname": "MaturityDate",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_MedicalReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivables - net"
       }
      }
     },
     "localname": "MedicalReceivable",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicalReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Receivables",
        "label": "Medical Receivables [Member]"
       }
      }
     },
     "localname": "MedicalReceivablesMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_MedicareMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Medicaid",
        "label": "Medicare Medicaid [Member]"
       }
      }
     },
     "localname": "MedicareMedicaidMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_N2010StockBonusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "N 2010 Stock Bonus Plan [Member]"
       }
      }
     },
     "localname": "N2010StockBonusPlanMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Management Fee Receivables From Related Party Medical Practices [Member]"
       }
      }
     },
     "localname": "NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetPatientFeeRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Patient Fee Revenue"
       }
      }
     },
     "localname": "NetPatientFeeRevenue",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_NotePayable1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt, notes payable and capital leases",
        "label": "Note Payable 1 [Member]"
       }
      }
     },
     "localname": "NotePayable1Member",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NotePayable2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt, notes payable and capital leases",
        "label": "Note Payable 2 [Member]"
       }
      }
     },
     "localname": "NotePayable2Member",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NotePayable3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt, notes payable and capital leases",
        "label": "Note Payable 3 [Member]"
       }
      }
     },
     "localname": "NotePayable3Member",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NumberOfInstallment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfInstallment]"
       }
      }
     },
     "localname": "NumberOfInstallment",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.",
        "label": "[custom:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders]"
       }
      }
     },
     "localname": "NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_OpeningMembersEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opening Members Equity for each class of members equity as of June 30.",
        "label": "Opening Members Equity"
       }
      }
     },
     "localname": "OpeningMembersEquity",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OperatingCashFlowsFromOperatingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingCashFlowsFromOperatingLeases",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OtherRevenueSourceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Revenue Source",
        "label": "Other Revenue Source [Member]"
       }
      }
     },
     "localname": "OtherRevenueSourceMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OutsideInvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outside Investors [Member]"
       }
      }
     },
     "localname": "OutsideInvestorsMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OwnershipPercentageAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:OwnershipPercentageAcquired-0]"
       }
      }
     },
     "localname": "OwnershipPercentageAcquired",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue, net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PaymentsOnNotesReceivableFromEmployeeStockholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments On Notes Receivable From Employee Stockholders",
        "label": "Payments on notes receivable from employee stockholders"
       }
      }
     },
     "localname": "PaymentsOnNotesReceivableFromEmployeeStockholders",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of consolidated net revenue from management fees.",
        "label": "[custom:PercentageOfConsolidatedNetRevenueFromManagementFees]"
       }
      }
     },
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims.",
        "label": "[custom:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims]"
       }
      }
     },
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PresentValueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Present Value discount"
       }
      }
     },
     "localname": "PresentValueDiscount",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Present Value discount, Financing Lease"
       }
      }
     },
     "localname": "PresentValueDiscountFinancingLease",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProductSalesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net"
       }
      }
     },
     "localname": "ProductSalesNet",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PropertyTaxAbatement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017",
        "label": "[custom:PropertyTaxAbatement]"
       }
      }
     },
     "localname": "PropertyTaxAbatement",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PropertyTaxAbatementFromSuffolkCountyIda": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017",
        "label": "[custom:PropertyTaxAbatementFromSuffolkCountyIda]"
       }
      }
     },
     "localname": "PropertyTaxAbatementFromSuffolkCountyIda",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ProvisionForBadDebts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForBadDebts",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right to use assets"
       }
      }
     },
     "localname": "PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right to use liability"
       }
      }
     },
     "localname": "PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfImagingCenter": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchaseOfImagingCenter",
        "negatedLabel": "Purchase of imaging center"
       }
      }
     },
     "localname": "PurchaseOfImagingCenter",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfOtherMriCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PurchaseOfOtherMriCenters-0]"
       }
      }
     },
     "localname": "PurchaseOfOtherMriCenters",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_PurchaseOfStandupMriCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PurchaseOfStandupMriCenters-0]"
       }
      }
     },
     "localname": "PurchaseOfStandupMriCenters",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_QuarterlyFinancialDataMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Member]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_RecordedSalesTaxObligationsInterestAndPenalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded sales tax obligations of interest and penalties. Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "[custom:RecordedSalesTaxObligationsInterestAndPenalties-0]"
       }
      }
     },
     "localname": "RecordedSalesTaxObligationsInterestAndPenalties",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ReimbursementOfAlternativeMinimumTaxCreditsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ReimbursementOfAlternativeMinimumTaxCreditsDescription]"
       }
      }
     },
     "localname": "ReimbursementOfAlternativeMinimumTaxCreditsDescription",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_ResearchDeveopmentAndDemonstrationEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research Deveopment And Demonstration Equipment",
        "label": "Research Deveopment And Demonstration Equipment [Member]"
       }
      }
     },
     "localname": "ResearchDeveopmentAndDemonstrationEquipmentMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing leases"
       }
      }
     },
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases(1)"
       }
      }
     },
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_RocklandManagementGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rockland Management Group [Member]"
       }
      }
     },
     "localname": "RocklandManagementGroupMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of management agreements with PC's owned by a relarted party.",
        "label": "[custom:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty-0]"
       }
      }
     },
     "localname": "ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of management agreements with PC's owned by two unrelated radiologists.",
        "label": "[custom:ScannersWithManagementWithCompanyLocatedInNewYorkState-0]"
       }
      }
     },
     "localname": "ScannersWithManagementWithCompanyLocatedInNewYorkState",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "FONR_SellingGeneralAndAdministrativeExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SellingGeneralAndAdministrativeExpenses]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpenses",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesNet",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 related parties \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ShareOfNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Of Net Income for each class of members equity as of June 30.",
        "label": "Share of Net Income"
       }
      }
     },
     "localname": "ShareOfNetIncome",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_SharesRegistered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharesRegistered-0]"
       }
      }
     },
     "localname": "SharesRegistered",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_ShippingAndHandlingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to shipping and handling expense for the period, which are expenses incurred with the objective of delivery of Fonar's products to its customers.",
        "label": "[custom:ShippingAndHandlingExpense]"
       }
      }
     },
     "localname": "ShippingAndHandlingExpense",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ShippingsAndHandlingCostPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping Costs"
       }
      }
     },
     "localname": "ShippingsAndHandlingCostPolicyTextBlock",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_SoftwareOrPatentsWrittenOff": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Software or patents written off"
       }
      }
     },
     "localname": "SoftwareOrPatentsWrittenOff",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StockIssuedToEmployeesUnderStockBonusPlansValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock issued to employees under stock bonus plans"
       }
      }
     },
     "localname": "StockIssuedToEmployeesUnderStockBonusPlansValue",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. The reserves are included in Other current liabilities' in the consolidated balance sheets.",
        "label": "[custom:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims]"
       }
      }
     },
     "localname": "StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note7OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Total Facilities Owned or Managed (at Beginning of Year)"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Total Facilities Owned or Managed (at End of Year)"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedAtEndOfYear",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_TotalPurchasePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:TotalPurchasePrice-0]"
       }
      }
     },
     "localname": "TotalPurchasePrice",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers Compensation Personal Injury",
        "label": "Workers Compensation Personal Injury [Member]"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjuryMember",
     "nsuri": "http://fonar.com/20210630",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DOMINICAN REPUBLIC"
       }
      }
     },
     "localname": "DO",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GREECE"
       }
      }
     },
     "localname": "GR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r545",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Series [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r258",
      "r280",
      "r302",
      "r304",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r502",
      "r504",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r258",
      "r280",
      "r302",
      "r304",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r502",
      "r504",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r258",
      "r280",
      "r299",
      "r302",
      "r304",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r502",
      "r504",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r258",
      "r280",
      "r299",
      "r302",
      "r304",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r502",
      "r504",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "NOTE 19 \u2013 ALLOWANCE FOR DOUBTFUL ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19AllowanceForDoubtfulAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r192",
      "r193",
      "r296",
      "r298",
      "r503",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r553",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r192",
      "r193",
      "r296",
      "r298",
      "r503",
      "r518",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r439",
      "r441",
      "r444",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance.",
        "label": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "NOTE 13 - OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r40",
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.",
        "label": "Due to related party medical practices"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.",
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r43"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Legal and other professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r472",
      "r493"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accounting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r43"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued salaries, commissions and payroll taxes"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Less: Accumulated depreciation and amortization of property and equipment"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r312",
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Paid-in capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r309",
      "r310",
      "r311",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r96",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r198",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Summary of Allowance For Doubtful Accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19AllowanceForDoubtfulAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r199",
      "r205",
      "r206",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r96",
      "r218",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfLeasedAsset": {
     "auth_ref": [
      "r96",
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense charged against earnings for the periodic recognition of capitalized leases. This element may apply to energy companies that lease mineral producing properties and to other enterprises that capitalize property, plant, or equipment obtained through capital leases.",
        "label": "Amortization of Leased Asset"
       }
      }
     },
     "localname": "AmortizationOfLeasedAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r112",
      "r175",
      "r180",
      "r187",
      "r203",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r371",
      "r379",
      "r393",
      "r433",
      "r435",
      "r467",
      "r488"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r58",
      "r112",
      "r203",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r371",
      "r379",
      "r393",
      "r433",
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r3",
      "r512",
      "r515",
      "r516",
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Total identifiable assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r301",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r301",
      "r303",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r360",
      "r361",
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "NOTE 18 \u2013 ACQUISTION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18Acquistion"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r120",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResources"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r36",
      "r435",
      "r513",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r36",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS \u2013 END OF YEAR",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS \u2013 BEGINNING OF YEAR"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r91",
      "r394"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r110",
      "r112",
      "r136",
      "r137",
      "r140",
      "r142",
      "r144",
      "r153",
      "r154",
      "r155",
      "r203",
      "r244",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r278",
      "r279",
      "r281",
      "r282",
      "r393",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r240",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "NOTE 14 - COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r161",
      "r162",
      "r195",
      "r391",
      "r392",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r195",
      "r391",
      "r392",
      "r511",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r158",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r161",
      "r162",
      "r195",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r377",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractReceivableDueFourToFiveYears": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "ContractReceivableDueFourToFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueOneToTwoYears": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "ContractReceivableDueOneToTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "ContractReceivableDueThreeToFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "ContractReceivableDueTwoToThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "auth_ref": [
      "r293",
      "r295"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r293",
      "r294",
      "r297"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation and Amortization"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfPropertyRepairsAndMaintenance": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.",
        "label": "Cost of Property Repairs and Maintenance"
       }
      }
     },
     "localname": "CostOfPropertyRepairsAndMaintenance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Total Costs and Expenses",
        "totalLabel": "Total Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-term contract or program.",
        "label": "`Costs and Estimated Earnings on Uncompleted Contracts"
       }
      }
     },
     "localname": "CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4ContractAssetsAndLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r334",
      "r341",
      "r343"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerListsMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.",
        "label": "Customer Lists [Member]"
       }
      }
     },
     "localname": "CustomerListsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": {
     "auth_ref": [
      "r277",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
        "label": "NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES"
       }
      }
     },
     "localname": "DebtAndCapitalLeasesDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r46",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r45",
      "r268",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r46",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r46",
      "r111",
      "r116",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r284",
      "r285",
      "r286",
      "r287",
      "r403",
      "r404",
      "r406",
      "r407",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fee on unused borrowings under debtor-in-possession financing arrangement.",
        "label": "Debtor-in-Possession Financing, Fee on Unused Borrowings"
       }
      }
     },
     "localname": "DebtorInPossessionFinancingFeeOnUnusedBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r335",
      "r341"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Federal deferred taxes"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r113",
      "r335",
      "r341",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred income tax - net",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r335",
      "r341"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "State deferred taxes"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred Tax Assets - gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Non-deductible accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Property and equipment and depreciation"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r331",
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r331",
      "r332",
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r320",
      "r328"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.",
        "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization.",
        "label": "Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital"
       }
      }
     },
     "localname": "DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r96",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Patient Fee Revenue - Net"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableNature": {
     "auth_ref": [
      "r102",
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.",
        "label": "Dividends Payable, Nature"
       }
      }
     },
     "localname": "DividendsPayableNature",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r71",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r134",
      "r136",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r387",
      "r388",
      "r478",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Net Income Per Share",
        "verboseLabel": "Basic Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r71",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r136",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r387",
      "r388",
      "r478",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Net Income Per Share",
        "terseLabel": "Diluted Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Diluted Income per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r114",
      "r322",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Taxes at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r322",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Change in the valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r322",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "negatedLabel": "Non Controlling interest"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r322",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Return to provision adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r322",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Expiration of tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r322",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State and local income taxes (benefit), net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-SignificantComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "auth_ref": [
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).",
        "label": "Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of employee stock ownership plan.",
        "label": "Employee Stock Ownership Plan (ESOP) Name [Axis]"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entities identify multiple employee stock ownership plans by unique name."
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r63",
      "r64",
      "r65",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r133",
      "r152",
      "r204",
      "r283",
      "r289",
      "r309",
      "r310",
      "r311",
      "r337",
      "r338",
      "r386",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r505",
      "r506",
      "r507",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r113",
      "r321"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r413",
      "r415",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Financing lease liability \u2013 current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Financing lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "verboseLabel": "Total lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Right-of-use-asset \u2013 financing lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r419",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r418",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r219",
      "r221",
      "r225",
      "r228",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r225",
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Other intangible assets - gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r211",
      "r212",
      "r435",
      "r465"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r215",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r75",
      "r97",
      "r126",
      "r127",
      "r128",
      "r129",
      "r141",
      "r144",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "(Loss) Income from operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r175",
      "r179",
      "r183",
      "r186",
      "r189",
      "r464",
      "r475",
      "r480",
      "r498"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes and noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "totalLabel": "Income from Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r66",
      "r71",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r136",
      "r142",
      "r143",
      "r388",
      "r474",
      "r476",
      "r478",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Income Per Common Share"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r234",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxCreditsAndAdjustments": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.",
        "label": "Income Tax Credits and Adjustments",
        "verboseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxCreditsAndAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r323",
      "r324",
      "r330",
      "r339",
      "r345",
      "r348",
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "NOTE 12 - INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r132",
      "r133",
      "r174",
      "r321",
      "r340",
      "r347",
      "r499"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for Income Taxes",
        "totalLabel": "Provision (Benefit) for Income Taxes - Net"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r318",
      "r319",
      "r324",
      "r325",
      "r329",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReceivable": {
     "auth_ref": [
      "r35",
      "r485"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.",
        "label": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r93",
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts, medical and management fee receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the assets (liabilities) created through trading commodity-based derivative instruments.",
        "label": "Increase (Decrease) in Commodity Contract Assets and Liabilities",
        "negatedLabel": "Contract assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInCommodityContractAssetsAndLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).",
        "label": "Increase (Decrease) in Intangible Assets, Current",
        "negatedLabel": "Abandoned patents"
       }
      }
     },
     "localname": "IncreaseDecreaseInIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Notes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r138",
      "r139",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Shares included upon conversion of Class C Common to calculate a diluted EPS"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "NOTE 8 - OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r217",
      "r223"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets - net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r67",
      "r172",
      "r402",
      "r405",
      "r479"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "NOTE 5 \u2013 INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.",
        "label": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessPolicy": {
     "auth_ref": [
      "r11",
      "r56",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).",
        "label": "Inventory Work in Process, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryWorkInProcessPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r80",
      "r81"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r202",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Short Term Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Stock issued for costs and expenses"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Components of lease expense"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "NOTE 7 \u2013 OPERATING &amp; FINANCING LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7OperatingFinancingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r112",
      "r181",
      "r203",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r372",
      "r379",
      "r380",
      "r393",
      "r433",
      "r434"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r112",
      "r203",
      "r393",
      "r435",
      "r469",
      "r491"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r112",
      "r203",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r372",
      "r379",
      "r380",
      "r393",
      "r433",
      "r434",
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r20",
      "r21",
      "r112",
      "r203",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r372",
      "r379",
      "r380",
      "r393",
      "r433",
      "r434"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Long-Term Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "NOTE 3 \u2013 ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term debt and capital leases, less current portion",
        "verboseLabel": "Long Term Debt, Notes Payable and Capital Leases less Current Portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Current portion of long-term debt and capital leases",
        "verboseLabel": "Current portion of Long Term Debt, Notes Payable and Capital Leases"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-Term Debt Over Five Years and Thereafter"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt, Notes Payable and Capital Leases"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r46",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r52",
      "r112",
      "r203",
      "r244",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r393",
      "r468",
      "r490"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "NOTE 10 \u2013 CONTROLLING AND NONCONTROLLING INTERESTS"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r52",
      "r76",
      "r368",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r91",
      "r94",
      "r97"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r60",
      "r61",
      "r65",
      "r70",
      "r97",
      "r112",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r132",
      "r133",
      "r141",
      "r175",
      "r179",
      "r183",
      "r186",
      "r189",
      "r203",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r388",
      "r393",
      "r477",
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income - Attributable to FONAR",
        "verboseLabel": "Basic Numerator: Net Income Available to Common Stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r61",
      "r65",
      "r132",
      "r133",
      "r375",
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net Income \u2013 Noncontrolling Interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r289",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r175",
      "r179",
      "r183",
      "r186",
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedLabel": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r416",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liability \u2013 current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r414",
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7OperatingFinancingLeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use-asset \u2013 operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization on right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r419",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r418",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note7-OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r43"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Litigation accruals"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Accrued interest and penalty"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r18",
      "r466",
      "r487"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Costs related to patient fee revenue"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r78",
      "r96",
      "r230"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and (Expenses):"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other intangible assets - net",
        "periodEndLabel": "Balance - End of Year",
        "periodStartLabel": "Balance - End of Year"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventorySupplies": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.",
        "label": "Purchased parts, components and supplies"
       }
      }
     },
     "localname": "OtherInventorySupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5-Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r43",
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncome": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Operating Income"
       }
      }
     },
     "localname": "OtherOperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOwnershipInterestsByNameAxis": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by ownership interests about other units or shares or classes of ownership in a partnership. Excludes limited or general partners' ownership interests.",
        "label": "Other Ownership Interests Name [Axis]"
       }
      }
     },
     "localname": "OtherOwnershipInterestsByNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOwnershipInterestsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the ownership interest, which details special or unusual rights. Does not include limited or general partners' ownership interests."
       }
      }
     },
     "localname": "OtherOwnershipInterestsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expense classified as other.",
        "label": "Other Selling, General and Administrative Expense"
       }
      }
     },
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r43",
      "r241"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromShortTermInvestments": {
     "auth_ref": [
      "r83",
      "r84",
      "r99"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments for (Proceeds from) Short-term Investments",
        "negatedLabel": "Proceeds of Short term investment"
       }
      }
     },
     "localname": "PaymentsForProceedsFromShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Cost of patents"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r85",
      "r363",
      "r364",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class A [Member]"
       }
      }
     },
     "localname": "PreferredClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 11.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r86",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLoans": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from principal payments made on loans related to operating activities.",
        "label": "Proceeds from Loans"
       }
      }
     },
     "localname": "ProceedsFromLoans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r60",
      "r61",
      "r65",
      "r90",
      "r112",
      "r124",
      "r132",
      "r133",
      "r175",
      "r179",
      "r183",
      "r186",
      "r189",
      "r203",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r370",
      "r374",
      "r376",
      "r382",
      "r383",
      "r388",
      "r393",
      "r480"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net Income",
        "verboseLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r235",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "NOTE 6 - PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and Equipment Before Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r233",
      "r435",
      "r481",
      "r492"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment \u2013 net",
        "verboseLabel": "Property and Equipment AfterAccumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r37",
      "r233",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r16",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note6-PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r16",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition adjustments included in property, plant and equipment (PPE) for utilities.",
        "label": "Property and equipment"
       }
      }
     },
     "localname": "PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "NOTE 20 - QUARTERLY FINANCIAL DATA (UNAUDITED)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note20-QuarterlyFinancialData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Class A And B Members' Equity (HDM Acquisition)"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RegulatedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Regulated Operations [Abstract]"
       }
      }
     },
     "localname": "RegulatedOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r300",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "auth_ref": [
      "r21",
      "r408",
      "r421",
      "r424",
      "r425",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.",
        "label": "Related Party Transaction, Description of Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r300",
      "r428",
      "r430",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note10ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r426",
      "r427",
      "r429",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "NOTE 16 \u2013 RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note16RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of borrowings and capital lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r317",
      "r448",
      "r535"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r289",
      "r312",
      "r435",
      "r489",
      "r508",
      "r509"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r133",
      "r204",
      "r309",
      "r310",
      "r311",
      "r337",
      "r338",
      "r386",
      "r505",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r68",
      "r112",
      "r170",
      "r171",
      "r178",
      "r184",
      "r185",
      "r191",
      "r192",
      "r195",
      "r203",
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r393",
      "r480"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Total Revenues - Net",
        "totalLabel": "Total Revenues \u2013 Net",
        "verboseLabel": "Total Revenues \u2013 Net"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r9",
      "r40"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales tax payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r472",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r161",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note19-AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetailsUsd"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Components Of The Benefit Provision For Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "auth_ref": [
      "r197",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.",
        "label": "Receivables - Non Current - net"
       }
      }
     },
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note3AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Long-term debt, notes payable and capital leases"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Components Of Company's Deferred Tax Assets And Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Fair value assets and assumed liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18AcquistionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Reconciliation Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the details pertaining to each employee stock ownership plan.",
        "label": "Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note14-CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r219",
      "r224",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/Note8-OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Other Intagible Assets - Net"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r31",
      "r32",
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note5InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Maturities Of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note11-Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Net assets acquired"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18AcquistionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
      "http://fonar.com/role/Note6-PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/Note6-PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note20-QuarterlyFinancialDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for detailed information about regulatory assets and liabilities, including current and noncurrent assets created when regulatory agencies permit the deferral of costs to the balance sheet that would otherwise be required to appear on the company's income statement and would be charged against current expenses or revenues, as well as current and noncurrent liabilities created when regulatory agencies permit.",
        "label": "NOTE 4 \u2013 CONTRACT ASSETS AND LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note4ContractAssetsAndLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r68",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r182",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Summarized Segment Financial Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule Of Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note18-Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Note18-Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r175",
      "r177",
      "r183",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "NOTE 17 - SEGMENT AND RELATED INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self-funded health insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative, inclusive of compensatory element of stock issuances of $83,277 and $0 for the years ended June 30, 2021 and 2020 respectively"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r19",
      "r470",
      "r471",
      "r486"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r106",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note8-OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r113",
      "r321",
      "r340"
     ],
     "calculation": {
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r110",
      "r112",
      "r136",
      "r137",
      "r140",
      "r142",
      "r144",
      "r153",
      "r154",
      "r155",
      "r203",
      "r244",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r393",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note10-ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r50",
      "r63",
      "r64",
      "r65",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r133",
      "r152",
      "r204",
      "r283",
      "r289",
      "r309",
      "r310",
      "r311",
      "r337",
      "r338",
      "r386",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r505",
      "r506",
      "r507",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r152",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/Note1-DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/Note16RelatedPartyTransactionsDetailsNarrative",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details",
      "http://fonar.com/role/Note20-QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock issued to employees under stock bonus plans, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r283",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Value, Employee Benefit Plan",
        "verboseLabel": "Compensatory element of stock issuances"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Note17-SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r289",
      "r305",
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note15-SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r27",
      "r28",
      "r112",
      "r200",
      "r203",
      "r393",
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r64",
      "r112",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r203",
      "r204",
      "r289",
      "r309",
      "r310",
      "r311",
      "r337",
      "r338",
      "r367",
      "r368",
      "r381",
      "r386",
      "r393",
      "r395",
      "r396",
      "r400",
      "r506",
      "r507",
      "r567"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Total Stockholders\u2019 Equity",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.",
        "label": "Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"
       }
      }
     },
     "localname": "StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note9-CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r401",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r401",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r401",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r401",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r436",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "NOTE 21 \u2013 SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note21SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "State income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note13-OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r291",
      "r292"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost \u2013 11,643 shares of common stock at June 30, 2021 and 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r156",
      "r157",
      "r159",
      "r160",
      "r163",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r117",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note12-IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r135",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Total Denominator for Diluted Earnings Per Share",
        "verboseLabel": "Weighted Average Basic Shares Outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Basic and Diluted Shares Outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r134",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Basic Shares Outstanding",
        "verboseLabel": "Basic Denominator: Weighted Average Shares Outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=d3e1280-108306"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21550-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406127&loc=d3e45031-112735"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918703-209980"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919784-209982"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1),(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r536": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r537": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r538": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r539": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r541": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r542": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r543": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r544": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r545": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r546": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r547": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r548": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r549": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r551": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r552": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r553": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r554": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r555": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r556": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r557": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r558": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r559": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r561": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r562": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r563": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r564": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r565": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r566": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>106
<FILENAME>0000355019-21-000040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-21-000040-xbrl.zip
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MN]CI6OZA[A G(PE%56/[&*E;9A'B*N(#-K7^"0]$4C2-UIV56+TX/7D-SCK
M5_'=_&;'A#!(Z?O5ZREX8\?Z!\^-3^MX7;,ZZG+VNA#^O'/> FC4[OQFU10;
M$I.F$4QUF;/ISM,*X<^?-F3-:FZ1WC!L<&C.R9.#,L9,-=RO"@O A?ATP]T
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M%8[TJG>*./<^,/D6B/Z]J'C.[!OW)3O^-O6;/3Q%&]&&O2ZI-'>&OY/#Q.K
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MHEUW"#U6817X(/VS6J;<R9>E*BC,'O1C$2RW,U_<!_JQ0HV4L :W?6>JD-%
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MI%HPQ2@P8Q4PXP4LL%/,9$4!SA4HP+F$1K('$:L05Y947%EUQ"JXVM)RM95
MK6FU7<->+PP(QA_7 Z.N$P ?V5)Q4Q?MZR1TAA*+1S==N!K'M8F'A>V4Z]LZ
M9Q-_(G!^#(,T1M?:>J ,[N3<[IE)4!/WNCBQ61W'<RI4.,=!N58MCGQICAR/
MXT6L*\61+\.1+[84<W'XA3#P:/6DP)GEP)DEU#ND-+%=KM;+-2U FA*W^NWS
M\1G&9JV+"8[*IUW<!2)"I11M:Y&(49<=0J39E(_'K  ;-.F)C9F& +Q 849B
MP[/*K^,PKC&"<:\0UQHOA&OKC662%](<R N'\6WE<6OI3C;'Z"3<9V)TPPCQ
M+,+1PPBARXRF20S'U@QNX:Z&T8J;<>> +K-0/+/<E=%F!TB>^<2L9CH6V@4.
M3V"=\'^[:T/*LL2CV L$<$ 'Q*#80X19!L*69UD(^6<5C'8!Y\K5@T(P>K6"
MD<2 %[$ECG$OC2+;.NE]LWF=YHISKO#>?Q$=VS\AD"VCZO<BL6 /NS8+W)NW
MT:' O0EQB 7=*^C>"T5'3\&]@NZ]8KJWF#H'RBD4)N+2'F"AZMIZ8-N7,.B
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MZX?UPUDI]@]BW1H8$S,3[?_^ST&]MO]S#*COBSY"UPH(O"54+_T4J8)E [;
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M:,&52DA/V $Q'I9C+R/O%OF48=K] G]TF$]=X3WN;6XT'-+]:X>'NR6#>>$
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M-S<^@SC+:>:*'\%RG\*.,D&*U$!AN_BM9"<5J\$<1 6.<IIP>W.CAOH8J6<
MD[ 7MM!6"%(C2,AQ5V?G:3A4KBL8:&$-0)8IP0+YTRRL %D(/@.@8( =<;R\
M,(:QG@@&I,)PFTG8]*),6.R$% B9<,]UC[8_8"XM[NV>1X9#T/F9^=H3;']E
MXLX@.:Z1D#4^C@*U>(K\,55Y$#'@-%B/1XZN#RA.,<"9',V(^3'P)R\DF?U:
M_35[.1GTI?&$SI&<PB#+_\5' P(-W($$D^SORY$]H./A9"C$ )G?29$\+4Y=
MQ<LEQ1LI9DP6WQ$ELL5]E":AD1@AM"9+*[+.5,5UE$C.XG5A& JN4CNV\27"
M#S3XLFL=+VH6+>NYTN0ETZVFQ+#HL4P+%D?_4/S,B#)%R\680Z6.XH>X9%7-
MA<TRM\(/R6A 3ONK4\HU)%LIF4&TR5=:V7E*!0%.E22:H581CSG>T I;E(]@
MY)K!B9N*.QX#VJ#9#@+';41]PAL$8(R[E)1/AA*<V_(^'J$U"DL9P]A)BA+G
M&Q#CJR31[Y9V]O: 3J#%@^Q+V1(U ;6M_>I/J$)CL#/IGR@(Q!2(YI"A5M;B
M8'2N[U3V0>!%0P2O;,C\HX#H4EP9X#25V]!.A#32ZK.)?A:HR':"UH(U(B;<
MSPSCW".J'(M89KJF4-W=W,BCO'+M*,4%ZQ<Y5ML/0\9*N^72:0)BL88#V$G2
MK[2-(8M%K.@2SXM-A)<43&&]1N+-#0P,\X);FXP=/0%(Z&83R)!)"N1[GZ,.
M,69?H.K/K6MM6*:=8*J]G91E9**W5D&TDPB43FDG,459/C8W2!D<$W5G.#ES
M 7BG$=M=_4$INT^H@DI(W]G^=X[OSIPS)4GM,!S0T^2)[I:M"@ D*-30QT!=
MF-#RQUDI@ AK:9*SDCX(^_P/&3N8^2W1;=?'*XZU?3"F4F _8_)@AKTV&G5;
M&1]A=P?6X2"3EQ?P/$-:>;8(VT'.X@BL)&KYZ*NRWNS4=2 MHE<Y!CH%"[OY
MG<DQV9320":<TQD .>8]NJ)M8[*)UO,E<#8W,/:2G+KD*U->J-B[E_M164]>
MX/6\?T2<,<20#0_7?4'YQR;30&R'&W5/M!U#P?0]$7@M?A>^$X44ZM['?!N"
M,U9 Z8<HK6)4*,;'X>5OV3(6CQ!+10)_%Z*?NW\2XK:RI?'BR ,GBXHH9F+R
M,@?SAM;G4IZFOE\F[W$Y;)<9!,-NX+]"CZ)K,5:0(TV%+.ZER+"E<I%*9/F-
M^7A]S$L1[12.%8X04R$H#9WKJAE5-= 9,.3 MAP.XX/W>W!WZ*]M%E2D_YEX
M/MUN.F73E<PE7]#NQ(9D-FZNT:%-"PO1]:ILS 8S?8HH),/+6.ED0@P'16>#
M8.Q[Z,.6H1>QBKT@JH4NN-)(>I9VH)*,(^.]F580C4=.6.[KRA2X* !"(&A
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MFQM9>1PN=\PU F+#*]<.G33.S(PC5%^Q,*,$#>>-V"B?8_@>FI,"NC=R>!7
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M24JJ(PF6V O-0T^)[Z4]714$GR:JPS0,$),>+C$P1D6<JXNH1KHL+P!-1O'
M8HT!3L=6&@B]M@!6.<V.7R_L^(NRX]<+.WYAQU]A.SY::C(>5=)&$B^Q=)T
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M\45Z]-SPRJ5E4&JJA7J+29,RUVUS V'55\(8=1R*'$[;EU1[.%<F1VB'M@7
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M-27G#]WVY[+R0&0(ALD)9\^T )>>5AKEU3ZE(0/%I,S+2S5<ZW($0U9P6Z]
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MIQ/]<WKWGO\*R7JHI7*SQ'T8,*TR4>3Q(2"I>DES18H':*TS#P>V.T?[Y'8
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MOL]!(!NK/\R*C#9-QK[HYUX/<OULK5UD8IO!3L/.D(I(@G^F;?JK*R*<,!A
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M7ZUU]ZG7:/2'6:\3'>3-53DFZR%K6"6J3E/X+&P=EFQ:).CJND[[<8191C.
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M@:]]L.ENO_@F==T7;%'E]"=A;>&;0HH(GH(H32'D2;!/+C-AD="K$'?C^C(
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MD*Q :WVSLT,/8>5(6&6UQ:\]A2FXN-OI_BSF>"ML[:,81K]HW?739F?+?3'
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ML%0BRI_#FHU-\D72!-,1]X7%Z7&:!;:&:F//'!4V8H.R-ZYMC6A*(YEJ4V6
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M=K81V^9,6AY"*$.63*]2@JS$.M+^M(:WU,W2OI\_QFSF\5.ODGZP+CEP,KZ
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MG'3/I.A'/W7W?9XAA,>^XY'"I)L3_)Q6S@X$G&/PFNYBK$O<MNOS4EVX<D[
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M^XQN +X:CT\(;,ACW>$=H;D[!/@8'?C 7!8'0%41M^(@NW'H=I8@%QZ'$I1
MS^%C>4T,X$,S#YY,\4HC:!7\-G[_ /0]Q_,GHM"C/ T4"W<-/,NT2$'6\L=,
MPQ]1!UKBCQ7%S_#W(1FZ@CL/R,^(*\@(_(LZB/MZG<"-%KI<&3B0@B>80[T
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M%>O5_5O3&EDW,YKQ.8>,;D."'@3U/5\/Z*'Y3<CQ/X/O'!,ER7$L:!*A)9!
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MOIVC@TB#CF#T_'P8>TB"$@7(E[1H@"0:MDQDB[\Q_ ;BO42SKY%U@AV GAZ
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MYYDG] WFQV*4F%S"[ JT23\#1Y,AJ>4R1&8,F7:)3$D&;05D:68IF6OMQ&^
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M@5D0U67RK?ND%*XNJFW9+/S)</>Q9:(JB!"HBV6U42^V8D)"^J#NC;;QVMS
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MA[O,KFE,64WR5_G,2O;;^N:5I1Z^J";*W4 +8,^V*(UTQVD,,1"*CX83>(8
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M9MX#T[7L2,Y_\_A8U![SM];780+:_+8E)?Y&&7FE: \'[CEUSXK":PKSJAP
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M=LW!H]W8U@,$89A#X;L -^A>#P-I#XG &E!E(*(%F0RBRH<P%!4IV%!L3&U
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M_OPKA2ED+WK+C9SCVX]9Y4>D2JD)W=7I*^3G&ZP"#XVA5524DL5J+G/Y^EY
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M!KD]999]-R1U?UN,\,1C1BE[:!&8BG36E0(0GJBBP(4QWH$R[OAT2/HUX0V
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M?Z,%6G9S H&Q@$:(C)"B26[P(#BX74]UILZ1R4+6J7^"YY_%RH!5$;C^8("
M-LA?A\1/NH%9F+..RRRK&>\;4A#<&7+S;UC'QLS6.O<$V=3!*,'*JG"H<#H2
M:1=KFFX]M3.IP;5IN25=&&>H3HP"WX;:9\$$!W79DC2L:7_-E5>(>;T55" )
M'OI\"H9]!$(L3N=HA,[P5\^LS&'R[B_NQIO6*++&)""1T$2S*M4=ZF"Q5HHR
M2I<<3K&#,RQK'/.&D0(+X$T+9(_X&8F?T..JJ&](%B.BN&CW/W'[CMU4@C'$
MM0F*=-09;R>7V+$G%5EX9B\!OYI@8OW#I=T.8RQVJ,PEQVRE(D*5C9XW#1::
M&0 %TRNQ4-.FD.5JE,642.\LZ+  ',.3KFK;KU2:&$/(FC6=0%Q/@<6)H (_
MHP]HX-?,LQW7@95$C>_W540E:KW'A/H=0,5="[:>G]PNQLJZ1T6OM4;;1%</
M0K[Q(AH:6)3DRJ;D<[\YIX47MG/!XN6^:/"><0V&EA6$N$7E.&?<CQ+2>5'2
M?BZP G?DZ%]C^B3^&-]]ZV/)+0OP047]S3T.1!W]93FEP4?N+7TKQ-JFE!LH
M;XGWV* [6W_[A:XH%$9T'3>@,-"1[IDF:&]B-_A-9ENRTUF?7!#UV.V*2]9B
M(8G]+.;7P<+;">[M?&$.[0J@^^$']4*"<7H[@!8;[1X8SA$QKX-?_^]?CG^<
ML55K_8*$.2/L@B-%G7Z$BL#5 QL"'>&9:!=EDBK$E(OP&M>_QL3AKA&4GQ 8
M#C VPMM%BHC:[_R(1Y.1>"(;B:=2/Q?@-M-W4NF_%^8M;'.2HFW]TU6KE@O@
M'V:U"EP1J_M+;IYM+/NWC_?M72JV>Q#\9_9P=C9]MN1DTV-EC:ER6(EC.IPK
M:WYYQ^<+XG !(-;5/B^SUM3L"RW%4+&QYDVJ=^[$O@UV%_ 5*[/^X5PO#RZO
MG[47_B].%W4X.M[D(J7\KUD@QA=GC&P%QA7)_8M@]]<*4VL^HW\=D&R?UI^,
M8),BDDRN2.Q?B/\^(.5*Z?/=R2ZQ+MG%<C;91?=$=KW+TK@C]3]R+>&[D%TL
M9Y-=]#!DETJF(KEL)I!DMX5H7^)CV'!OELO_'\O=_RW-4X<+I XB?"TH6T"V
MZ+YU/X@F;\L/ _EM;;H/(*TO%[&+#[X]=>?2V4@TE5J7MD-'SM<I)7X0>;F,
M4G1#UT3A=L W$\=,*<NEHE^4$HM$P0;,9H-#*_[:M3O>_Z.BOB%58U$SNAJ9
M."=K!)G_:>"_D@[<5?G54*??G"L4#B(_V26XX6Z!G4+=8A,?A7HE/LYGT6OG
MF-G$<H&Z)B1VP#=2D6@L%HG%8L%A'-^/G"H'$;)KDY-0?.11+UD>EV/'3$[+
MI>[^R"D=B<:SD4QB;7LTT')XMT8HF?P=B#C !K[_;VNTDEOQ/&"QA>K'2V?0
M2([%U/IFZU= &A"VL5P*+P/-]GPB$8G',Y%,=K[;V?KTL5^_<4B@AQ+CRPGT
M13;$QXOK8:*$OC.!+I?K_A%H-AN/Q)-K6],'(L^C,K'Q==,E%J#GFF"-_TH=
MC.V0M3E!,3H2VF= *[VQ5F":@]M:ZR[;DN3T=OQA^=D#PB(6)]INRP3BB4@B
MFHDDLBMZ4:Z!L(<5U'\BS:RM2<\):M/LE-Y;V<>G9&%]#_1QTLR\6-T!Q<0C
MR5PJ$D^OG09Q,(IALM-N;#([4]R7\A-_BN7W-J-&0[S:'>1EH01#B172V;Y,
M>SC1D3,S4VK*GBDUG[[=-K./ZN5MM?'1[_G=H,694Y-IF_G*(!DS;J[>6OTM
MYM30\]%Q(:XC<D5%TWT8#WM,A4W^E.&[ 2ZX -X%@)-*(UK%)]!)K 332 ,V
MN6M 3T.KMI1U3X;";?H!4LA-*B39\%^.-3@D@V'8O%25K<_-+ _#RG5Q3(8"
M1\@?!SQ4GTJ8\F4Z,[QGP&08SH#69S^02+JBB?+2+T8 D&^(E-+1P3"LX=M/
MVF?1VZT._WF$S8 IA8MS*/K1D8KY.*F3M,:,B)X&K1KJ&1(GX5VNWW4MV3;+
MT9='22T64_<[F% 6O*YK=Z_9X=4@>OEP/\L@@M)U+1%V73M4U[5$V'5M!?7D
MVF8C;PIQ/E_7XSY2C[_,X9.V:_B0482*G8]T\[GF7Y.KK6II?!T$6VB;J?O'
M5"_=K-R^^M=\;2O_D\^-SO+8>(SQ;^\7^FN_NG-$WZS1&19=P]ZP*M^\#&*)
M;""O99>-SF)M4ZE5DC>=AWX^L_-)EX?N=!9MFS>=3"+[=/MT8>R R02YTUE
M"_[]-[+S E%^H D\L1M7CX&MN SL3]YLFP]/^?.+]]?4^<3O>>R>(; CM9%Z
M1],"/TEO;%R[S@8=+D)[VH>]>F#LF-#,;A:\AK/K8<>R=J8'"?/399*+494Y
M@!8&,(B;=IFO<P'!L&_M+T"03B3\']4#$G$.FJ5/H3GGVMXA-/UP':?2Z?W
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M64#PV>BOE"CO]D1L)-T&HZ$_76NGD]/"\3L!&+\3W<2("<?O!&VL2CA^QY-
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M)1WQ;.#Y1$AD*WHW;4UDV_>VS&9*O10:I>1P;L<>-/@9\ET[U!*2;R#(-Q,
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M*NI!SHSFJCNRS]:!FDJ[]_5,WQMX^_2$9 '0>A\K_0:2GMQY-W9AI.:L3<L
MK<N"6D"GTI@F]QBRE<U#NK58,5,R00$2IB /"2J%.!Z*O>!F[-^0BW8G XFT
M$HR<EQ0:T8(F2"-EO7KQ@O:7V>NLDV_7*O/"CPQ$#3*1 ,+H RJW2+$&_BCI
M,:YA"V[M$J-XV[P]/Y>?TQ?QM]>W(\KZWV'=43:L.SI4W5$VK#M:09S1MJG&
M^;OWQ_K5Y>NV]7\!)D[WF0MMLWMW^W23.]<O4L=TYC7*D#8M1VF5G^6^_#)Y
M&F];TK!/@/A=EA1KFZ8P%(K3 E*FVW9X/-;FK9A%\/FK4I*_[5Y?!K,V:[LF
MGN9Y_3Y[V;IMJ#LHY]E)GU;_:G#VV.OS3[+>;(."SFB@#5XJD!<?&LW[2=*V
M+;E5\YY9<TSYS!XGKRH]A(T?12:6+8R;8T:0U>&G4=3L#C^:QZR%-@W82B*C
MEA#D8D(O+^BB <8J-=E=#2[XOHI83Q2LG4ZM6AS8G/L]J]Y'0"-$BO_ 3'/9
M=ZR#*]Z5M>Z<]7]ZXMC&XK!CJ!JK_%'[O&R5?D2@1$CNBB-R%%'6#)48RD[S
M&F(%$K^ ^QB>CX1U'CO?*T,-N^OF.L/,&T4;^8<\] )A786<AK^B3#L?32V4
M<[T"-5X4OV@S)&@J@E$"+RPCE?29$57;V^)&.+30Y41Z"T/;/-6+5[RJDE%]
M7? _$7>.@;4?!6\+8?"<]7A#HKUKH3J-/CC$)*#QM(]>5^+%H=V!&*HN,'F-
M&!UUIUVKA [;:HH*$S==PRP));CF3[K[R2EL()]&_#70((<L](O+KQSY7F@C
M:\*V,^*ZWFMTM1K2F]3/5<+G'",!"A1J"CE?7A;PTU#()57E5T.=-E1%IX1=
M),LNFQ!O3N[CT<Y+WKR=OBV+*6#CH/E[EYM9-=C=6V>QBTG;Z16I$_0_VY#5
MDHGL"5^O<6Z N]G*/B1&QM7K[04ZZ#7.SUW?T26F?;W$"+C'G=GF$8>;:8R=
M><T=,AV6>9W9%$6! I#R, _?&3$H8LX!8 35@,'1Y@DN5R_4O<K0N5/5V$1:
M5CI+&MPMJ!>=Z5;GN)=)O:WMJ 9?,<0B]9YA-ZZ:*>ZDA6@@MG7^C71QER3J
MFP=?N]T<6]/1R,O=/1O"'RVRZE-2;P0=\92N2+0B4O_*6IEZ@A%6@2=KISHW
MNG[)-&2B2H SVO$J2ZS5%BP%$U_G/?+@=N[JH:+AUR0"TE#=H@U"#FYM%=\8
M%8U$XG<'>"M.5UU;>R:2W](-V"119.,_PQ-^I21-+6;![LZ"#OL#[N786F!?
M+968S_I3KU5H5B?WXMJL=MU%]RL98RLB\;Y)QN).KF5> CZC0:*61H_W%\F]
M7(M?DL[G2XG8!H"G&:!'G@%MP1.T^!>L16'I#'FWV R9Z>X=$5B@\0/HC(%.
M3V[XO@S/<$T$"@5(]>J0Z <1KI&/T*ZLW/V(NVE60?@7E"[/-7D=VI W\N32
M/(_\#S\<_<N51/Q918/O%HG+E#S\ V3_0G8,#709/_[I;>+ <WV#QU89?M9V
M2D1@5H-F\+3Y->T)3!I+=E6L'5@O(/"@2-*,4:JQYXF"P$:.>#NB8&RFC]#6
MEZJH8<E//20DG RS0[!> ;'Q11Z3$&']'CQ.(\RD8S+F*DSYPZRQ0]O!DW:J
M?-?=MWX]QG/4-[>[G@-$HI'DT(H-Q?I$1D)=I1),V+JA@$M>?V&AMODNHF(E
MV\R\=[,'ZQ= -LPY.]ZF1<"ZZ0Q[+_['NH]IGI\G.O%629_-@OEBBC%=W@'8
MMRPD<BKP$^U%"O[+K73Y>#]6ZU+BN];B?[^K3+47&06Z]OY>%J>9^.7K=[U*
MIW)B)<_YA+7X$2SW&]$PYX1?_^]?F85WNYO$&$6E"X): M4Z7-FCE1S551RF
M1LR^)H>;?J5&:R?@ .8> L,!1G0)WCK%5Y4UU;Z\7K#FB-1[0"!MH]8VY7,U
M'3=O;C_*.5];LJ32NV].L5 1XLBIH4TA.S<VD'7./CK8,G#XGTN0C&TW>]0M
M5=;J&A/?6U^5SVV?.=STP[UJN^]JF++6KM(^["V%>!@\/-S.G^S!PA6QTD!T
M^/'=.-Y4V;/OCZZ4%P22Z?+[6]I.W],<"F\GR+>S2-/,.9HFXY<.'1(*S,.H
M/8V,/27*95/AR_Q5OE88#_Q1+IE)\)N+DO^+1[<V"5Q'"+%U)P+W4U3Q6]>+
M!:<A3XA%J['(_?*9AKIGXL?90,3X@A? /"@N?G14*9K-9&!CV7@L[NPL0'PR
M]1F?+$RKX!V0>:F$QDA21A#B)!SSJ7E^W:IU6]78+MLJ+6"3.]<CK1/1Q07G
M7"$!^,A&%V)2R%!#?/H:0\U& \U08RL8:E%2-"24R)!6VZMY<7$9?TF+@_>'
M-__;1NT #NQ4<[Y,>KA ^,,W\(%_NP9RZU)3?$UJ"GL0_FDH].,K$GZ6M?F0
MW(H/AE%Y0_&^#_3]^:EPB*X=_RK+@BOR=7[YRDNYVOG31]RG#J;[#7&5(5]_
M=7#KC^G^]W6:/T0+P'7B$3;.^AX1V[CQ:-C&,D3D+1%YAR&UM0.[@>Y9^<D4
M]4S;'"6SV4YC*DFZ]!WZL:SJG)8+.Z<=JG-:+NR<MH(,DVWS"E6GUXV;Q])]
M_SN0H?MTQ;:9?YRT8CQ?JSX.CJCSU1H]TK8 2ZEM2@/I5A";Z/YY=H1?D,%2
M\[E36J5MWI2;YKE:O7M\R!X18#;IE+;K*B9_B)UL=4;!\'60:A/U#8G7%76:
MUZ"6+"\+UR)M/(-U0G=UDX,Y6>C!L6 4ZIK?:IN#R]CC8SW5*]]NRZ4^*RZS
MMQQ/M,U<0FXE.Q5CVII=]JN]WI)VKS=,F7?-?/&.R[=:Y;L6X5O7U7RA>EV]
M\[9V/+I:NF#NM>KT"()>"!C?2#&D0CHRLZGVKC;;/.FYM;C2D>,[BJ$[D]-Y
M@K6TU9#UNQ^2@\$_P^',*WA*4=%TK2J7/[I(T^H]&(H G:\Q$[#^Z?R1/+MU
M_63),QEIJ]5!19!C^5HL)CQ\7E.9Q/_XA/#A"5@FPI5Y528MP#EK)Q'NWH6K
M]K (_,KQ%U'^RUEFNJ4/6#^S.<[1.=9<*+3-B5[AC0?A<M1(;<R:_W\"<+I#
MH.$RZPPOV%< ??D6@OY;AJB="KZ2JP3SHS%5H\GHE'<)P6^6"OG]+C#E*KQ,
MZ]?%RY&9NDK&O^L%AM5^BU!O05'FW@O<\HR_NG2J\.:.I30QK-/\4IUFQHE3
M,^VR:Z@J$NJR2X>P50CWV,UBOERNFT]I ]N</25Z>]MYZ-YWCJY<TZ5/B>SL
MH$$M-+2^<U7<)P/O]UT0MP8R^CQM+I>,9+*)0);"A:@71-3[6HQX!>HED]E(
M,K%VYL.!JC ]PYLM&6*;HY8UND1B/*+&[:O6N!'KF>"F.=F'H0LA=J1 *!AA
MUN(J$IY#0Y]'K*<SD5PF&Z0,Q0 9!B&J;H^J.Y,MB6@N$D\&'577L53RLC '
MNV56BVN,MR.$J$"JFNFHUC:?].Y#DB]W-:WKCPFS],E=62_@#4:V-QBYO,'K
MV#+?PYGHDZ?P,V5Q?53T5PYET_%()AT6PH5XM5NAD4EE(NGLVCFL![="K!CD
MG5+"H'.9()J+XRLI_K%GWKU>Q0-<:7&--.TW7<0Z%*0!0-/U4+<+O&[GQ4.?
M>7\F$TE%HP%7[$(\/5(\W9DL26/E-YM:,:0B$'BZJ0$RGYRSIDG"A%*B]'9>
M>E5[-[KXO<P04>80@0Q$53N6*/MBH.6/*;!:YA$_0&W5JMK@K<E@UR)QOG*8
M\)Q8,I))Y()5@O7'5\,&",?WCN([DZ:Q5#R23:P=I0QT=>%1I1;[7[Y0E<=(
MACH#)S5W6:5"RI4CO.JUMAGO#,[U1CT^[N^\/G-548)I--ZGT6FC<MG;LB@A
M91<E5&L/Y=I=O1D6(/A2@$"QB/2R%6528B18@S5ABB(9GP5%"9XQ<!U>(F/%
MM &"(@-G$'E81K"D-,DFUR*D&\CZUO4"Y8552ZN7:9OE%^FQ)%W7;\?\YY4!
M*?P/%_7!3PZZ?(/T_OGD_5+;G#;XRO/YC7S]\KHQ"W.!Z5NZR1<GX^>>Z]/G
M>^-2?NA\UUSN[W>!65<R?J_THIV+8DTSPRE(?V9*=YB,?ZPW%R;C!P88GR?C
M9UVZ6QV&G-MJ6\L8C22L-KC3*:N5\_RC&;V.MTWE:E@U;@R]6C^^!/R&H78'
MO&9E6<*L8"W"@86AR/CPM%198^</TZ#WX?FRS)3%..AO'#,62>02D41\;7=M
MF'G_AZ+<[IRHD50R&8DF@C[WR--==-[A]ZBH;U6YH2K@EEXB* RCE<R.;N7'
M[";QQ5D#>KNSPG[/1/EL1'<<"%4AS!/XA#X78YO/I5B9:"2:"U-;0I3U&V5W
M)U*B$').!AQEEXS3FA<M%5$6M0$2SA5%@&CHC*AQY;*X9,T#BM=?QA^/T>=-
M:KP.ELNRW$D;ANB#%J*?(_&5B.JWX9).)R+)6,#R3,*.U7\*)N_0'DHGLY%,
M9F.-*TPK"6Y:"<:@$1;"TX;$RSHD-KT;(IG/]7F:2=JE&GSE,VVS5DPC[2HY
M_ACD?$H[8;\490')"QNPQ6-ML\^GJXV+FMA\W[PW)KTWFHR2YLZX1K/>*#?O
MGDEOO/+M?;4!O6J/.=TAF'NU$.[TA&086^@6X7AH;JGA?TB07<QWN\80&K0B
M 3.[D8KY'6FC2;S(_%#!ZJ=)?D%>7-PR,P(M,,$!K8H:=(/I_3XF0.TKAV4I
M!]@F>V4M%N-B+)/[>J+Y$'U['68_SUM93J[P![8:[:IH+?4MLUG2;?.M^*%G
M7^OQ2G)C1N@0I-V+TH+:M\R-^)Z)#^'M!/EVPN2&,"WE6]Y<F)82&& L2TLY
MLC22DLCW96P'B%W6K6N),O*]X_>6DI?+9M;1I,]51=/:73M7M_WY*X4I#&?*
M?XA:NVV5PSJPMQ^[0<,.4FE8X"].%W4XWA(=NT#F*7'Y=4VWOV8!N_\TA=40
M7>5H9D!K+X79+EI71K+Q-/Y?F$-S6!I<RYIU:# :TJ#/-!C='PU""\]D!-]H
M(&EP"S&_I\XW3:0A7NT.(G0A 8V1I%!<!5P4T%"1-5VEV+E,V'\/V]9A*/D]
M"'7[Z?WRD<#S#DM^LT^T=\XRTI$HEMRI5-B_S4<**NQ!)(<4M%KZ^D9!J4@N
M&HOD@M0!T5][>L?[O^&[ U%&JLNG_Z=(UMP^):L-9_>3(8]8)&57@&H'2CK6
MSW.1:"I G2V_'V5]46?=3N*&E+6V]/W3*"OX)F_%4#$0#14YXK>'+P#_XGNW
MB\AEH_N4OC:8\9,5!M^012P2OLLAM8-!!)%D*AI)I]>ND0AE[]?I*KM/V1O2
MU;JBUU^ZBN>@%&'M8M9 2][]V\#7B-?00)%8.P)Q.%*5,8+[_>Y">!\18_MI
M&\Q5%X!#;K%("J\ U0YJ/>+@+XMDLVN/FPOE\-=):Q^!X)"TOBZ(_26M:"23
M@#2,[VD$;[>W@B%*D&L7B$R\#;+O]L T*ON4Q]9][(5/!*L_P Y$M!=ZV[..
M7"(72<>"WCX@)%<WN9;W*>-#<MU&[/^9Y.J/&1YJ_Y]RAN(F@OP/U]1W-YLY
M%8EG,I'T^J/10@/7=UTU&J+X#OMUI&*11"81B64#%$L)?K35-5IS;>0*U=^E
M'"#AX@ N>)9<X,3_EA#\ ]-'W@75I;3C-+%TY*(Y?J@VWO,)Q>"1S3O(7:Y_
MC5"U.7*S&SO++: Z[ZX ZJ^H320BR7@FDEP__S(T7 - N1G?*9?-D3!JM<S'
M<"K+L4%(N;N@W)UI$(EH)!K-16*IH#=9/1H;=AF<_IP.>U^,?M60_E7K-]_3
MD;HC=]8A>_ZM@HG/G95CD6PJ&HD%;3AJ2%*[J.ZW2.H+UO8?2U([$Z68I!)I
MF":PL3OXNW7/_(.:%+I5/-JH<#WE%;".C-:<(E[5."3#M,W%S0FY":]Q__&V
M=,M%W?P 1A;7>U;?6+RSL=A%6DN1/!KHC.+)&$4F&FNWMPXF+WW:$Z[ZA(0W
M.L9?*UH;+HC;?K+1761CIG/I"%:!YI@!$!Y#:?J?;? .D&,.)\J[P(E8SL:)
M[2*6P<*)6,[&B=G@X!YP(I9,1E+9%;;6]A@1.3U1D39"^,-C)$U_+>@'BC[(
M6%]WC]]X(M4VQT8_FWQ L?1+RN<9T;N2" 20UG'FCO=_SLZXBH@DX3?7X/M8
M%6EAOHOD+OK-9:+<V9FEZ@GBV-H1W?Z9KHQ^<VD0QNP7EHA.$X5SO>:F&QUR
M_>ZA*VQAO/V%:L1<SY%$XF\'J@N[DB22?R_N/@80Y=P@MH#[+P=,X#<^)=\1
MN_]R-4S(] )J"@ ]$W6_]8_U&OQIV1X2BUO,N#<.*HVCT. ;77"Y'17Q;V<=
M$E?ZS8T(2JQWX2,O?F#T'KG6'WE7=)^.0(F<;!6BNNDPUC8O1%6=],<Q[5S\
M%G3H/EZR;=;X#S-[DSJ_(:U[MSD>O;;HW*5%?6B81\]<J=?RS=.38KW9J#?S
M=]5ZC?03;MT76M52-0]3L;< 3KQM9@:)ZN-KKYLPWHX(.+7Z7;EU>G)7YXKU
M6JM^72WE[\HEKE*MY6O%:OZ::]WA7T##Y=:F6)-(OS>?G\4;[35^1("YO*^5
M3T_F=/F-@( Y0[?Z5AKK'Q_5QFS[YJTY@Q\=1Q>=SO]!!Q!90*B.=3FL!<I]
MDNJM+1MMD'+IRJM?;)M/#^GN1;%1DC^V95R?\65G>$&B;?9J']5^H7MSCKH;
M]^RND;$%&>Y__K]L/!;[EX->Z)A]U<ZY_^&'6%E@E(I_OB[G6^76<5C=1^4A
M,%2,4Z<G%=11#5Z=8CX02T>X2K[%B9IF8+,_W[HGOSR+QB,<13[NQYTRPF21
M3<9__N+N!HB3T03O /,17A4X%?P(6-LG$Q 0_J^N</QH)$TYGA,,O"_\@ZKP
MW4&$ZTJ\IN%3X#W@I^';IR>\QB$1QFYR/5'F00=35$ZQT)\]QG5@1"]GC+!-
M!HZ*$3Y&5QQA_5?I<9,!(N_C]V1%)W\G;\$<!=3K648(W@Y;0>!&;.HOUYG"
M\Z<G=.]P.AB^0+>)H4>,P(DH2=BVPHQI*,K(7HZN@3Y&2*9K80M0Z<NBB;]/
MMTM\ELX6.!&8&])T;HB_H CDH/@1#AK)@3)Y)N'OGY[@E_'7%*Q/D[/ NG!,
M^UR_N#R#-:R*[3W%N@,!8 _;P-?"4P7U3.F=&7A_^$2(]J[CV<XE$:O&DJA/
MB?N'QV=DL)[@Z\#W8B_<QQJK3C:#3Q.+<T.,= ,X;A]?/QE[07<GJC.0^T41
MB'R0<[[G?$)1Z=@, N$.@O$9BB&#XQ>VI(E#4>+5TQ-\*(3->8(/?4,4");T
M%J )Q4X;,\%7Y4 ?7C P)B%,7C*\<VE@I(B!4(SE?G&/B!OP^#$DX><!DOA+
MR@B.@5$87Y"LB=2OQB[/QG+=O21O <.UL("A1R /:$/T_@@W0?30@+ +/H,_
M#C_#%! >3HB_@H\J*H*&41]I("6%TQ-19D_))+A,/.84Q3$/@(_IM*3(.1Q!
M%O<)G8-A4Z3[!H8"W3_0&/@%L$%'<%P0R33L$1"!#F_#I=(-G)XX$!^(W0%>
M -^<C%?7R!H,.<E6*((",FIP%!'?"=X^ELP:W@)&YHYBZ!;UPBP=&Y<B[+<S
MM E@%64!?[ZKGY[ )!:&!+Q +X\>!].)C3@#'FA@""@-8!(QB+LZQQA+$2 N
M3XF$ROP+?$<B+VD8(CIPB[&HZ@8!D@C;!KN;<21R+=R8EPP,$?@[/FW/@.KJ
M63S%H)Y2:&!TX5V$B-^:\Z.YFU-XM8(&^PHXK^1$6Q@N]**:'PWC/5KOBV_C
M[F<.KL7?7^75]"I$7_1-I>=3>'[--RS=J:L2<Q3)]HZKB$:9**/4%<(HZ0T1
M=JDQ<O8RBCP5,;HX)&BP'-$F%-=D!7,R+!< 9\'73@G4X5G'H3D<DY9S!SR)
M4;(E4S3"_X$FQSQF.U@0S.D8F)O!PRJ[/1!:>?HR/-1B/$[#/$)P&- /PBK2
M_^9;1<8T?H*B9.FXIR>$E"* 2<:(LFC,15Q:EHU0F)\@&Y.8D(ZXF9*C8&A>
MV>Y%61=B>P6]".K6$/_* $V!U[T\"U9E[&J&2>$= =P\K- 2[8O5GWFMAO,J
M-5BFSVLU=4/%BH$& [6&0U@4\P;@T.11N#5Z1Q*2^_AJ>I@/<7&0)[$H#5S]
MXJHV2U81UE'QNY0V-:RQ]A7\,4MPT64QJ"1\W9'3DXDE'_'W=)"=@'UX=_3[
M:188X^E%]?@N R>0.-O\G>>>QB*:X*4 ;, [@951O8H;(UE05'I-M \T4K6(
MK5X2[1PK6CIY=SEC IF/-2(R'PR#6P+9@7$2P<Z[<P*'@,:]!I7+R]F>C+4+
M%]IXT5 0!>>R;358QWA D)=!G*H"[O=Z"$GX]XHA":#L@1J E:L.WCOZ0&H7
MIIU1),"40-4%7L+:L**JRH3<*>A1A-[BT7^KA2;Y5PS3FZ%1S5<0-4*N3)?"
M"Q 46RI]B:JO:& ;6!3#%"];4U>)%L./>:R)=B1$=%'7F4 5!U#(@!%VE-59
MD#;1\C!\9WE#MC:,%^[R&L9I29D0%6F.<-W4Q6M$O_ &:$4BK'J*!)_X?1Q\
MVN]9<95ZK;G0$7-M:5PW/&9X^+]W<+FVDZ7[]=%QN6(;6;WP-UFQ;=Z4ZO?9
MTMW[353Z?)9<!O_C,^\)?H3R:$N/._)I<E[?H#-/KM(VR]U"ZOF]8^8_I(V=
M4TT/&=OCE=:CY;"6:S?)==]L@%IX.T&^G0V&I-E#L^(;)?SO)+SQC, G!CLJ
MRZ2'24?E_F%[7#@,[D^>,&9+8;HM(A#= &NL9N!_'L JEH1S 6PQE/8RJRT^
M.ZMM5W/GXD&8@_/GS*+*?!+AM/5C"]5*!JKAW=U-8*D;$BY86J !USD[$6H.
M<?S/^M[T7#YW((A$H0%!:NV.G"$%^$(![@IERF31M\'\KY['Y[*B9#*22/Z1
MD\]V)1T3H<FTLP+GP@:B#W3\NXFRBNX3!VHU\L4C^"W<8IEX))8*V\?ZB,"9
M+TBN "/NFEL/E&P*M$#Z8G?T7<FF9$C:OG2&_A)C'Z@(K2+RY#%()SB$O^2>
MC&03F4@N[/[F)Q(7ORJ?@HJ\:V\^E%%!-)I2(4W[TM'Q*SR]HACJ*M).'8%<
M@C/X+98R\50DM7Z_I1"%M[/[U^'L047==?<>"J6 &T[ID+A]T3F_Q-O%\4K5
M,WT,\@F?P6_Y%,^F(K%X@#H*?S\4SG]5/@44==?=>RB? F<TW4%!' ]-WT*Z
MWAE=1S<03:3QWJ=$[EQ7P*64YSC^TGTL'<E!#\MX@":>?C^<KGQ!5AT)+G_I
M&'[C<#R2S66#@\!'9ELU:!T=78@6TUF5/<'J7QUVGI^QX:R2'7:##W!W)79U
M*_I!T[+)!\]-'ZP#_(_%?(84/RTZUZYY"10W_^]?9[-,)1M))7+@9PQ23_>?
M(3DL)8?D:G*P$\.)Q/HB<40X^W6:4GXTU.(]]IYH)P:S3)*!FF/R\_B,2X74
M#\,R,PUO@M8).VPNORPG98FIMURK)]7[,]<=W#[Q2X[G\YRD>"05S48RV;45
M_I P D$87\ES^2X4\MDY?3:,L0D9@Q3CP%.*=Y@"'9[ 1B@LZ^09;9N\E+O,
M/AHO2#G:3I[KMMJ.A:VV#]5J.Q:VVEY!AIFV>?TPDO,= 241_QW(<*9=\*3X
MEKI]O#A_W9;'[+-ELK\MMC'K%6N3E^SC6_JM%3LBL-1\;K$=;YO3?&Z0:R9K
M-Y7$$0%FERVV4VW3N!UE>&E8+=Y].XZ0;)O-SOEC];)YW1K-MNL)2&.JVA<;
M57,_B@IT"320\',E4(ZI#]?!1V\](A#[T.@VCQ4>$*Q--.1I_SK:E^(.J</
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M$Q,'@A=O)*2;D.Z;2#?2VJ/TVRJ/]M3=:N9@E#9V,#"LTG[6MO$K@ES$A>1
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MFNC#3WL+9;:#.X/T+>5:[I..9/ZV1PP54D+'T[C_0LEGR\.V]GN4<9GSK<-
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M_IB06>A[I1;)Z<F%IEH&UU3@F\/8]R'!>.8*I3.TV4.*^4(7&N@-9I \V:E
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M\ZQKRF%L]I  RR*>MB,[%)T IT;A38U7@[?U"$9,9&E67$$C\/;%*_ 81DF
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MBG1D 4Y"8"\4#5 SGK4<N)US94Z1G3ZCLN%YW^G)!W<X#"(/IP!J8P+(0"B
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MF $6F$.C6[8[(YKS@7$[@$A)$__@-$Q1X'IL0#"G>!J<4L3"*\$<E.E/R]8
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M+5$1=; 4;..A(\]*AQO7E:ET7>Q,*Z4"4?6Z55%(-&'B*)LVLV.R5QKV87E
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M9P>FZ1BF0WE%F?</29*+<NX-N1OI'W0%"4B-PXO.,U=8'8&UY-BX-JIK(\V
MXQ^6:"#KLRY6L\FGD<FMXA2/CYON"$;I_P.<XV]:N0J;)MN_*X/CSO4P6WDR
M\%Z IY[/_\^<5OUN;%I.ZL 3U/"='K$@XS++;6W>-@C='=+4 <;T%&/"0E6E
MCS91+*K8&-0+<_WQ,S(&DZFOC15=GR"'.$-*+N @ WYA6K.=(? ZXKV-#!45
M3WD@&+&13OC"$;>P"/5-+$S;<C&#_RIUX)ADMLE%1:J'=;><]HSBBY;:.;7Z
M\%^@=5ZJXZ4-::?]<ZUF5/+E:4]=60.[YC@;;A/;:)X$^L%A-J(@G(."].:?
M8B6S0CG@__4<&+Q-'6 .W?SVYY^Z_8NQY$GQIY6UIH.38G];V_]DU>R!S<]*
MF14=:#:R^< :8T^F<5X)&K  4SA#S5+A_+30!L45,<Z;4,6R">C0P'Y?7(.2
MG)3&7K8RRX;$/4C#6^PQ90JM/LDD0R E3G@"/2B\<Y9^:0("5"'C *]D@<)
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MZW7LV:>-OELW4#Y3>(&B\\74\&=1:M%A<2--C^4K=_(KF]\MI;;EHRAD5EQ
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MRV_@5'MF88\W,9&TN7P#XI$)Z9^%/K6V<0AFR[ETN9R<U,:0T1X(6/,;P*Y
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M-9-6-?#+QCR\4UBC ?K4I;)>_73W^=O/?")B/:(/>IR9=$6?S9<SGV)T3X'
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MJ]'@-'=,"S0]FUHW:&^:(^Y5994N Z^@ANI>UC:F\^CL!P9,AG@*^HA2IF'
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M(]LT#*KS6,LXR%ND0=ZBZ>=PAE^&QVCPI><TTZG%?.RJ]V;;SU5%O<#61G!
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MW<!>W88!^\"HSK+6Y$JYC%[UOC;66*R+<VB3!;DXCEB8FG1I?VC <7HU8?2
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MM3$EC;#M!6AB#1I!G811)U''>ALOJ_-*=CYER"D=CD0:3X+ )J@39^H(HUZ
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M<KFWX>;-"G#_%_FY6](1-]1Z\P_N*(ENL;^Y'TEW,H9I5RVEI_4_DJ8RHIP
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MR'2&DQ .7 J< ^% 7?:, 'X'??V.]EUF!7BILX'W,8TT1:>Y=Y0QER;3CI7
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MG&>#;J6$O=<F0>(VMWO;?UF?^?%KIO?R94<>9+^=]OA=?7<>3UR]MBE!'N"
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MAC*W[:)<[@B&J(B%V%SV/7K"8-H7W;(+T?@BN18L(?GVU#,,DG=3[0M&%_4
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MCK$>)4@JGOEE,G%*6H"JF_!4#2WI1:BA%L7WIJKUU40=(F2HAVC4/-W4:G,
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M_OP9.XBS-)FY3A OYI$YP3Y!MLR2Q2SPN]-H_9,Z^/$4;6"=;9+%]T$AA9[
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MB=9LKJ4#^3_"]>G@V]+NH6EK=_N(H2(6H+C!AB_H3+B]>QG9NTS?;D\[Q_P
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M^F@HML<P1S??'^L.Y)31+"/'#>ZZ(6H4Y;#57_&,6L&YV+&319T$MI8^MHH
MB,&>QQ(*\7R@-VQ4 $GE(.=T,K=1+<BPB8CD6O4K8S I_Q/GR>\K+CHMYD8X
MX0[?[DG=9M39<M&L%YW%[ !)UBS@*I9T?($%2)RARY)TW05R.BLX%G8><-@@
M:][DMN,]_2KW2!(< Q>]#C,XQI8&4K"09KKH]]AZS,U'9)4.VVNOI9)0!V/5
M_>^,.$;;+[T5J#T\Y/Q.X+TX -RJ^["O8W_O%?=(C>V*4E/O:K%BV_=GV5VQ
MOH>P]PU3H?A 4WU$L3&JP(!>D%#?AA2;-]$@:UX_%\[S\<>2OG6YV'=ECEXM
M=XM7^IU]26X4\_Z=I3J5'6AQ= ^29+L\:D?YPGB%#;#$^L%2XR<$F7+4%'2N
M($BZ.[L!?,QTI:UJ=="UI2]'A8!EBD',Z'+P"*)*:I&-%$81(,5T)I)2)M83
MZ1" FC5D#L@'O".^&IOYTM-OW!HA]\@B\-6^SH 9;!*&%%BQZ$9&=FW@;Z#,
M2.?G#=>3X=_U;*QFJ0UN25^^]"M:[\D36SL98:3U)I8[$@@Y>;ZD1!D,+UZX
MM$P5OW]?F7NI-&! I9@8BB<=1G[&4"P8"2C;R245RD4JV9?LZTB^WI0_7'EN
M7'^@=BQ%-5#&.\T^[8WJJ$CMJ& ?;_<Q4;PZ4^@!XW;C$=H)"')5UUZAM/PB
M2N:1PGIE2$E+[T#13->4\Z?.JRB$,[XX"N_NVI=<-IO^N8+).T/;#[8:HW?,
MF^RA&I&6F:);0,>AOIRH< :V9%X^O#)#:7?5//$TS/A\:*GPMCX^GKEXH=7^
M_<O6XOE.13&7\._L5SX[^=$,TQR&5E]7_N1Z HD_TBP$MEIA"1DFO*3^1.R%
M U(46^K51\YSMQ8,0@/BK8<O^%;'[J&0VH,UE OXA-7(;WO:@%1"Z<\(NJP?
MS2QRAAB\E$.SIGK:,1XT*Z(_N'.0[ES?'BW91)2S/IF)6UU_;S(@4?YE\*YT
MB\>($OR4^@^I26&Z[%>:+#V2>MW@!NH(2;T-.28E]G-5/R<FIG"L=X="M5[3
M??+!CJ1N92%+I1D5Q%&4*".'*<_L16QQ? ,3;I2>Z.>.#/#;4CQ+T1KMV.&1
M$/&9+<+CT^<[![J+$%=P-LNZ/^8NEX<<Y-][775)LG;!:SGX ],/VD-E($C!
MQ=>@DS(60+*%WX")!#8Z$P,YB'57B:Y?I=KJB '@HFS\EOSR]H PZ6OO#;IU
M=F0HL[$Y?!X[&ER#( Q6),/XT3+^R*UHD0"$T 63[<P!IHAV*U%VX=54YFJ[
MY*UCW=I7=>IO#:]PBK6)GK[0I<"SI7HMAZ+#B&.*0]8V:9;S=Q>C'IH(IAYN
M/% V'QI@<#G1KA&[^GQ\']$OXJNU^LW'6JD/XU(;!;,*$$0(ONT(/!T@[O+D
MI'X%P=*.&#Z5,C<B0\FKF(\^/2)RH!KW^NV=>M'.;RU+TCX'QR[?I)>E*I_L
MM#GD*]XDX_!ZI9EY*(^2_"JX-WP.7!FK1@@QV5$AC.>("WAHO]+9CVNC>% M
MH.J4HK^AMS@N/+2+K$R7W$#G>(GNJ(^4M*:9^Q6,"U::>\/\LM0$2IZO,_FD
MR2J3%O2M#4R!D7)J "6)I(\A59]@E"T]U]NMF[IK0R!_1SA/053YD]1'KUX"
MTG?F11(<P@,>MCA(T")H,LPW2'XL 0,*:*(D2/%O0B(1;0:YUW*?45+ <-30
MF;<9A4<'OW0K7<M.Y18XR[6-O1KAETY50;3VCW$0ZV,;0\C"K1"6%NRA>D;"
MZ3HE1TK'/]L\.:9\XRQ^=LA<J?U69XO5=G8AGO>CIW.+5<T-.S0=8Q:'ZW[.
M2X!1TE^=Z\-Q"Q/81Q_HMF2+14LR#P7:G,5G@_YP0;HAE3P)'Z4Y#.GFV9C'
MA+6EA(Y(?4@)U-3Q)PHT.'QV.8(^<[/3Y PA_0.>N@M&AVCW(W0KM@9=02[K
MPDH:NY$G)X4* Y4?FRB./(RTR37<$ZC@K/(R>T8K'?X^*HG7ZOJ9D4]8(19P
M%G$-SX\($):BAWPPWDT1OF%B4N,J=\6%.=28LT1Z>DTM2EC=3)ZKT;A+!I-5
MH6+2/96)*%*S&2SDOSCP=)0%M/S4LEHIV]^4]QI2'6_W\S7C&I9P$R8 $BJ0
MI%.0;=Q,E /&$0,\5TT4OL@AF*)Y"];!1DO1:2734=CS=9A]-.W L?IE_;!.
M0T0LDF2#X0!;]X"$.?A5V!83F/^X^O EHXHMXPNV!DE!Y=\UVP?G<ALO/'R0
M(/Z9T\IT]/Y,5B<B&.N#_\PS8;"80D8056XVRT?:,2$.*4IW_&A>1BS#+AF]
MPRZY9F=&'<Y3N3<(+]C<KIBM3FX#>%'.$-5<I1Z9!,=@IHP'X0B^F&+B\O6:
MU:*Y:-(GN-UBW?3^R=V4\+NNB.ZPO5_(6U?7WIX)3'SZ]+5-S-W1G\T.V ,6
M-[*>+=13EH/5:Z&Y*"]?'A/Z.&^J9>V\A4O\I.G_[(/7UJ26I$+?#M(,44<9
M3Q"$_*U^,*'& R743S6@F-_KF234[F(K\E=JH57=Y:AGQ-$<'_S440FVL&_T
MJWG\:%J?\). &01U=W\<]CQB&[K7SIJF0VT[1BIN_RJ_H7%P6[BZD6N*6_0H
M1U3=GA'1HY6Z]TY5;;FF#;A)I BJ+S8Y3F.^XM\.IJS7K-*Q9; [6%(0+ GT
MP28CZV!):^E;>HGX>(Q\8!%9[C83$!G[[%>_8;QQ>T3+=/;L+M<4Y<@L_\;C
MCT;!R]VRGG"F0#)-F E566L\5:4BA;[%\[$-F6,2WYDNLL6N;0.;U-Q?2FU2
MN7+7/6IX::=EYF?.\+'^/*7W?*%][X;!5D6L%YB"K^592B^D@^2*MGR!%AG?
M5J1$)!-9[1PPO+Y1D5Q;;KXQY3VT;LZNT?0XTV9;E%+;BSU8I6L5&&8?IA*S
M5#LA3%5=OP'1O_Z;V,I&C&QC!'AQ%ZFCMK\#(SSG EZ+W;.U)_GQ2[%MA:JW
MOCU-%Z)&;3,,?ONXI*,9&>Z.F\T?M*6-_91>W6?UK'#Y"@YIW;S<#;;,1MO2
MQ?,H,8P')FH+X N#^%K;6*8BE1%"PK<%/(^<.0[NDI-U_'1J<)0K?XTQ>.!^
M5":?P<_'/^/LKBO?=@CN6J:J!L?F,7FQ-)?/* VJW$/F.W ;2B+$>P(I'VEM
M.?2L7*E6*N*=[XQRQS,MC1Y=X="471UJUA(_K8P8Y;13U!G*% G"3VAS>8KJ
M2-#@07XH'F@'1=!\XY&)UO4-=<T9VY;C73(5;N[TX7<^LUN+7?'6T<LHJ/R\
M8_)>)1M1"AGWP8 *$91_>IL[%[6"YF#C%^+]T/E+ZL&1UH7B'I_*&U?NKO,Y
M/W:Z5BXY47>@)7-*RO#YJ>M' F6S8I;?Y^>$!S;>*'K'-QCL&EJ$PWW%'FIO
MUD/WCPLPKAK[0AG23$TA%;?).,;5+HO-1_LF&EM&/3;5^(ZRY'X8?+9:;W+G
M]-3;W,EI5/TR[UQ]\$(%71Q.K*L@P2E;J-V3&NQA <^IR%:7YI+B_EA4WMUG
M4YDJK9QB<J<GMV<L(^^S "[L61"71\%2IVBJ?ABY9FFJ[T3B5837];1Y&Q_A
MK;@  WF3YOJT<2._LW%LKS\9N!Q>K)ID^QQW7!3]]B/] 'F&4D;MHAVF[Z0^
M)(""D5<HD2.-NAOP>)1M<?_VW.>E(Y<?J6<9@P$9B7<&K>O#&Q$70[]:=Z!7
M;L^U1>VOG2MJTESV\K[NWG=IRM'=7@)N$ &Z:5Q&ZZ$<&!CC';1]4,5M *M]
MEV"$9:&Y:$1GS-8NR>8=K\C71#F':W?+;ZRY[']^T2M;.\-C>[;LONVW\.>H
M\ GL-9#P"$,*M>C""*/<24]2)ONWH/93 XK]F'*#>F-ZKVN&CK0[V%FK=>R<
M\(&'[Q<RO81OY3*3!Q]NLCE$ '@3637S!O%YJ(L%"--W%*)V4%TGX4OY%L3;
M)BJUKY$B<QFV(7LNUVV<>_HR[53]GH=%VTQ<OJMW!Q>"?OA1#LHU1AI(*"W8
M#>&-+R8A6JHSU8B(B2>2OC=,7$D7<Z&B)ZV:ZETOQ9&L0]DMA=Z=;SUR=M'%
M-&2ER=Z"QP!>-65B/[I/J4D/6\@EO;)2O*S:N=Q@US RR )N84C^.:EK <N?
M!3J9 A^#-9>?,27I%I_H.D6Z@[IQZGI.*DZ?DF"JF7['C8(6>24V(M9:%3\X
M=B%(AS!4E<0D!"&/!50JH<7)^<P\<!(KOA"!WDU6_"R(:XL*JT3='>.(/$I,
MMO;DJO><ZHA)D_+/<+1[=.5QQ7PFEJCJLA(R8+"K2?8R73@30:A$DDZ7V5*5
MP)9^-D@#U&Y$2B.B(G*Z_\U&;VWYF[8H/]\#^8LK9\:"?BKE(JI*G.X_ZLXL
MFNQ;H\Z"K?-@58\@#&!^D)9_+9^!8>P?:88LC^J"5?H>%%ZR(Z"%&5A'_ OS
M4WJ<WV)YM@N_J[5\A-@!$O6"1SV9UV#I+("J.(CXZ6M!-R^G[0$_Q--,04(Z
MM#^;RD<W$VBG5I=,8;<09)GZQ4H6 ,W(!FUJ#BBR@#N7P'9_?%47@Q=1P\/D
M_9'.=!Y96#?Y&/9[_._Q_RO&A_>CG"":][&9K?[-LAB&G<HSR4/?A1UU1)*@
M( Z:S8V@.%+2,UF #PV95?(3Z[M:%U6 [*^^/!Z"K*;3'/NQ) =E!&DA&.=$
M9@%*91URV'G1<%,8)*#='U.U^88O+T\7]//B?ZK>O.8G.82:>\Q3CA4>IJ(#
MXPYBUHSQ $&R> RN]*534UTID(8/>2BQ4 ;*9[" =X8,] PN[7_'> ZFXFG&
M';Y^N@("!M737W=D_>H#9\VH+.!O5J2Q]==NIYW@F?RY:4P6X)W% K2%(72F
MB\[!Z-4/($3!5+6P@'O_("9V4TR)DW#7*@O@*6&^4V%ZP?\>.DIH>R:9AW^A
MB=)F%_+%=MK)_EHCGGM4)DA8LQWUA; &QP'5X%P+%K!G%D&*QOS%P7^37/%9
M*.;I#"X[E@ZR@*1/H#=44=_&DS=5YXS^=1/4O:EP^H8(>O-O@'^ 5$O8DH7)
MQT5U6/H,4QA:KRW]+0+6Q6C9=-D Q,1+T>\4F5Y_ MT?JG$@%(3I\F5_ZOWK
MXM%?RGJQ@/?Q9#KX1?CO1>CR?(-B)?X3PCL.\>WO;7H)0Y8I7JS^SU8#VUQK
ME; \^Z8K+3<=<Q4R8BGS+VKA_T$K+2=Z[#^N'D;AV+QNN;D2YCNHB&?\Q3&[
M_L$QOK_<":F6L$#XTPM_<4SZSUO_T5X=GBM<T%KAH]Z0%\2%NYC@/-^F:KE0
M)V+4UYCZ#U)BO/9$WXQ1;\$2<J-80,(ELI3M3S6,Z&OAC?RU'C$!&"!,/>!(
M<8*M*FPZ[X^@01#UD*.^B)6_[V. _Z1O'/B/IH0FLJ6XM/3'-B,PM*M_9\F[
ML%NP33/_,XI ML<L5G?13R!K>&!KG']G2P'3O[H8\P\6@*:I^"/VZ.#G/UR,
M7=VTRC/U3>/]Z4TF8I[GC]RSHSAOYMXD"X#0( U<*?Y#RMY**A/Q*\)AFROM
MKTO\5S=LPL<BSR:Z'4E FX*;@-/Y3T'TJ[-U,_'^O&6!!6S>8_4&$H+]%4:(
MZ7^X";9I+N<6& F*LTGF@U]YLD#AP/COISSA<_I+)B&\"\;_C+V_:+9,^ \)
MH2Y(1_]*R^J,7Q'QUT@N0E(/0'?8L8"=_R&\_^*4BL7JL98_8><74/W3VO^Z
MD!:T*>1AZ#('E'6_\."7RG-_XR-_]BVLT7XM@^>;\'^D)K!_52 V&'^!MO\S
M-ZC^@:>9.E A^3M+C8S'E,W@QW8C)G>"WAR=MAVNW_%K2I'/8TTX('-7++X0
MIB?]D_'^ \K' (._>=CO\?_7CI\\NK6$XW[8,9K+=P7ZRWTS-QD'SG.LP'[Q
MC\LS3!%8.@1:+_X2S!LT)M]):+-<1H4P@@LT.0#;HBN<) .CJV,76< 2G&KY
M+%"CD074,<IZ5M#]82:+,9EN8W63NU-']VV,^^4HWI>W(H0-92TQ8P)69)F"
M+])!NAB^B\%MHN:O>/4M"T@V3Q^/19PU>]LKSG;U"*!W5>6&_(%Q3*KA#:YS
M6GQVG<#&N715\M#.QX^N9CP[S-%_H 15O70C1OQ9K&_VS^@3E=D'_'Z<]'#R
M><.]KY68]4YQ*"WA\:.[G:6![+?3C_^H.?4"AH&R%6G[LPI+,\1 >+6T%L/$
M7(Q1)\"H\ KDYPIF7S%$H&@Q2%#E"\SJK,:_^YX;:A/HN<ZQ@-LNZ$$\Q:H1
M,MN3E-(-]F8(U^,JP1X-A%\P3=D=0IZA(Y^ &*")2QQN]N]^MO$(($& D6P0
M/PV0HBQ@U)X*%8B2S@9W%N .^9YSB 5DA9-AC&QD$@O8N!]0P[;\X]_^'"4D
M"R*22]DL0&4K3653&K1I_0CK"/^QN6B:-]C=SNQF 13[8.P:#]D-B&$[(G[B
M?_#H+CXJ4GVKU##KPPF.E.O&0X?G3V=DI?%^5Y_&C"TS^?&DK4R^UHF1'&).
MVIYGX24>JX&->F>Y*/61O&_'+ES+=IA5NOTXBFE(MV440]1A%9YB J<^/&\B
MC-I'JDA$27N&E@;2S63]H].>-[&_2L[<%WK\8.?V.&XE!1%3!!H;L(P;:L%6
M2BW^),*3L:*U?KK!?)'^2IGS3H^B?.\]SMAY0[40>>_KMTNF/-(7*NVY$E?Q
MD*^EH!K2@E9!A=Y8;\,"EW:0RMJJ)<U'@ND-3>BIHXJJ4GMQ)##Q/7A;9/(6
M>!EQ?GG4M0U&.FW[&62*()-QYB6/YIB&@\_"9<><E)UJY?AG]T2(9M\J"[PC
M;8YX;>J](R,I6.J/A]%>8ZN1]*W+)^-=!AM5C2,FMVVWAB4UNBA^U"S'/ V(
MC%-N>K5EW65?>ZRO9JA^+!K*U=8Z*(>Q2R&3%6/K1Q@/47XJ:3]@;/A#X6'/
MYYFJS?>"4#Y58U5'9-JTM+^49!1FO;^H>%(41ZLKB[G" K@=H$01JB,S0UB
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M.KL9Y]FX,*1G&TV5KGV"CQI!,%>X:)NXN+IACK#*LOL0D0[VI+;A5YYSHGM
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M"TH%-_HW>JM"1Q]6'=;GVL$3NRGA'0K8GHO4;_"-A4=%S.ZA;<C?2PMLK-U
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M_]QA&>"4L6"8-<?(>7F22_+KZVS U]_KGG9#YEXG[](>@ZZMFHC8V"1E*V]
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M^H_8L*4N]3E\$ISB/[9\E1+ULUP+H><Q\6EHW0KF63<QI%>QKR;V5(B4BM:
MK%LD8KI4,SK-G@A2GK2)@!9"+:S5$4:&MQ>$$3J:A:BBEIHI#.YO<)??IR[+
M<IG9V=K:LMU[QL%OYW<+.$.*7UK;F"D:$X60;I49UT/S XY-*7M<*N0*71@N
MQUS'MO81JK$K>G1#U@<G@49FH2)5X'%MV7,K'_);5/N$9]-(X+><O=Z!5TZN
MB)YEN2WD>G*Z.+:']I,RF,E(XB-4W0+4GH);49E1=VAMV&_D$([U=E'4.VHV
MHGPJ<7>RCR&(79\ G2  X0'$Z,8O9[KAD@AIX%PXVJ]VA&'FZ7?+ZE''$#1@
M+(:#$J$.TMED/"5P;-F14O31PB]!NBP9I]G#16B?AC?E9T(I[]5.L+M/G,&(
M 9\H*)8 )[,<H]PI6JB BH/#A)ZZ.[HXZ9TO]JUW4"W[[7,_YTAX]-@2,AI/
MN:ZSYV$]<(>Z9<M!]H;#0OP\>9&- 4;SA)?R<1.1!@3PG>&H=A_QRT@2"KV;
MVAV?.B1N);1(FS@JD-JX1^)8A6$T:C\#!::0/KP'7HK'F9)VAR4.Z'ZT[36J
MW;0O6 QF_Y 3%)]JVA/W?,L=^1@+11('_,;Y2/=3:AJ1\1ADT%QL'5F)X\8M
MP\MFOC>Y3O(8'?H8TOV) -Z7@JKJ;U$%2?)=!R*\G<^SV+DG*.+1B6=3)R..
MC_UVV6 ;4HVH9B/C*;YXAJ@+&<<0Q=/T1YN\J2BSX>4-2_4.X05;@\<Q2?8.
M2[IDU<<_=AVZVJ"7D7ZOC7*0IP]SIXQ7'?D;9:4N[H;"ZZJ:FJJJ&JL#?.$A
MGQ1CPM6>1XH*ALB%E L=5&7_"@?4RQ@B9F? >%".Z<XE\.$8YK=),N\VU".\
M3W^Z&KVRWSL4$G1>PS#K0W)IU7ZVD:B+=W[>Q![![,:V9DRS#9<D,TR >?)4
MB-QC,H45YU/Z>Q?7!7/M+]];^S]8NRMDD_&W5(MA'[6BD12OM&5OROUKX:N[
MO*>/-L1'J5!A\=\)_F#\4G>+DI#ODY*:AR9'.%"\63SE%'9:>(@R!=6*C9F6
M;:BCY^9@I%Y;O/X8FM]UW6CFA?"AT;=MB9#(\3O23UO&AYGY@N-0^6PBLM;R
M#;(:N5Q<YFD+/$/#9/V):6*T!196ZZ'WWVD/SS@-.=KR#>H5]#]8H/IOGR']
M]_9QPB'87^Z70?YB#^D]R'^Y7^:<.-]2=\V>>_N_A=**H38V,M6"$D:5+;/\
MA<!&I]J7%ZI'%0YRN*?B4;V1RH_N*R\)S\Z/2<X.2_^4>'J#F.^2R:7/_FS1
M (M0W>7E?4HT,CS?K@=;4\>00-(N,^,1"EY.NX$DZKEV2ZI;)G1B/5S.X,?Y
MACHW4\6741/[Q755+T8&.TFZBZU!.XL H]<T9\K]0C@_X$(>2SYP02];P\"R
M/+NT5)#K9X7MQ=FTGZX#(,B\]6/$!=?7,E.N>*4T*3UDHUOLQQA#Q('%JT),
M ]0DEO&N5,.60:^PB"2G]T^\#-P>"Y=/YX8+=N5(Z;Y6%\@\IEA5*7/]"O&[
MS<YR(*<YZ+FEVQ!/7#2A%ME!B,.P#QGM)VJ*M,KO>3O@LZ]^2'H;<OZ-16C>
MGB"E,UW"^R;V6BM./.]]F+_K.QL3'KI49S13$7[>EBH5WZ]$-6X,^HX\A'IG
MQ3#.8O%*T#VGJPU@'?"4YKT_)KU4HJH]-3YGI>]*T>70UX<$0;+UWW'A2[#
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MC^A4 B-,8R&8\:TG[T #C81J7)&72?",OV+^RC]O;!D*70KK0@/F'VR3;?Q
M'H;@$M.&\W7F3I2=4M69S_LW[S,R-SVA.V^)>AMK'[BQ79;EIN7\&3L7^ [T
M_>,)=',1_+'0$$:L^0MCM;0=@U#=X9%]LB]O;DIUUOVW\]VL /S7C$:38/?#
M&S:S*P.F5*Q9F/!VQS?[L0\#+YTU'"2P!][/O:>HS(AP"(J!=*7SNF.W<JCV
M_*N+_B$-N^\J14XF"*STT+L]/IFU\!]V/\-&$N[XLM6B#J"D.]",&M*D8K6%
MQE(L<H6+V!'5-X'YO39CVDS*#O C[=7\*B>TBU=V#;K'LU%PX!$D1&(\@K9J
ME&'QAYBX["FB)+:A@^7_W/F7B;X8;NJ[=;_68*_6'2GE(YEG56Y:N#XI$![^
MB>JR \P'.PUCK2$4R-=76[+YS@Q,H#Q)9/\\V>V)_D94FU&2$XGZ#,\X@H]%
M,<[9B0/^;D"Q!_$P$>L^OE!AH(2TE\X5=ZGQ9YL5]P\=<1:J!@MBZ7&]9 68
M<HD\XZ3BA.\\2Z%.)]Y9]&CU)6R;"XL@Y%FM%8:;I48*O&,5(-OP*13&323]
M(1,W/=4?Y3!IQ_.LR'\$-)U\CGJN=F.^-8BZ\F.?2OJ(RI^%"#(HB8$$A61^
MEW*>FP4^NZ8F[,=%U*GTNX8I+HQ<@_EMON]Z%V##5@.U =Y-G51, K2)<<6W
M/P2-'/6!(:9*%XG@LC@A_AE9HA<<1P$A?1XP+TH=1H1G\7[(5$--BPHJ4138
ML3<=US]E)^YZ0WW).><+667M_6]B68L0[$,R(?TO8"G,_REMHQ;\BWX@NL#N
MA?^/J$+G9PW=P:^+@OC?!V/Z)NO:+AU"7M0E5%C?.;M*&X@QLX*VSK,%L*[0
MUG;V'L!K$AU7N:ITV(8!Y#O[U_&+!.,#S2KT:RP00KDWVRHW5?)_/.A![[3F
MY<'23Q7&J-A>=?@:<='K,3Y#<K'FOMFV_;/\=J?N:TOR"-\<<Q.74?$PR_ZV
M:LZOM.><K,,@H_C_M?)T?W']?UF_K*17KZWX4;Q#5O06A$ERTHUV:R??6/[
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MK1*T?RC<KWSZ]LO,'5&[[5B:L:)2_XK&TU8$:E#!??MS];L*LCVMQK^&LA2
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MJ(00+D+0>TGM6GVD!,=@[^7$SP^+,PDWA_>DW9LK(5VPD((HZ%<;F[>?40*
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M(K8:P.%"!I,HKP/*G6%;?6_58.5VD&,/I"M*2C<T/NEB?K:Y6GW(>(&'WR
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M70<BG^"VPQ*ZCO8DWJ;4]@#H*51JOMP@3D6H^%5.)^UUI*]M A>1LW]"Z^K
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MX )G?4J/>_JRR]C!L6=;K]5<87V^<NH)?F_=^A:8.L3 ,_\!1$(",]1%A5'
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MA=JMI5A"^UJV"^67C,#\=NL*X<PW)WMX"T(G4C]D/AY^*5IR5V3\J-=IL_[
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M 0%0:Z"K4C]D6 RVH7UTH]I<17!D[16^*]<Y6\[ZQ^'K8.>)RB&? .8OQA&
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M ""\.ZRT8]*S<^M:SCW,P_4/]+Y^^0\'!SOU5'@;]A_T4CWG\ #RU<$N*C"
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MZ&/,!X #Y.J<.C!,5_.M^![R8.Q2H'HQ7D5*61'R!O+QQ^=/\"CX,Q@^$M:
M34+A"U%DZQ:Y'@Q?+4T-)>2ZV/!.XRLQ0\8JOX8:S'+]^=G49^7L%_77Y%+O
M/XO>I3,GJE",Z:_N%]3KN][0,/T6([=V]G=.$(7Z^)]NX.]P'Z9U$XY2_*SP
M?PVU^C^0#?Y/=9GM/V+/DGV8^C\1326Z_F'02*SI^7_Z!@310[,YY[X$Y1O5
M6#RDLX/<% NH7@1#AN$_WP%-QN/^2QA1W8C"3\.2C74!M6?,3X%XG"A0^EZK
MFGYU8+WR[/R[(BJ'7>V=C);:*7NM7,&+5_5ZG][:I[:0Q\O<8XJ_%\S<HU7.
M_/3(UT,-+N/3*@X7ON#'&W!=)[;.DX_S31Q]1HN4'<GIP=L_) _5L7<?IZ6E
MT\4L)\.HUJ3KL!RZ]8= X ;\=XZ(^@]XW9'"#BP\_JN8=4A:C<F=1$8[ UZT
MTT 5C!=QRAU&O?05;48Y&^AY57%8T>7'_;I4FN.8X.VS06HF-\RD8UE T1_U
MQXLFTBW([T7(V.Y[HATP$86(OM,4Y$N"7 "A"Y,:[2_:M&8>6I#Z\.=!]=>%
M;$\.%D5H$DVO$P'B1N0[J]9LNAXM)=*,SJ<'"AN,K?],1U1C=BI0D<'IMJ*;
MO5@0S8DE/BC%3?F(!MPKL;Y)<>NZU5=Z04=@HO9+C4NZ4 S7W,-W^,>SCX+J
MOD&_\DZ<8G*?(F.I1P \9F_Z>[A(JP;=-/8L<V*XV8 \TZ'DWCJ@SFM9_NQ*
MDMRIS)F;%Z7%7CC9W6N@GF"\;H4R)U$LZ_ X&(]NW2A"HS+6N?B0SN$3JH<L
M#N0<82E\),9W@KH_TTNA>S5%^YO\L*LUJ.+[D,JPWX:05;0-Z?9EPD7_K [;
M$##HOOF73@]>@B*?UQHKG\[NV8:(A9Q;Y1T7M078:$: :_>&+06TBYA?Z<]#
MD@F/N$_)AT6>'N@(%'? O<T(\-7CV&2E6]!44>UVS,,(T!0BQ)D#&,%?U7Q+
M*#Y/('#:K7H?0I-2WR*>1NJ\:V?-4URY7BF+*E:W.ZNP!@]^?*J[YX=L#37N
MI-5*74,F<:.AX5%!Y*U$I_&[FZ#7RYK+^)W!HM;#O,$QD78,9(=_\NPLRZ W
M6W;H 6IG!!ZY^!0HX@KXM0_]!B,>X5M&#P<J*8&G&&4*]8.&005 GWW *:M7
MS2WQ8_ALJ\07--FB;.\?]FD'(&FE?LQ1D^#]2B^7B*Z-=9*M1)AB SS^H(/@
M73>=G#5KIO@\DC4%V.]$%S[X5^SZ[\&J[0-+\R__1K-_93A^\2_AK>CWM9JK
MJ!__:;MJ&YO)7!]?_-1GIP59-+$ (+;N^TV)YD":%_FGWNX$U#M %,4+]!_^
MTRK5/1Q-%HEC&E"4Z,+9U!ZR7C+=]2K@0H:?';RC(?-A(6N)D2(XQK6"_A3#
M;SC6<42Z2*X@?DN"%U#%M8&$YK(OS*>6LH+DZ=!*91Y@=@WKH^KNI4.OKAH/
M,9M!\N5 V@@M%E?B'';30>,:I@2LSIW?*@U\/_<#%%'$;ZM+D+^$1=":8W>C
M=I:<UK%_HM(-=%#Z$8T@IX/<(;$N3.D"N27 953<,2X*++9H6#WP0$/+4)1B
MH%')P4T;1+RYQ1.II\IVG7N^,1+ T9:@=\;\_)AQ$XJ,FA;)G>%$:,_G%'"[
MY8HO-\0HDW@^W?SXNOX(]/I0W:L0G:&!U@EZ+2I(F'IO&P)?@\F@".T@>'S:
MAGQ<^/4G/E0$S@H)4'7NH5\MA?^)TS.L 2=08WI *GR$.7"(KD9NZ,9P^TWI
M-3;2%.K*3(.DB]<W(::!812-HI6N^P[QCIJWA 1X[CGBM"..DKJ, CY11;5G
M?WKCE7?6.$' B1-GU&+6-('?YG?=@,FSO',"7@B-R:5'$P-R";C. /A[B9&&
MRI 14N<-:T)?4VZN0T-6]_M)VYR0_9?VA[MPL7"VPW/E'ZS.T84$J<V,9M0E
M=(RQ.J,0X3N#BVW=0VY],.-S^QXW?H.J$%/(&W<[3N%\_-WAK_U?GI;7Z/C8
M3',@3F,.;%A/K%%)P$>*%O4[($X[A."EZ*+;L:+TL^0?K=H4I;A?[GMX_)8Z
MLBR$JJ5K'6N@BA8N^+P+^LNY+J&ZA](SSA<TW&T(.(K9]=)NX^J,YBCF,R[_
M(0,JP&J^/IUQQ)_ "\CV$!<HW-2L8:8>0AYH?^$#8F,G=FRMRZSC7>Q#G0F3
M-PF==RN&-%IFW$H_"B4&_%1_(7S#"<+W=2.0/".U+]-=L#5):=5O/EIQI;)L
M:#9VP%1(Y"\S7+1-O@=]V) NIY131X$.FC=JI[;N<YCD=<0!<LTTEGB C)ZY
MGB(1<GJJSVY85PW*-K6IFG8P6J[1\HI+4>KC^)-O2K-,(CU9:.H=Z4M6^VON
MM!.)+N=R,JIHNHOH7V]MT)I3U@.%Y*5I)SK_W$Q@+ H_FB>)7_:0O&<_795=
MJ96HV:QW94FC]_3&FS,C+X(#TF[''/_T\)R+BVCHQ%OC8\#:C!-=B(VY1Y#&
M"=3CJ.X D;S6#N>Y4V<%MZ% 8XN3*JM<B,9?O.*-B(&^8G%'+ES@;":2HN$:
MY1MB+VW"!:=2'S6Q)X>'C0SDE86;T7L=URRS5[4SM*S'-BW@O>=(%#IO'Q90
MP"W_FDF!H-I=88$H(7\F)\4Q]GE(D\T;8YFOI'7_!'\K/UV:QS;DS=EY$2_)
M=&,W/0=J=>1.,?EV!>,CB&O;D$C$.G8?ZGT%Y3Q2C\S;+8D6[<?GA?7.F P;
MGBC)O1WC$'>5OU'ABL*95&>YJ#XBQY;.AX54GWV'/G*0*PKW.2N7UGI"Z;NF
M?KZ=.F>]F8O27YU8\?X!I0M J4>!4Z&TZPO&.L!-&BO"$> H#=$ZFX8'9J:U
MXG7SCFSQG R1C[ TL)*==<DB2AR]$/KSJT-P&G^GWS:D!%JO]1"I#%A2_2C7
M2\F>I\ES#UL5?:D>R-CBI=RNY$+55QK<PEFRW(KXH@_E3==GV>3#+KY_(5\]
MF*SGJ49T<GEK>IK:L!F?]@-]9!M"/@9---;_R@21K=T3%L [IF0'JZGN@CYP
MG6MKN80PG0')9+EINNF;71Z35>JU+R_43)XZ?')1:-4DX>U=CK!>2DH'&.>0
MSZ*3T?68R%KX ZBPL>H"K$YG:#&?=90N7I1+XSE&_75]Q/R72F2DKY2=>\J3
MF)O\1\<G>HA/ J)8;^8XG'WZ(_G[X%/!%%F/I7?^&-WJ!7*YL+BN6DO U>;*
M\+ 5;#\\HO4@!47G<V-R>=)T0B1M@<#0&8;]>8HP.J;97B&Y@.P68N?NN.KB
M 8J+Z]&@04+F?59;][&3C=^?,3-[LHX'C;]->8C>A3A$\78@_YR+TWEQ)\Y0
MZ4559;'9C941ZNA#SF1\1U-?J-S'0S7E8A.S5A4L5<]XGMZ,'RQV.7\K8R,
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M, ?S#S)RF?M#@MN0,C5DS#*-,,EF^=70;7JSRD63?C;P^B#[(''W05L/\ZF
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M0E\=(-&K2K:)$2'9]L/WP!<R7OP;515?Z7)B,*$&$# Y2N?8A.E#]-,DB8*
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M.]0N5!.3L?!6[8!EG$^+Y(5Z6;\MDE%5!XKCGD(@UF'>;[%Z+5![$UXOON+
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M]/!6WI%GY6_'@^XJ.N:#J!+AR/TD.BR.:D5>;@5\Z-VV %2?) =&Q3=&G W
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M3VS/%X_EP_(Q(/)E"!@_W66VS;G?,E^PM-O?:B@O$\P<G'JN(^R_3#@A5>%
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M:E#I^&\387?4E;9 _?7%_7@:/98*/_\?4$L#!!0    ( ,"63%.CC3I,"R$
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MR_HAE1RA(CF<N)7T\"XQ4!)@5S^,L"WVY+@N&Y!="3U\0PSI'S*BGZ@/[][
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M-BD_F51G2A6AAJ%9G8 4LT75:F== ):(3+^%<8Y"!/3@E/E]6!9<G^0H2L7
M\S!RJZD..Q-<'(68UP\S"Y$#A4_(PX]5XG> UEN<_3-*GB,I!4^TONK[5H(H
MRHE#/SB3@XFQ'X9#D$#RY%\,#*7[M>^%UVCC!R@[0$H9ROY,JA=NA0R>@7,
MQ_'LX&4$ @X9CP-S4Z^II4JU+:D#)D>+U8%G1,NC50T%QUQ&] LD$I>>M(#J
MF.D5.GT]$[FR1*FIGA7/  TWN3UN>:/QH.#K6='J&T%466FY7F4/-R7<EV@4
ME,*JW6 JT&7*3+]I2PQ;8,_/?$<)S:6SN*R>:N]9^["+25*_$3 +_(T384FQ
MT2Z64;WA']-;>7^N#KUV*.;,I./M&HSE#>_&![."ZNU8$%\FJR6[J**XR^-
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M>LCZE&#P3%/M6C%%:\OS7>8>VS,D7CRX7;0&(9UR\$Q3+1HMQPGHA;DM=E-
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M#;,CA@3N4R/NF0(L!&F]] 9#AG@0ETK]I'\BV_Z7@[\Y,V1ZV$'+4+$0>2N
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M5RR:#Q,6<[Q W@CY+=O&WZB32PC,92/7",4B&(4@+R20^!+UTV'\_VGYCYW
M\_$&N4Q GUSL>7"DQUZ[D^BN/]+9N0'-"6KAI*=*APR^ZQ/9>H]H^0GCI4?F
M[I_8_3IP6! +-X0\&D"N?VT S<(.A&@A\<Z7(+H@TW!N/@N/(WM^SQK7""N
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MB#Q/U0)R?*K+#<_Q,-\-6!RV0.@4FZ'8B81R-%[M4[!&6R.\RP@ZU0!#229
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MW@V<?P?N3@B&9&]53MC+T,G"7.%.60 NEF'CB $A/E!S5=[5RP 1<E.X?Q5
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M:7XON$^]/<XI?/T@[N=:>RY3^-+5<5FX^UD_ZT%![F>A44@QBJW%7X'EHJ5
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MW_"YI,R/YY][4Z-S-YWV1G-C.&BU!\/!?,!P9\\RHH>I /0-G?4;RV>1C&&
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MI5LTL]0KS?#1:ELLB5H4=BG,E\!M6W6>#VB*8@DZ*W*&M,F4P<YCX'K^[73
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MD<I(:#/7X5Q<=2US[6#/MQ:#C;FF>BQB%4[2@),<H'+5\3+(LG"EKUKYA)Q
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M*D&]MF#/'T<?!=P:G);W347.O*(T B%?$LXE'4T+H5\YS*.S-2VWCU),#!^
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M?T<?]"_UGV^")QQ_@Z@DX8?4K^\'MFJE[UR#7>$L2L-Y,@WU6-L3?-)VLN(
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M.N;?39ILSV^B%Q*<'LG?HZ<8HUF>X^*TJ=!5%&R3-"^B=0M5GAHIA)VE2EK
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MW14!A+":3S_X$<1'%R'B&O_@6WL*^?.OZV<""DL.)(C%7(=^$<AQ^._+@*"
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MG]6,^L7MY2G>0,AQ9BP .$J,>Q(@."*%)4N+^W<%^*F=5S[%T?HZ3@/Y+,M
MQG'%/![>J%A>)P"( 3PJ68D\)HB8I)?O?Q$DOV3EOEB_KK)TC3'=996WT4HW
M_V:H[98S5BX-V62D"HAG-G@E#.Q,H)Z-LUZ/Y7,RCVX:I]7<TO4O#\\!>8'+
MLLAI#TJ R6?!E4J.EQ<,'!@M,B@T %'/ *9LP8%I(J9ZABIEU-/V-#[+NRJ
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M>I0HFR>623N=EU=#'LS#BT7!L$>-CXLT1.8\2MJ!./DG_DIKF]+9HWV0H1=
MQ+K'11 E.)P'64(O[IRMU^6N9"L$5W@3K2-93F2BZ))NYH[TF:?7 D-"8ZB"
M\T:-( HK22#D>\QPD)?9J[;G$PFZ))<<:)],O)0;\GQ?D2?!6_J-56,V*4)N
MZ%8+HKRZ934HT#K-NR(U[]^?_>XW'U%>7;Y*9\6KGI.)RTO; ^$=/^PP'I_X
M'O"9#?1@S11(\8DG#*Y)1YNAR_I25=+MU@.]',E'?T"(=1LE:4;@+)("DU<I
MZSMY,9>DDH'L4VHL Z87E  ;,XE.6=)]9&D<TR6]J):&.P.U2.I2/:MJA696
M%%GT5!9TG\=C.G1'PZYC&?<;Z YY(>K@.,4R&/X?U1UQ_ 4?97LSRK,D-.[,
M]6J>IOV53DC6 H0ZL+I]0[3:50.6/8(GY7 F<A5DR^RAH/DX2[-7.'N@N;+1
M-*9<V=_LL,XA^82Q3!-,2+6"JYE6/D-$'Z49JBQ4<XB(V$#,"$BN,F3YK"R>
M26;U#QP:O29>R1\W90[(.3G6 ,I%"4PM!RL]U"D"YMVR+/*"1'B2G5B\DX&6
M;^8)7-!1KZ<"FGL\3E/R]32!L*^W!F39/1MI>EJ+L^F8#=3 L-$<JVH1[VWT
MQSU?#3MCI88G)IITPPIQB,PS[("'C(/:^W)^+?*\-&=8(^V574/(2F95HG!9
M-<!GPJ@S5*E I9,^DU.K>"66)H=3R<.EF#Y[$_,,7NY6'RS/-1LU>3&W6Q#$
M((<;#H8R8,@C <9=7%*+G:@BUBHH(IP4UQ@WI01PL=PT57+*(.XN?)\EX564
M5P=B1SX=9LI9?:T#G6W+<$VTXYUZ1P#/[[UBUM &XZ:VQ%E[<*^SB8+6*)M=
M#ANSIZ)UEH;ENG@(8ISS=]&)1=S14 RNH]?P=R"T$8(2W"5'I5!.Q8YYG8GD
M.S]4-4P(4>_I#< 98;7L>TM%G7UW#=CV^TOD8/! #8X[/E#7F*%MGMW1G-%(
MX8L9H_H-YCP1*'IEC=01)8<X+;B,DD&UY5>_]D;DA'>W01)L,;U!LREIHXA)
M"F%G_-(";CDEE83!(QV\,7<Z^=YU\8ZBDQAKS?K;JD3,JJD08T4>E0W/G-*[
MIZ&:W !D!FI1VQ-34U((X#URS3!6,QCV,W^@FC> M<5GA$J\E:<1:FEP!X8&
MEVE>T&'E_.L>)[EV>DDN[G;N4@UZ.&\IEO4>H P!\O.51)R%H4;A5*79Z8/J
M4/F8]D>;HDBKDG97KET+N2O<+A7U3@PS?&)>-/U0D9+.IS?R=\(1T;A![YM8
MRQ-G5"Y(N"-2@<@A!4XMEW+QJ,X;JX:CT6F^CVT 8IS8/0O^#0V\%38*44_E
MIFS& 4C>Q08CU)?EIBT%6:>)DCQ!J>&\')@:.E<93"SNG9CF&/7=+;_NXB0\
MBH>X^@8HT_,4!M5N2$*?6,D[JVR1:KFUD\T_>&289!)EZJN0F@/%1XW35C25
MV'H[[%4[,)W4II-J0'KR>YQC\HF>Z=H\B?MQNJ<^U8-SZ:R14L?ME)L!_.$\
MG$+!.WMM4/([>RJ=:D-$IP6$: ^8G6#]A!.2H<3$L5FXBY*(SA85T0M6,\Y4
MV>F19RN'!D>:C33!D-$*+K^BRI3/T+929^P,!@;.Z(4;<9F3?]:52*A!2L17
MA.,JQI*_5Z5)HCPOJWT_Y$__^H>/9Q]^_WMF\U_?H4V:(1*'T2MI!SG"24BB
MK[B."0G.^1ZOZ=-C* =0QS.IAA.N?N>N3>:L82UY2-!);FD[^G3UD<A2775S
MD^;Y-?D^=+==E)2DG=7COS3)+S!I#K@I&%##;_ZS4N_=ES/_2AICFH51$F2O
MBP+O<G'A <'B,0Q(+AL!A)??;W ^\<!JW #>Q#B05-8091#J8  )(VPT9+AX
M*I%U/G=GLFPJ% 234*G0B2O[UR2B'=&WC>*OH%1,'C4F:=,<2;F-V$*(PR Z
M$(%6^4\,CP\VE13"E1@8AKP04#21KXBL2B($DFZ9(H4Z9 LG!B:\R+'Q=&DD
MZSL/@?"%!3W2TZ;-:D;EB#K Z)2<=U1:![@>2ZH!AEM&,,5]&"B&F2>*UKG@
MP:GIA"?"'/U,?G73!C?6CWNK8Y>ICDJ&)D_,+-UQ]1+EY#EL'JV[ [<^8I?
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M;5^HM4$%L+;*GN'TI%3<2[U#DXE"B:QW1AD"E-?3/'PD(+L!HLP+\HR,!,*
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M;*&G5U19 \+F+O;+3YK3N*_M.G3J?OIU,Z?$7;E:%PR#+0'+Z@2<(:8V+!>
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M)YKF[L?&JG+:*"ST6Y="V-FDMA9P&\>DDMX)801/U@%UE/CA1)SH']=>;AA
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M.*\5!4FGF/HGX/;;*%9J[YBZ_N,D8["YK:@-.<'2VV?VVZ@;.<$O97VH2<:
M$UM>,6J"I7\"8K^)$GYV?AE6/YMN$2[%32JC337WMLE^O*II)_S8@JFA^==U
M7(91LJ5W#GZ)XECT54WTX-RS-PGUT>;&H,]5NOU,>YQ%:?A0!%FA^E1:M.//
M<Q'$;"O\.9HG(5T?ITWO1%OD2&LODR*_#/91$<31/W HVOHDDG*V54T.L=UN
MQHMXG[96XQI_\EH0K3O)$WWPAW13? DRO,Q604&W!OV<107YQW*S$7F@%'=&
M 0/0+1<4LC!(H0?([96I-5":H7VE@[Y42B0\;( DFK/P;V5>T.UFUVEFL,*K
MD'=Z;;T.]N >>IFP=VJ9(A1$'E\W)A^UZW=;+*+J^DGW/*GCEQ6'.$G'?ZS6
MO?Y[&64X5(P<1B50/N=X4\8WT48VCCS,I-,8<03G!V'D 'MP(LWA3G#!J#;9
M[ B-Q?ON!%5R*M.(VH;28'J!=;D9OQG9.]4H.26]D0,#6BLUX!#7!*:JGZ2A
MF2,E$-I=12]1B),P7P6O=-OT75"4F2P"RX1=TDP-N$\OL2086BGA<<4T&F%4
M2Y^A2AX(C1Z*=/W+<QJ'.,OI<:?BE5:N6NSVP;I8;B[3A,3=G+4?\F]ZXH0D
MG/%K]?>"MHH'O"XS5K-AF5Q%<4F"]3S(:"7*?(6SA^= 2DHWCW9Z.L3ARQR<
M*W'P7##-SZ&SW/B\]^A_1]7#$7WZ&:J>3SN,#D']7RT&U .!.A2T $J- S5
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MN/)+\0/=>5Y$=ZA9)I%$"ZA6"UZPN,1K944R[81IR N(*A/.[GB&K*?^]+Q
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M= S0&R5N_V\B<F!@_GV6Q8<@7\U5PLGP;/-'CJ$[^E$\N3U=%-&]$\K^U(P
M'2&T[:D2>0C#! .3GB,?0/>%J%B)FI<G?.'013?WU^FI2AAJ<NYBRE+,%UEE
MZ+'AVY^:$;XCA&Y5]M0L\/5*,Q&&RX2RO1:3REO21WZCW;%^3#.0#_.ZDE_-
MU2K-BFN9W>&]1<>+U@!RA@ /D=J),&8Z>F[8T /F"T&<5$+Y!B\O"<%UAN'9
M<BLG3^M(Y&C' +1>XK70L;?GLH?N/L;UVCIWB1A@,US6/AMEZXV1U]%&K>BQ
M1QL+-2,@1P@]\&A3L?)_M,%<2DK[9DLL%=)U ^=JRPB[O2*V,WD; HR?)Q+/
M=VSS:@!3S%0LDS#?=4KJVBH[R!CA-$1:YW8)@,VT1[.HV'#S-7;L)M7ET:@-
MU$+-"-P10@_<0"M6_C=0E!+_0R/F/H@E>:.@[QXF[,9?4):[Y@\:+>=4VV3W
M<N3\0:?G/]<I1;\$A3RG(A(V'?F^$C#2,T\#;^7:!L83I:T-_A-1=ZU^&5#J
MPNV?;1$HD83ENFLB*L&$D4R@:$+)YE'W88YW9O:T,$4NG+'2O0@9N7L/D]>F
M((1^&_*@J"N"^ RT-JX9FS_3["NZ#8 IG^>J:(3]^MG=GM$.T4O,]G6S)A)(
MI?P@B Y6J"I&\6_]Y[5\*,19G"Z^_L<3;K^G:?@MBN-IE"_B%.MAH$PDD@VV
MCN:,4.LCY2YHAD;41.+?_O&Y6JQD6,9RMCP/,BQ[C=\=B@LY"_)H 7O*-(I+
M^!Q<4[1/%W8C63'"]= 1M.)K-#\T! Q'_(@*XCD1Q)4V7LT7-(*BH#CI1;7;
M:%^ (8K03<L2^9XB=T%=L:C<[OG@ZGPEZ41T/Q4C+ <(V[+<MU]_MA]_^(!8
M:RO8F5$A+[$>YNYM[I!UVIL-(Y@/D;YK]2IN+XE=^Y:;CQ*T0TNP_)(,/Z89
M5DK&)S+C19+/\ D-2VO94RN.XL1(%0X<0+LV50)&L$H<7OGSI]FD$=O1M'<K
MC_\O$DO*!;??VT:BQ[</:4Y!#.>JQIH,S8%CEOR!$7_K6.(=@YF&UMOB0'H&
MMN]!8K<Q'\2'%<(7"2@CF'^SI2[ =C#F?3DRV ../)#>>M&7LZ>O@[J EI=X
M.U?5RC0/$]-2?H;OU_4W&=_+3R#IROI=&,J#@38<+'JKO(MB)(C3I'+E@Q-B
MD8H;*>9!%$[$7U@'?);XNAR[!#V4LO)'<XX:Q;S^EMJP'LB"$=1C)6^ER",^
MDX9;7P_,@2'3!=Z!=4]21A@/E?B 5>P/T4&*O,JD]>%B,!-&*(^7_3AK&5ER
M7LTNS'L3,\)ZN,R'K&F/R Y1ZH\PQ8<N:N3!".?1HA]E22-'QBO:A7=?6D8X
M#Q;Y@.7L$=5!ZAS='_R)1AZ,4!XM^G%6,W#DO)H=>/>E983S8)$/6<U\43U=
M%C([!-HM!D\(7[O<XT .D!=[J,>@^X0 '8&AIIZ(J3>GKXZ'O=.[-"NB_U%*
M9YW]I>>5Y@$<>0%^C(%8U,']^#FA/#OD&]KLP_OUY["YZ+X8&\[HR2I%CTNS
ML;K@]5ITZ!1T7*N,8?6T]6'?E<MHC?![N39P&CH,\Q&<GK1&[#/:QRJ$WZN9
MH9/@/O^/X/2T]6&/13!:'[S:!@,FH8]1.);=D]6,W@;C"/7@84 :1[*IO"DH
MTF8=%4%,9M/L)HYN57&99GCO/(N21;0.8JR1O=\T.6H'C!3I<<;5NE"$7E0N
M#^Q'!S-13\JT%8V^T)&O&51=]8>A--BC4%T*U2=KA?L4%&5&X:6.&>SR^3AJ
M#T].Y08/[#"=J[OKU#_?3@A'G#JGC\*1^_A!-:_;P^'Q=,_G8_GQIL_YEG[<
M+GY,W>M^B7\TU?/YL'O$R7.]^QZWBQ]4\SI?C1]/\[@;%GLF;Z]1>OQ>?C3]
MZV?"'E\%GY)Y>Y'HH"<=UUJ/;[S.N7D^.0WK,90>^K2K1U2QVL2:Z7CBFK.O
MS"I*D &%:KLI&&'=4]!6I)"&AF'Y6I6#!S:7:DR8FN>+1-(HCDC+=K.;J:8=
M96<.9LH(\N.-95<K*LY-O:#$2-O<G5GAMHOE4@ZFA;],Q%.YE*#F(8Q"W07_
MGH%8-O6PMV2$^1X!=X$TS0E 4U612+A @>F92)=.XSC]AEX]O7!IDW$&J4/:
M7HA5]*)BX!^_1H$ DR8(#AE]\@\/9L(3VX&R=R+=X 4+U&1=PH,5EY3%]H'W
MAY<]AB. ^BS9?-(:<H%4O?;0;1*>^'1*VFOO](=1%2:@#D.7CC.'I1DC++JD
MVYW_.BYBZ_CG:_JQ%MA5F839IJ$_'=6X.PDX0=)+SA8X5!I-D6WO8GZK;$_E
M.I,+94_ WV-)YZ0D;+I3V+>S_72,0!LD;GMCJXDGHB*G\T&3@>=TF4ZS:JL!
M(U#L<KF28/JUG*J3_\<TFZ;E3;$LXW[UZ/M1,LB--%+@7;PLQ><GM>%$574^
MP"DA*L2E'<[FCR[A;_!C\R/XWTV02_C)_P%02P,$%     @ P)9,4ZNM#&3T
M7P  @@ & !4   !F;VYR+3(P,C$P-C,P7W!R92YX;6SMO7N3XD:V+_K_C;C?
M@>.YX9@=,=A=U>YV]WC/.<&SFQ@*,%#V]OG'H4()I6DA83VJ"W_ZFYF20(A\
MK!02F6!VQ!Y75V6FUEJ_?*U'KO7?_^=U[39>4! ZOO>O;^Z^>_-- WD+WW:\
MU;^^>9PU6[/.8/!-(XPLS[9<WT/_^L;SO_D___O__7\:^/_^^W\UFXV^@US[
MGXVNOV@.O*7_4V-DK=$_&Y^0AP(K\H.?&K]8;DQ^X_<=%P6-CK_>N"A"^ _)
MA__9>/?=W1NKT6P"QOT%>;8?/$X'NW&?HV@3_O/[[[]^_?J=Y[]87_W@2_C=
MPE_#!IQ%5A2'N]'>O+Y)_R_I_M^NXWWY)_F?)RM$#2PO+_SG:^C\ZQORW?2S
M7]]^YP>K[^_?O+G[_G\>AK/%,UI;3<<C<EN@;[)>9!16O[N/'S]^3_^:-3UJ
M^?H4N-DWWGZ?D;,;&?_5$;3/41(Z_PPI>4-_8444=NEG&MP6Y%_-K%F3_*IY
M=]]\>_?=:VA_DPF?2C#P731%RP;Y+T9O]]6E[UD!0>M[\I?O.SZ>C9A,VN<Y
M0,M_?8-;!'CH^[LW[]^^(0/_[:!1M-W@61DZ9%)]T_B^W$>]T'<=VXJ0W;9<
M(JG9,T)1*"=$TK%.XB96@+SH&47.PG)+4\H<I6*RR1)#:_R9<+P<X.UEC53(
MY?>NG<S2(@8.52,#L\A??'GV71OOL;T_8B?:EJ6?/U*-Y'>L\+GO^E^5EJ!P
M@ J('?D1NFMV4;@(G W9.\?+=APZ'@K#EF</'2P<&XL'_]RQ-DYDN5,4^G&P
M0%(N3A^Y(O;NF[-XO;:"+<;=67G.$D]7+VHM%G[L1?A6,,&R7C@PAE3'JHB%
MM^D7PBE:(.?%>G+1 [+)LMO_ @ORP?*L%9TM^!]CO#*#/D*Y/A .*_Y410+X
M :^)*+ 642L,\0Y/)Y#UY+A.! 0.-$!%Q+X;>"]8,'X I(W5OB)2WC<G@;]!
M 5UG9*?;$,@@1(E[5D3>C^,-N5'CA=-W/'R XQ^&"%^[0&*3=JZ(R ]-.K\'
M'KYOKAPR_>D4@I HZ5H1@1^;Z0Y*CS4(7>P>51TG;^A:\UW<<84GS\C'MX7=
M+[ L4(!"F/P4AZJ*@;OFT/=633SZNHN>(O([?*G<IEM?*CKX1"TS7E6LW#>3
MN]K<>@42R^Q1%3EODP71B0-R=53<P^6]JR+SAR;6Z-=.1"]>!"*?GN[(@]X3
M8"-41>X[?"O9X#'(QRPWNR82BT"PI@HQB&3P*%61_7Z*7'+'Q7I$M)T'EA?B
M\QE_!R9A:>^JR/RQ.4.K]*:3?E-5M+ AJB+X0VN!S^L03!VC?56D?&RY> X1
MU;SO!UT_?HJ6L9O=,$'$@4:H2E-XT_PYQM,)!>XVO5-8;M>*+)!J(.M<%9%W
ML_@I1'_$>#KUR+T1IKAP>YU9RZI#VZI)ZX)^?DX.\DH9.AS1+"42SFTM'SR'
M0@EG46&8&I1+.)W\7K4JFG "(?WK5CKAU *'J%<!A9,+&N"\VA^<^%(#:M $
M%3@J/6HM6J$"X8)^M6N("F0"QSB/@J! M\I -2@+"I1R>YU%<5 @5&&<NI4(
MA6LB; BM[I\NBBS'#4=60 ["%Y!OH=HOG?F6WWP,$9X[0V>)!MYOR K"9DI9
ME3=_^5?.S?8$"QUO2?A./D7X#AGC_RQ\W(%@6(L$5#YX;F'TK,##_PXG*)@]
M6P&J10"RCYR9Z3(K_=2QJU)YF]6HH/2^-L?7M>/A%"; ^:DQ38QS'V_L?6N1
M7L=TR$Y,@EFFEC(KK^9/5V5^:8H,)_B/6*/+ML&V0S6]\)&H'C3,TLXZ*QW!
M=7VS*L-.,V>CR?^LP")TC%J-/LQ?*C!1?M1:V2JS&-5&JLJ^U>19IYKT/Q-K
M2[V2"I"4'+)^ALB&=7"O"'P/_[A(0N:(#W;C>TGT'.W1>]T@+U0YM&O_N'8A
MI9:&N9\T/XMLQ-^LV]!;9BDK#U:O\7?_V]PO1R@:+UMKO.-'SI_49J0 9J4?
MJIGYOA]\M0)[Z/M?, [D;8(=NVB\9+>N0 @G?;!F8>RI2?Y4)=_0L>MEL<QZ
M51RJEE"\,G3#1JC,6=,$.5>:G^WU UH_[<+E%:965=\XKW^JE'GSM*$U^*S
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M([N(LMM#A6^"2BSB^-SFS60"$+L(+U:JT 0J:+U:,).O<\N60!T@BS^A#UM
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MV]QZ%=XP=APR&H,U3S,PXK)K"""3@%SL[=[K!GDARK;] QZ%/@!Y9^U6-Q7
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MCERYHXW;P0@?PD7ZUB08W-QIQGINAC=WFGF@W-QIU^Y.N_D-KLEOL+-6))Y
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M?UM13)ZH%[CTMBD(081P!?4>N>^AP9LE? 1P%2=3YH"J<$Q9O^N-Y02TADB
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M 3ONP+VAL!A@5U+BRZA5M7O\"%<YN3V@@)ED9A)S7],"ZL1AA+\;X&5,XG:
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M0_8X2'8"^4%"AE :0?=% 0"A,D_F:%_"FI2BW9N=S@M<F=*0S?B:2E12%_K
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M9\%'57$8W19.,.REQ',%TV(_U_M8=N01N./%F,_Q!B51^T07IDQ34? GAO)
MND]&\-0H*2)#=NO"Q-[3F9_5D\#ODZ1[X'4O&T;W:5MVW</$8PBT>&(&E$F2
MO8'>WBCAK2A)Y$"3)_IXOF+60IJF<))M4O06(ES+IPT,A/\'[?!7)$)#)@3G
M$.LZ;HQ_>S2ME4]Y_D"Z/36GGO,R$1D"<-$^G9+-!Y+; 0C8>^V 25BN^ IF
MK&L"ECJ67?U5T2-QRQ1[GC0GI(Y/,=FQP/PJ[VJ&Y>^TQ"9LSDSQ7AP3>+1]
M,8//^9W,P P\+X]#S_FLF>+KZ#N>$Z$AWL?L 9:LMW)(U4%:0J2]?;#^XP?4
MV";V?B@-<MF@*K%JB--$0/.>XI&UEJ8T41[(#*Q+S'$XZFS&S?#.D'1WKHL6
M46RYV4,8>4I,?A_=AHN2$_E(K95)Q1"%9N03X]H&1:BU"A L%X"HCV[#0S7P
MR:5B"'R=.(S\-0FL<Q-+Z+.SD>(G[*3;D% -@ "Y&()@+BNR/(4;L[$9!V#9
MRPZ3)4-R<.=HDUU;&$W-P$4PO_A(G"NKVF!MK;">VK<6I.RX.&A=VDMW?#1W
MMK#SJ0EY-V1SZN!S$#.>>-FF3OBEO6TC;_&\M@))L)J\IQG+H^RV)><O=U$U
M"\*,3&ELF[2G&1!")ZD4P2)[9BA8M-)X&M,_0M*,>)SFP,WQ0VW15\!I6#1-
MBIBO[\E(\HQNG;VGV)7")/$'^?H)R9LOK.&1;7\AR'R7/M(X=5QP-(\I,%;$
MMV&'8ACM,VI-T<9R E)X\ 'S'R%21%'@10!UUI\(169D/]I+P2(Q!$2^F@E)
M9P/KK3OV3AU'%:G4]:)XMU7L32^_.M$S><5I>=NY'UEN<9O@;+CEAM(=%J>
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M4!(LC\N:A-HE=BKG*::O.3D2+;31?>PKB9/)7TVR[%%/+&3],UOJ]D,KR57
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M+LW21\)-@V@[#RPOQ,HZ,8.VM_F_B"_]*F/\Q3;T$A+*F7!-F1BR>S^KK1E
MJT]O 7+UGA?DH99CHX'W@N>7'_!3B5+7&J>Q[E=-_%ESX!@4LFK(SMB.0\?#
M6P/-:QDZ5(+";9#;P8RE<.X]CRN.W!PT#=\DA:G4S@'H:@;FDCD,0*S 5FU7
M9=@U3Z%T4&W/",'SAGG]8Q8',BE^?+?L)RA8$+FN4'M[Z-Q)FO"7QPE#:@YO
M.8NS1A+ K@Q 7:%*QW1D*9YYEQ)1#]T&R;-"*Y6&45O )/ 7"-EA'\N,AD1D
ML3#D%ZWETG$=?*D39=*"#J#;B*IC?2M*MZ;5/(F#Q;,5(A(*;7EVO'D(G XB
M7/$BNH0]=,<AG7TU ^17.W+4!:" VU%[W=JA1M0XLJO+NX09Q0IN0!F=^T5]
ME^=PDO72??4].WY .=:$XMR/+#>;0I/ 86:@(2U9#74GMS@[5GQIG6.1]?U@
M5SDHT<D\FS2(79*G:E]*"++TX&/ISCVA=T&JRMR0ZVZFP'?\]9/C63L%/M'E
MQ\M,CG=OWJ17=W9L8]]R@E\L-Q9$?=;P*=UY+W1<H6M#S(@P]+OFT/=634SB
MNHN>(O*[+/$F65!)SJ\APKMJ"&[8%&;A^, .5K_#/PW'HT_->6_ZT.CVVO-_
MT+_,&I/6;RU:IGG4W57$&?9:,_PG2M(<D]0@-.$.A*I&2E8#T]5("6LDE.%O
M&)&K(Z%&'L=>;*<U#RV6\,##E,2 2CK,QF:8I=FR+R:A9=%O2E3W(7%'^Y<,
MC:%ID=2"F26$96A>]#+9D+(M<HZ_)G;:L5M?&BAL+@P)*"X2)_.N\=J; 8IH
M>DE0J3ES/#YXTV/W3IPRGM%0MW5>/$<.<L9SV:Q)S<Q]\!XJUWM3XC%*R?7^
MW')]"Y7K6T6YUJ9XEY+K6R/C7 Y/F4Q5FEH1ZL8!5IYDZ3RA_36[=B4W-N$M
M1R:4NE9(FCV6$&*Y+J&$MT18+77OZ4")<^DW>)7T _1'C+S%=KQ,9H*S2!.V
M0M>): 3=7M)3EHI<,D8"6A+%LM#5YA<]!;J:\.)L;@^DI@S)S(/W5,ZN=MA$
M]U5*83MC\5:3&-N^_X6:-,?+=HS)9]>X($V9+75[%!6$*N#4D"V%7 KGZ:6P
M$P>!<"-A-M;M-%3;/@3\&H)(P8*":07;2VE;W6K&*=MYGEM#X,B'0A%FB!,H
M0+8C6":"+KH]86K@2'DW!*/\HBYXE<9/KK.BX@V5MC? ,$ L/YJ!92D9Y?#=
M9#54AXG<N#Q0!EY0\.2'B+:]A+EQZJ10T%PO:3K4- ^,\E<?^J#3:S"IZ;<\
MZ#+&K+S[#5F!Q$_]L:R?^EMKO?FIZ*EN-O8$-<;+@N>Z08AJO&M0LFY.ZKHW
MB2G:)&HFGAN3P/$6SL9R!]X(S\;Y5^2^H ??BYY/WDO G]%LG01YQ&N1[%_F
M6-HO?HZ$R,J??_5/G7+P[^@VT%8XZ52%>YMU!X+!A DB>:K_DFX+\]EG7E[
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M;=+K=IK!*_].@/=[X?N!']CV6V+6'<\_]Z:-SN-TVAO-&\-!JST8#N8#^IB
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M83J@GH/DS$AMR4(90SMKT_L!0E<3@"'Z'.=LSSGYQ\O<[Y4O8/R!=!M+N;>
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M]T!.<_ &:, .*.2XKL663(7]5R7KB-L<*NCJ<SJIKA$)QX9,?Y&%9T^[X$X
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M87)?,3 M:RYH=&U02P$"% ,4    " # EDQ302"G-KX!  "0"@  %
M        @ $/SP( 9F]N87)?97AH:6)I="TR,2YH=&U02P$"% ,4    " #
MEDQ3TA;.L#\"  "&#   %               @ '_T ( 9F]N87)?97AH:6)I
M="TR,RYH=&U02P$"% ,4    " # EDQ3*!%/SH &   =,@  %
M    @ %PTP( 9F]N87)?97AH:6)I="TS,2YH=&U02P$"% ,4    " # EDQ3
M-O D%@$$  #@'0  %               @ $BV@( 9F]N87)?97AH:6)I="TS
M,BYH=&U02P$"% ,4    " # EDQ3?#^]G8T_ 0#HJ0$ %0
M@ %5W@( 9F]N87)?<W1O8VLM9W)A<&@N:G!G4$L! A0#%     @ P)9,4[I;
MT81;&@  !!P! !$              ( !%1X$ &9O;G(M,C R,3 V,S N>'-D
M4$L! A0#%     @ P)9,4Z.-.DP+(0  JI\! !4              ( !GS@$
M &9O;G(M,C R,3 V,S!?8V%L+GAM;%!+ 0(4 Q0    ( ,"63%/&]1#/_D0
M &X9!  5              "  =U9! !F;VYR+3(P,C$P-C,P7V1E9BYX;6Q0
M2P$"% ,4    " # EDQ3_9@G1MN&  #,/0< %0              @ $.GP0
M9F]N<BTR,#(Q,#8S,%]L86(N>&UL4$L! A0#%     @ P)9,4ZNM#&3T7P
M@@ & !4              ( !'"8% &9O;G(M,C R,3 V,S!?<')E+GAM;%!+
4!08     #  ,  X#  !#A@4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
